0001144204-11-046535.txt : 20110815 0001144204-11-046535.hdr.sgml : 20110815 20110815093155 ACCESSION NUMBER: 0001144204-11-046535 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20110630 FILED AS OF DATE: 20110815 DATE AS OF CHANGE: 20110815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLAR ENERTECH CORP CENTRAL INDEX KEY: 0001307873 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 980434357 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51717 FILM NUMBER: 111033450 BUSINESS ADDRESS: STREET 1: 655 WEST EVELYN AVE., STREET 2: SUITE 2 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 BUSINESS PHONE: 650-688-5800 MAIL ADDRESS: STREET 1: 655 WEST EVELYN AVE., STREET 2: SUITE 2 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 FORMER COMPANY: FORMER CONFORMED NAME: SAFER RESIDENCE CORP DATE OF NAME CHANGE: 20041104 10-Q 1 v231343_10q.htm FORM 10-Q Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the quarterly period ended June 30, 2011
   
 
OR
   
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the transition period from ________________ to _________________
  
Commission File Number 333-120926
 
SOLAR ENERTECH CORP.
(Exact name of registrant as specified in its charter)

Delaware
 
98-0434357
State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization
 
Identification No.)

655 West Evelyn Avenue, Suite #2
Mountain View, CA 94041
(Address of principal executive offices) (Zip Code)
  
Registrant’s telephone number, including area code (650) 688-5800
  
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes     x     No    ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  
Yes    x    No     ¨
  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 
Large accelerated filer
¨
 
Accelerated Filer     ¨
 
           
 
Non-accelerated filer
¨
 
Smaller reporting company      x
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes     ¨        No    x
      
Number of shares outstanding of registrant’s class of common stock as of August 8, 2011: 181,670,962
 
 
 

 
 
SOLAR ENERTECH CORP

FORM 10-Q

INDEX
  
   
PAGE
 
Part I. Financial Information
 
Item 1.
Financial Statements
 
 
Consolidated Balance Sheets – June 30, 2011 (Unaudited) and September 30, 2010
3
 
Unaudited Consolidated Statements of Operations – Three and Nine Months Ended June 30, 2011 and 2010
4
 
Unaudited Consolidated Statements of Cash Flows – Nine Months Ended June 30, 2011 and 2010
5
 
Notes to Unaudited Consolidated Financial Statements
6
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
29
Item 3.
Quantitative and Qualitative Disclosures about Market Risks
40
Item 4.
Controls and Procedures
40
 
Part II. Other Information
 
Item 1.
Legal Proceedings
42
Item 1A.
Risk Factors
42
Item 2.
Unregistered Sale of Equity Securities and Use of Proceeds
43
Item 3.
Defaults upon Senior Securities
43
Item 4.
Removed and Reserved
43
Item 5.
Other Information
43
Item 6.
Exhibits
44
Signatures
45
 
 
2

 
 
PART I
 
ITEM 1. FINANCIAL STATEMENTS
Solar EnerTech Corp.
Consolidated Balance Sheets

   
June 30, 2011
   
September 30, 2010
 
   
(Unaudited)
       
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 2,250,000     $ 6,578,000  
Accounts receivable, net of allowance for doubtful accounts of $443,000 and $42,000 at June 30, 2011 and September 30, 2010, respectively
    10,094,000       6,546,000  
Advance payments and other
    510,000       1,274,000  
Inventories, net
    3,166,000       4,083,000  
VAT receivable
    249,000       870,000  
Other receivable
    252,000       690,000  
Total current assets
    16,521,000       20,041,000  
Property and equipment, net
    8,999,000       8,874,000  
Other assets
    749,000       735,000  
Deposits
    80,000       102,000  
Total assets
  $ 26,349,000     $ 29,752,000  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Accounts payable
  $ 9,898,000     $ 7,895,000  
Customer advance payment
    353,000       2,032,000  
Accrued expenses
    2,670,000       2,596,000  
Accounts payable and accrued liabilities, related parties
    -       5,817,000  
Short-term loans
    1,008,000       1,312,000  
Convertible notes, net of discount
    1,443,000       -  
Derivative liabilities
    133,000       -  
Warrant liabilities
    49,000       -  
Total current liabilities
    15,554,000       19,652,000  
Convertible notes, net of discount
    -       1,531,000  
Derivative liabilities
    -       422,000  
Warrant liabilities
    -       902,000  
Total liabilities
    15,554,000       22,507,000  
                 
STOCKHOLDERS' EQUITY:
               
Common stock - 400,000,000 shares authorized at $0.001 par value, 172,710,388 and 170,338,954 shares issued and outstanding at June 30, 2011 and September 30, 2010, respectively
    172,000       170,000  
Additional paid in capital
    99,874,000       97,656,000  
Other comprehensive income
    3,555,000       2,755,000  
Accumulated deficit
    (92,806,000 )     (93,336,000 )
Total stockholders' equity
    10,795,000       7,245,000  
Total liabilities and stockholders' equity
  $ 26,349,000     $ 29,752,000  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
3

 
 
Solar EnerTech Corp.
Consolidated Statements of Operations
(Unaudited)

   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
                         
Sales
  $ 12,203,000     $ 16,355,000     $ 38,390,000     $ 51,799,000  
Cost of sales
    (12,762,000 )     (15,051,000 )     (38,080,000 )     (47,637,000 )
     Gross profit (loss)
    (559,000 )     1,304,000       310,000       4,162,000  
                                 
Operating expenses:
                               
Selling, general and administrative
    1,394,000       2,475,000       5,799,000       7,243,000  
Research and development
    63,000       54,000       216,000       287,000  
Loss (gain) on debt extinguishment
    (23,000 )     -       (55,000 )     18,549,000  
Reversal of payroll related tax accrual
    -       -       (5,817,000 )     -  
   Total operating (income) expenses
    1,434,000       2,529,000       143,000       26,079,000  
                                 
   Operating income (loss)
    (1,993,000 )     (1,225,000 )     167,000       (21,917,000 )
                                 
Other income (expense):
                               
Interest income
    -       1,000       4,000       5,000  
Interest expense
    (67,000 )     (59,000 )     (247,000 )     (5,383,000 )
Gain on change in fair market value of compound embedded derivative
    181,000       717,000       263,000       1,115,000  
Gain on change in fair market value of warrant liability
    628,000       1,393,000       853,000       4,369,000  
Impairment loss on investment
    -       (1,000,000 )     -       (1,000,000 )
Other expense
    (60,000 )     (485,000 )     (510,000 )     (929,000 )
   Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
                                 
                                 
Net income (loss) per share - basic
  $ (0.01 )   $ (0.004 )   $ 0.003     $ (0.18 )
Net income (loss) per share - diluted
  $ (0.01 )   $ (0.004 )   $ 0.002     $ (0.18 )
                                 
Weighted average shares outstanding - basic
    161,543,403       156,502,573       160,990,033       128,327,753  
Weighted average shares outstanding - diluted
    161,543,403       156,502,573       170,925,106       128,327,753  

The accompanying notes are an integral part of these consolidated financial statements.
 
 
4

 
 
Solar EnerTech Corp.
Consolidated Statements of Cash Flows
(Unaudited)
 
   
Nine Months Ended June 30,
 
   
2011
   
2010
 
Cash flows from operating activities:
           
Net income (loss)
  $ 530,000     $ (23,740,000 )
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
               
Depreciation of property and equipment
    1,901,000       1,842,000  
Loss (gain) on disposal of property and equipment
    (5,000 )     51,000  
Stock-based compensation
    2,013,000       2,221,000  
Accounts payable and accrued liabilities, related parties
    (5,817,000 )     127,000  
Amortization of other assets
    12,000       -  
Loss (gain) on debt extinguishment
    (55,000 )     18,549,000  
Impairment loss on investment
    -       1,000,000  
Payment of interest by issuance of shares
    54,000       210,000  
Amortization of note discount and deferred financing cost
    94,000       5,146,000  
Gain on change in fair market value of compound embedded derivative
    (263,000 )     (1,115,000 )
Gain on change in fair market value of warrant liability
    (853,000 )     (4,369,000 )
Changes in operating assets and liabilities:
               
Accounts receivable, net
    (3,301,000 )     (6,075,000 )
Advance payments and other
    816,000       441,000  
Inventories, net
    1,078,000       (962,000 )
VAT receivable
    650,000       (84,000 )
Other receivable
    448,000       236,000  
Accounts payable, accrued liabilities and customer advance payment
    38,000       7,175,000  
Net cash provided by (used in) operating activities
    (2,660,000 )     653,000  
                 
Cash flows from investing activities:
               
Acquisition of property and equipment
    (1,750,000 )     (463,000 )
Proceeds from sales of property and equipment
    38,000       9,000  
Net cash used in investing activities
    (1,712,000 )     (454,000 )
                 
Cash flows from financing activities:
               
Borrowing under short-term loans
    4,864,000       1,141,000  
Short-term loans repayment
    (5,207,000 )     (412,000 )
Net cash provided by (used in) financing activities
    (343,000 )     729,000  
                 
Effect of exchange rate on cash and cash equivalents
    387,000       15,000  
Net increase (decrease) in cash and cash equivalents
    (4,328,000 )     943,000  
Cash and cash equivalents, beginning of period
    6,578,000       1,719,000  
Cash and cash equivalents, end of period
  $ 2,250,000     $ 2,662,000  
                 
Cash paid:
               
Interest
  $ 78,000     $ -  
Supplemental disclosure of non-cash activities:
               
Extinguishment of convertible notes by issuance of common stock
  $ (200,000 )   $ (5,729,000 )
Extinguishment of convertible notes by issuance of Series B-1 Note
    -       (1,815,000 )
Issuance of Series B-1 Note
    -       1,535,000  
Acquisition of other assets
    -       732,000  

The accompanying notes are an integral part of these consolidated financial statements
   
 
5

 
 
SOLAR ENERTECH CORP.
Notes to Consolidated Financial Statements
June 30, 2011 (Unaudited)
 
NOTE 1 — ORGANIZATION AND NATURE OF OPERATIONS

Solar EnerTech Corp. was originally incorporated under the laws of the State of Nevada on July 7, 2004 as Safer Residence Corporation and was reincorporated to the State of Delaware on August 13, 2008 (“Solar EnerTech” or the “Company”).  The Company engaged in a variety of businesses until March 2006, when the Company began its current operations as a photovoltaic (“PV”) solar energy cell (“PV Cell”) manufacturer. The Company’s management decided that, to facilitate a change in business that was focused on the PV Cell industry, it was appropriate to change the Company’s name. A plan of merger between Safer Residence Corporation and Solar EnerTech Corp., a wholly-owned inactive subsidiary of Safer Residence Corporation, was approved on March 27, 2006, under which the Company was to be renamed “Solar EnerTech Corp.” On April 7, 2006, the Company changed its name to Solar EnerTech Corp.  On August 13, 2008, the Company reincorporated to the State of Delaware.

The Company conducts a substantial part of its operations under a wholly-owned subsidiary in Shanghai, China named Solar EnerTech (Shanghai) Co., Ltd.

On April 27, 2009, the Company entered into a Joint Venture Agreement with Jiangsu Shunda Semiconductor Development Co., Ltd. to form a joint venture in the United States by forming a new company, to be known as Shunda-SolarE Technologies, Inc., in order to jointly pursue opportunities in the United States solar market. The Agreement was valid for 18 months and expired on October 27, 2010. After its formation, the joint venture company’s name was later changed to SET-Solar Corp. Since the agreement expired on October 27, 2010, SET-Solar Corp. became an independent company and transactions with SET-Solar Corp after that date are not considered as related party transactions.

On January 15, 2010, the Company incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement its existing production facilities to meet increased sales demands.

On February 8, 2010, the Company acquired land use rights of a 68,025 square meter parcel of land located in Yizheng, Jiangsu Province of China, which will be used to house the Company’s second manufacturing facility.

NOTE 2 — LIQUIDITY AND GOING CONCERN

The Company has incurred significant net losses during each period from inception through June 30, 2011 and has an accumulated deficit of approximately $92.8 million at June 30, 2011. The conditions described raise substantial doubt about the Company’s ability to continue as a going concern. The independent auditor’s report on the Company’s most recent annual report on Form 10-K for the year ended September 30, 2010 also contained an explanatory paragraph stating that the Company’s recurring net losses and negative cash flows from operations raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s consolidated financial statements have been prepared on the assumption that it will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

During fiscal year 2010, significant steps were taken to reach positive gross margins including securing sales contracts from recurring customers and establishing new customer relationships, which had improved operating cash inflows. In addition, the Company engaged in various cost cutting programs and renegotiated most of the contacts to reduce operating expenses. Due to the above efforts taken, the Company has been generating positive gross margins throughout all quarters in fiscal year 2010 and first quarter of fiscal year 2011. However, since the second quarter of fiscal year 2011, the gross margin has been negative, mainly because of the devaluation of Euro dollar against RMB natively affecting the Company’s return, usually 45-60 days after the cargo was shipped, and decrease in average selling price of solar modules from $1.91 per watt in the first quarter of fiscal year 2011 to $1.58 per watt in the third quarter of fiscal year 2011, coupled with a decline in sales volume from 8 MW in the first quarter of fiscal year 2011 to 7.7 MW in the third quarter of fiscal year 2011 because of a down-turn of European markets, which forms more than half of the Company’s revenue. Europe has been playing a large role in creating demand growth in the global PV market through its feed-in tariff (FIT) programs. However, since the beginning of the fiscal year 2011European markets has been slowing down significantly due to the waning economy with its failed expensive aid packages to Greece, Portugal, and Ireland. As a result, even Germany, the long-term and strongest proactive player in the PV industry, has cancelled its mid-year tariff reduction, leaving module shipments well in excess of demand as well as low sales orders. In addition, the Company’s lower production volume resulting in higher fixed production cost per unit and lower gross margin.

 
6

 
 
On March 19, 2010, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby the Company issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.  On May 11, 2011, the Company executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of the Company’s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, the Company’s liquidity and financial position raises substantial doubt about the Company’s ability to continue as a going concern.

As discussed in “Note 17 - Commitments and Contingencies”, (i) Pursuant to a joint research and development laboratory agreement with Shanghai University and as of June 30, 2011, the Company has a commitment to fund Shanghai University’s prescribed research and development activities for approximately $3.2 million to be funded in full by December 15, 2014.  If the Company fails to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If the Company is unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, the Company is not in breach as it has not received any additional compensation requests for pre-approved funding payments from Shanghai University. (ii) On August 21, 2008, the Company acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash. The Company may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million shares as the product shipment has not occurred. (iii) The paid-in capital of Solar EnerTech (Shanghai) Co., Ltd as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be funded by June 2011. As of June 30, 2010, the Company has not funded the outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase the remaining balance recently. In order to meet the registered capital requirement, the Company is in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. The Company has not received the approval from Shanghai Government as of the date of the Company's Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to the Company in September 2011. (iv) The Company’s subsidiary in Yizheng Jiangsu Province was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.  In order to fund the registered capital requirement, the Company will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. (v) On February 8, 2010, the Company acquired land use rights of a parcel of land at the price of approximately $0.7 million. As part of the acquisition of the land use right, the Company is required to complete construction of a facility by February 8, 2012.

As of June 30, 2011, the Company had a cash and cash equivalents balance of approximately $2.3 million and short term loans outstanding of approximately $1.0 million. Operating cash outflows amounted to $2.7 million in the nine months ended June 30, 2011, mainly due to payments to the Company’s vendors based on contractual terms. There have been no significant changes in the payment terms of the Company’s major vendors in the three months ended June 30, 2011 compared to the same period in the prior year. If the Company is unable to successfully generate enough revenues to cover its costs or secure additional financing, the Company’s liquidity and results of operations may be materially and adversely affected and may not continue as a going concern.

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Principles of Consolidation and Basis of Accounting

Prior to August 19, 2008, the Company operated its business in the People’s Republic of China through Solar EnerTech (HK) Corporation, Limited (“Solar EnerTech HK”) and Solar EnerTech (Shanghai) Co., Ltd (“Infotech Shanghai” and together with Solar EnerTech HK, “Infotech”). While the Company did not own Infotech, the Company’s financial statements have included the results of the financials of each of Solar EnerTech HK and Infotech Shanghai since these entities were wholly-controlled variable interest entities of the Company through an Agency Agreement dated April 10, 2006 by and between the Company and Infotech (the “Agency Agreement”). Under the Agency Agreement the Company engaged Infotech to undertake all activities necessary to build a solar technology business in China, including the acquisition of manufacturing facilities and equipment, employees and inventory. The Agency Agreement continued through April 10, 2008 and then on a month to month basis thereafter until terminated by either party.

To permanently consolidate Infotech with the Company through legal ownership, the Company acquired Infotech at a nominal amount on August 19, 2008 through a series of agreements. In connection with executing these agreements, the Company terminated the original agency relationship with Infotech.

The Company had previously consolidated the financial statements of Infotech with its financial statements pursuant to FASB ASC 810-10 “Consolidations”, formerly referenced as FASB Interpretation No. 46(R),  due to the agency relationship between the Company and Infotech and, notwithstanding the termination of the Agency Agreement, the Company continues to consolidate the financial statements of Infotech with its financial statements since Infotech became a wholly-owned subsidiary of the Company as a result of the acquisition.
 
 
7

 
  
The Company’s consolidated financial statements include the accounts of Solar EnerTech Corp. and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. These consolidated financial statements have been prepared in U.S. dollars and in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents
 
Cash and cash equivalents are defined as cash on hand, demand deposits and short-term, highly liquid investments that are readily convertible to known amounts of cash within ninety days of deposit.

Currency and Foreign Exchange
 
The Company’s functional currency is the Renminbi as substantially all of the Company’s operations are in China. The Company’s reporting currency is the U.S. dollar.

Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Transactions and balances in other currencies are converted into U.S. dollars in accordance with FASB ASC 830, “Foreign Currency Matters,” formerly referenced as SFAS No. 52, “Foreign Currency Translation”, and are included in determining net income or loss.

For foreign operations with the local currency as the functional currency, assets and liabilities are translated from the local currencies into U.S. dollars at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Translation adjustments resulting from the process of translating the local currency consolidated financial statements into U.S. dollars are included in determining comprehensive loss.

Property and Equipment

The Company’s property and equipment are stated at cost net of accumulated depreciation. Depreciation is provided using the straight-line method over the related estimated useful lives, as follows:

   
Useful Life (Years)
Office equipment
 
3 to 5
Machinery
 
10
Production equipment
 
5
Automobiles
 
5
Furniture
 
5
Leasehold improvement
 
the shorter of the lease term or  5 years
   
Expenditures for maintenance and repairs that do not improve or extend the lives of the related assets are expensed to operations. Major repairs that improve or extend the lives of the related assets are capitalized.

Inventories

Inventories are stated at the lower of cost or market. Cost is determined by the weighted-average method. Market is defined principally as net realizable value. Raw material cost is based on purchase costs while work-in-progress and finished goods are comprised of direct materials, direct labor and an allocation of manufacturing overhead costs. Inventory in-transit is included in finished goods and consists of products shipped but not recognized as revenue because it does not meet the revenue recognition criteria. Provisions are made for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of net realizable value.

 
8

 
  
Warranty Cost

The Company provides product warranties and accrues for estimated future warranty costs in the period in which revenue is recognized. The Company’s standard solar modules are typically sold with a two-year warranty for defects in materials and workmanship and a ten-year and twenty five-year warranty against declines of more than 10.0% and 20.0%, respectively, of the initial minimum power generation capacity at the time of delivery. The Company therefore maintains warranty reserves to cover potential liabilities that could arise from its warranty obligations and accrues the estimated costs of warranties based primarily on management’s best estimate. In estimating warranty costs, the Company applied Accounting Standards Codification Topic 460 (“ASC 460”) – Guarantees, specifically paragraphs 460-10-25-5 to 460-10-25-7 of the FASB Accounting Standards Codification. This guidance requires that the Company make a reasonable estimate of the amount of a warranty obligation. It also provides that in the case of an entity that has no experience of its own, reference to the experience of other entities in the same business may be appropriate. Because the Company began to commercialize its products in fiscal year 2007, there is insufficient experience and historical data that can be used to reasonably estimate the expected failure rate of its solar modules. Thus, the Company considers warranty cost provisions of other China-based manufacturers that produce photovoltaic products that are comparable in engineering design, raw material input and functionality to the Company’s products, and sold to a similar target and class of customer with similar warranty coverage. In determining whether such peer information can be used, the Company also considers the years of experience that these manufacturers have in the industry. Because the Company’s industry is relatively young as compared to other traditional manufacturing industries, the selected peer companies that the Company considers have less than ten years in manufacturing and selling history. In addition, they have a manufacturing base in China, offer photovoltaic products with comparable engineering design, raw material input, functionality and similar warranty coverage, and sell in markets, including the geographic areas and class of customer, where the Company competes. Based on the analysis applied, the Company accrues warranty at 1% of sales. The Company has not experienced any material warranty claims to date in connection with declines of the power generation capacity of its solar modules and will prospectively revise its actual rate to the extent that actual warranty costs differ from the estimates. As of June 30, 2011 and September 30, 2010, the Company’s warranty liability was $1,481,000 and $1,125,000, respectively. The Company’s warranty costs for the nine months ended June 30, 2011 and 2010 were $324,000 and $411,000, respectively. The Company did not make any warranty payments during the nine months ended June 30, 2011 and 2010.

Other Assets

The Company acquired land use rights to a parcel of land from the government in the People’s Republic of China (“PRC”). All land in the PRC is owned by the PRC government and cannot be sold to any individual or entity. The government in the PRC, according to relevant PRC law, may sell the right to use the land for a specified period of time. Thus, the Company’s land purchase in the PRC is considered to be leased land and recorded as other assets at cost less accumulated amortization. Amortization is provided over the term of the land use right agreements on a straight-line basis, which is for 46.5 years from February 8, 2010 through August 31, 2056.

Impairment of Long Lived Assets

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. When such factors and circumstances exist, management compares the projected undiscounted future cash flows associated with the future use and disposal of the related asset or group of assets to their respective carrying values. Impairment, if any, is measured as the excess of the carrying value over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. No loss on property and equipment impairment was recorded during the nine months ended June 30, 2011 and 2010.

Investments

Investments in an entity where the Company owns less than twenty percent of the voting stock of the entity and does not exercise significant influence over operating and financial policies of the entity are accounted for using the cost method. Investments in the entity where the Company owns twenty percent or more but not in excess of fifty percent of the voting stock of the entity or less than twenty percent and exercises significant influence over operating and financial policies of the entity are accounted for using the equity method. The Company has a policy in place to review its investments at least annually, to evaluate the carrying value of the investments in these companies. The cost method investment is subject to impairment assessment if there are identified events or changes in circumstance that may have a significant adverse affect on the fair value of the investment. If the Company believes that the carrying value of an investment is in excess of estimated fair value, it is the Company’s policy to record an impairment charge to adjust the carrying value to the estimated fair value, if the impairment is considered other-than-temporary.

 
9

 
  
On August 21, 2008, the Company entered into an equity purchase agreement in which it acquired two million shares of common stock of 21-Century Silicon, Inc., a polysilicon manufacturer based in Dallas, Texas (“21-Century Silicon”), for $1.0 million in cash. The two million shares of common stock represented approximately 7.8% of 21-Century Silicon’s outstanding equity. In connection with the equity purchase agreement, the Company also signed a memorandum of understanding with 21-Century Silicon for a four-year supply framework agreement for polysilicon shipments.  The first polysilicon shipment from 21-Century Silicon was initially expected in March 2009, but was subsequently delayed to March 2010. On March 5, 2009, the Emerging Technology Fund, created by the State of Texas, invested $3.5 million in 21-Century Silicon to expedite production and commercialization of research. The Company’s ownership of 21-Century Silicon became 5.5% as a result of the dilution. This first polysilicon shipment that was to be delivered in March 2010 was further delayed without a specified date given by 21-Century Silicon. As a result of the continued delays in shipment, in July 2010, members of the Company’s executive team, including the CEO, visited 21-Century Silicon and conducted reviews of the production facility and technical development.  The review indicated that 21-Century Silicon’s production facility and technical development were significantly below expected standards. Based on the findings from this visit, the timing of the first polysilicon shipment is unknown and it is unknown whether it will even occur. In addition, management of 21-Century Silicon expressed the need for more funding to sustain operations. Moreover, 21-Century Silicon could not provide the Company with updated financial information concerning 21-Century Silicon’s working capital condition and future cash flows.  The Company considered the above findings were indicators that a significant adverse effect on the fair value of the Company’s investment in 21-Century Silicon had occurred. Accordingly, an impairment loss of $1.0 million was recorded in the Consolidated Statements of Operations for the fiscal year ended September 30, 2010 to fully write-down the carrying amount of the investment. The Company may also be obligated to acquire an additional two million shares of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million common shares (at $0.50 per share) as the product shipment has not occurred.  On October 7, 2010, the X-Change Corporation announced that it has acquired 21-Century Silicon, Inc. The terms of the acquisition are anticipated to involve a change in control of the Company and the appointment of new directors. The X-Change Corporation is anticipated to issue 20 million shares of its unregistered, restricted common stock to the shareholders of 21-Century Silicon in exchange for 100% of the issued and outstanding stock of 21-Century Silicon. As of the date of this report, the X-Change Corporation has not issued its shares to the Company.

Income Taxes

The Company accounts for income taxes under the liability method per the provisions of Accounting Standards Codification Topic 740 (“ASC 740”), “Income Taxes”.

Under the provisions of ASC 740, deferred tax assets and liabilities are determined based on the differences between their financial statement carrying values and their respective tax bases using enacted tax rates that will be in effect in the period in which the differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
 
Valuation Allowance

Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, the Company considers all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.
 
Unrecognized Tax Benefits
 
Effective on October 1, 2007, the Company adopted the provisions related to uncertain tax positions under ASC 740, “Income Taxes”, formerly referenced as FIN 48, “Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109”.  Under ASC 740, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority based on the technical merits of the associated tax position.  An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company also elected the accounting policy that requires interest and penalties to be recognized as a component of tax expense. The Company classifies the unrecognized tax benefits that are expected to be effectively settled within one year as current liabilities, otherwise, the unrecognized tax benefits will be classified as non-current liabilities.

Fair Value of Warrants

The Company’s management used the binomial valuation model to value the warrants issued in conjunction with convertible notes entered into in March 2007. The model uses inputs such as implied term, suboptimal exercise factor, volatility, dividend yield and risk free interest rate. Selection of these inputs involves management’s judgment and may impact estimated value. Management selected the binomial model to value these warrants as opposed to the Black-Scholes-Merton model primarily because management believes the binomial model produces a more reliable value for these instruments because it uses an additional valuation input factor, the suboptimal exercise factor, which accounts for expected holder exercise behavior which management believes is a reasonable assumption with respect to the holders of these warrants.

Stock-Based Compensation

On January 1, 2006, Solar EnerTech began recording compensation expense associated with stock options and other forms of employee equity compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation”, formerly referenced as SFAS 123R, “Share-Based Payment”.

 
10

 
  
The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula and a single option approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The following assumptions are used in the Black-Scholes-Merton option pricing model:

Expected Term — The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding.

Expected Volatility — The Company’s expected volatilities are based on historical volatility of the Company’s stock, adjusted where determined by management for unusual and non-representative stock price activity not expected to recur. Due to the limited trading history, the Company also considered volatility data of guidance companies.

Expected Dividend — The Black-Scholes-Merton valuation model calls for a single expected dividend yield as an input. The Company currently pays no dividends and does not expect to pay dividends in the foreseeable future.

Risk-Free Interest Rate — The Company bases the risk-free interest rate on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.

Estimated Forfeitures — When estimating forfeitures, the Company takes into consideration the historical option forfeitures over the expected term.

Revenue Recognition

The Company recognizes revenues from product sales in accordance with guidance provided in FASB ASC 605, “Revenue Recognition”, which states that revenue is realized or realizable and earned when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and collectability is reasonably assured. Where a revenue transaction does not meet any of these criteria it is deferred and recognized once all such criteria have been met. In instances where final acceptance of the product, system, or solution is specified by the customer, revenue is deferred until all acceptance criteria have been met.

On a transaction by transaction basis, the Company determines if the revenue should be recorded on a gross or net basis based on criteria discussed in the Revenue Recognition topic of the FASB Subtopic 605-405, “Reporting Revenue Gross as a Principal versus Net as an Agent”. The Company considers the following factors to determine the gross versus net presentation: if the Company (i) acts as principal in the transaction; (ii) takes title to the products; (iii) has risks and rewards of ownership, such as the risk of loss for collection, delivery or return; and (iv) acts as an agent or broker (including performing services, in substance, as an agent or broker) with compensation on a commission or fee basis.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are carried at net realizable value. The Company records allowance for doubtful accounts based upon its assessment of various factors. The Company considers historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect customers’ ability to pay.

Shipping and Handling Costs

The Company incurred shipping and handling costs of $318,000 and $1,414,000 for the nine months ended June 30, 2011 and 2010, respectively, which are included in selling expenses. Shipping and handling costs include costs incurred with third-party carriers to transport products to customers.

Research and Development Cost

Expenditures for research activities relating to product development are charged to expense as incurred. Research and development cost for the nine months ended June 30, 2011 and 2010 were $216,000 and $287,000, respectively.

Comprehensive Income (Loss)

Comprehensive income (loss) is defined as the change in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners.  Comprehensive income (loss) is reported in the consolidated statements of shareholder’s equity.  Other comprehensive income (loss) of the Company consists of cumulative foreign currency translation adjustments.

 
11

 
  
Segment Information

The Company identifies its operating segments based on its business activities. The Company operates within a single operating segment - the manufacture of solar energy cells and modules in China. The Company’s manufacturing operations and fixed assets are all based in China. The solar energy cells and modules are distributed to customers, located in Europe, Australia, North America and China.

During the nine months ended June 30, 2011 and 2010, the Company had one and three customers, respectively that accounted for more than 10% of net sales.

Recent Accounting Pronouncements

In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) (“ASU 2011-04”). The amendments to this update provide a uniform framework for applying the principles of fair value measurement and include (i) amendments that clarify the Board’s intent about the application of existing fair value measurement and disclosure requirements and (ii) amendments that change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. These amendments do not require additional fair value measurements. The Company will adopt ASU 2011-04 in the second quarter of fiscal year 2012. The Company does not believe the adoption of ASU 2011-04 will have a material impact on the Company’s consolidated financial statements.
 
In June 2011, the FASB issued ASU 2011-05, “Presentation of Comprehensive Income” (“ASU 2011-05”). ASU 2001-05 amends Topic 220, “Comprehensive Income”, to allow an entity the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 does not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income, nor does it change the option for an entity to present components of other comprehensive income either net of related tax effects or before related tax effects. This ASU is effective for the Company’s financial statements for annual and interim periods beginning on or after December 15, 2011, and must be applied retrospectively. The Company will adopt ASU 2011-05 in the first quarter of fiscal year 2012. The adoption of ASU 2011-05 is not expected to have a material impact on the Company’s consolidated financial statements.

NOTE 4 — FINANCIAL INSTRUMENTS

The Company’s assets that are potentially subject to significant concentration of credit risk are primarily cash and cash equivalents, advance payments to suppliers and accounts receivable.

The Company maintains cash deposits with financial institutions, which from time to time may exceed federally insured limits. The Company has not experienced any losses in connection with these deposits and believes it is not exposed to any significant credit risk from cash. At June 30, 2011 and September 30, 2010, the Company had approximately $82,000 and $82,000, respectively in excess of insured limits.

Advance payments to suppliers are typically unsecured and arise from deposits paid in advance for future purchases of raw materials. The Company does not require collateral or other security against the prepayments to suppliers for raw materials.  In the event of a failure by the Company’s suppliers to fulfill their contractual obligations and to the extent that the Company is not able to recover its prepayments, the Company would suffer losses. The Company’s prepayments to suppliers have been steadily decreasing due to the change in the industry practice from requiring full cash advance to secure key raw material (silicon wafers) as a result of the financial crisis in 2008 to requiring less or no cash advance during fiscal year 2009 as the economy is recovering from the crisis. The economic crisis may affect the Company’s customers’ ability to pay the Company for its products that the Company has delivered.  If the customers fail to pay the Company for its products and services, the Company’s financial condition, results of operations and liquidity may be adversely affected.

Other financial instruments that potentially subject the Company to concentration of credit risk consist principally of accounts receivable.  Concentrations of credit risk with respect to accounts receivable are limited because a number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk.  The Company controls credit risk through credit approvals, credit limits and monitoring procedures.  The Company performs credit evaluations for all new customers but generally does not require collateral to support customer receivables. All of the Company’s customers have gone through a very strict credit approval process. The Company diligently monitors the customers’ financial position. Payment terms for our solar module sales generally range from 0 to 60 days. In some cases, these terms are extended up to 200 days for certain qualifying customers of whom the Company applied rigorous credit requirements. The Company has also purchased insurance from the China Export & Credit Insurance Company to insure the collectability of the outstanding accounts receivable balances of a key customer. During the nine months ended June 30, 2011 and 2010, the Company had one and three customers, respectively that accounted for more than 10% of net sales.

 
12

 
   
Foreign exchange risk and translation

The Company may be subject to significant currency risk due to the fluctuations of exchange rates between the Chinese Renminbi, Euro and the United States dollar.

The local currency is the functional currency for the China subsidiary.  Assets and liabilities are translated at end of period exchange rates while revenues and expenses are translated at the average exchange rates in effect during the period.  Equity is translated at historical rates and the resulting cumulative translation adjustments, to the extent not included in net income, are included as a component of other comprehensive income (loss) until the translation adjustments are realized. Included in other comprehensive income were foreign currency translation adjustment gains of $800,000 and $98,000 for the nine months ended June 30, 2011 and 2010, respectively.   Foreign currency transaction gains and losses are included in earnings. For the nine months ended June 30, 2011 and 2010, the Company recorded foreign exchange losses of $0.5 million and $0.9 million, respectively.

NOTE 5 — ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS

At June 30, 2011 and September 30, 2010, the accounts receivable, net of allowance for doubtful accounts consists of:

   
June 30, 2011
   
September 30, 2010
 
Accounts receivable, gross
  $ 10,537,000     $ 6,588,000  
Allowance for doubtful accounts
    (443,000 )     (42,000 )
Accounts receivable, net
  $ 10,094,000     $ 6,546,000  

The following table summarizes the activities of the allowance for doubtful accounts as of June 30, 2011 and September 30, 2010:

   
Allowance for doubtful
accounts
 
As of September 30, 2009
  $ 117,000  
Addition
    -  
Write-down
    (75,000 )
As of September 30, 2010
  $ 42,000  
Addition
    421,000  
Write-down
    (20,000 )
As of June 30, 2011
  $ 443,000  
NOTE 6 — ADVANCE PAYMENTS AND OTHER

At June 30, 2011 and September 30, 2010, advance payments and other consist of:

   
June 30, 2011
   
September 30, 2010
 
Prepayment for raw materials
  $ 285,000     $ 673,000  
Prepayment for equipment
    18,000       402,000  
Others
    207,000       199,000  
Total advance payments and other
  $ 510,000     $ 1,274,000  
 
 
13

 
  
NOTE 7 — INVENTORIES

At June 30, 2011 and September 30, 2010, inventories consist of:

   
June 30, 2011
   
September 30, 2010
 
Raw materials
  $ 3,133,000     $ 2,639,000  
Finished goods
    33,000       1,444,000  
Total inventories
  $ 3,166,000     $ 4,083,000  

NOTE 8 — PROPERTY AND EQUIPMENT

The Company depreciates its assets over their estimated useful lives. A summary of property and equipment at June 30, 2011 and September 30, 2010 is as follows:

   
June 30, 2011
   
September 30, 2010
 
Production equipment
  $ 9,816,000     $ 8,130,000  
Leasehold improvements
    3,879,000       3,709,000  
Automobiles
    312,000       366,000  
Office equipment
    363,000       348,000  
Machinery
    3,065,000       2,916,000  
Furniture
    41,000       40,000  
Total property and equipment
    17,476,000       15,509,000  
Less:  accumulated depreciation
    (8,477,000 )     (6,635,000 )
Total property and equipment, net
  $ 8,999,000     $ 8,874,000  

NOTE 9 — OTHER ASSETS

Other assets at June 30, 2011 and September 30, 2010 mainly consist of the following:

   
June 30, 2011
   
September 30, 2010
 
             
Land use rights
           
Cost
  $ 773,000     $ 746,000  
Less: Accumulated amortization
    (24,000 )     (11,000 )
Total other assets
  $ 749,000     $ 735,000  

On February 8, 2010, the Company acquired land use rights of a 68,025 square meter parcel of land located in Yizheng, Jiangsu Province of China, which will be used to house the Company’s second manufacturing facility. For each of the next five years, annual amortization expense of the land use rights will be approximately $17,000 with an estimated useful life of 46.5 years.

NOTE 10 — SHORT TERM LOANS

At June 30, 2011 and September 30, 2010, short-term loans consist of:

   
June 30, 2011
   
September 30, 2010
 
             
Short-term loans
  $ 1,008,000     $ 1,312,000  

On March 25, 2010, the Company entered into a one year contract with China Export & Credit Insurance Corporation (“CECIC”) to insure the collectability of outstanding accounts receivable for two of the Company’s key customers. The Company pays a fee based on a fixed percentage of the accounts receivable outstanding and expenses this fee when it is incurred. In addition, on March 30, 2010, the Company entered into a one year revolving credit facility arrangement with Industrial Bank Co., Ltd. (“IBC”) that was secured by the accounts receivable balances of the two key customers insured by CECIC above. The cost of the insurance on accounts receivable is recorded as selling, general and administrative costs in the Consolidated Statements of Operations of the Company. On May 5, 2011, the Company terminated the credit facility arrangement with IBC and on the same day, the Company entered into a revolving credit facility arrangement with Bank of China (“BOC”), which is also secured by the accounts receivable balances of the key customers insured by CECIC above.

 
14

 
  
If the insured customer fails to repay the amounts outstanding due to the Company, the insurance proceeds will be remitted directly to BOC instead of the Company.  The amount drawn down as of June 30, 2011, amounted to $1,008,000, of which $302,000 and $706,000 are due on August 2 and August 15, 2011, respectively. There have been no insurance claims submitted to CECIC. There are no commitment fees associated with the unused portion of the credit facility. The interest rate of the credit facility is variable and ranged from 3.78% to 5.30% during the nine months ended June 30, 2011. The weighted average interest rate on this credit facility during the nine months ended June 30, 2011 was 4.42% per annum.  
 
NOTE 11 — INCOME TAX

The Company has no taxable income and no provision for federal and state income taxes is required for the nine months ended June 30, 2011 and 2010, respectively, except certain state minimum tax.

The Company conducts its business in the United States and in various foreign locations and generally is subject to the respective local countries’ statutory tax rates.

Utilization of the U.S. federal and state net operating loss carry forwards may be subject to substantial annual limitation due to certain limitations resulting from ownership changes provided by U.S. federal and state tax laws. The annual limitation may result in the expiration of net operating losses carryforwards and credits before utilization. The Company has net operating losses in its foreign jurisdictions and those losses can be carried forward 5 years from the year the loss was incurred. As of June 30, 2011 and 2010, the Company’s deferred tax assets were subject to a full valuation allowance.

Under the New Income Tax Law in the PRC, dividends paid by PRC enterprises out of profits earned post-2007 to non-PRC tax resident investors are subject to PRC withholding tax of 10%. A lower withholding tax rate may be applied based on applicable tax treaties with certain countries.

The New Income Tax Law also provides that enterprises established under the laws of foreign countries or regions and whose “place of effective management” is located within the PRC are considered PRC tax resident enterprises and subject to PRC income tax at the rate of 25% on worldwide income. The definition of “place of effective management" refers to an establishment that exercises, in substance, overall management and control over the production and business, personnel, accounting, properties, etc. of an enterprise. If the Company or any of its non-PRC subsidiaries is treated as a “resident enterprise” for PRC tax purposes, the Company or such subsidiary will be subject to PRC income tax. The Company will continue to monitor its tax status with regard to the PRC tax resident enterprise regulation but does not anticipate a material adverse impact to the financial statements as a whole.
 
There are no ongoing examinations by taxing authorities at this time. The Company’s tax years starting from 2006 to 2010 remain open in various tax jurisdictions. The Company has not recorded any unrecognized tax benefits; and does not anticipate any significant changes within the next 12 months.

NOTE 12 — CONVERTIBLE NOTES

On March 7, 2007, Solar EnerTech entered into a securities purchase agreement to issue $17.3 million of secured convertible notes (the “Notes”) and detachable stock purchase warrants the “Series A and Series B Warrants”). Accordingly, during the quarter ended March 31, 2007, Solar EnerTech sold units consisting of:

 
$5.0 million in principal amount of Series A Convertible Notes and warrants to purchase 7,246,377 shares (exercise price of $1.21 per share) of its common stock;

 
$3.3 million in principal amount of Series B Convertible Notes and warrants to purchase 5,789,474 shares (exercise price of $0.90 per share) of its common stock ; and

 
$9.0 million in principal amount of Series B Convertible Notes and warrants to purchase 15,789,474 shares (exercise price of $0.90 per share) of its common stock.

These Notes bear interest at 6% per annum and are due in 2010. Under their original terms, the principal amount of the Series A Convertible Notes may be converted at the initial rate of $0.69 per share for a total of 7,246,377 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest). Under their original terms, the principal amount of the Series B Convertible Notes may be converted at the initial rate of $0.57 per share for a total of 21,578,948 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest).

 
15

 
  
The Company evaluated the Notes for derivative accounting considerations under FASB ASC 815 and determined that the notes contained two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative” or “CED”). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account “gain (loss) on fair market value of compound embedded derivative” in the accompanying consolidated statements of operations.

In connection with the issuance of the Notes and Series A and Series B Warrants, the Company engaged an exclusive advisor and placement agent (the “Advisor”) and issued warrants to the Advisor to purchase an aggregate of 1,510,528 shares at an exercise price of $0.57 per share and 507,247 shares at an exercise price of $0.69 per share, of the Company’s common stock (the “Advisor Warrants”). In addition to the issuance of the warrants, the Company paid $1,038,000 in commissions, an advisory fee of $173,000, and other fees and expenses of $84,025.

The Series A and Series B Warrants (including the Advisor Warrants) were classified as a liability, as required by FASB ASC 480, “Distinguishing Liabilities from Equity”, formerly referenced as SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity”, due to the terms of the warrant agreement which contains a cash redemption provision in the event of a fundamental transaction. The warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account “gain (loss) on fair market value of warrant liability” in the accompanying consolidated statements of operations.

In conjunction with the March 2007 financing, the Company recorded a total deferred financing cost of $2.5 million, of which $1.3 million represented cash payment and $1.2 million represented the fair market value of the Advisor Warrants. The deferred financing cost is amortized over the three year life of the notes using a method that approximates the effective interest rate method. The Advisor Warrants were recorded as a liability and adjusted to fair value in each subsequent period.

On January 7, 2010 (the “Conversion Date”), the Company entered into a Series A and Series B Notes Conversion Agreement (the “Conversion Agreement”) with the holders of Notes representing at least seventy-five percent of the aggregate principal amounts outstanding under the Notes to restructure the terms of the Notes. As of the Conversion Date, approximately $9.8 million of the Series A and B Convertible Notes were effectively converted into 64,959,227 shares of the Company’s common stock along with 1,035,791 shares of the Company’s common stock as settlement of the accrued interest on the Series A and B Convertible Notes, and the remaining $1.8 million of the Series B Notes were exchanged into another convertible note as further discussed below. In connection with the Conversion Agreement, on January 7, 2010, the Company entered into an Amendment (the “Warrant Amendment”) to the Series A, Series B and Series C Warrants with the holders of at least a majority of the common stock underlying each of its outstanding Series A Warrants, Series B Warrants and Series C Warrants (collectively the “PIPE Warrants”). The Warrant Amendment reduced the exercise price for all of the PIPE Warrants from $1.21, $0.90 and $1.00, respectively, to $0.15, removed certain maximum ownership provisions and removed anti-dilution provisions for lower-priced security issuances.
 
The Conversion Agreement resulted in modifications or exchanges of the Notes and PIPE Warrants, which should be accounted for pursuant to FASB ASC 405-20, “Liabilities” and FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No. 96-19, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments". The combination of the adjustment to conversion price and the automatic conversion of the Notes effectively resulted in the settlement of the Notes through the issuance of shares of the Company’s common stock and amendment of the PIPE Warrants’ terms. Since the Company is relieved of its obligation for the Notes, the transaction is accounted for as an extinguishment of the Notes upon issuance of ordinary shares and modification of the PIPE Warrants’ terms. The loss on extinguishment associated with the Conversion Agreement amounted to approximately $17.2 million.

On January 19, 2010, a holder of approximately $1.8 million of the Company’s formerly outstanding Series B Notes and Series B Warrants (hereinafter referred to as the “Holder”) of the Company’s common stock disputed the effectiveness of the Conversion Agreement and the Warrant Amendment.  Accordingly, the Holder did not tender its Series B Notes for conversion. After negotiations with the Holder, on March 19, 2010, the Company entered into an Exchange Agreement with the Holder (the “Exchange Agreement”), whereby the Company issued the Series B-1 Note with a principal amount of $1.8 million (the “Series B-1 Note”) to the Holder along with 283,498 shares of the Company’s common stock as settlement of the accrued interest on the Holder’s Series B Notes and 666,666 shares of the Company’s common stock as settlement of the outstanding dispute regarding the effectiveness of the Company’s Conversion Agreement and the Warrant Amendment.  The Company did not capitalize any financing costs associated with the issuance of the Series B-1 Note.  As of June 30, 2011, the Company has an outstanding convertible note with a principal balance of $1,540,261 consisting of the Series B-1 Note, which was recorded at a carrying amount of $1,443,000. The Series B-1 Note bears interest at 6% per annum and is due on March 19, 2012. During the nine months ended June 30, 2011, the Company issued 784,768 shares of its common stock to settle the accrued interest on the Series B-1 Note.

 
16

 

 
The Exchange Agreement resulted in modifications or exchanges of the Holder’s rights under its former Series B Note, which should be accounted for pursuant to FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No. 96-19, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments", and FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No.06-06, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments". The loss on debt extinguishment associated with the Exchange Agreement amounted to approximately $1.3 million.

The costs associated with the Conversion Agreement were directly derived from the execution of the Company’s plan in improving its liquidity and business sustainability. The related loss on debt extinguishment was a cost that was integral to the continuing operations of the business which is different in nature to the continuing interest payments and change in fair value of the compound embedded derivative and warrant liability. Accordingly, the loss on debt extinguishment is included in operating expenses in the accompanying consolidated statements of operations.

The Company evaluated the Series B-1 Note for derivative accounting considerations under FASB ASC 815 and determined that the Series B-1 Note contained two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative”). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account “gain (loss) on fair market value of compound embedded derivative” in the accompanying consolidated statements of operations.

On March 19, 2010, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby the Company issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum. On May 11, 2011, the Company executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of the Company’s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, the Company’s liquidity and financial position raises substantial doubt about the Company’s ability to continue as a going concern. 

The loss (gain) on debt extinguishment is computed as follows:

   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Fair value of the common shares
  $ 85,000     $ 25,000     $ 155,000     $ 18,863,000  
Fair value of Series B-1 Note
    -       -       -       3,108,000  
Unamortized deferred financing costs associated with the converted notes
    -       -       -       594,000  
Fair value of the CED liability associated with the converted notes
    (13,000 )     -       (26,000 )     (74,000 )
Accreted amount of the notes discount
    (95,000 )     (25,000 )     (184,000 )     (7,544,000 )
Common shares issued in conjunction with Series B-1 Note
    -       -       -       100,000  
Loss on extinguishment of warrants
    -       -       -       3,502,000  
Loss (gain) on debt extinguishment
  $ (23,000 )   $ -     $ (55,000 )   $ 18,549,000  

During the three and nine months ended June 30, 2011, $100,000 and $200,000, respectively of the Series B-1 Note was converted into 1,000,000 and 1,666,667 shares of the Company’s common stock, respectively. As a result, the Company recorded a cumulative gain on debt extinguishment of approximately $23,000 and $55,000 during the three and nine months ended June 30, 2011, respectively.

During the three months ended June 30, 2010, $25,000 of the Series B-1 Note was converted into 166,667 shares of the Company’s common stock. There was no gain on debt extinguishment during the three months ended June 30, 2010. The Company recorded a cumulative loss on debt extinguishment of approximately $18.5 million as a result of the Conversion Agreement and the Exchange Agreement during the nine months ended June 30, 2010.
 
 
17

 
  
The following table summarizes the valuation of the Notes and the related Compound Embedded Derivative, the Series A and Series B Warrants (including the Advisor Warrants), and the Series B-1 Note and the related Compound Embedded Derivative:

Carrying amount of Series B-1 Note at March 19, 2010
  $ 1,815,000  
Fair value of compound embedded derivative liabilities
    (1,573,000 )
Loss on debt extinguishment
    1,293,000  
Amortization of note discount and conversion effect
    (4,000 )
Carrying amount of Series B-1 Note at September 30, 2010
  $ 1,531,000  
Amortization of note discount and conversion effect
    (88,000 )
Carrying amount of Series B-1 Note at June 30, 2011
  $ 1,443,000  
         
Fair value of the Series B-1 compound embedded derivative liabilities at March 19, 2010
  $ 1,573,000  
Gain on fair market value of embedded derivative liability
    (1,131,000 )
Effect on debt conversion
    (20,000 )
Fair value of the Series B-1compound embedded derivative liabilities at September 30, 2010
  $ 422,000  
Gain on fair market value of embedded derivative liability
    (263,000 )
Effect on debt conversion
    (26,000 )
Fair value of the Series B-1compound embedded derivative liabilities at June 30, 2011
  $ 133,000  
         
Fair value of warrant liability at September 30, 2009
  $ 2,068,000  
Loss on PIPE warrant extinguishment
    3,502,000  
Cashless exercise of warrants
    (157,000 )
Gain on fair market value of warrant liability
    (4,511,000 )
Fair value of warrant liability at September 30, 2010
  $ 902,000  
Gain on fair market value of warrant liability
    (853,000 )
Fair value of warrant liability at June 30, 2011
  $ 49,000  

Series B-1 Note

The material terms of the Series B-1 Note are as follows:

Interest Payments

The Series B-1 Note bears interest at 6% per annum and the principal of $1.5 million is due on March 19, 2012. Accrued interest is payable quarterly in arrears on each of January 1, April 1, July 1 and October 1,  beginning on the first such date after issuance, in cash or registered shares of common stock at the option of the Company. If the Company elects to pay any interest due in registered shares of the Company’s common stock: (i) the issuance price will be 90% of the 5-day weighted average price of the common stock ending on the day prior to the interest payment due date, and (ii) a trigger event shall not have occurred.

Voting Rights

The holder of the Series B-1 Note does not have voting rights under these agreements.

Dividends

Until all amounts owed under the Series B-1 Note have been converted, redeemed or otherwise satisfied in accordance with their terms, the Company shall not, directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on its capital stock without the prior express written consent of the required holders.
 
Conversion Right

At any time or times on or after the issuance date of the Series B-1 Note, the holder is entitled to convert, at the holder’s sole discretion, any portion of the outstanding and unpaid conversion amount (principal, accrued and unpaid interest and accrued and unpaid late charges) may be converted into fully paid and non-assessable shares of common stock, at the conversion rate discussed next.

 
18

 
  
Conversion Rate

The number of shares of common stock issuable upon conversion of the Series B-1 Note is determined by dividing (x) the conversion amount (principal, interest and late charges accrued and unpaid), by (y) the then applicable conversion price (initially $0.15 and currently $0.10 for Series B-1 Note after the execution of Amendment on May 11, 2011, subject to adjustment as provided in the agreement). No adjustment in the conversion price of the Series B-1 Note will be made in respect of the issuance of additional shares of common stock unless the consideration per share of an additional share of common stock issued or deemed to be issued by the Company is less than the conversion price of the Series B-1 Note in effect on the date of, and immediately prior to, such issuance. Should the outstanding shares of common stock increase (by stock split, stock dividend, or otherwise) or decrease (by reclassification or otherwise), the conversion price of the Series B-1 Note in effect immediately prior to the change shall be proportionately adjusted.

Redemptions

The Series B-1 Note permits the holder the right of redemption in the event of certain specified triggering events such as:
 
1)
The suspension from trading or failure of the common stock to be listed on the principal market or an eligible market for a period of five (5) consecutive trading days or for more than an aggregate of ten (10) trading days in any 365-day period;

2)
The Company’s (A) failure to cure a conversion failure by delivery of the required number of shares of common stock within ten (10) trading days after the applicable conversion date or (B) notice, written or oral, to any holder of the Series B-1 Note, including by way of public announcement or through any of its agents, at any time, of its intention not to comply with a request for conversion of any Series B-1 Note into shares of common stock that is tendered in accordance with the provisions of the Series B-1 Note;

3)
The Company's failure to pay to the Holder any amount of principal (including, without limitation, any redemption payments), interest, late charges or other amounts when and as due under this Series B-1 Note except, in the case of a failure to pay any interest and late charges when and as due, in which case only if such failure continues for a period of at least five (5) business days;

4)
 (A) The occurrence of any payment default or other default under any indebtedness of the Company or any of its subsidiaries that results in a redemption of or acceleration prior to maturity of $100,000 or more of such indebtedness in the aggregate, or (B) the occurrence of any material default under any indebtedness of the Company or any of its subsidiaries having an aggregate outstanding balance in excess of $100,000 and such default continues uncured for more than ten (10) business days, other than, in each case (A) or (B) above, or a default with respect to any other Series B-1 Note;

5)
The Company or any of its subsidiaries, pursuant to or within the meaning of Title 11, U.S. Code, or any similar Federal, foreign or state law for the relief of debtors (A) commences a voluntary case, (B) consents to the entry of an order for relief against it in an involuntary case, (C) consents to the appointment of a receiver, trustee, assignee, liquidator or similar official, (D) makes a general assignment for the benefit of its creditors or (E) admits in writing that it is generally unable to pay its debts as they become due;

6)
A court of competent jurisdiction enters an order or decree under any bankruptcy law that (A) is for relief against the Company or any of its subsidiaries in an involuntary case, (B) appoints a custodian of the Company or any of its subsidiaries or (C) orders the liquidation of the Company or any of its subsidiaries;
7)
A final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company or any of its subsidiaries and which judgments are not, within sixty (60) days after the entry thereof, bonded, discharged or stayed pending appeal, or are not discharged within sixty (60) days after the expiration of such stay; provided, however, that any judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount set forth above so long as the Company provides the holder with a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory to the holder) to the effect that such judgment is covered by insurance or an indemnity and the Company will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance of such judgment; and

8)
The Company breaches any representation, warranty, covenant or other term or condition of any transaction document, except, in the case of a breach of a covenant which is curable, only if such breach continues for a period of at least ten (10) consecutive business days.

 
19

 
  
At any time after becoming aware of a trigger event, the holder may require the Company to redeem all or any portion of the Series B-1 Note at an amount equal to any accrued and unpaid liquidated damages, plus the greater of (A) the conversion amount to be redeemed multiplied by the redemption premium (125% for trigger events described above in subparagraphs 1 to 5 and 8 above or 100% for other events), or (B) the conversion amount to be redeemed multiplied by the quotient of (i) the closing sale price at the time of the trigger event (or at the time of payment of the redemption price, if greater) divided by (ii) the conversion price, provided, however, (B) shall be applicable only in the event that a trigger event of the type specified above in subparagraphs 1, 2 or 3 has occurred and remains uncured or the conversion shares otherwise could not be received or sold by the holder without any resale restrictions.

Rights upon Fundamental Transaction, Change of Control and Qualified Financing

The Series B-1 Note also contains certain provisions relating to the occurrences of a fundamental transaction limiting the type of entity that can be a successor entity and requiring the successor entity to assume the obligations of the Series B-1 Note.  In addition, the Series B-1 Note contains certain provisions relating to a change of control or qualified financing which permit the holder the right of redemption for all or a portion of the Series B-1 Note.
 
1)
Assumption. The Company may not enter into or be party to a fundamental transaction, as such terms is defined in the Series B-1 Note, unless:
 
 
The successor entity assumes in writing all of the obligations of the Company under the Series B-1 Note and related documents; and

 
The successor entity (including its parent entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an eligible market.
 
2)
Redemption Right on Change of Control. At any time during the period beginning on the date of the holder’s receipt of a change of control notice and ending twenty (20) trading days after the consummation of such change of control, the holder may require the Company to redeem all or any portion of the Series B-1 Note in cash for an amount equal to any accrued and unpaid liquidated damages, plus the greater of (i) the product of (x) the conversion amount being redeemed and (y) the quotient determined by dividing (A) the greater of the closing sale price of the common stock immediately prior to the consummation of the change of control, the closing sale price immediately following the public announcement of such proposed change of control and the closing sale price of the common stock immediately prior to the public announcement of such proposed change of control by (B) the conversion price and (ii) 125% of the conversion amount being redeemed .

 3)
Redemption Right on Subsequent Financing. In the event that the Company or any of its subsidiaries shall issue any of its or its subsidiaries' equity or equity equivalent securities, or commit to issue or sell in one or more series of related transactions or financings, including without limitation any debt, preferred stock or other instrument or security that is, at any time during its life and under any circumstances, convertible into or exchangeable or exercisable for shares of common stock, options or convertible securities (any such offer, sale, grant, disposition or announcement of such current or future committed financing is referred to as a "Subsequent Financing"), the Company is obligated to provide the Holder written notice of the Subsequent Financing and the Holder, at its option, may require the Company to redeem the Series B-1 Note up to the Redemption Amount.

 
(A) In the event that the Gross Proceeds of the Subsequent Financing equals or exceeds $15,000,000 (a “Qualified Financing”), the “Redemption Amount” shall equal 100% of the Principal Amount then outstanding.  For purposes hereof, “Gross Proceeds” shall mean the aggregate proceeds received or receivable by the Company in respect of one or more series of related future transactions or financings for which the Company is committed in connection with such Qualified Financing.
 
 
 
(B) In the event that the Gross Proceeds of the Subsequent Financing is less than $15,000,000, the Redemption Amount shall equal a pro-rated portion of the Principal Amount equaling a ratio, the numerator of which is the amount of proceeds raised by the Company in the Subsequent Financing and the denominator which is $15,000,000. 

NOTE 13 — STOCKHOLDERS’ EQUITY

Warrants

During March 2007, in conjunction with the issuance of $17,300,000 in convertible debt, the board of directors approved the issuance of Warrants to purchase shares of the Company’s common stock. Under their original terms, the 7,246,377 Series A warrants and the 21,578,948 Series B warrants are exercisable at $1.21 and $0.90, respectively and expire in March 2012. In addition, in March 2007, as additional compensation for services as placement agent for the convertible debt offering, the Company issued the Advisor Warrants, which entitle the placement agent to purchase 507,247 and 1,510,528 shares of the Company’s common stock at exercise prices of $0.69 and $0.57 per share, respectively. The Advisor Warrants expire in March 2012.

 
20

 
  
The Series A and Series B Warrants (including the Advisor Warrants) are classified as a liability in accordance with FASB ASC 480, “Distinguishing Liabilities from Equity”, due to the terms of the warrant agreements which contain cash redemption provisions in the event of a fundamental transaction, which provide that the Company would repurchase any unexercised portion of the warrants at the date of the occurrence of the fundamental transaction for the value as determined by the Black-Scholes Merton valuation model. As a result, the warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account “gain (loss) on fair market value of warrant liability” in the accompanying Consolidated Statements of Operations.

Additionally, in connection with the offering, all of the Company’s Series A and Series B warrant holders waived their full ratchet anti-dilution and price protection rights previously granted to them in connection with the Company’s March 2007 convertible note and warrant financing.

On January 12, 2008, the Company sold 24,318,181 shares of its common stock and 24,318,181 Series C warrants (the “Series C Warrants”) to purchase shares of common stock for an aggregate purchase price of $21.4 million in a private placement offering to accredited investors. Under its original terms, the exercise price of the Series C Warrants is $1.00 per share. The warrants are exercisable for a period of 5 years from the date of issuance of the Series C Warrants.

For the services in connection with this closing, the placement agent and the selected dealer, Knight Capital Markets, LLC and Ardour Capital Investments, received an aggregate of a 6.0% cash commission, a 1.0% advisory fee and warrants to purchase 1,215,909 shares of common stock at $0.88 per share, exercisable for a period of 5 years from the date of issuance of the warrants. The net proceeds from issuing common stock and Series C warrants in January 2008 after all the financing costs were $19.9 million and were recorded in additional paid in capital and common stock. Neither the shares of common stock nor the shares of common stock underlying the warrants sold in this offering were granted registration rights.

In connection with the Conversion Agreement, on January 7, 2010, the Company entered into an Amendment (the “Warrant Amendment”) to the Series A, Series B and Series C Warrants with the holders of at least a majority of the common stock underlying each of its outstanding Series A Warrants, Series B Warrants and Series C Warrants (collectively the “PIPE Warrants”). The Warrant Amendment reduced the exercise price for all of the PIPE Warrants from $1.21, $0.90 and $1.00, respectively, to $0.15, removed certain maximum ownership provisions and removed anti-dilution provisions for lower-priced security issuances. Given the above, the liability associated with the PIPE Warrants at the pre Conversion Agreement exercise price was considered extinguished and was replaced with the liability associated with the PIPE Warrants at the post Conversion Agreement exercise price, which were recorded at fair value.

There were no warrants exercised during the nine months ended June 30, 2011. During the nine months ended June 30, 2010, a warrants holder exchanged 1,147,394 warrants for 450,878 shares of the Company’s common stock after a cashless exercise.

A summary of outstanding warrants as of June 30, 2011 is as follows:

   
Number of
Shares
   
Exercise
Price ($)
 
Recognized as
Granted in connection with convertible notes — Series A
    7,246,377       1.21  
Discount to notes payable
Granted in connection with convertible notes — Series B
    21,578,948       0.90  
Discount to notes payable
Granted in connection with common stock purchase — Series C
    24,318,181       1.00  
Additional paid in capital
Granted in connection with placement service
    507,247       0.69  
Deferred financing cost
Granted in connection with placement service
    1,510,528       0.57  
Deferred financing cost
Granted in connection with placement service
    1,215,909       0.88  
Additional paid in capital
Extinguishment in accordance with the Conversion Agreement
    (53,143,506 )     N/A  
Loss on debt extinguishment
Issuance in accordance with the Conversion Agreement
    53,143,506       0.15  
Warrant liabilities
Cashless exercise of warrants
    (1,147,394 )     0.15  
Additional paid in capital
Outstanding at June 30, 2011
    55,229,796            
 
 
21

 
 
At June 30, 2011, the range of warrant prices for shares under warrants and the weighted-average remaining contractual life is as follows:

Warrants Outstanding and Exercisable
 
               
Weighted-
 
         
Weighted-
   
Average
 
Range of
       
Average
   
Remaining
 
Warrant
 
Number of
   
Exercise
   
Contractual
 
Exercise Price 
 
Warrants
   
Price
   
Life
 
$0.15
    51,996,112     $ 0.15       1.10  
$0.57-$0.88
    3,233,684     $ 0.71       1.02  

Restricted Stock

On August 19, 2008, Mr. Leo Young, the Company’s Chief Executive Officer, entered into a Stock Option Cancellation and Share Contribution Agreement with Jean Blanchard, a former officer, to provide for (i) the cancellation of a stock option agreement by and between Mr. Young and Ms. Blanchard dated on or about March 1, 2006 and (ii) the contribution to the Company by Ms. Blanchard of the remaining 25,250,000 shares of common stock underlying the cancelled option agreement.

On the same day, an Independent Committee of the Company’s Board adopted the 2008 Restricted Stock Plan (the “2008 Plan”) providing for the issuance of 25,250,000 shares of restricted common stock to be granted to the Company’s employees pursuant to forms of restricted stock agreements.

The 2008 Plan provides for the issuance of a maximum of 25,250,000 shares of restricted stock in connection with awards under the 2008 Plan. The 2008 Plan is administered by the Company’s Compensation Committee, a subcommittee of the Company’s Board of Directors, and has a term of 10 years. Restricted stock vest over a three year period and unvested restricted stock are forfeited and cancelled as of the date that employment terminates. Participation is limited to employees, directors and consultants of the Company and its subsidiaries and other affiliates. During any period in which shares acquired pursuant to the 2008 Plan remain subject to vesting conditions, the participant shall have all of the rights of a stockholder of the Company holding shares of stock, including the right to vote such shares and to receive all dividends and other distributions paid with respect to such shares.  If a participant terminates his or her service for any reason (other than death or disability), or the participant’s service is terminated by the Company for cause, then the participant shall forfeit to the Company any shares acquired by the participant which remain subject to vesting Conditions as of the date of the participant’s termination of service. If a participant’s service is terminated by the Company without cause, or due to the death or disability of the participant, then the vesting of any restricted stock award shall be accelerated in full as of the effective date of the participant’s termination of service.

On July 2, 2011, the Company issued 8,600,000 shares of restricted common stock to the Company’s employees pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.  The issuance of the shares of restricted stock was not registered under the Securities Act in reliance on the exemption from registration provided under Regulation S, as promulgated under the Securities Act. Shares of restricted stock were issued only to non-U.S. persons in offshore transactions who met the conditions under Regulation S.

Out of the 8,600,000 shares of restricted common stock issued, the Company issued 1,000,000 shares of restricted common stock to Yihong Yao, the Company’s Chief Financial Officer, pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.

Issuance of fully vested restricted stock to the Company’s former Board of Directors

On January 12, 2010, the Company issued 400,000 shares of fully vested restricted stock to the Company’s former board of directors on their resignation date. As the former directors no longer provide services to the Company, these awards were properly accounted for as awards to non-employees in accordance with FASB ASC 718.

 
22

 
  
The following table summarizes the activity of the Company’s unvested restricted stock units as of June 30, 2011 and September 30, 2010 is presented below:
    
   
Restricted Stock
 
   
  
   
Weighted-
 
   
Number of 
   
average grant-
 
    shares    
date fair value
 
Unvested as of September 30, 2009
    23,150,000     $ 0.62  
Restricted stock canceled
    (10,000,000 )   $ 0.62  
Restricted stock granted
    400,000     $ 0.31  
Restricted stock vested
    (400,000 )   $ 0.31  
Unvested as of September 30, 2010
    13,150,000     $ 0.62  
Restricted stock canceled
    (80,000 )   $ 0.62  
Restricted stock vested
    (2,630,000 )   $ 0.62  
Unvested as of June 30, 2011
    10,440,000     $ 0.76  

The total unvested restricted stock as of June 30, 2011 and September 30, 2010 were 10,440,000 and 13,150,000 shares, respectively.

Stock-based compensation expense for restricted stock for the three and nine months ended June 30, 2011 were $0.7 million and $2.0 million, respectively. As of June 30, 2011, the total unrecognized compensation expense net of forfeitures related to unvested awards was $0.4 million and is expected to be amortized over a weighted average period of 0.14 years.

Issuance of common shares to non-employees

On February 1, 2010, the Company issued 400,000 shares of common stock to the Company’s third party financial advisors. These awards were properly accounted for as awards to non-employees in accordance with FASB ASC 718.

Options

Amended and Restated 2007 Equity Incentive Plan

In September 2007, the Company adopted the 2007 Equity Incentive Plan (the “2007 Plan”) that allows the Company to grant non-statutory stock options to employees, consultants and directors. A total of 10 million shares of the Company’s common stock are authorized for issuance under the 2007 Plan. The maximum number of shares that may be issued under the 2007 Plan will be increased for any options granted that expire, are terminated or repurchased by the Company for an amount not greater than the holder’s purchase price and may also be adjusted subject to action by the stockholders for changes in capital structure. Stock options may have exercise prices of not less than 100% of the fair value of a share of stock at the effective date of the grant of the option.

On February 5, 2008, the Board of Directors of the Company adopted the Amended and Restated 2007 Equity Incentive Plan (the “Amended 2007 Plan”), which increases the number of shares authorized for issuance from 10 million to 15 million shares of common stock and was to be effective upon approval of the Company’s stockholders and upon the Company’s reincorporation into the State of Delaware.  

On May 5, 2008, at the Company’s Annual Meeting of Stockholders, the Company’s stockholders approved the Amended 2007 Plan.  On August 13, 2008, the Company reincorporated into the State of Delaware. As of June 30, 2011 and September 30, 2010, 13,726,667 and 12,860,000 shares of common stock, respectively remain available for future grants under the Amended 2007 Plan.

 
23

 
  
These options vest over various periods up to four years and expire no more than ten years from the date of grant. A summary of activity under the Amended 2007 Plan is as follows:

   
Options Available
For Grant
   
Number of Options
Outstanding
   
Weighted Average
Fair Value Per
Share
   
Weighted Average
Exercise Price Per
Share
 
Balance at September 30, 2009
    12,060,000       2,940,000     $ 0.39     $ 0.62  
Options granted
    (250,000 )     250,000     $ 0.13     $ 0.20  
Options cancelled
    1,050,000       (1,050,000 )   $ 0.39     $ 0.62  
Balance at September 30, 2010
    12,860,000       2,140,000     $ 0.32     $ 0.55  
Options cancelled
    866,667       (866,667 )   $ 0.20     $ 0.32  
Balance at June 30, 2011
    13,726,667       1,273,333     $ 0.32     $ 0.60  

The total fair value of shares vested during the nine months ended June 30, 2011 and 2010 were approximately $21,000 and $36,000, respectively.

At June 30, 2011 and September 30, 2010, 1,273,333 and 2,140,000 options were outstanding, respectively and had a weighted-average remaining contractual life of 6.40 years and 7.66 years, respectively. Of these options, 1,270,833 and 1,542,917 shares were vested and exercisable on June 30, 2011 and September 30, 2010, respectively.  The weighted-average exercise price and weighted-average remaining contractual term of options currently exercisable were $0.60 and 6.38 years, respectively.

There were no employee stock options granted during the three and nine months ended June 30, 2011.

In accordance with the provisions of FASB ASC 718, the Company has recorded stock-based compensation expense of $0.7 million and $2.0 million for the three and nine months ended June 30, 2011, respectively, which include the compensation effect for the options and restricted stock. The Company recorded $0.7 million and $2.2 million for the three and nine months ended June 30, 2010, respectively, which include the compensation effect for the options and restricted stock. The stock-based compensation expense is based on the fair value of the options at the grant date.  The Company recognized compensation expense for share-based awards based upon their value on the date of grant amortized over the applicable service period, less an allowance estimated future forfeited awards.

NOTE 14 — FAIR VALUE OF FINANCIAL INSTRUMENTS

In September 2006, the FASB issued SFAS 157, “Fair Value Measurements”, codified in FASB ASC 820, “Fair Value Measurements and Disclosures”, which defines fair value to measure assets and liabilities, establishes a framework for measuring fair value, and requires additional disclosures about the use of fair value. FASB ASC 820 is applicable whenever another accounting pronouncement requires or permits assets and liabilities to be measured at fair value. FASB ASC 820 does not expand or require any new fair value measures. FASB ASC 820 is effective for fiscal years beginning after November 15, 2007. In December 2007, the FASB agreed to a one year deferral of FASB ASC 820’s fair value measurement requirements for nonfinancial assets and liabilities that are not required or permitted to be measured at fair value on a recurring basis. The Company adopted FASB ASC 820 on October 1, 2008, which had no effect on the Company’s financial position, operating results or cash flows.

FASB ASC 820 defines fair value and establishes a hierarchal framework which prioritizes and ranks the market price observability used in fair value measurements. Market price observability is affected by a number of factors, including the type of asset or liability and the characteristics specific to the asset or liability being measured. Assets and liabilities with readily available, active, quoted market prices or for which fair value can be measured from actively quoted prices generally are deemed to have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. Under FASB ASC 820, the inputs used to measure fair value must be classified into one of three levels as follows:
 
 
Level 1 -
Quoted prices in an active market for identical assets or liabilities;

 
Level 2 -
Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and

 
Level 3 -
Assets and liabilities whose significant value drivers are unobservable.
 
24

 
  
Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment.

The Company’s liabilities measured at fair value on a recurring basis consisted of the following types of instruments as of June 30, 2011:

   
Fair Value at
June 30, 2011
   
Quoted prices in
active markets
for identical
assets
   
Significant other
observable inputs
   
Significant
unobservable
inputs
 
   
 
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
                         
Derivative liabilites
  $ 133,000       -       -     $ 133,000  
Warrant liabilities
    49,000       -       -       49,000  
                                 
Total liabilities
  $ 182,000       -       -     $ 182,000  

The method used to estimate the value of the Series B-1 Note compound embedded derivatives (“CED”) was a binomial model with the following assumptions:

   
June 30, 2011
   
September 30, 2010
 
Implied term (years)
    0.72       1.46  
Suboptimal exercise factor
    2.50       2.50  
Volatility
    60.60 %     66.30 %
Dividend yield
    0.00 %     0.00 %
Risk-free interest rate
    0.14 %     0.34 %

The fair value of the Series A and Series B Warrants (including the Advisor Warrants) were estimated using a binomial valuation model with the following assumptions:

   
June 30, 2011
   
September 30, 2010
 
Implied term (years)
    0.68       1.43  
Suboptimal exercise factor
    2.5       2.5  
Volatility
    65 %     78 %
Dividend yield
    0 %     0 %
Risk free interest rate
    0.13 %     0.33 %

The carrying values of cash and cash equivalents, accounts receivable, accrued expenses, accounts payable, accrued liabilities and amounts due to related party approximate fair value because of the short-term maturity of these instruments. The Company does not invest its cash in auction rate securities.

At June 30, 2011, the principal outstanding and the carrying value of the Company’s Series B-1 Note were $1,540,261 and $1,443,000, respectively. The Series B-1 Note contains two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative”), which are measured at fair value both initially and in subsequent periods. The fair value of the convertible notes can be determined based on the fair value of the entire financial instrument.
 
 
25

 
  
NOTE 15 — COMPREHENSIVE INCOME (LOSS)

The components of comprehensive income (loss) were as follows:

   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
Other comprehensive income:
                               
Change in foreign currency translation
    452,000       87,000       800,000       98,000  
Comprehensive income (loss)
  $ (859,000 )   $ (571,000 )   $ 1,330,000     $ (23,642,000 )

The accumulated other comprehensive income at June 30, 2011 and September 30, 2010 comprised of accumulated translation adjustments of $3.6 million and $2.8 million, respectively.

NOTE 16 — NET INCOME (LOSS) PER SHARE

The following table presents the computation of basic and diluted net income (loss) per share applicable to common stockholders:
 
   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Calculation of net income (loss) per share - basic:
                       
                         
Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
Weighted-average number of common shares outstanding
    161,543,403       156,502,573       160,990,033       128,327,753  
Net income (loss) per share - basic
  $ (0.01 )   $ (0.004 )   $ 0.003     $ (0.18 )
                                 
Calculation of net income (loss) per share - diluted:
                               
                                 
Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
Less:  Gain on change in fair market value of compound embedded derivative
    -       -       (263,000 )     -  
    Interest expense on convertible notes
    -       -       136,000       -  
Net income (loss) assuming dilution
  $ (1,311,000 )   $ (658,000 )   $ 403,000     $ (23,740,000 )
                                 
Weighted-average number of common shares outstanding
    161,543,403       156,502,573       160,990,033       128,327,753  
Effect of potentially dilutive securities:
                               
Convertible notes
    -       -       9,935,073       -  
Weighted-average number of common shares outstanding assuming dillution
    161,543,403       156,502,573       170,925,106       128,327,753  
                                 
Net income (loss) per share - diluted
  $ (0.01 )   $ (0.004 )   $ 0.002     $ (0.18 )
 
During the nine months ended June 30, 2011, 1,273,333 stock options, 55,229,796 warrants and 10,440,000 restricted stocks were excluded from the calculation of earnings per share because their effect would be anti-dilutive.

NOTE 17 — COMMITMENTS AND CONTINGENCIES

Research and development commitment

Pursuant to a joint research and development laboratory agreement with Shanghai University, dated December 15, 2006 and expiring on December 15, 2016, Solar EnerTech is committed to fund the establishment of laboratories and completion of research and development activities. On November 12, 2010, the Company amended the agreement with Shanghai University and extended the funding commitment from five years to eight years, and consequently the agreement will end on December 15, 2014. Based on the amendment, the Company has committed to fund no less than RMB 30 million ($4.5 million) cumulatively across the eight years. The funding requirements are based on specific milestones agreed upon by the Company and Shanghai University. As of June 30, 2011, there are approximately $3.2 million remaining to be funded in full by December 15, 2014.

The Company will continue to invest in research and development as it grows its business. The payment to Shanghai University will be used to fund program expenses and equipment purchase. Shanghai University needs to obtain the pre-approval from the Company before incurring expenditures on the program. If the Company fails to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If the Company is unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, the Company is not in breach as it has not received any additional compensation requests for pre-approved funding payment from Shanghai University.

 
26

 
  
The agreement is for shared investment in research and development on fundamental and applied technology in the fields of semi-conductive photovoltaic theory, materials, cells and modules. The agreement calls for Shanghai University to provide equipment, personnel and facilities for joint laboratories. The Company will provide funding, personnel and facilities for conducting research and testing. Research and development achievements from this joint research and development agreement will be available to both parties. The Company is entitled to intellectual property rights including copyrights and patents obtained as a result of this research.

Other than capital expenditure related to purchase of fixed assets, expenditures under this agreement will be accounted for as research and development expenditures under FASB ASC 730, "Research and Development” and expensed as incurred.

Capital commitments

On August 21, 2008, the Company acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash as previously discussed in “Note 3 — Summary of Significant Accounting Policies – Investments”  above.  In July 2010, members of the Company’s executive team, including the CEO, visited 21-Century Silicon and conducted reviews of the production facility and technical development. The review indicated that 21-Century Silicon’s production facility and technical development were significantly below expected standards. In addition, management of 21-Century Silicon expressed the need for more funding to sustain operations. Moreover, 21-Century Silicon could not provide the Company with updated financial information concerning 21-Century Silicon’s working capital condition and future cash flows. The timing of the first polysilicon shipment is unknown and it is unknown whether it will even occur. The Company considered the factors above as indicators that a significant adverse effect on the fair value of the Company’s investment in 21-Century Silicon had occurred.  Accordingly, an impairment loss of $1.0 million was recorded in the Consolidated Statements of Operations for the fiscal year ended September 30, 2010 to fully write-down the carrying amount of the investment. The Company may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million shares as the product shipment has not occurred. On October 7, 2010, the X-Change Corporation announced that it has acquired 21-Century Silicon, Inc. The terms of the acquisition is anticipated to involve a change in control of the Company and the appointment of new directors. The X-Change Corporation is anticipated to issue 20 million shares of its unregistered, restricted common stock to the shareholders of 21-Century Silicon in exchange for 100% of the issued and outstanding stock of 21-Century Silicon. As of the date of this report, the X-Change Corporation has not issued its shares to the Company.

On September 22, 2008, the registered capital of Solar EnerTech (Shanghai) Co., Ltd was increased from $25 million to $47.5 million, which was approved by the Board of Directors of the Company and authorized by Shanghai Municipal Government (the “Shanghai Government”). The paid-in capital as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be originally funded by September 21, 2010. In August 2010, the Company received the approval of the Shanghai Government to extend the funding requirement date by nine months to June 2011. As of June 30, 2010, the Company has not funded the outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase the remaining balance recently. In order to meet the registered capital requirement, the Company is in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. The Company has not received the approval from Shanghai Government as of the date of the Company's Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to the Company in September 2011.

On January 15, 2010, the Company incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement its existing production facilities to meet increased sales demands.  The subsidiary was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.  In order to fund the registered capital requirement, the Company will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. The registered capital requirement outstanding as of June 30, 2011 is $23.4 million.

On February 8, 2010, the Company acquired land use rights of a parcel of land at the price of approximately $0.7 million. This piece of land is 68,025 square meters and is located in Yizheng, Jiangsu Province of China, which will be used to house the Company’s second manufacturing facility. As part of the acquisition of the land use right, the Company is required to complete construction of the facility by February 8, 2012.

Convertible note

On March 19, 2010, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby the Company issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.  On May 11, 2011, the Company executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of the Company’s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. Notwithstanding the above, the Company’s liquidity and financial position raises substantial doubt about the Company’s ability to continue as a going concern. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041.

 
27

 
  
NOTE 18 — RELATED PARTY TRANSACTIONS

At June 30, 2011 and September 30, 2010, the accounts payable and accrued liabilities, related party balance was $0 million and $5.8 million, respectively. The $5.8 million accrued liability at fiscal year ended September 30, 2010 represents $4.8 million of compensation expense related to the Company’s obligation to withhold tax upon exercise of stock options by Mr. Young in the fiscal year 2006 and the related interest and penalties, and $1.0 million of indemnification provided by the Company to Mr. Young  for any liabilities he may incur as a result of previous stock options granted to him by Ms. Blanchard, a former officer, in conjunction with the purchase of Infotech on August 19, 2008.

Both the Company’s obligation to withhold tax upon the exercise of stock options by Mr. Young and the indemnification has a three year statute of limitation. The statute of limitation expired as of December 31, 2010. As a result, the Company released the $5.8 million on December 31, 2010.

NOTE 19 — FOREIGN OPERATIONS

The Company identifies its operating segments based on its business activities. The Company operates within a single operating segment, the manufacture of solar energy cells and modules in China.

The Company’s manufacturing operations and fixed assets are all based in China. The Company’s sales occurred in Europe, Australia, North America and China.

NOTE 20 — SUBSEQUENT EVENTS

On July 2, 2011, the Company issued 8,600,000 shares of restricted common stock to the Company’s employees pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.  The issuance of the shares of restricted stock was not registered under the Securities Act in reliance on the exemption from registration provided under Regulation S, as promulgated under the Securities Act. Shares of restricted stock were issued only to non-U.S. persons in offshore transactions who met the conditions under Regulation S.

Out of the 8,600,000 shares of restricted common stock issued, the Company issued 1,000,000 shares of restricted common stock to Yihong Yao, the Company’s Chief Financial Officer, pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.
 
On August 2, 2011, the Company paid the short term loans of approximately $302,000 to BOC. The remaining short term loans of approximately $706,000 will be due to BOC on August 15, 2011.
  
 
28

 
  
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

All references to “Solar EnerTech”, the “Company,” “we,” “our,” and “us” refer to Solar EnerTech Corp. and its subsidiaries.

The following discussion contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, readers can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue.” These statements relate to events that involve known and unknown risks, uncertainties and other factors, including those listed under the headings “Risks Related to Our Business and Our Industry,” “Risks Related to Doing Business in China” and “Risks Related To an Investment in Our Securities” in our Form 10-K filed with the Securities and Exchange Commission on December 17, 2010 as well as other relevant risks detailed in our filings with the SEC which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The information set forth in this report on Form 10-Q should be read in light of such risks and in conjunction with the consolidated financial statements and the notes thereto included elsewhere in this Form 10-Q.

Overview

Solar EnerTech Corp. is a solar product manufacturer with its headquarters based in Mountain View, California, and with low-cost operations located in Shanghai, China.  Our principal products are monocrystalline silicon and polycrystalline silicon solar cells and solar modules. Solar cells convert sunlight to electricity through the photovoltaic effect, with multiple solar cells electrically interconnected and packaged into solar modules to form the building blocks for solar power generating systems. We primarily sell solar modules to solar panel installers who incorporate our modules into their power generating systems that are sold to end-customers located in Europe, Australia, North America and China.

We have established our manufacturing base in Shanghai, China to capitalize on the cost advantages offered in manufacturing of solar power products.  In our 67,107-square-foot manufacturing facility we operate two 25 MW solar cell production lines and a 50 MW solar module production facility.  We believe that the choice of Shanghai, China for our manufacturing base provides us with convenient and timely access to key resources and conditions to support our growth and low-cost manufacturing operations.

Our solar cells and modules are sold under the brand name “SolarE”.  Our total sales for the nine months ended June 30, 2011 was $38.4 million and our end users are mainly in Europe and Australia.  In anticipation of entering the US market, we have established a headquarter office which also serves as marketing, purchasing and distribution office in Mountain View, California. Our goal is to become a worldwide supplier of PV cells and modules.

We purchase our key raw materials, silicon wafer, from the spot market.  We do not have a long term contract with any silicon supplier.

We have been able to increase sales since our inception in 2006. Although our efforts to reach profitability have been adversely affected by the global recession, the credit market contraction and a volatile polysilicon market, during fiscal year 2010 and the first quarter of fiscal year 2011 we had significantly improved our gross margin as a result of declines in raw materials costs and the efficiencies gained from greater capacity utilization at our facilities. However, during the second quarter of fiscal year 2011, the gross margin was negative 2%, mainly because of the decrease in average selling price of solar modules and decline in sales volume due to the cessation of production during the extended Chinese New Year holiday and installation of the new plasma-enhanced chemical vapor deposition (PECVD) machine.

In December 2006, we entered into a joint venture with Shanghai University to operate a research facility to study various aspects of advanced PV technology. Our joint venture with Shanghai University is for shared investment in research and development on fundamental and applied technologies in the fields of semi-conductive photovoltaic theory, materials, cells and modules. The agreement calls for Shanghai University to provide equipment, personnel and facilities for joint laboratories. It is our responsibility to provide funding, personnel and facilities for conducting research and testing. Research and development achievements from this joint research and development agreement will be available for use by both parties. We are entitled to the intellectual property rights, including copyrights and patents, obtained as a result of this research. The research and development we will undertake pursuant to this agreement includes the following:

 
we plan to research and test theories of PV, thermo-physics, physics of materials and chemistry;

 
we plan to develop efficient and ultra-efficient PV cells with light/electricity conversion rates ranging from 20% to 35%;

 
29

 
  
 
we plan to develop environmentally friendly high conversion rate manufacturing technology of chemical compound film PV cell materials;

 
we plan to develop highly reliable, low-cost manufacturing technology and equipment for thin film PV cells;

 
we plan to research and develop key material for low-cost flexible film PV cells and non-vacuum technology; and

 
we plan to research and develop key technology and fundamental theory for third-generation PV cells.

On January 7, 2010 (the “Conversion Date”), we entered into a Series A and Series B Notes Conversion Agreement (the “Conversion Agreement”) with the holders of Notes representing at least seventy-five percent of the aggregate principal amounts outstanding under the Notes to restructure the terms of the Notes. On January 7, 2010, as part of the Conversion Agreement, approximately $9.8 million of convertible notes outstanding were successfully converted into shares of our common stock. On January 19, 2010, a holder of approximately $1.8 million of our formerly outstanding Series B Notes and Series B Warrants disputed the effectiveness of the Conversion Agreement and the Warrant Amendment.  Accordingly, such holder did not tender its Series B Notes for conversion. After negotiations with such holder, on March 19, 2010, we entered into an Exchange Agreement with the holder Capital Ventures International (“CVI”) (“Exchange Agreement”), whereby we issued the Series B-1 Note with a principal amount of $1.8 million (the “Series B-1 Note”) due on March 19, 2012 and an interest at 6% per annum, which extended the original maturity date by 24 months, in exchange for the Series B Notes.

On March 19, 2010, we entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby we issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum. On May 11, 2011, we executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of our listing from the OTCBB to the OTCQB, (b) the failure of us to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common shares, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. Notwithstanding the above, our liquidity and financial position raises substantial doubt about our ability to continue as a going concern. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. 

As of June 30, 2011, we had cash and cash equivalents balance of approximately $2.3 million and short term loans outstanding of approximately $1.0 million. On May 5, 2011, we entered into a credit facility arrangement with BOC, in which we can draw up to the cumulative amount of accounts receivable outstanding from our key customer. If we are unable to successfully generate enough revenues to cover our costs or secure additional financing, our liquidity and results of operations may be materially and adversely affected. Other than as discussed in this report, we know of no trends, events or uncertainties that are reasonably likely to impact our future liquidity.

On July 6, 2011, our Board of Directors approved the appointment of Child, Van Wagoner & Bradshaw, PLLC as our new auditor replacing Ernst & Young Hua Ming (“E&Y China”). The resignation of E&Y China on May 17, 2011 was not related to any disagreements with our management on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of E&Y China would have caused it to make reference thereto in any reports on our financial statements for the past two fiscal years.
 
Environmental, Health and Safety Regulations

In our manufacturing process, we will use, generate and discharge toxic, volatile or otherwise hazardous chemicals and wastes in our manufacturing activities. We are subject to a variety of foreign, federal, state and local governmental laws and regulations related to the purchase, storage, use and disposal of hazardous materials. If we fail to comply with present or future environmental laws and regulations, we could be subject to fines, suspension of production or a cessation of operations. In addition, under some foreign, federal, state and local statutes and regulations, a governmental agency may seek recovery and response costs from operators of property where releases of hazardous substances have occurred or are ongoing, even if the operator was not responsible for the release or otherwise was not at fault.

Management believes that we have all environmental permits necessary to conduct our business and have obtained all necessary environmental permits for our facility in Shanghai. Management also believes that we have properly handled our hazardous materials and wastes and have appropriately remediated any contamination at any of our premises. We are not aware of any pending or threatened environmental investigation, proceeding or action by foreign, federal, state or local agencies, or third parties involving our current facilities. Any failure by us to control the use of or to restrict adequately the discharge of, hazardous substances could subject us to substantial financial liabilities, operational interruptions and adverse publicity, any of which could materially and adversely affect our business, results of operations and financial condition.

 
30

 
  
Solar Energy Industry

We believe that economic and national security issues, technological advances, environmental regulations seeking to limit emissions by fossil fuel, air pollution regulations restricting the release of greenhouse gasses, aging electricity transmission infrastructure and depletion and limited supply of fossil fuels, has made reliance on traditional sources of fuel for generating electricity less attractive. Government policies, in the form of both regulation and incentives, have accelerated the adoption of solar technologies by businesses and consumers. For example, in the U.S., the Energy Policy Act (EPACT) enacted a 30% investment tax credit for solar, and in January 2006, California approved the largest solar program in the country's history that provides for long term subsidies in the form of rebates to encourage use of solar energy where possible.

Government Subsidies and Incentives

Various subsidies and tax incentive programs exist at the federal and state level to encourage the adoption of solar power including capital cost rebates, performance-based incentives, feed-in tariffs, tax credits and net metering. Capital cost rebates provide funds to customers based on the cost or size of a customer's solar power system. Performance-based incentives provide funding to a customer based on the energy produced by their solar system. Under a feed-in tariff subsidy, the government sets prices that regulated utilities are required to pay for renewable electricity generated by end-users. The prices are set above market rates and may be differentiated based on system size or application. Feed-in tariffs pay customers for solar power system generation based on kilowatt-hours produced, at a rate generally guaranteed for a period of time. Tax credits reduce a customer's taxes at the time the taxes are due. Under net metering programs, a customer can generate more energy than used, during which periods the electricity meter will spin backwards. During these periods, the customer "lends" electricity to the grid, retrieving an equal amount of power at a later time. Net time metering programs enable end-users to sell excess solar electricity to their local utility in exchange for a credit against their utility bills. Net metering programs are usually combined with rebates, and do not provide cash payments if delivered solar electricity exceeds their utility bills. In addition, several states have adopted renewable portfolio standards, which mandate that a certain portion of electricity delivered to customers come from a set of eligible renewable energy resources. Under a renewable portfolio standard, the government requires regulated utilities to supply a portion of their total electricity in the form of renewable electricity. Some programs further specify that a portion of the renewable energy quota must be from solar electricity.

Despite the benefits of solar power, there are also certain risks and challenges faced by solar power. Solar power is heavily dependent on government subsidies to promote acceptance by mass markets. We believe that the near-term growth in the solar energy industry depends significantly on the availability and size of these government subsidies and on the ability of the industry to reduce the cost of generating solar electricity. The market for solar energy products is, and will continue to be, heavily dependent on public policies that support growth of solar energy. There can be no assurances that such policies will continue. Decrease in the level of rebates, incentives or other governmental support for solar energy would have an adverse affect on our ability to sell our products.

Critical Accounting Policies

We consider our accounting policies related to principles of consolidation, revenue recognition, inventory reserve, and stock based compensation, fair value of equity instruments and derivative financial instruments to be critical accounting policies. A number of significant estimates, assumptions, and judgments are inherent in determining our consolidation policy, when to recognize revenue, how to evaluate our equity instruments and derivative financial instruments, and the calculation of our inventory reserve and stock-based compensation expense. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates. Management believes that there have been no significant changes during the nine months ended June 30, 2011 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis or Plan of Operations in our Annual Report on Form 10-K filed for the year ended September 30, 2010 with the Securities and Exchange Commission (the “SEC”). For a description of those critical accounting policies, please refer to our 2010 Annual Report on Form 10-K.

Inventories

Inventories are stated at the lower of cost or market. Cost is determined by the weighted-average method. Market is defined principally as net realizable value. Raw material cost is based on purchase costs while work-in-progress and finished goods are comprised of direct materials, direct labor and an allocation of manufacturing overhead costs. Inventory in-transit is included in finished goods and consists of products shipped but not recognized as revenue because it does not meet the revenue recognition criteria. Provisions are made for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of net realizable value.

 
31

 
  
Impairment of Long Lived Assets

We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. When such factors and circumstances exist, management compares the projected undiscounted future cash flows associated with the future use and disposal of the related asset or group of assets to their respective carrying values. Impairment, if any, is measured as the excess of the carrying value over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. No loss on property and equipment impairment was recorded during the nine months ended June 30, 2011 and 2010.

Investment

Investment in an entity where we own less than twenty percent of the voting stock of the entity and do not exercise significant influence over operating and financial policies of the entity are accounted for using the cost method. Investment in the entity where we own twenty percent or more, but not in excess of fifty percent of the voting stock of the entity or less than twenty percent and exercises significant influence over operating and financial policies of the entity are accounted for using the equity method. We have a policy in place to review our investments at least annually and to evaluate the carrying value of the investments in these companies. The cost method investment is subject to impairment assessment if there are identified events or changes in circumstance that may have a significant adverse affect on the fair value of the investment. If we believe that the carrying value of an investment is in excess of estimated fair value, it is our policy to record an impairment charge to adjust the carrying value to the estimated fair value, if the impairment is considered other-than-temporary.

On August 21, 2008, we entered into an equity purchase agreement in which we acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash which was subsequently written down in full. See “Note 3 – Summary of Significant Accounting Policies – Investments” in the Notes to Consolidated Financial Statements of this Form 10-Q.

Warranty Cost

We provide product warranties and accrue for estimated future warranty costs in the period in which revenue is recognized. Our standard solar modules are typically sold with a two-year warranty for defects in materials and workmanship and a ten-year and twenty five-year warranty against declines of more than 10.0% and 20.0%, respectively, of the initial minimum power generation capacity at the time of delivery. We therefore maintain warranty reserves to cover potential liabilities that could arise from our warranty obligations and accrue the estimated costs of warranties based primarily on management’s best estimate. In estimating warranty costs, we applied FASB ASC 460 – Guarantees, specifically paragraphs 460-10-25-5 to 460-10-25-7 of the FASB Accounting Standards Codification. This guidance requires that we make a reasonable estimate of the amount of a warranty obligation. It also provides that in the case of an entity that has no experience of its own, reference to the experience of other entities in the same business may be appropriate. Because we began to commercialize our products in fiscal year 2007, there is insufficient experience and historical data that can be used to reasonably estimate the expected failure rate of our solar modules. Thus, we consider warranty cost provisions of other China-based manufacturers that produce photovoltaic products that are comparable in engineering design, raw material input and functionality to our products, and sold to a similar target and class of customer with similar warranty coverage. In determining whether such peer information can be used, we also consider the years of experience that these manufacturers have in the industry. Because our industry is relatively young as compared to other traditional manufacturing industries, the selected peer companies that we consider have less than ten years in manufacturing and selling history. In addition, they have a manufacturing base in China, offer photovoltaic products with comparable engineering design, raw material input, functionality and similar warranty coverage, and sell in markets, including the geographic areas and class of customer, where we compete.  Based on the analysis applied, we accrue warranty at 1% of sales. We have not experienced any material warranty claims to date in connection with declines of the power generation capacity of its solar modules and will prospectively revise its actual rate to the extent that actual warranty costs differ from the estimates.

Income Taxes

We account for income taxes under the liability method per the provisions of FASB ASC 740, “Income Taxes”, formerly referenced as SFAS No. 109, “Accounting for Income Taxes”.

Under the provisions of FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between their financial statement carrying values and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 
32

 
  
Valuation Allowance

Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, we consider all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that we change our determination as to the amount of deferred tax assets that can be realized, we will adjust our valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.

Unrecognized Tax Benefits

Effective on October 1, 2007, we adopted the provisions related to uncertain tax positions under FASB ASC 740, “Income Taxes”, formerly referenced as FIN 48, “Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109”. Under FASB ASC 740, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority based solely on the technical merits of the associated tax position. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. We also elected the accounting policy that requires interest and penalties to be recognized as a component of tax expense. We classify the unrecognized tax benefits that are expected to result in payment or receipt of cash within one year as current liabilities, otherwise, the unrecognized tax benefits will be classified as non-current liabilities.

Fair Value of Derivative Financial Instruments and Warrants

Our management used the binomial valuation model to value the derivative financial instruments and warrants. The model uses inputs such as implied term, suboptimal exercise factor, volatility, dividend yield and risk free interest rate. Selection of these inputs involves management’s judgment and may impact estimated value. Management selected the binomial model to value these derivative financial instruments and warrants as opposed to the Black-Scholes-Merton model primarily because management believes the binomial model produces a more reliable value for these instruments because it uses an additional valuation input factor, the suboptimal exercise factor, which accounts for expected holder exercise behavior which management believes is a reasonable assumption with respect to the holders of these warrants.

Stock-Based Compensation

On January 1, 2006, Solar EnerTech began recording compensation expense associated with stock options and other forms of employee equity compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation”.

We estimate the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula and a single option approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The following assumptions are used in the Black-Scholes-Merton option pricing model:

Expected Term — Our expected term represents the period that our stock-based awards are expected to be outstanding.

Expected Volatility — We expected volatilities are based on historical volatility of our stock, adjusted where determined by management for unusual and non-representative stock price activity not expected to recur. Due to the limited trading history, we also considered volatility data of guidance companies.

Expected Dividend —The Black-Scholes-Merton valuation model calls for a single expected dividend yield as an input. We currently pay no dividends and do not expect to pay dividends in the foreseeable future.

Risk-Free Interest Rate— We base the risk-free interest rate on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.

Estimated Forfeitures— When estimating forfeitures, We take into consideration the historical option forfeitures over the expected term.

Revenue Recognition

We recognize revenues from product sales in accordance with guidance in FASB ASC 605, “Revenue Recognition”, which states that revenue is realized or realizable and earned when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and collectability is reasonably assured. Where a revenue transaction does not meet any of these criteria it is deferred and recognized once all such criteria have been met. In instances where final acceptance of the product, system, or solution is specified by the customer, revenue is deferred until all acceptance criteria have been met.

 
33

 
  
On a transaction by transaction basis, we determine if the revenue should be recorded on a gross or net basis based on criteria discussed in the Revenue Recognition topic of the FASB Subtopic 605-405, “Reporting Revenue Gross as a Principal versus Net as an Agent”. We consider the following factors to determine the gross versus net presentation: if we (i) act as principal in the transaction; (ii) take title to the products; (iii) have risks and rewards of ownership, such as the risk of loss for collection, delivery or return; and (iv) act as an agent or broker (including performing services, in substance, as an agent or broker) with compensation on a commission or fee basis.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are carried at net realizable value. We record our allowance for doubtful accounts based upon our assessment of various factors. We consider historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect customers’ ability to pay.

Recent Accounting Pronouncements

For recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our consolidated condensed financial statements, see “Note 3 — Summary of Significant Accounting Policies” in the Notes to Consolidated Financial Statements of this Form 10-Q.

Results of Operations for the three and nine months ended June 30, 2011 and 2010

The following discussion of the financial condition, results of operations, cash flows and changes in financial position of our Company should be read in conjunction with our audited consolidated financial statements and notes filed with the SEC on Form 10-K and its subsequent amendments.

Sales, Cost of Sales and Gross Profit (Loss)

   
Three Months Ended June 30, 2011
   
Three Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Sales
  $ 12,203,000       100.0 %   $ 16,355,000       100.0 %   $ (4,152,000 )     (25.4 )%
Cost of sales
    (12,762,000 )     (104.6 )%     (15,051,000 )     (92.0 )%     2,289,000       (15.2 )%
Gross profit (loss)
  $ (559,000 )     (4.6 )%   $ 1,304,000       8.0 %   $ (1,863,000 )     (142.9 )%

   
Nine Months Ended June 30, 2011
   
Nine Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Sales
  $ 38,390,000       100.0 %   $ 51,799,000       100.0 %   $ (13,409,000 )     (25.9 )%
Cost of sales
    (38,080,000 )     (99.2 )%     (47,637,000 )     (92.0 )%     9,557,000       (20.1 )%
Gross profit (loss)
  $ 310,000       0.8 %   $ 4,162,000       8.0 %   $ (3,852,000 )     (92.6 )%

For the three months ended June 30, 2011, we reported total sales of $12.2 million, representing a decrease of $4.2 million, or 25.4%, compared to $16.4 million of sales in the same period of the prior year. For the three months ended June 30, 2011, our $12.2 million in sales mainly comprised of solar module sales. In comparison, our $16.4 million in sales in the same period of the prior year comprised of $15.8 million in solar module sales, $0.2 million in solar cell sales and $0.4 million in resale of raw materials. The solar module shipments decreased from 8.6 MW in the three months ended June 30, 2010 to 7.7 MW in the three months ended June 30, 2011. In addition, the unit selling price decreased from $1.64 per watt for the three months ended June 30, 2010 to $ 1.58 per watt for the three months ended June 30, 2011. The decline in sales was mainly due to a downturn in major European markets which has left module shipments well in excess of demand.

For the nine months ended June 30, 2011, we recorded $38.4 million in revenue which comprised of $37.8 million in solar module sales and $0.6 million in solar cell sales compared to $51.8 million of revenue in the same period of the prior year which comprised of $44.4 million in solar module sales, $4.9 million in solar cell sales and $2.5 million in resale of raw materials. The decrease in module sales resulted from the decrease in solar module shipments from 24.3 MW for the nine months ended June 30, 2010 to 21.7 MW for the nine months ended June 30, 2011, and also from decrease in average selling price from $1.82 per watt for the nine months ended June 30, 2010 to $ 1.73 per watt for the nine months ended June 30, 2011.

For the three months ended June 30, 2011, we incurred a gross loss of $0.6 million, representing a decrease of $1.9 million, or 142.9%, compared to a gross profit of $1.3 million in the same period of the prior year.  The decrease in gross profit was primarily due to a decrease in average selling price for solar modules, lower production volume for the three months ended June 30, 2011 (resulting in higher fixed production cost per unit and lower gross margin), and lower sales volume which caused the total margin to decrease.

 
34

 
  
For the nine months ended June 30, 2011, we incurred a gross profit of $0.3 million, representing a decrease of $3.9 million or 92.6% compared to a gross profit of $4.2 million in the same period of the prior year.  The decrease in gross profit was primarily due to the decrease of sales price and higher unit production cost from lower production volume and various increases in raw material cost (other than wafer).

Selling, general and administrative

   
Three Months Ended June 30, 2011
   
Three Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Selling, general and administrative
  $ 1,394,000       11.4 %   $ 2,475,000       15.1 %   $ (1,081,000 )     (43.7 )%
 
   
Nine Months Ended June 30, 2011
   
Nine Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Selling, general and administrative
  $ 5,799,000       15.1 %   $ 7,243,000       14.0 %   $ (1,444,000 )     (19.9 )%

For the three months ended June 30, 2011, our selling, general and administrative expenses were $1.4 million, representing a decrease of $1.1 million, or 43.7%, from $2.5 million in the three months ended June 30, 2010. Selling, general and administrative expenses as a percentage of sales for the three months ended June 30, 2011 decreased to 11.4% from 15.1% for the three months ended June 30, 2010. The decrease in the selling, general and administrative expenses was primarily due to a decrease in sales orders which caused a decrease in variable cost such as shipping and handling costs.

For the nine months ended June 30, 2011, our selling, general and administrative expenses were $5.8 million, representing a decrease of $1.4 million or 19.9% from $7.2 million in the nine months ended June 30, 2010. Selling, general and administrative expenses as a percentage of net sales for the nine months ended June 30, 2011 increased to 15.1% from 14.0% for the nine months ended June 30, 2010. The decrease in the selling, general and administrative expenses were primarily due to a decrease of $0.2 million in stock-based compensation expenses related to employee options and restricted stock from $2.1 million for the nine months ended June 30, 2010 to $1.9 million for the nine months ended June 30, 2011. Excluding stock-based compensation expenses, our selling, general & administrative expenses decreased by approximately $1.2 million primarily due to a decrease in sales and marketing activities.

Research and development

   
Three Months Ended June 30, 2011
   
Three Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Research and development
  $ 63,000       0.5 %   $ 54,000       0.3 %   $ 9,000       16.7 %
 
   
Nine Months Ended June 30, 2011
   
Nine Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Research and development
  $ 216,000       0.6 %   $ 287,000       0.6 %   $ (71,000 )     (24.7 )%

Research and development expenses in the three months ended June 30, 2011 and 2010 were flat at $0.1 million. Research and development expenses as a percentage of sales for the three months ended June 30, 2011 increased to 0.5% from 0.3% for the three months ended June 30, 2010.

Research and development expense in the nine months ended June 30, 2011 and 2010 were $0.2 million and $0.3 million, respectively. Research and development expense as a percentage of net sales for the nine months ended June 30, 2011 and 2010 remained the same at 0.6%.

In accordance with our joint research and development laboratory agreement with Shanghai University, dated December 15, 2006 (amended on November 12, 2010) expiring on December 15, 2016, we committed to fund the establishment of laboratories and completion of research and development activities at no less than RMB 30 million ($4.5 million) cumulatively within eight years (extended from five years). The funding requirements are based on specific milestones agreed upon by Shanghai University and us. Shanghai University needs to obtain the pre-approval from us before incurring expenditures on the program. There was $13,000 funding to Shanghai University during the nine months ended June 30, 2011. As of June 30, 2011, there are approximately $3.2 million remaining to be funded in full by December 15, 2014.

 
35

 
  
Loss (gain) on debt extinguishment
  
   
Three Months Ended June 30, 2011
   
Three Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Loss (gain) on debt extinguishment
  $ (23,000 )     (0.2 )%   $ -       0.0 %   $ (23,000 )     0. %
 
   
Nine Months Ended June 30, 2011
   
Nine Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Loss (gain) on debt extinguishment
  $ (55,000 )     (0.1 )%   $ 18,549,000       35.8 %   $ (18,604,000 )     (100.3 )%

For the three months ended June 30, 2011, $100,000 of Series B-1 Note was converted into 1,000,000 shares of our common shares. As a result, we recorded a cumulative gain on debt extinguishment of approximately $23,000 as a result of the Conversion Agreement and the Exchange Agreement during the three months ended June 30, 2011.

During the nine months ended June 30, 2011, $200,000 of the Series B-1 Note was converted into 1,666,667 shares of our common stock. As a result, we recorded a cumulative gain on debt extinguishment of approximately $55,000 as a result of the Conversion Agreement and the Exchange Agreement during the nine months ended June 30, 2011.

There was no loss on debt extinguishment recorded during the three months ended June 30, 2010. During the nine months ended June 30, 2010, we recorded a cumulative loss on debt extinguishment of approximately $18.5 million as a result of the Conversion Agreement and the Exchange Agreement.

Reversal of payroll related tax accrual

   
Three Months Ended June 30, 2011
   
Three Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Reversal of payroll related tax accrual
  $ -       0.0 %   $ -       0.0 %   $ -       0.0 %
 
   
Nine Months Ended June 30, 2011
   
Nine Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Reversal of payroll related tax accrual
  $ (5,817,000 )     (15.2 )%   $ -       0.0 %   $ (5,817,000 )     0.0 %

The reversal of payroll related tax accrual of $5.8 million during the nine months ended June 30, 2011 represented $4.8 million of compensation expense related to our obligation to withhold tax upon exercise of stock options by Mr. Young in the fiscal year 2006 and the related interest and penalties, and $1.0 million of indemnification provided by us to Mr. Young  for any liabilities he may incur as a result of previous stock options granted to him by Ms. Blanchard, a former officer, in conjunction with the purchase of Infotech on August 19, 2008.

Both our obligation to withhold tax upon the exercise of stock options by Mr. Young and the indemnification have a three year statute of limitation. The statute of limitation expired as of December 31, 2010. As a result, we have released the $5.8 million in the nine months ended June 30, 2011.

 
36

 
  
Other income (expense)

   
Three Months Ended June 30, 2011
   
Three Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Interest income
  $ -       0.0 %   $ 1,000       0.0 %   $ (1,000 )     (100.0 )%
Interest expense
    (67,000 )     (0.5 )%     (59,000 )     (0.4 )%     (8,000 )     13.6 %
Gain on change in fair market value
                                               
of compound embedded derivative
    181,000       1.5 %     717,000       4.4 %     (536,000 )     (74.8 )%
Gain on change in fair market value
                                               
of warrant liability
    628,000       5.1 %     1,393,000       8.5 %     (765,000 )     (54.9 )%
Impairment loss on investment
    -       0.0 %     (1,000,000 )     (6.1 )%     1,000,000       (100.0 )%
Other expense
    (60,000 )     (0.5 )%     (485,000 )     (3.0 )%     425,000       (87.6 )%
Total other income (expense)
  $ 682,000       5.6 %   $ 567,000       3.5 %   $ 115,000       20.3 %
 
   
Nine Months Ended June 30, 2011
   
Nine Months Ended June 30, 2010
   
Year-Over-Year Change
 
   
Amount
   
% of net sales
   
Amount
   
% of net sales
   
Amount
   
% of change
 
Interest income
  $ 4,000       0.0 %   $ 5,000       0.0 %   $ (1,000 )     (20.0 )%
Interest expense
    (247,000 )     (0.6 )%     (5,383,000 )     (10.4 )%     5,136,000       (95.4 )%
Gain on change in fair market value
                                               
of compound embedded derivative
    263,000       0.7 %     1,115,000       2.2 %     (852,000 )     (76.4 )%
Gain on change in fair market value
                                               
of warrant liability
    853,000       2.2 %     4,369,000       8.4 %     (3,516,000 )     (80.5 )%
Impairment loss on investment
    -       0.0 %     (1,000,000 )     (1.9 )%     1,000,000       (100.0 )%
Other expense
    (510,000 )     (1.3 )%     (929,000 )     (1.8 )%     419,000       (45.1 )%
Total other income (expense)
  $ 363,000       0.9 %   $ (1,823,000 )     (3.5 )%   $ 2,186,000       (119.9 )%

For the three months ended June 30, 2011, total other income was $0.7 million, representing an increase of $0.1 million, or 20.3%, compared to total other income of $0.6 million for the same period of the prior year. Other expense as a percentage of sales for the three months ended June 30, 2011 was 5.6% compared to other income as a percentage of sales of 3.5% for the same period in the prior year. We incurred interest expenses of $67,000 and $59,000 in the three months ended June 30, 2011 and 2010, respectively, primarily related to 6% interest charges on the Series B-1 Note. In the three months ended June 30, 2011, we recorded a gain on change in fair market value of warranty liability of $0.6 million and a gain on change in fair market value of compound embedded derivative of $0.2 million compared to a gain on change in fair market value of warrant liability of $1.4 million and a gain on change in fair market value of compound embedded derivative of $0.7 million during the three months ended June 30, 2010.  Other expenses of $0.1 million and $0.5 million for the three months ended June 30, 2011 and 2010, respectively, were primarily related to foreign exchange loss.

The $1.0 million in impairment loss on investment for the three and nine months ended June 30, 2010 is related to the write-down of our investment in 21-Century Silicon, which we consider as unrecoverable.  No write-down of investment is recorded for the nine months ended June 30, 2011.

For the nine months ended June 30, 2011, total other income was $0.4 million, representing an increase of $2.2 million or 119.9% compared to $1.8 million for the same period of the prior year. Other expenses as a percentage of net sales for the nine months ended June 30, 2011 decreased to 0.9% from 3.5% for the nine months ended June 30, 2010. In the nine months ended June 30, 2011, we recorded a gain on change in fair market value of compound embedded derivative of $0.3 million and a gain on change in fair market value of warrant liability of $0.9 million compared to a gain on change in fair market value of compound embedded derivative of $1.1 million and a gain on change in fair market value of warrant liability of $4.4 million during the nine months ended June 30, 2010. The lower conversion price of the compound embedded derivative and warrant in the nine months ended June 30, 2011 compared to that in the nine months ended June 30, 2010, resulted in less decrease in the fair value of the compound embedded derivative and warrant liability and less gains on change in fair market value of the compound embedded derivative and warrant liability. We incurred interest expenses of $0.2 million and $5.4 million in the nine months ended June 30, 2011 and 2010, respectively, primarily related to the amortization of the discount on the convertible notes and deferred financing cost, and 6% interest charges on Series A and B, and Series B-1 Convertible Notes. Other expenses of $0.5 million and $0.9 million for the nine months ended June 30, 2011 and 2010, respectively, were primarily related to foreign exchange loss.

 
37

 
  
Liquidity and Capital Resources

   
June 30, 2011
   
September 30, 2010
   
Change
 
                   
Cash and cash equivalents
  $ 2,250,000     $ 6,578,000     $ (4,328,000 )

As of June 30, 2011, we had cash and cash equivalents of $2.3 million as compared to $6.6 million at September 30, 2010. We will require a significant amount of cash to fund our operations. Changes in our operating plans, an increase in our inventory, increased expenses, or other events, may cause us to seek additional equity or debt financing in the future. In order to continue as a going concern, we will need to continue to generate new sales while controlling our costs.  If we are unable to successfully generate enough sales to cover our costs, our liquidity and results of operations may be materially and adversely affected and we may not continue as a going concern.

Our liquidity is impacted to a large extent based on both the nature of the products we sell and also the geographical location of our customers, as our payment terms on sale vary greatly depending on both factors. With respect to the products we sell, while in the past we have engaged in transactions where we have resold our raw materials due to our overstock of materials relative to our then limited production capacity, as our production capacity has increased over the years, our sales now consist primarily of solar modules to solar panel installers in Europe and Australia who incorporate our modules into their power generating systems that are sold to end-customers. Payment terms for the sale of our modules are generally longer than payment terms where we resell our raw materials in China and as a result, our payment terms have lengthened relative to prior years. In addition, with respect to the geographic location of our customers, the payment terms for the sale of our solar modules are generally longer for our customers in the United States than for our customers in Europe and Australia. While our current sales to customers in the United States are limited, if we are able to increase our sales in the U.S. market or in other markets that may have longer payment terms, our payment terms may lengthen. Payment terms for our solar module sales generally range from 0 to 60 days. In some cases, these terms are extended up to 200 days for certain qualifying customers of whom we applied rigorous credit requirements. If we have more sales of products or in geographies with longer payment terms, the longer payment terms will impact the timing of our cash flows.

   
Nine Months Ended June 30,
       
   
2011
   
2010
   
Change
 
                   
Net cash provided by (used in):
                 
Operating activities
  $ (2,660,000 )   $ 653,000     $ (3,313,000 )
Investing activities
    (1,712,000 )     (454,000 )     (1,258,000 )
Financing activities
    (343,000 )     729,000       (1,072,000 )
Effect of exchange rate changes on cash and cash equivalents
    387,000       15,000       372,000  
Net increase (decrease) in cash and cash equivalents
  $ (4,328,000 )   $ 943,000     $ (5,271,000 )

Net cash used in operating activities was $2.7 million for the nine months ended June 30, 2011, representing an increase of $3.3 million, compared to net cash provided by operating activities of $0.7 million for the nine months ended June 30, 2010. Cash flow from operating activities reflected a net income of $0.5 million adjusted for non-cash items, including depreciation of property and equipment, stock-based compensation, reversal of payroll related tax accruals, gain on debt extinguishment, amortization of note discount and deferred financing cost, the change in the fair market value of the compound derivative liabilities and warrants liabilities, and payment of interest by issuance of shares. The increase of $3.3 million in net cash used in operating activities from the nine months ended June 30, 2010 to the nine months ended June 30, 2011 was mainly attributable to more cash out flow for purchase of raw materials in the nine months ended June 30, 2011 compared to the same period in 2010. The payment terms granted by our major vendors were from 0 to 60 days. There was no material changes in the payment terms granted by our major vendors in the nine months ended June 30, 2011 compared to the same period in the prior year. The net income excluding non-cash expenses for the nine months ended June 30, 2011 decreased compared to the same period in 2010, coupled with lower balances in accounts payable, accrued liabilities and customer advance payment as of June 30, 2011 compared to June 30, 2010.

Net cash used in investing activities were $1.7 million and $0.5 million in the nine months ended June 30, 2011 and 2010, respectively. The increase of $1.3 million in net cash used in investing activities was primarily due to higher property and equipment acquisitions during the nine months ended June 30, 2011 compared to the nine months ended June 30, 2010.

Net cash used in financing activities was $0.3 million in the nine months ended June 30, 2011 and net cash used provided by financing activities in the nine months ended June 30, 2010 was $0.7 million. The increase of $1.1 million in net cash used in financing activities was primarily due to us paying off our credit facility at IBC.

 
38

 
  
Our consolidated balance sheet, statements of operations and cash flows have been prepared on the assumption that we will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

On March 19, 2010, we entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby we issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum. On May 11, 2011, we executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of our listing from the OTCBB to the OTCQB, (b) the failure of us to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. Notwithstanding the above, our liquidity and financial position raises substantial doubt about our ability to continue as a going concern. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041.  

On March 25, 2010, we entered into a one year contract with China Export & Credit Insurance Corporation (“CECIC”) to insure the collectability of outstanding accounts receivable for two of the key customers. We pay a fee based on a fixed percentage of the accounts receivable outstanding and expense this fee when it is incurred. In addition, on March 30, 2010, we entered into a one year revolving credit facility arrangement with IBC that is secured by the accounts receivable balances of the two key customers insured by CECIC above. On March 25, 2011, we renewed our contract with CECIC for another one year to insure the collectability of outstanding accounts receivable of one of the key customers for up to $3.5 million. On May 5, 2011, we terminated the credit facility arrangement with IBC and on the same day, we entered into a revolving credit facility arrangement with Bank of China (“BOC”), which is also secured by the accounts receivable balances of the key customers insured by CECIC above. If the insured customer fails to repay the amounts outstanding due to us, the insurance proceeds will be remitted directly to BOC instead of us.  The interest rate of the credit facility is variable and ranged from 3.78% to 5.30% during the nine months ended June 30, 2011. The amount drawn down as of June 30, 2011, amounted to $1,008,000 and there have been no insurance claims submitted to CECIC. We have repaid all amounts subsequently on August 12, 2011 when the loan came due. The credit facility contains certain non-financial ratios related covenants, including maintaining creditworthiness, complying with all contractual obligations as requested by BOC, fulfillment of other indebtedness (if any), maintaining its business license and continuing operations, ensuring its financial condition does not deteriorate, remaining solvent, and other conditions, as defined in the credit facility agreement. We complied with these covenants as of June 30, 2011. If we fail to comply with our covenants on our credit facility, our debt may be accelerated or future drawdown requests may not be honored.

As of June 30, 2011, we had cash and cash equivalents balance of approximately $2.3 million and short term loans outstanding of approximately $1.0 million. If we experience a material shortfall versus our operating plans, we have a range of actions we can take to remediate the cash shortage, including but not limited to raising additional funds through debt financing, securing a credit facility, entering into secured or unsecured bank loans, or undertaking equity offerings such as a rights offering to existing shareholders. However, due to the conditions of capital and credit markets, we cannot be sure that external financing will be available when needed or that, if available, financing will be obtained on terms favorable to us or our stockholders. If we are unable to successfully generate enough revenues to cover our costs or secure additional financing, our liquidity and results of operations may be materially and adversely affected.

Off-Balance Sheet Arrangements

Pursuant to a joint research and development laboratory agreement with Shanghai University, dated December 15, 2006 and expiring on December 15, 2016, we are committed to funding the establishment of laboratories and completion of research and development activities. On November 12, 2010, we amended the agreement with Shanghai University and extended the commitment from five years to eight years, and consequently the agreement will end on December 15, 2014. Based on the amendment, we committed to fund no less than RMB 30 million ($4.5 million) cumulatively across the eight years. The funding requirements are based on specific milestones agreed upon by Shanghai University and us. As of June 30, 2011, there are approximately $3.2 million remaining to be funded in full by December 15, 2014.

We intend to increase research and development spending as we grow our business. The payment to Shanghai University will be used to fund program expenses and equipment purchase. Shanghai University needs to obtain the pre-approval from us before incurring expenditures on the program. If we fail to make pre-approved funding payments, when requested, we will be deemed to be in breach of the agreement. If we are unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, we are not in breach as we have not received any additional compensation requests for pre-approved funding payment from Shanghai University.

 
39

 
  
On August 21, 2008, we entered into an equity purchase agreement in which we acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash. However, 21-Century Silicon’s production facilities and technical development were significantly below expected standards and was in a working capital deficit. Therefore, we considered the above findings as indicators that a significant adverse effect on the fair value of our investment in 21-Century Silicon had occurred. Accordingly, an impairment loss of $1.0 million was recorded to fully write-down the carrying amount of the investment as of June 30, 2010. See “Note 3 — Summary of Significant Accounting Policies – Investments” in the Notes to Consolidated Financial Statements of this Form 10-Q.

On September 22, 2008, the registered capital of Solar EnerTech (Shanghai) Co., Ltd was increased from $25 million to $47.5 million, which was approved by our Board of Directors and authorized by Shanghai Municipal Government (the “Shanghai Government”). The paid-in capital as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million, originally to be funded by September 21, 2010. In August 2010, we received the approval of the Shanghai Government to extend the funding requirement date by nine months to June 2011. As of June 30, 2010, we have not funded the outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase the remaining balance recently. In order to meet the registered capital requirement, we are in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. We have not received the approval from Shanghai Government as of the date of our Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to us in September 2011.

On January 15, 2010, we incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement our existing production facilities to meet increased sales demands.  The subsidiary was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.  In order to fund the registered capital requirement, we will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. The registered capital requirement outstanding as of June 30, 2011, is $23.4 million.

On February 8, 2010, we acquired land use rights of a parcel of land at the price of approximately $0.7 million. This piece of land is 68,025 square meters and is located in Yizheng, Jiangsu Province of China, which will be used to house our second manufacturing facility. As part of the acquisition of the land use right, we are required to complete construction of the facility by February 8, 2012.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a Smaller Reporting Company as defined by Rule 12b-2 of the Exchange Act and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As required by Rule 13a-15 of the Securities Exchange Act of 1934, our Chief Executive Officer and Chief Financial Officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities Exchange Commission, and to ensure that such information required to be disclosed by our company in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our company's management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the lack of finance and accounting personnel with an appropriate level of knowledge, experience and training in the application of U.S. GAAP. Our fiscal 2010 financial reporting close process was ineffective in recording certain transactions according to the applicable accounting pronouncement and preparing certain critical financial statement disclosures. Our plan to remediate the material weaknesses primarily consisted of hiring finance and accounting personnel with an appropriate level of knowledge, experience and training in the application of U.S. GAAP and training, educating and equipping our existing personnel on U.S. GAAP accounting matters and enhance our accounting and finance policy.

We are in the process of implementing the following measures to remediate these material weaknesses: (a) hire additional financial reporting and accounting personnel with relevant account experience, skills, and knowledge in the preparation of financial statements under the requirements of U.S. GAAP; (b) continue to work with internal and external consultants to improve the process for collecting and reviewing information required for the preparation of financial statements; and (c) enhance our accounting and finance policy and procedure manuals to provide guidance to our finance and accounting staff and develop tools or checklists to improve the completeness and accuracies of financial disclosures.

 
40

 
 
Changes in Internal Control over Financial Reporting
 
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has concluded there were no changes in our internal controls over financial reporting that occurred during the quarter ended June 30, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 
41

 
 
PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None

ITEM 1A. RISK FACTORS

Except as set forth below, the Company’s risk factors are included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010 and remain the same.

We have a limited amount of cash to fund our operations.  If we cannot obtain additional sources of cash, our growth prospects and future profitability may be materially adversely affected and we may not be able to continue as a going concern.

During the third quarter of fiscal year 2011, the gross margin was negative 5%, mainly because of the decrease in average selling price of solar modules from $1.91 per watt in the first quarter of 2011 to $1.58 per watt in the third quarter of fiscal year 2011, coupled with a decline in sales volume from 8 MW in the first quarter of 2011 to 7.7 MW in the third quarter of fiscal year 2011 due to a downturn in major European markets which has left module shipments well in excess of demand. Also, the devaluation of Euro dollar against RMB natively affecting our return, usually 45-40 days after cargo was shipped. The FIT policy cancellation caused high inventory and low sales orders, and the lower production volume resulted in a higher fixed cost per unit, driving down margins. We have already secured orders from two major customers amounting to 40 MW in volume and anticipate additional volume from other existing customers. Additionally, in May 2011, to finance projected operating requirements, we successfully entered into agreement of accounts receivable financing with Bank of China (“BOC”). Through the agreement, we can get the financing we need to support our operations.

On March 19, 2010, we entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby we issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.  On May 11, 2011, we executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of our listing from the OTCBB to the OTCQB, (b) the failure of us to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, our liquidity and financial position raises substantial doubt about our ability to continue as a going concern.

Pursuant to a joint research and development laboratory agreement with Shanghai University, there are approximately $3.2 million remaining of research and development commitment to be funded in full by December 15, 2014.  If we fail to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If we are unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, we are not in breach as it has not received any additional compensation requests for pre-approved funding payment from Shanghai University.

On August 21, 2008, we acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash. We may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by us. As of June 30, 2011, we have not yet acquired the additional two million shares as the product shipment has not occurred. The paid-in capital of Solar EnerTech (Shanghai) Co., Ltd as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be funded by June 2011. As of June 30, 2010, we have not funded the outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase the remaining balance recently. In order to meet the registered capital requirement, we are in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. We have not received the approval from Shanghai Government as of the date of our Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to us in September 2011.

Our subsidiary in Yizheng Jiangsu Province was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.  In order to fund the registered capital requirement, we will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. On February 8, 2010, we acquired land use rights of a parcel of land at the price of approximately $0.7 million. As part of the acquisition of the land use right, we are required to complete construction of the facility by February 8, 2012.

 
42

 
  
As of June 30, 2011, we had a cash and cash equivalents balance of approximately $2.3 million and short term loans outstanding of approximately $1.0 million. Operating cash outflows amounted to $2.7 million in the nine months ended June 30, 2011, mainly due to payments to our vendors based on contractual terms. There have been no significant changes in the payment terms of our major vendors in the three months ended June 30, 2011 compared to the same period in the prior year. If we are unable to successfully generate enough revenues to cover our costs or secure additional financing, our liquidity and results of operations may be materially and adversely affected and may not continue as a going concern.

If we fail to comply with our covenants on our credit facility, our debt may be accelerated or future drawdown requests may not be honored.

Our credit facility with BOC contains provisions whereby BOC can demand repayment of outstanding debt if we do not comply with any of the covenants, including but not limited to, maintaining our creditworthiness, complying with all our contractual obligations as requested by BOC, fulfillment of other indebtedness (if any), maintaining our business license and continuing operations, ensuring our financial condition does not deteriorate, remaining solvent, and other conditions, as defined in the credit facility agreement. Since certain of the covenants are broadly constructed and subjective in nature, BOC may have the right to demand repayment of any outstanding debt as it may determine in its own discretion. In addition, if BOC views that our creditworthiness has deteriorated for any reason as it determines, BOC may not honor any future drawdown requests from us.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Form 8-K filed by the Company on July 8, 2011 is hereby incorporated by reference.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

The Form 8-K filed by the Company on May 11, 2011 is hereby incorporated by reference.

ITEM 4. REMOVED AND RESERVED

None

ITEM 5. OTHER INFORMATION

On August 10, 2011, we entered into an amendment ("Labor Contract Amendment") to the labor contract between the Company and Yihong Yao, the Company's Chief Financial Officer, dated May 16, 2011.  Under the Labor Contract Amendment, the parties agree that the issuance of 1,000,000 shares of restricted common stock to Yihong Yao on July 2, 2011 pursuant to the Company's 2008 Restricted Stock Plan (with such award to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter) supersedes any obligation of the Company to issue the stock option grant to purchase up to 500,000 shares of the Company's Common Stock referenced in the original labor contract.  The Company does not have any further obligations to issue equity securities to Yihong Yao.

A copy of the Labor Contract Amendment is attached as Exhibit 10.3 hereto and is incorporated herein by reference. The foregoing description of the Labor Contract Amendment does not purport to be complete and is qualified in its entirety by reference to the Labor Contract Amendment.

 
43

 
  
ITEM 6. EXHIBITS

(a) Pursuant to Rule 601 of Regulation S-K, the following exhibits are included herein or incorporated by reference.
 
10.1
 
Amendment to Series B-1 Convertible Note and Waiver Agreement between Solar EnerTech Corp. and Capital Ventures International dated May 11, 2011, incorporated by reference from Exhibit 10.1 to our Form 8-K filed on May 11, 2011.
     
10.2
 
English summary of Labor Contract between the Company and Yihong Yao dated May 16, 2011.
     
10.3
 
Amendment to Labor Contract between the Company and Yihong Yao dated August 10, 2011.
     
31.1
 
Section 302 Certification - Chief Executive Officer
     
31.2
 
Section 302 Certification - Chief Financial Officer
     
32.1
 
Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer.
     
32.2
 
Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer.
     
101
  
Interactive Data File (XBRL)
 
 
44

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SOLAR ENERTECH CORP.

Date: August 15, 2011
By:
/s/ Yihong Yao
     
   
Yihong Yao
   
Chief Financial Officer
  
 
45

 
 
EX-10.2 2 v231343_ex10-2.htm EXHIBIT 10.2 Unassociated Document
 
Exhibit 10.2


Summary of CFO’s Chinese Labor Contract
 
 
Name: Ms. Susan Y H Yao.
 
Position: CFO
 
Reporting to: CEO
 
Starting date: May 16, 2011
 
Probation period: Three months
 
Contract length: May 16, 2011 to May 15, 2014
 
Compensation: monthly salary of 50,000 RMB yuan
 
Bonus: approximately one month’s pay at the end of year
 
Incentives:
 
 
-  
Option to purchase 500,000 shares the company’s common stock;
 
 
-  
A commute vehicle provided by the company
 
 
-  
Lunch and cell phone expenses
 
 
-  
Social security benefits and insurance



Solar Enertech Corp
Susan Y H Yao
 
 
 

 
EX-10.3 3 v231343_ex10-3.htm EXHIBIT 10.3 Unassociated Document
 
Exhibit 10.3


Amendment Agreement
to the original Chinese Labor Contract of Susan Y H Yao


This amendment agreement is entered by and between Solar Enertech Corp. (the “Company”) and Susan Y H Yao (the “Employee”) on August 10, 2011.

On May 16, 2011, the Company and the Employee entered a labor contract complying with China law. The key elements in the original labor contract are as follows:

Name: Ms. Susan Y H Yao.
Position: CFO
Contract length: May 16, 2011 to May 15, 2014
Compensation: monthly salary of 50,000 RMB yuan
Bonus: approximately one month’s pay at the end of year
Incentives:
 
-
Option to purchase 500,000 shares the company’s common stock;
 
-
A commute vehicle provided by the company
 
-
Lunch and cell phone expenses
Social security benefits and insurance

This Amendment is made in reference of the stock options contemplated to be granted therein the original labor contract.

The parties confirm that the grant of 1,000,000 restricted shares, vesting over 3 years, subject to a 1 year cliff and the balance vesting in equal monthly installments thereafter, is to supersede any obligation to grant the 500,000 options referenced in her letter and no further obligation to issue equity exists.
 
 
/s/ Leo Shi Young
/s/ Susan Y H Yao
Solar Enertech Corp
Susan Y H Yao

 
 

 
EX-31.1 4 v231343_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1
CERTIFICATION OF PRESIDENT AND CEO — PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULES 13a-14(A) AND 15d-14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934

I, Leo Shi Young, certify that:

1.
I have reviewed this Form 10-Q for the quarter ended June 30, 2011 of Solar EnerTech Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and  internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
b. 
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
c. 
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
d. 
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
b. 
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 15, 2011
By: /s/ Leo Shi Young
   
 
Leo Shi Young
 
President and Chief Executive Officer
 
 
 

 
 
EX-31.2 5 v231343_ex31-2.htm EXHIBIT 31.2
 
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULES 13a-14(A) AND 15d-14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934

I, Yihong Yao, certify that:

1.
I have reviewed this Form 10-Q for the quarter ended June 30, 2011 of Solar EnerTech Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and  internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2011
By: /s/ Yihong Yao
   
 
Yihong Yao
 
Chief Financial Officer
  
 
 

 
EX-32.1 6 v231343_ex32-1.htm EXHIBIT 32.1
 
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Report of Solar EnerTech Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Leo Shi Young, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: August 15, 2011
By: /s/ Leo Shi Young
   
 
Leo Shi Young
 
President and Chief Executive Officer
 
 
 

 
EX-32.2 7 v231343_ex32-2.htm EXHIBIT 32.2
 
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Report of Solar EnerTech Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yihong Yao, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: August 15, 2011
By: /s/ Yihong Yao
   
 
Yihong Yao
 
Chief Financial Officer
 
 
 

 
EX-101.INS 8 soen-20110630.xml XBRL INSTANCE DOCUMENT 0001307873 2010-04-01 2010-06-30 0001307873 2009-10-01 2010-06-30 0001307873 2010-09-30 0001307873 2011-04-01 2011-06-30 0001307873 2010-10-01 2011-06-30 0001307873 2011-06-30 0001307873 2011-08-08 0001307873 2009-09-30 0001307873 2010-06-30 xbrli:shares iso4217:USD iso4217:USDxbrli:shares SOLAR ENERTECH CORP 0001307873 --09-30 Smaller Reporting Company SOEN 181670962 10-Q false 2011-06-30 Q3 2011 6578000 2250000 1719000 2662000 6546000 10094000 1274000 510000 4083000 3166000 870000 249000 690000 252000 20041000 16521000 8874000 8999000 735000 749000 102000 80000 29752000 26349000 7895000 9898000 2032000 353000 2596000 2670000 5817000 0 1312000 1008000 0 1443000 0 133000 19652000 15554000 1531000 0 422000 0 0 49000 22507000 15554000 170000 172000 97656000 99874000 2755000 3555000 -93336000 -92806000 7245000 10795000 29752000 26349000 42000 443000 0.001 0.001 400000000 400000000 170338954 172710388 170338954 172710388 16355000 51799000 12203000 38390000 15051000 47637000 12762000 38080000 1304000 4162000 -559000 310000 2475000 7243000 1394000 5799000 54000 287000 63000 216000 0 -18549000 23000 55000 2529000 26079000 1434000 143000 -1225000 -21917000 -1993000 167000 1000 5000 0 4000 59000 5383000 67000 247000 717000 1115000 181000 263000 1393000 4369000 628000 853000 1000000 1000000 0 0 -485000 -929000 -60000 -510000 -658000 -23740000 -1311000 530000 -0.004 -0.18 -0.01 0.003 -0.004 -0.18 -0.01 0.002 156502573 128327753 161543403 160990033 156502573 128327753 161543403 170925106 1842000 1901000 -51000 5000 2221000 2013000 210000 54000 5146000 94000 6075000 3301000 -441000 -816000 962000 -1078000 84000 -650000 -236000 -448000 7175000 38000 127000 -5817000 653000 -2660000 463000 1750000 9000 38000 -454000 -1712000 1141000 4864000 412000 5207000 729000 -343000 15000 387000 943000 -4328000 -5729000 -200000 -1815000 0 1535000 0 732000 0 <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >NOTE 1 &#8212; ORGANIZATION AND NATURE OF OPERATIONS </font> </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Solar EnerTech Corp. was originally incorporated under the laws of the State of Nevada on July&#160;7, 2004 as Safer Residence Corporation and was reincorporated to the State of Delaware on August 13, 2008 (&#8220;Solar EnerTech&#8221; or the &#8220;Company&#8221;).&#160;&#160;The Company engaged in a variety of businesses until March 2006, when the Company began its current operations as a photovoltaic (&#8220;PV&#8221;) solar energy cell (&#8220;PV Cell&#8221;) manufacturer. The Company&#8217;s management decided that, to facilitate a change in business that was focused on the PV Cell industry, it was appropriate to change the Company&#8217;s name. A plan of merger between Safer Residence Corporation and Solar EnerTech Corp., a wholly-owned inactive subsidiary of Safer Residence Corporation, was approved on March 27, 2006, under which the Company was to be renamed &#8220;Solar EnerTech Corp.&#8221; On April&#160;7, 2006, the Company changed its name to Solar EnerTech Corp.&#160;&#160;On August 13, 2008, the Company reincorporated to the State of Delaware. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company conducts a substantial part of its operations under a wholly-owned subsidiary in Shanghai, China named Solar EnerTech (Shanghai) Co., Ltd. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On April 27, 2009, the Company entered into a Joint Venture Agreement with Jiangsu Shunda Semiconductor Development Co., Ltd. to form a joint venture&#160;in the United States by forming a new company, to be known as Shunda-SolarE Technologies, Inc., in order to jointly pursue opportunities in the United&#160;States solar market. The Agreement was valid for 18 months and expired on October 27, 2010. After its formation, the joint venture company&#8217;s name was later changed to SET-Solar Corp. Since the agreement expired on October 27, 2010, SET-Solar Corp. became an independent company and transactions with SET-Solar Corp after that date are not considered as related party transactions. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January 15, 2010, the Company incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement its existing production facilities to meet increased sales demands. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On February 8, 2010, the Company acquired land use rights of a 68,025 square meter parcel of land located in Yizheng, Jiangsu Province of China, which will be used to house the Company&#8217;s second manufacturing facility. </font> </div> </div> <div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 2 &#8212; LIQUIDITY AND GOING CONCERN </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company has incurred significant net losses during each period from inception through June 30, 2011 and has an accumulated deficit of approximately $92.8 million at June 30, 2011. The conditions described raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The independent auditor&#8217;s report on the Company&#8217;s most recent annual report on Form 10-K for the year ended September 30, 2010 also contained an explanatory paragraph stating that the Company&#8217;s recurring net losses and negative cash flows from operations raises substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company&#8217;s consolidated financial statements have been prepared on the assumption that it will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >During fiscal year 2010, significant steps were taken to reach positive gross margins including securing sales contracts from recurring customers and establishing new customer relationships, which had improved operating cash inflows. In addition, the Company engaged in various cost cutting programs and renegotiated most of the contacts to reduce operating expenses. Due to the above efforts taken, the Company has been generating positive gross margins throughout all quarters in fiscal year 2010 and first quarter of fiscal year 2011. However, since the second quarter of fiscal year 2011, the gross margin has been negative, mainly because of the devaluation of Euro dollar against RMB natively affecting the Company&#8217;s return, usually 45-60 days after the cargo was shipped, and decrease in average selling price of solar modules from $1.91 per watt in the first quarter of fiscal year 2011 to $1.58 per watt in the third quarter of fiscal year 2011, coupled with a decline in sales volume from 8 MW in the first quarter of fiscal year 2011 to 7.7 MW in the third quarter of fiscal year 2011 because of a down-turn of European markets, which forms more than half of the Company&#8217;s revenue. Europe has been playing a large role in creating demand growth in the global PV market through its feed-in tariff (FIT) programs. However, since the beginning of the fiscal year 2011European markets has been slowing down significantly due to the waning economy with its failed expensive aid packages to Greece, Portugal, and Ireland. As a result, even Germany, the long-term and strongest proactive player in the PV industry, has cancelled its mid-year tariff reduction, leaving module shipments well in excess of demand as well as low sales orders. In addition, the Company&#8217;s lower production volume resulting in higher fixed production cost per unit and lower gross margin. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On <font style="display:inline;font-family:times new roman;" >March 19, 2010, the Company entered into an Exchange Agreement (the </font>&#8220;Exchange Agreement&#8221;) with Capital Ventures International (&#8220;CVI&#8221;) whereby the Company issued a Series B-1 Convertible Note (the &#8220;Note&#8221;) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.&#160;&#160;On May 11, 2011, the Company executed an amendment with CVI (&#8220;Amendment&#8221;) whereby CVI waives the following Trigger Events: (a) the migration of the Company&#8217;s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, the Company&#8217;s liquidity and financial position raises substantial doubt about the Company&#8217;s ability to continue as a going concern. </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >As discussed in &#8220;Note 17 - Commitments and Contingencies&#8221;, (i) Pursuant to a joint research and development laboratory agreement with Shanghai University and as of June 30, 2011, the Company has a commitment to fund Shanghai University&#8217;s prescribed research and development activities for approximately $3.2 million to be funded in full by December 15, 2014.&#160;&#160;If the Company fails to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If the Company is unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, the Company is not in breach as it has not received any additional compensation requests for pre-approved funding payments from Shanghai University. (ii) On August 21, 2008, the Company acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash. The Company may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million shares as the product shipment has not occurred. (iii) The paid-in capital of Solar EnerTech (Shanghai) Co., Ltd as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be funded by June 2011. As of June 30, 2010, the Company has not funded the&#160;outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase&#160;the remaining balance recently. In order to meet the registered capital requirement, the Company is in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. The Company has not received the approval from Shanghai Government as of the date of the Company's Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to the Company in September 2011. (iv) The Company&#8217;s subsidiary in Yizheng Jiangsu Province was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.&#160;&#160;In order to fund the registered capital requirement, the Company will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. (v) On February 8, 2010, the Company acquired land use rights of a parcel of land at the price of approximately $0.7 million. As part of the acquisition of the land use right, the Company is required to complete construction of a facility by February 8, 2012. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >As of June 30, 2011, the Company had a cash and cash equivalents balance of approximately $2.3 million and short term loans outstanding of approximately $1.0 million<font style="display:inline;font-family:times new roman;" >. </font>Operating cash outflows amounted to $2.7 million in the nine months ended June 30, 2011, mainly due to payments to the Company&#8217;s vendors based on contractual terms. There have been no significant changes in the payment terms of the Company&#8217;s major vendors <font style="display:inline;font-family:times new roman;" >in the three months ended June 30, 2011 compared to the same period in the prior year. If the Company is unable to successfully generate enough revenues to cover its costs or secure additional financing, the Company&#8217;s liquidity and results of operations may be materially and adversely affected and may not continue as a going concern. </font> </font> </div> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >NOTE 3 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </font> </font> </div><div style="display:block;text-indent:0pt;" >&#160; </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Principles of Consolidation and Basis of Accounting </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Prior to August 19, 2008, the Company operated its business in the People&#8217;s Republic of China through Solar EnerTech (HK) Corporation, Limited (&#8220;Solar EnerTech HK&#8221;) and Solar EnerTech (Shanghai) Co., Ltd (&#8220;Infotech Shanghai&#8221; and together with Solar EnerTech HK, &#8220;Infotech&#8221;). While the Company did not own Infotech, the Company&#8217;s financial statements have included the results of the financials of each of Solar EnerTech HK and Infotech Shanghai since these entities were wholly-controlled variable interest entities of the Company through an Agency Agreement dated April&#160;10, 2006 by and between the Company and Infotech (the &#8220;Agency Agreement&#8221;). Under the Agency Agreement the Company engaged Infotech to undertake all activities necessary to build a solar technology business in China, including the acquisition of manufacturing facilities and equipment, employees and inventory. The Agency Agreement continued through April&#160;10, 2008 and then on a month to month basis thereafter until terminated by either party. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >To permanently consolidate Infotech with the Company through legal ownership, the Company acquired Infotech at a nominal amount on August 19, 2008 through a series of agreements. In connection with executing these agreements, the Company terminated the original agency relationship with Infotech. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company had previously consolidated the financial statements of Infotech with its financial statements pursuant to FASB ASC 810-10 &#8220;Consolidations&#8221;, formerly referenced as FASB Interpretation No. 46(R),&#160;&#160;due to the agency relationship between the Company and Infotech and, notwithstanding the termination of the Agency Agreement, the Company continues to consolidate the financial statements of Infotech with its financial statements since Infotech became a wholly-owned subsidiary of the Company as a result of the acquisition. </font> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" > </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s consolidated financial statements include the accounts of Solar EnerTech Corp. and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. These consolidated financial statements have been prepared in U.S. dollars and in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Use of Estimates </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Cash and Cash Equivalents </font> </div><div style="display:block;text-indent:0pt;" >&#160; </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Cash and cash equivalents are defined as cash on hand, demand deposits and short-term, highly liquid investments that are readily convertible to known amounts of cash within ninety days of deposit. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Currency and Foreign Exchange </font> </div><div style="display:block;text-indent:0pt;" >&#160; </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s functional currency is the Renminbi as substantially all of the Company&#8217;s operations are in China. The Company&#8217;s reporting currency is the U.S. dollar. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Transactions and balances in other currencies are converted into U.S. dollars in accordance with FASB ASC 830, &#8220;Foreign Currency Matters,&#8221; formerly referenced as SFAS No.&#160;52,<font style="display:inline;font-style:italic;" >&#160; </font>&#8220;Foreign Currency Translation&#8221;, and are included in determining net income or loss. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >For foreign operations with the local currency as the functional currency, assets and liabilities are translated from the local currencies into U.S. dollars at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Translation adjustments resulting from the process of translating the local currency consolidated financial statements into U.S. dollars are included in determining comprehensive loss. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Property and Equipment </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s property and equipment are stated at cost net of accumulated depreciation. Depreciation is provided using the straight-line method over the related estimated useful lives, as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="margin-left:18pt;text-align:left;" ><table cellspacing="0" cellpadding="0" width="90%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="top" width="33%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Useful&#160;Life&#160;(Years) </font> </div> </td> </tr><tr><td valign="top" width="33%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Office equipment </font> </div> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3 to 5 </font> </div> </td> </tr><tr><td valign="top" width="33%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Machinery </font> </div> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >10 </font> </div> </td> </tr><tr><td valign="top" width="33%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Production&#160;equipment </font> </div> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >5 </font> </div> </td> </tr><tr><td valign="top" width="33%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Automobiles </font> </div> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >5 </font> </div> </td> </tr><tr><td valign="top" width="33%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Furniture </font> </div> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >5 </font> </div> </td> </tr><tr><td valign="top" width="33%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Leasehold improvement </font> </div> </td><td valign="top" width="2%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="top" width="65%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >the shorter of the lease term or&#160;&#160;5 years </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" >&#160; &#160; </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Expenditures for maintenance and repairs that do not improve or extend the lives of the related assets are expensed to operations. Major repairs that improve or extend the lives of the related assets are capitalized. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Inventories </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Inventories are stated at the lower of cost or market. Cost is determined by the weighted-average method. Market is defined principally as net realizable value. Raw material cost is based on purchase costs while work-in-progress and finished goods are comprised of direct materials, direct labor and an allocation of manufacturing overhead costs. Inventory in-transit is included in finished goods and consists of products shipped but not recognized as revenue because it does not meet the revenue recognition criteria. Provisions are made for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of net realizable value. </font> </div><br /> <div style="display:block;text-indent:0pt;" > </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Warranty Cost </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company provides product warranties and accrues for estimated future warranty costs in the period in which revenue is recognized. The Company&#8217;s standard solar modules are typically sold with a two-year warranty for defects in materials and workmanship and a ten-year and twenty five-year warranty against declines of more than 10.0% and 20.0%, respectively, of the initial minimum power generation capacity at the time of delivery. The Company therefore maintains warranty reserves to cover potential liabilities that could arise from its warranty obligations and accrues the estimated costs of warranties based primarily on management&#8217;s best estimate. In estimating warranty costs, the Company applied Accounting Standards Codification Topic 460 (&#8220;ASC 460&#8221;) &#8211; Guarantees, specifically paragraphs 460-10-25-5 to 460-10-25-7 of the FASB Accounting Standards Codification. This guidance requires that the Company make a reasonable estimate of the amount of a warranty obligation. It also provides that in the case of an entity that has no experience of its own, reference to the experience of other entities in the same business may be appropriate. Because the Company began to commercialize its products in fiscal year 2007, there is insufficient experience and historical data that can be used to reasonably estimate the expected failure rate of its solar modules. Thus, the Company considers warranty cost provisions of other China-based manufacturers that produce photovoltaic products that are comparable in engineering design, raw material input and functionality to the Company&#8217;s products, and sold to a similar target and class of customer with similar warranty coverage. In determining whether such peer information can be used, the Company also considers the years of experience that these manufacturers have in the industry. Because the Company&#8217;s industry is relatively young as compared to other traditional manufacturing industries, the selected peer companies that the Company considers have less than ten years in manufacturing and selling history. In addition, they have a manufacturing base in China, offer photovoltaic products with comparable engineering design, raw material input, functionality and similar warranty coverage, and sell in markets, including the geographic areas and class of customer, where the Company competes. Based on the analysis applied, the Company accrues warranty at 1% of sales. The Company has not experienced any material warranty claims to date in connection with declines of the power generation capacity of its solar modules and will prospectively revise its actual rate to the extent that actual warranty costs differ from the estimates. As of June 30, 2011 and September 30, 2010, the Company&#8217;s warranty liability was $1,481,000 and $1,125,000, respectively. The Company&#8217;s warranty costs for the nine months ended June 30, 2011 and 2010 were $324,000 and $411,000, respectively. The Company did not make any warranty payments during the nine months ended June 30, 2011 and 2010. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Other Assets </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company acquired land use rights to a parcel of land from the government in the People&#8217;s Republic of China (&#8220;PRC&#8221;). All land in the PRC is owned by the PRC government and cannot be sold to any individual or entity. The government in the PRC, according to relevant PRC law, may sell the right to use the land for a specified period of time. Thus, the Company&#8217;s land purchase in the PRC is considered to be leased land and recorded as other assets at cost less accumulated amortization. Amortization is provided over the term of the land use right agreements on a straight-line basis, which is for 46.5 years from February 8, 2010 through August 31, 2056. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Impairment of Long Lived Assets </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. When such factors and circumstances exist, management compares the projected undiscounted future cash flows associated with the future use and disposal of the related asset or group of assets to their respective carrying values. Impairment, if any, is measured as the excess of the carrying value over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. No loss on property and equipment impairment was recorded during the nine months ended June 30, 2011 and 2010. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Investments </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Investments in an entity where the Company owns less than twenty percent of the voting stock of the entity and does not exercise significant influence over operating and financial policies of the entity are accounted for using the cost method. Investments in the entity where the Company owns twenty percent or more but not in excess of fifty percent of the voting stock of the entity or less than twenty percent and exercises significant influence over operating and financial policies of the entity are accounted for using the equity method. The Company has a policy in place to review its investments at least annually, to evaluate the carrying value of the investments in these companies. The cost method investment is subject to impairment assessment if there are identified events or changes in circumstance that may have a significant adverse affect on the fair value of the investment. If the Company believes that the carrying value of an investment is in excess of estimated fair value, it is the Company&#8217;s policy to record an impairment charge to adjust the carrying value to the estimated fair value, if the impairment is considered other-than-temporary. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On August 21, 2008, the Company entered into an equity purchase agreement in which it acquired two million shares of common stock of 21-Century Silicon, Inc., a polysilicon manufacturer based in Dallas, Texas (&#8220;21-Century Silicon&#8221;), for $1.0 million in cash. The two million shares of common stock represented approximately 7.8% of 21-Century Silicon&#8217;s outstanding equity. In connection with the equity purchase agreement, the Company also signed a memorandum of understanding with 21-Century Silicon for a four-year supply framework agreement for polysilicon shipments.&#160;&#160;The first polysilicon shipment from 21-Century Silicon was initially expected in March 2009, but was subsequently delayed to March 2010. On March 5, 2009, the Emerging Technology Fund, created by the State of Texas, invested $3.5 million in 21-Century Silicon to expedite production and commercialization of research. The Company&#8217;s ownership of 21-Century Silicon became 5.5% as a result of the dilution. This first polysilicon shipment that was to be delivered in March 2010 was further delayed without a specified date given by 21-Century Silicon. As a result of the continued delays in shipment, in July 2010, members of the Company&#8217;s executive team, including the CEO, visited 21-Century Silicon and conducted reviews of the production facility and technical development.&#160;&#160;The review indicated that 21-Century Silicon&#8217;s production facility and technical development were significantly below expected standards. Based on the findings from this visit, the timing of the first polysilicon shipment is unknown and it is unknown whether it will even occur. In addition, management of 21-Century Silicon expressed the need for more funding to sustain operations. Moreover, 21-Century Silicon could not provide the Company with updated financial information concerning 21-Century Silicon&#8217;s working capital condition and future cash flows.&#160;&#160;The Company considered the above findings were indicators that a significant adverse effect on the fair value of the Company&#8217;s investment in 21-Century Silicon had occurred. Accordingly, an impairment loss of $1.0 million was recorded in the Consolidated Statements of Operations for the fiscal year ended September 30, 2010 to fully write-down the carrying amount of the investment.&#160;The Company may also be obligated to acquire an additional two million shares of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million common shares (at $0.50 per share) as the product shipment has not occurred. &#160;On October 7, 2010, the X-Change Corporation announced that it has acquired 21-Century Silicon, Inc. The terms of the acquisition are anticipated to involve a change in control of the Company and the appointment of new directors. The X-Change Corporation is anticipated to issue 20 million shares of its unregistered, restricted common stock to the shareholders of 21-Century Silicon in exchange for 100% of the issued and outstanding stock of 21-Century Silicon. As of the date of this report, the X-Change Corporation has not issued its shares to the Company. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Income Taxes </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company accounts for income taxes under the liability method per the provisions of Accounting Standards Codification Topic 740 (&#8220;ASC 740&#8221;), &#8220;Income Taxes&#8221;. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Under the provisions of ASC 740, deferred tax assets and liabilities are determined based on the differences between their financial statement carrying values and their respective tax bases using enacted tax rates that will be in effect in the period in which the differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Valuation Allowance </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, the Company considers all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Unrecognized Tax Benefits </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Effective on October 1, 2007, the Company adopted the provisions related to uncertain tax positions under ASC 740, &#8220;Income Taxes&#8221;, formerly referenced as FIN 48, &#8220;Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109&#8221;.&#160; Under ASC 740, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority based on the technical merits of the associated tax position.&#160; An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company also elected the accounting policy that requires interest and penalties to be recognized as a component of tax expense. The Company classifies the unrecognized tax benefits that are expected to be effectively settled within one year as current liabilities, otherwise, the unrecognized tax benefits will be classified as non-current liabilities. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Fair Value of Warrants </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s management used the binomial valuation model to value the warrants issued in conjunction with convertible notes entered into in March 2007. The model uses inputs such as implied term, suboptimal exercise factor, volatility, dividend yield and risk free interest rate. Selection of these inputs involves management&#8217;s judgment and may impact estimated value. Management selected the binomial model to value these warrants as opposed to the Black-Scholes-Merton model primarily because management believes the binomial model produces a more reliable value for these instruments because it uses an additional valuation input factor, the suboptimal exercise factor, which accounts for expected holder exercise behavior which management believes is a reasonable assumption with respect to the holders of these warrants. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Stock-Based Compensation </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January&#160;1, 2006, Solar EnerTech began recording compensation expense associated with stock options and other forms of employee equity compensation in accordance with FASB ASC 718, &#8220;Compensation &#8211; Stock Compensation&#8221;, formerly referenced as SFAS 123R, &#8220;Share-Based Payment&#8221;. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula and a single option approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The following assumptions are used in the Black-Scholes-Merton option pricing model: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Expected Term &#8212; The Company&#8217;s expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Expected Volatility &#8212; The Company&#8217;s expected volatilities are based on historical volatility of the Company&#8217;s stock, adjusted where determined by management for unusual and non-representative stock price activity not expected to recur. Due to the limited trading history, the Company also considered volatility data of guidance companies. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Expected Dividend &#8212; The Black-Scholes-Merton valuation model calls for a single expected dividend yield as an input. The Company currently pays no dividends and does not expect to pay dividends in the foreseeable future. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Risk-Free Interest Rate &#8212; The Company bases the risk-free interest rate on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Estimated Forfeitures &#8212; When estimating forfeitures, the Company takes into consideration the historical option forfeitures over the expected term. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Revenue Recognition </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company recognizes revenues from product sales in accordance with guidance provided in FASB ASC 605, &#8220;Revenue Recognition&#8221;, which states that revenue is realized or realizable and earned when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and collectability is reasonably assured. Where a revenue transaction does not meet any of these criteria it is deferred and recognized once all such criteria have been met. In instances where final acceptance of the product, system, or solution is specified by the customer, revenue is deferred until all acceptance criteria have been met. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On a transaction by transaction basis, the Company determines if the revenue should be recorded on a gross or net basis based on criteria discussed in the Revenue Recognition topic of the FASB Subtopic 605-405, &#8220;Reporting Revenue Gross as a Principal versus Net as an Agent&#8221;. The Company considers the following factors to determine the gross versus net presentation: if the Company (i) acts as principal in the transaction; (ii) takes title to the products; (iii) has risks and rewards of ownership, such as the risk of loss for collection, delivery or return; and (iv) acts as an agent or broker (including performing services, in substance, as an agent or broker) with compensation on a commission or fee basis. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Accounts Receivable and Allowance for Doubtful Accounts </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Accounts receivable are carried at net realizable value. The Company records allowance for doubtful accounts based upon its assessment of various factors. The Company considers historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect customers&#8217; ability to pay. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Shipping and Handling Costs </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company incurred shipping and handling costs of $318,000 and $1,414,000 for the nine months ended June 30, 2011 and 2010, respectively, which are included in selling expenses. Shipping and handling costs include costs incurred with third-party carriers to transport products to customers. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Research and Development Cost </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Expenditures for research activities relating to product development are charged to expense as incurred. Research and development cost for the nine months ended June 30, 2011 and 2010 were $216,000 and $287,000, respectively. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Comprehensive Income (Loss) </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Comprehensive income (loss) is defined as the change in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners.&#160;&#160;Comprehensive income (loss) is reported in the consolidated statements of shareholder&#8217;s equity.&#160;&#160;Other comprehensive income (loss) of the Company consists of cumulative foreign currency translation adjustments. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Segment Information </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company identifies its operating segments based on its business activities. The Company operates within a single operating segment - the manufacture of solar energy cells and modules in China. The Company&#8217;s manufacturing operations and fixed assets are all based in China. The solar energy cells and modules are distributed to customers, located in Europe, Australia, North America and China. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >During the nine months ended June 30, 2011 and 2010, the Company had one and three customers, respectively that accounted for more than 10% of net sales. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Recent Accounting Pronouncements </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In May&#160;2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) (&#8220;ASU 2011-04&#8221;). The amendments to this update provide a uniform framework for applying the principles of fair value measurement and include (i)&#160;amendments that clarify the Board&#8217;s intent about the application of existing fair value measurement and disclosure requirements and (ii)&#160;amendments that change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. These amendments do not require additional fair value measurements. The Company will adopt ASU 2011-04 in the second quarter of fiscal year 2012. The Company does not believe the adoption of ASU 2011-04 will have a material impact on the Company&#8217;s consolidated financial statements. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" >&#160; </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In June&#160;2011, the FASB issued ASU 2011-05, &#8220;Presentation of Comprehensive Income&#8221; (&#8220;ASU 2011-05&#8221;). ASU 2001-05 amends Topic 220, &#8220;Comprehensive Income&#8221;, to allow an entity the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 does not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income, nor does it change the option for an entity to present components of other comprehensive income either net of related tax effects or before related tax effects. This ASU is effective for the Company&#8217;s financial statements for annual and interim periods beginning on or after December&#160;15, 2011, and must be applied retrospectively. The Company will adopt ASU 2011-05 in the first quarter of fiscal year 2012. The adoption of ASU 2011-05 is not expected to have a material impact on the Company&#8217;s consolidated financial statements. </font> </div> </div> <div><div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 4 &#8212; FINANCIAL INSTRUMENTS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s assets that are potentially subject to significant concentration of credit risk are primarily cash and cash equivalents, advance payments to suppliers and accounts receivable. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company maintains cash deposits with financial institutions, which from time to time may exceed federally insured limits. The Company has not experienced any losses in connection with these deposits and believes it is not exposed to any significant credit risk from cash. At June 30, 2011 and September&#160;30, 2010, the Company had approximately $82,000 and $82,000, respectively in excess of insured limits. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Advance payments to suppliers are typically unsecured and arise from deposits paid in advance for future purchases of raw materials. The Company does not require collateral or other security against the prepayments to suppliers for raw materials.&#160;&#160;In the event of a failure by the Company&#8217;s suppliers to fulfill their contractual obligations and to the extent that the Company is not able to recover its prepayments, the Company would suffer losses. The Company&#8217;s prepayments to suppliers have been steadily decreasing due to the change in the industry practice from requiring full cash advance to secure key raw material (silicon wafers) as a result of the financial crisis in 2008 to requiring less or no cash advance during fiscal year 2009 as the economy is recovering from the crisis. The economic crisis may affect the Company&#8217;s customers&#8217; ability to pay the Company for its products that the Company has delivered.&#160;&#160;If the customers fail to pay the Company for its products and services, the Company&#8217;s financial condition, results of operations and liquidity may be adversely affected. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Other financial instruments that potentially subject the Company to concentration of credit risk consist principally of accounts receivable.&#160;&#160;Concentrations of credit risk with respect to accounts receivable are limited because a number of geographically diverse customers make up the Company&#8217;s customer base, thus spreading the trade credit risk.&#160;&#160;The Company controls credit risk through credit approvals, credit limits and monitoring procedures.&#160;&#160;The Company performs credit evaluations for all new customers but generally does not require collateral to support customer receivables. All of the Company&#8217;s&#160;customers have gone through a very strict credit approval process. The Company&#160;diligently&#160;monitors the customers&#8217; financial position. Payment terms for our solar module sales generally range from 0 to 60 days. In some cases, these terms are extended up to 200 days for certain qualifying customers of whom the Company applied rigorous credit requirements. The Company has also&#160;purchased insurance from the China Export &amp;amp; Credit Insurance Company to insure the collectability of the outstanding accounts receivable balances of a key customer. During the nine months ended June 30, 2011 and 2010, the Company had one and three customers, respectively that accounted for more than 10% of net sales. </font> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div> </div> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><br /> Foreign exchange risk and translation </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company may be subject to significant currency risk due to the fluctuations of exchange rates between the Chinese Renminbi, Euro and the United States dollar. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The local currency is the functional currency for the China subsidiary.&#160;&#160;Assets and liabilities are translated at end of period exchange rates while revenues and expenses are translated at the average exchange rates in effect during the period.&#160;&#160;Equity is translated at historical rates and the resulting cumulative translation adjustments, to the extent not included in net income, are included as a component of other comprehensive income (loss) until the translation adjustments are realized. Included in other comprehensive income were foreign currency translation adjustment gains of $800,000 and $98,000 for the nine months ended June 30, 2011 and 2010, respectively.&#160;&#160;&#160;Foreign currency transaction gains and losses are included in earnings. For the nine months ended June 30, 2011 and 2010, the Company recorded foreign exchange losses of $0.5 million and $0.9 million, respectively. </font> </div> </div> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 7 &#8212; INVENTORIES </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011 and September 30, 2010, inventories consist of: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June&#160;30,&#160;2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September&#160;30,&#160;2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Raw materials </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,133,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2,639,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Finished goods </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >33,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >1,444,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Total inventories </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >3,166,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >4,083,000 </font> </font> </td> </tr> </table> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 8 &#8212; PROPERTY AND EQUIPMENT </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company depreciates its assets over their estimated useful lives. A summary of property and equipment at June 30, 2011 and September 30, 2010 is as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June&#160;30,&#160;2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September&#160;30,&#160;2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Production equipment </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >9,816,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >8,130,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Leasehold improvements </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,879,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,709,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Automobiles </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >312,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >366,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Office equipment </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >363,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >348,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Machinery </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,065,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2,916,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Furniture </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >41,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >40,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Total property and equipment </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >17,476,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >15,509,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Less:&#160;&#160;accumulated depreciation </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(8,477,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(6,635,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Total property and equipment, net </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >8,999,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >8,874,000 </font> </font> </td> </tr> </table> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 11 &#8212; INCOME TAX </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company has no taxable income and no provision for federal and state income taxes is required for the nine months ended June 30, 2011 and 2010, respectively, except certain state minimum tax. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company conducts its business in the United States and in various foreign locations and generally is subject to the respective local countries&#8217; statutory tax rates. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Utilization of the U.S. federal and state net operating loss carry forwards may be subject to substantial annual limitation due to certain limitations resulting from ownership changes provided by U.S. federal and state tax laws. The annual limitation may result in the expiration of net operating losses carryforwards and credits before utilization. The Company has net operating losses in its foreign jurisdictions and those losses can be carried forward 5 years from the year the loss was incurred. As of June 30, 2011 and 2010, the Company&#8217;s deferred tax assets were subject to a full valuation allowance. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Under the New Income Tax Law in the PRC, dividends paid by PRC enterprises out of profits earned post-2007 to non-PRC tax resident investors are subject to PRC withholding tax of 10%. A lower withholding tax rate may be applied based on applicable tax treaties with certain countries. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The New Income Tax Law also provides that enterprises established under the laws of foreign countries or regions and whose &#8220;place of effective management&#8221; is located within the PRC are considered PRC tax resident enterprises and subject to PRC income tax at the rate of 25% on worldwide income. The definition of &#8220;place of effective management" refers to an establishment that exercises, in substance, overall management and control over the production and business, personnel, accounting, properties, etc. of an enterprise. If the Company or any of its non-PRC subsidiaries is treated as a &#8220;resident enterprise&#8221; for PRC tax purposes, the Company or such subsidiary will be subject to PRC income tax. The Company will continue to monitor its tax status with regard to the PRC tax resident enterprise regulation but does not anticipate a material adverse impact to the financial statements as a whole. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >There are no ongoing examinations by taxing authorities at this time. The Company&#8217;s tax years starting from 2006 to 2010 remain open in various tax jurisdictions. The Company has not recorded any unrecognized tax benefits; and does not anticipate any significant changes within the next 12 months. </font> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 13 &#8212; STOCKHOLDERS&#8217; EQUITY </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Warrants </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >During March&#160;2007, in conjunction with the issuance of $17,300,000 in convertible debt, the board of directors approved the issuance of Warrants to purchase shares of the Company&#8217;s common stock. Under their original terms, the 7,246,377 Series A warrants and the 21,578,948 Series B warrants are exercisable at $1.21 and $0.90, respectively and expire in March&#160;2012. In addition, in March 2007, as additional compensation for services as placement agent for the convertible debt offering, the Company issued the Advisor Warrants, which entitle the placement agent to purchase 507,247 and 1,510,528 shares of the Company&#8217;s common stock at exercise prices of $0.69 and $0.57 per share, respectively. The Advisor Warrants expire in March&#160;2012. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Series A and Series B Warrants (including the Advisor Warrants) are classified as a liability in accordance with FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;, due to the terms of the warrant agreements which contain cash redemption provisions in the event of a fundamental transaction, which provide that the Company would repurchase any unexercised portion of the warrants at the date of the occurrence of the fundamental transaction for the value as determined by the Black-Scholes Merton valuation model. As a result, the warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account &#8220;gain (loss) on fair market value of warrant liability&#8221; in the accompanying Consolidated Statements of Operations. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Additionally, in connection with the offering, all of the Company&#8217;s Series&#160;A and Series&#160;B warrant holders waived their full ratchet anti-dilution and price protection rights previously granted to them in connection with the Company&#8217;s March&#160;2007 convertible note and warrant financing. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January 12, 2008, the Company sold 24,318,181 shares of its common stock and 24,318,181 Series C warrants (the &#8220;Series C Warrants&#8221;) to purchase shares of common stock for an aggregate purchase price of $21.4 million in a private placement offering to accredited investors. Under its original terms, the exercise price of the Series C Warrants is $1.00 per share. The warrants are exercisable for a period of 5 years from the date of issuance of the Series C Warrants. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >For the services in connection with this closing, the placement agent and the selected dealer, Knight Capital Markets, LLC and Ardour Capital Investments, received an aggregate of a 6.0% cash commission, a 1.0% advisory fee and warrants to purchase 1,215,909 shares of common stock at $0.88 per share, exercisable for a period of 5 years from the date of issuance of the warrants. The net proceeds from issuing common stock and Series C warrants in January 2008 after all the financing costs were $19.9 million and were recorded in additional paid in capital and common stock. Neither the shares of common stock nor the shares of common stock underlying the warrants sold in this offering were granted registration rights. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In connection with the Conversion Agreement, on January 7, 2010, the Company entered into an Amendment (the &#8220;Warrant Amendment&#8221;) to the Series A, Series B and Series C Warrants with the holders of at least a majority of the common stock underlying each of its outstanding Series A Warrants, Series B Warrants and Series C Warrants (collectively the &#8220;PIPE Warrants&#8221;). The Warrant Amendment reduced the exercise price for all of the PIPE Warrants from $1.21, $0.90 and $1.00, respectively, to $0.15, removed certain maximum ownership provisions and removed anti-dilution provisions for lower-priced security issuances. Given the above, the liability associated with the PIPE Warrants at the pre Conversion Agreement exercise price was considered extinguished and was replaced with the liability associated with the PIPE Warrants at the post Conversion Agreement exercise price, which were recorded at fair value. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >There were no warrants exercised during the nine months ended June 30, 2011. During the nine months ended June 30, 2010, a warrants holder exchanged 1,147,394 warrants for 450,878 shares of the Company&#8217;s common stock after a cashless exercise. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >A summary of outstanding warrants as of June 30, 2011 is as follows: </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="95%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="49%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Number&#160;of </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Shares </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Exercise </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Price&#160;($) </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Recognized&#160;as </font> </font> </div> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Granted in connection with convertible notes &#8212; Series A </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >7,246,377 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1.21 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Discount to notes payable </font> </div> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Granted in connection with convertible notes &#8212; Series B </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >21,578,948 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.90 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Discount to notes payable </font> </div> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" nowrap="nowrap" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Granted in connection with common stock purchase &#8212; Series C </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >24,318,181 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1.00 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Additional paid in capital </font> </div> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Granted in connection with placement service </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >507,247 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.69 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Deferred financing cost </font> </div> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Granted in connection with placement service </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,510,528 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.57 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Deferred financing cost </font> </div> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Granted in connection with placement service </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,215,909 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.88 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Additional paid in capital </font> </div> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Extinguishment in accordance with the Conversion Agreement </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(53,143,506 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >N/A </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Loss on debt extinguishment </font> </div> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="49%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Issuance in accordance with the Conversion Agreement </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >53,143,506 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.15 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Warrant liabilities </font> </div> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="49%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Cashless exercise of warrants </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(1,147,394 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.15 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Additional paid in capital </font> </div> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="49%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Outstanding at June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >55,229,796 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="27%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" >&#160; </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011, the range of warrant prices for shares under warrants and the weighted-average remaining contractual life is as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="99%" colspan="12" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Warrants&#160;Outstanding&#160;and&#160;Exercisable </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="25%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Weighted- </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="25%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Weighted- </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Average </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="25%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Range&#160;of </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Average </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Remaining </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="25%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Warrant </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Number&#160;of </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Exercise </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Contractual </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="25%" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Exercise&#160;Price&#160; </font> </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Warrants </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Price </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="23%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Life </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="25%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$0.15 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="22%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >51,996,112 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="22%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.15 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="22%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1.10 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="25%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$0.57-$0.88 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="22%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,233,684 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="22%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.71 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="22%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1.02 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Restricted Stock </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On August 19, 2008, Mr. Leo Young, the Company&#8217;s Chief Executive Officer, entered into a Stock Option Cancellation and Share Contribution Agreement with Jean Blanchard, a former officer, to provide for (i) the cancellation of a stock option agreement by and between Mr. Young and Ms. Blanchard dated on or about March 1, 2006 and (ii) the contribution to the Company by Ms. Blanchard of the remaining 25,250,000 shares of common stock underlying the cancelled option agreement. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On the same day, an Independent Committee of the Company&#8217;s Board adopted the 2008 Restricted Stock Plan (the &#8220;2008 Plan&#8221;) providing for the issuance of 25,250,000 shares of restricted common stock to be granted to the Company&#8217;s employees pursuant to forms of restricted stock agreements. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The 2008 Plan provides for the issuance of a maximum of 25,250,000 shares of restricted stock in connection with awards under the 2008 Plan. The 2008 Plan is administered by the Company&#8217;s Compensation Committee, a subcommittee of the Company&#8217;s Board of Directors, and has a term of 10&#160;years. Restricted stock vest over a three year period and unvested restricted stock are forfeited and cancelled as of the date that employment terminates. Participation is limited to employees, directors and consultants of the Company and its subsidiaries and other affiliates. During any period in which shares acquired pursuant to the 2008 Plan remain subject to vesting conditions, the participant shall have all of the rights of a stockholder of the Company holding shares of stock, including the right to vote such shares and to receive all dividends and other distributions paid with respect to such shares.&#160;&#160;If a participant terminates his or her service for any reason (other than death or disability), or the participant&#8217;s service is terminated by the Company for cause, then the participant shall forfeit to the Company any shares acquired by the participant which remain subject to vesting Conditions as of the date of the participant&#8217;s termination of service. If a participant&#8217;s service is terminated by the Company without cause, or due to the death or disability of the participant, then the vesting of any restricted stock award shall be accelerated in full as of the effective date of the participant&#8217;s termination of service. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On July 2, 2011, the Company issued 8,600,000 shares of restricted common stock to the Company&#8217;s employees pursuant to the Company&#8217;s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.&#160;&#160;The issuance of the shares of&#160;restricted stock was not registered under the Securities Act in reliance on the exemption from registration provided under Regulation S, as promulgated under the Securities Act. Shares of&#160;restricted stock were issued only to non-U.S. persons in offshore transactions&#160;who met the conditions under Regulation S. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Out of the 8,600,000 shares of restricted common stock issued, the Company issued 1,000,000 shares of restricted common stock to Yihong Yao, the Company&#8217;s Chief Financial Officer, pursuant to the Company&#8217;s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-style:italic;font-family:times new roman;" >Issuance of fully vested restricted stock to the Company&#8217;s former Board of Directors </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January 12, 2010, the Company issued 400,000 shares of fully vested restricted stock to the Company&#8217;s former board of directors on their resignation date. As the former directors no longer provide services to the Company, these awards were properly accounted for as awards to non-employees in accordance with FASB ASC 718. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The following table summarizes the activity of the Company&#8217;s unvested restricted stock units as of June 30, 2011 and September&#160;30, 2010 is presented below: </font> </div><div style="display:block;text-indent:0pt;" >&#160; <font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160;&#160; </font> </div><div style="margin-left:9pt;text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="28%" colspan="6" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Restricted&#160;Stock </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="70%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160;&#160; </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Weighted- </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="70%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Number&#160;of&#160; </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >average&#160;grant- </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;text-align:center;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >shares </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >date&#160;fair&#160;value </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Unvested&#160;as&#160;of&#160;September 30, 2009 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >23,150,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Restricted stock canceled </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(10,000,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Restricted stock granted </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >400,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.31 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Restricted stock vested </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(400,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.31 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Unvested as of September 30, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >13,150,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Restricted stock canceled </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(80,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Restricted stock vested </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(2,630,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Unvested as of June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >10,440,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.76 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The total unvested restricted stock as of June 30, 2011 and September 30, 2010 were 10,440,000 and 13,150,000 shares, respectively. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Stock-based compensation expense for restricted stock for the three and nine months ended June 30, 2011 were $0.7 million and $2.0 million, respectively. As of June 30, 2011, the total unrecognized compensation expense net of forfeitures related to unvested awards was $0.4 million and is expected to be amortized over a weighted average period of 0.14 years. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-style:italic;font-family:times new roman;" >Issuance of common shares to non-employees </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On February 1, 2010, the Company issued 400,000 shares of common stock to the Company&#8217;s third party financial advisors. These awards were properly accounted for as awards to non-employees in accordance with FASB ASC 718. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Options </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-style:italic;font-family:times new roman;" >Amended and Restated 2007 Equity Incentive Plan </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In September&#160;2007, the Company adopted the 2007 Equity Incentive Plan (the &#8220;2007 Plan&#8221;) that allows the Company to grant non-statutory stock options to employees, consultants and directors. A total of 10 million shares of the Company&#8217;s common stock are authorized for issuance under the 2007 Plan. The maximum number of shares that may be issued under the 2007 Plan will be increased for any options granted that expire, are terminated or repurchased by the Company for an amount not greater than the holder&#8217;s purchase price and may also be adjusted subject to action by the stockholders for changes in capital structure. Stock options may have exercise prices of not less than 100% of the fair value of a share of stock at the effective date of the grant of the option. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On February 5, 2008, the Board of Directors of the Company adopted the Amended and Restated 2007 Equity Incentive Plan (the &#8220;Amended 2007 Plan&#8221;), which increases the number of shares authorized for issuance from 10 million to 15 million shares of common stock and was to be effective upon approval of the Company&#8217;s stockholders and upon the Company&#8217;s reincorporation into the State of Delaware.&#160;&#160; </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On May 5, 2008, at the Company&#8217;s Annual Meeting of Stockholders, the Company&#8217;s stockholders approved the Amended 2007 Plan.&#160;&#160;On August 13, 2008, the Company reincorporated into the State of Delaware. As of June 30, 2011 and September 30, 2010, 13,726,667 and 12,860,000 shares of common stock, respectively remain available for future grants under the Amended 2007 Plan. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >These options vest over various periods up to four years and expire no more than ten years from the date of grant. A summary of activity under the Amended 2007 Plan is as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="93%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="52%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Options&#160;Available </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >For&#160;Grant </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Number&#160;of&#160;Options </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Outstanding </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Weighted&#160;Average </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Fair&#160;Value&#160;Per </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Share </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Weighted&#160;Average </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Exercise&#160;Price&#160;Per </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Share </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Balance at September 30, 2009 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >12,060,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2,940,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.39 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Options granted </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(250,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >250,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.13 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.20 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Options cancelled </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >1,050,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(1,050,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.39 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.62 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Balance at September 30, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >12,860,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2,140,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.32 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.55 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Options cancelled </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >866,667 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(866,667 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.20 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.32 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Balance at June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >13,726,667 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >1,273,333 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.32 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.60 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The total fair value of shares vested during the nine months ended June 30, 2011 and 2010 were approximately $21,000 and $36,000, respectively. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011 and September 30, 2010, 1,273,333 and 2,140,000 options were outstanding, respectively and had a weighted-average remaining contractual life of 6.40 years and 7.66 years, respectively. Of these options, 1,270,833 and 1,542,917 shares were vested and exercisable on June 30, 2011 and September 30, 2010, respectively.&#160; The weighted-average exercise price and weighted-average remaining contractual term of options currently exercisable were $0.60 and 6.38 years, respectively. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >There were no employee stock options granted during the three and nine months ended June 30, 2011. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In accordance with the provisions of FASB ASC 718, the Company has recorded stock-based compensation expense of $0.7 million and $2.0 million for the three and nine months ended June 30, 2011, respectively, which include the compensation effect for the options and restricted stock. The Company recorded $0.7 million and $2.2 million for the three and nine months ended June 30, 2010, respectively, which include the compensation effect for the options and restricted stock. The stock-based compensation expense is based on the fair value of the options at the grant date.&#160;&#160;The Company recognized compensation expense for share-based awards based upon their value on the date of grant amortized over the applicable service period, less an allowance estimated future forfeited awards. </font> </div> </div> <div><div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 14 &#8212; FAIR VALUE OF FINANCIAL INSTRUMENTS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In September 2006, the FASB issued SFAS 157, &#8220;Fair Value Measurements&#8221;, codified in FASB ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221;, which defines fair value to measure assets and liabilities, establishes a framework for measuring fair value, and requires additional disclosures about the use of fair value. FASB ASC 820 is applicable whenever another accounting pronouncement requires or permits assets and liabilities to be measured at fair value. FASB ASC 820 does not expand or require any new fair value measures. FASB ASC 820 is effective for fiscal years beginning after November 15, 2007. In December 2007, the FASB agreed to a one year deferral of FASB ASC 820&#8217;s fair value measurement requirements for nonfinancial assets and liabilities that are not required or permitted to be measured at fair value on a recurring basis. The Company adopted FASB ASC 820 on October 1, 2008, which had no effect on the Company&#8217;s financial position, operating results or cash flows. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >FASB ASC 820 defines fair value and establishes a hierarchal framework which prioritizes and ranks the market price observability used in fair value measurements. Market price observability is affected by a number of factors, including the type of asset or liability and the characteristics specific to the asset or liability being measured. Assets and liabilities with readily available, active, quoted market prices or for which fair value can be measured from actively quoted prices generally are deemed to have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. Under FASB ASC 820, the inputs used to measure fair value must be classified into one of three levels as follows: </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:45pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:81pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Level&#160;1&#160;- </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Quoted prices in an active market for identical assets or liabilities; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:45pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:81pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Level&#160;2&#160;- </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:45pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:81pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Level&#160;3&#160;- </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Assets and liabilities whose significant value drivers are unobservable. </font> </div> </td> </tr> </table> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div>&#160;&#160; </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company&#8217;s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s liabilities measured at fair value on a recurring basis consisted of the following types of instruments as of June 30, 2011: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="95%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="40%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Fair&#160;Value&#160;at </font><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >June&#160;30,&#160;2011 </font> </font> </font> </div> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Quoted&#160;prices&#160;in </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >active&#160;markets </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >for&#160;identical </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >assets </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Significant&#160;other </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >observable&#160;inputs </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Significant </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >unobservable </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >inputs </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="40%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(Level 1) </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(Level 2) </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(Level 3) </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="40%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="40%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Derivative liabilites </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >133,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >133,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="40%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Warrant liabilities </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >49,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >49,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="40%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="40%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Total liabilities </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >182,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >- </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >- </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >182,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The method used to estimate the value of the Series B-1 Note compound embedded derivatives (&#8220;CED&#8221;) was a binomial model with the following assumptions: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="60%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="64%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="16%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June 30, 2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="16%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September 30, 2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Implied term (years) </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.72 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1.46 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Suboptimal exercise factor </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2.50 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2.50 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Volatility </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >60.60 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >66.30 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Dividend yield </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.00 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.00 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Risk-free interest rate </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.14 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.34 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The fair value of the Series A and Series B Warrants (including the Advisor Warrants) were estimated using a binomial valuation model with the following assumptions: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="60%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="64%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="16%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June 30, 2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="16%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September 30, 2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Implied term (years) </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.68 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1.43 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Suboptimal exercise factor </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2.5 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2.5 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Volatility </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >65 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >78 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Dividend yield </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="64%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Risk free interest rate </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.13 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >0.33 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >% </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The carrying values of cash and cash equivalents, accounts receivable, accrued expenses, accounts payable, accrued liabilities and amounts due to related party approximate fair value because of the short-term maturity of these instruments. The Company does not invest its cash in auction rate securities. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011, the principal outstanding and the carrying value of the Company&#8217;s Series B-1 Note were $1,540,261 and $1,443,000, respectively. The Series B-1 Note contains two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the &#8220;compound embedded derivative&#8221;), which are measured at fair value both initially and in subsequent periods. The fair value of the convertible notes can be determined based on the fair value of the entire financial instrument. </font> </div> </div> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 15 &#8212; COMPREHENSIVE INCOME (LOSS) </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The components of comprehensive income (loss)&#160;were as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:right;" ><table cellspacing="0" cellpadding="0" width="98%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="52%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="22%" colspan="6" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Three Months Ended June 30, </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="22%" colspan="6" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Nine Months Ended June 30, </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="52%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Net income (loss) </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(1,311,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(658,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >530,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(23,740,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Other comprehensive income: </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="padding-left:0pt;padding-bottom:2px;margin-left:9pt;text-align:left;" ><div style="display:block;margin-left:9pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Change in foreign currency translation </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >452,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >87,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >800,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >98,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Comprehensive income (loss) </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(859,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(571,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,330,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(23,642,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The accumulated other comprehensive income at June 30, 2011 and September 30, 2010 comprised of accumulated translation adjustments of $3.6 million and $2.8 million, respectively. </font> </div> </div> <div><div><div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 17 &#8212; COMMITMENTS AND CONTINGENCIES </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Research and development commitment </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Pursuant to a joint research and development laboratory agreement with Shanghai&#160;University, dated December&#160;15, 2006 and expiring on December&#160;15, 2016, Solar EnerTech is committed to fund the establishment of laboratories and completion of research and development activities. On November 12, 2010, the Company amended the agreement with Shanghai University and extended the funding commitment from five years to eight years, and consequently the agreement will end on December 15, 2014. Based on the amendment, the Company has committed to fund no less than RMB 30&#160;million ($4.5 million) cumulatively across the eight years. The funding requirements are based on specific milestones agreed upon by the Company and Shanghai University. As of June 30, 2011, there are approximately $3.2 million remaining to be funded in full by December 15, 2014. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company will continue to invest in research and development as it grows&#160;its business. The payment to Shanghai&#160;University will be used to fund program expenses and equipment purchase. Shanghai University needs to obtain the pre-approval from the Company before incurring expenditures on the program. If the Company fails to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If the Company is unable to correct the breach within the requested time frame, Shanghai&#160;University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, the Company is not in breach as it has not received any additional compensation requests for pre-approved funding payment from Shanghai&#160;University. </font> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div> </div> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><br /> The agreement is for shared investment in research and development on fundamental and applied technology in the fields of semi-conductive photovoltaic theory, materials, cells and modules. The agreement calls for Shanghai&#160;University to provide equipment, personnel and facilities for joint laboratories. The Company will provide funding, personnel and facilities for conducting research and testing. Research and development achievements from this joint research and development agreement will be available to both parties. The Company is entitled to intellectual property rights including copyrights and patents obtained as a result of this research. </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Other than capital expenditure related to purchase of fixed assets, expenditures under this agreement will be accounted for as research and development expenditures under FASB ASC 730, "Research and Development&#8221; and expensed as incurred. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Capital commitments </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On August 21, 2008, the Company acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash as previously discussed in &#8220;Note 3 &#8212; Summary of Significant Accounting Policies &#8211; Investments&#8221;&#160;&#160;above.&#160;&#160;In July 2010, members of the Company&#8217;s executive team, including the CEO, visited 21-Century Silicon and conducted reviews of the production facility and technical development. The review indicated that 21-Century Silicon&#8217;s production facility and technical development were significantly below expected standards. In addition, management of 21-Century Silicon expressed the need for more funding to sustain operations. Moreover, 21-Century Silicon could not provide the Company with updated financial information concerning 21-Century Silicon&#8217;s working capital condition and future cash flows. The timing of the first polysilicon shipment is unknown and it is unknown whether it will even occur. The Company considered the factors above as indicators that a significant adverse effect on the fair value of the Company&#8217;s investment in 21-Century Silicon had occurred.&#160;&#160;Accordingly, an impairment loss of $1.0 million was recorded in the Consolidated Statements of Operations for the fiscal year ended September 30, 2010 to fully write-down the carrying amount of the investment.&#160;The Company may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million shares as the product shipment has not occurred. On October 7, 2010, the X-Change Corporation announced that it has acquired 21-Century Silicon, Inc. The terms of the acquisition is anticipated to involve a change in control of the Company and the appointment of new directors. The X-Change Corporation is anticipated to issue 20 million shares of its unregistered, restricted common stock to the shareholders of 21-Century Silicon in exchange for 100% of the issued and outstanding stock of 21-Century Silicon. As of the date of this report, the X-Change Corporation has not issued its shares to the Company. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On September 22, 2008, the registered capital of Solar EnerTech (Shanghai) Co., Ltd was increased from $25 million to $47.5 million, which was approved by the Board of Directors of the Company and authorized by Shanghai Municipal Government (the &#8220;Shanghai Government&#8221;). The paid-in capital as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be originally funded by September 21, 2010. In August 2010, the Company received the approval of the Shanghai Government to extend the funding requirement date by nine months to June 2011. As of June 30, 2010, the Company has not funded the&#160;outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase&#160;the remaining balance recently. In order to meet the registered capital requirement, the Company is in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. The Company has not received the approval from Shanghai Government as of the date of the Company's Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to the Company in September 2011. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January 15, 2010, the Company incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement its existing production facilities to meet increased sales demands.&#160;&#160;The subsidiary was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.&#160;&#160;In order to fund the registered capital requirement, the Company will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. The registered capital requirement outstanding as of June 30, 2011 is $23.4 million. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On February 8, 2010, the Company acquired land use rights of a parcel of land at the price of approximately $0.7 million. This piece of land is 68,025 square meters and is located in Yizheng, Jiangsu Province of China, which will be used to house the Company&#8217;s second manufacturing facility. As part of the acquisition of the land use right, the Company is required to complete construction of the facility by February 8, 2012. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Convertible note </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On <font style="display:inline;font-family:times new roman;" >March 19, 2010, the Company entered into an Exchange Agreement (the </font>&#8220;Exchange Agreement&#8221;) with Capital Ventures International (&#8220;CVI&#8221;) whereby the Company issued a Series B-1 Convertible Note (the &#8220;Note&#8221;) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.&#160;&#160;On May 11, 2011, the Company executed an amendment with CVI (&#8220;Amendment&#8221;) whereby CVI waives the following Trigger Events: (a) the migration of the Company&#8217;s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. Notwithstanding the above, the Company&#8217;s liquidity and financial position raises substantial doubt about the Company&#8217;s ability to continue as a going concern. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. </font> </div> </div> </div> </div> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 18 &#8212; RELATED PARTY TRANSACTIONS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011 and September 30, 2010, the accounts payable and accrued liabilities, related party balance was $0 million and $5.8 million, respectively. The $5.8 million accrued liability at fiscal year ended September 30, 2010 represents $4.8 million of compensation expense related to the Company&#8217;s obligation to withhold tax upon exercise of stock options by Mr. Young in the fiscal year 2006 and the related interest and penalties, and $1.0 million of indemnification provided by the Company to Mr. Young&#160;&#160;for any liabilities he may incur as a result of previous stock options granted to him by Ms. Blanchard, a former officer, in conjunction with the purchase of Infotech on August 19, 2008. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Both the Company&#8217;s obligation to withhold tax upon the exercise of stock options by Mr. Young and the indemnification has a three year statute of limitation. The statute of limitation expired as of December 31, 2010. As a result, the Company released the $5.8 million on December 31, 2010. </font> </div> </div> 902000 0 0 0 0 5817000 0 78000 0 12000 <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 5 &#8212; ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011 and September 30, 2010, the accounts receivable, net of allowance for doubtful accounts consists of: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="80%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June&#160;30,&#160;2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September&#160;30,&#160;2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Accounts receivable, gross </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >10,537,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >6,588,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:2px;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Allowance for doubtful accounts </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(443,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(42,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:4px;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Accounts receivable, net </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >10,094,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >6,546,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The following table summarizes the activities of the allowance for doubtful accounts as of June 30, 2011 and September 30, 2010: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="80%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="82%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="16%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Allowance&#160;for&#160;doubtful </font> </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >accounts </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >As of September 30, 2009 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >117,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Addition </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="padding-bottom:2px;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Write-down </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(75,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >As of September 30, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >42,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Addition </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >421,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="padding-bottom:2px;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Write-down </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(20,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >As of June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >443,000 </font> </font> </td> </tr> </table> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 6 &#8212; ADVANCE PAYMENTS AND OTHER </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011 and September 30, 2010, advance payments and other consist of: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June&#160;30,&#160;2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September&#160;30,&#160;2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Prepayment for raw materials </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >285,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >673,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Prepayment for equipment </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >18,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >402,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Others </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >207,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >199,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Total advance payments and other </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >510,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >1,274,000 </font> </font> </td> </tr> </table> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 10 &#8212; SHORT TERM LOANS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At June 30, 2011 and September 30, 2010, short-term loans consist of: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="65%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >June&#160;30,&#160;2011 </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >September&#160;30,&#160;2010 </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="70%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Short-term loans </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,008,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,312,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On March 25, 2010, the Company entered into a one year contract with China Export &amp;amp; Credit Insurance Corporation (&#8220;CECIC&#8221;) to insure the collectability&#160;of outstanding accounts receivable for two of the Company&#8217;s key customers. The Company pays a fee based on a fixed percentage of the accounts receivable&#160;outstanding and expenses this fee when it is incurred. In addition, on March 30, 2010, the Company entered into a one year revolving credit facility&#160;arrangement with Industrial Bank Co., Ltd. (&#8220;IBC&#8221;) that was secured by the accounts receivable balances of the two key customers insured by&#160;CECIC above. The cost of the insurance on accounts receivable is recorded as selling, general and administrative costs in the Consolidated Statements of Operations of the Company. On May 5, 2011, the Company terminated the credit facility arrangement with IBC and on the same day, the Company entered into a revolving credit facility arrangement with Bank of China (&#8220;BOC&#8221;), which is also secured by the accounts receivable balances of the key customers insured by CECIC above. </font> </div><br /> <div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-size:8pt;font-family:times new roman;" > </font> </div> </div> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >If the insured customer fails to repay the amounts outstanding due to the Company, the insurance proceeds will be remitted directly to&#160;BOC instead of the Company. &#160;The amount drawn down as of June 30, 2011, amounted to $1,008,000, of which $302,000 and $706,000 are due on August 2 and August 15, 2011, respectively.&#160;There have been no insurance claims&#160;submitted to CECIC. There are no commitment fees associated with the unused portion of the credit facility. The interest rate of the credit facility is variable and ranged from 3.78% to 5.30% during the nine months ended June 30, 2011. The weighted average interest rate on this credit facility during the nine months ended June 30, 2011 was 4.42% per annum. </font> </div> </div> <div><div><div><div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >NOTE 12 &#8212; CONVERTIBLE NOTES </font> </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On March&#160;7, 2007, Solar EnerTech entered into a securities purchase agreement to issue $17.3 million of secured convertible notes (the &#8220;Notes&#8221;) and detachable stock purchase warrants the &#8220;Series A and Series B Warrants&#8221;). Accordingly, during the quarter ended March&#160;31, 2007, Solar EnerTech sold units consisting of: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >&#183; </font> </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$5.0 million in principal amount of Series&#160;A Convertible Notes and warrants to purchase 7,246,377 shares (exercise price of $1.21 per share) of its common stock; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >&#183; </font> </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$3.3 million in principal amount of Series&#160;B Convertible Notes and warrants to purchase 5,789,474 shares (exercise price of $0.90 per share) of its common stock ; and </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >&#183; </font> </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$9.0 million in principal amount of Series&#160;B Convertible Notes and warrants to purchase 15,789,474 shares (exercise price of $0.90 per share) of its common stock. </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >These Notes bear interest at 6% per annum and are due in 2010. Under their original terms, the principal amount of the Series&#160;A Convertible Notes may be converted at the initial rate of $0.69 per share for a total of 7,246,377 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest). Under their original terms, the principal amount of the Series&#160;B Convertible Notes may be converted at the initial rate of $0.57 per share for a total of 21,578,948 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest). </font> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div> </div> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><br /> The Company evaluated the Notes for derivative accounting considerations under FASB ASC 815 and determined that the notes contained two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the &#8220;compound embedded derivative&#8221; or &#8220;CED&#8221;). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account &#8220;gain (loss) on fair market value of compound embedded derivative&#8221; in the accompanying consolidated statements of operations. </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In connection with the issuance of the Notes and Series A and Series B Warrants, the Company engaged an exclusive advisor and placement agent (the &#8220;Advisor&#8221;) and issued warrants to the Advisor to purchase an aggregate of 1,510,528 shares at an exercise price of $0.57 per share and 507,247 shares at an exercise price of $0.69 per share, of the Company&#8217;s common stock (the &#8220;Advisor Warrants&#8221;). In addition to the issuance of the warrants, the Company paid $1,038,000 in commissions, an advisory fee of $173,000, and other fees and expenses of $84,025. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Series A and Series B Warrants (including the Advisor Warrants) were classified as a liability, as required by FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;, formerly referenced as SFAS No. 150, &#8220;Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity&#8221;, due to the terms of the warrant agreement which contains a cash redemption provision in the event of a fundamental transaction. The warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account &#8220;gain (loss) on fair market value of warrant liability&#8221; in the accompanying consolidated statements of operations. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >In conjunction with the March 2007 financing, the Company recorded a total deferred financing cost of $2.5 million, of which $1.3 million represented cash payment and $1.2 million represented the fair market value of the Advisor Warrants. The deferred financing cost is amortized over the three year life of the notes using a method that approximates the effective interest rate method. The Advisor Warrants were recorded as a liability and adjusted to fair value in each subsequent period. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January 7, 2010 (the &#8220;Conversion Date&#8221;), the Company entered into a Series A and Series B Notes Conversion Agreement (the &#8220;Conversion Agreement&#8221;) with the holders of Notes representing at least seventy-five percent of the aggregate principal amounts outstanding under the Notes to restructure the terms of the Notes. As of the Conversion Date, approximately $9.8 million of the Series A and B Convertible Notes were effectively converted into 64,959,227 shares of the Company&#8217;s common stock along with 1,035,791 shares of the Company&#8217;s common stock as settlement of the accrued interest on the Series A and B Convertible Notes, and the remaining $1.8 million of the Series B Notes were exchanged into another convertible note as further discussed below. In connection with the Conversion Agreement, on January 7, 2010, the Company entered into an Amendment (the &#8220;Warrant Amendment&#8221;) to the Series A, Series B and Series C Warrants with the holders of at least a majority of the common stock underlying each of its outstanding Series A Warrants, Series B Warrants and Series C Warrants (collectively the &#8220;PIPE Warrants&#8221;). The Warrant Amendment reduced the exercise price for all of the PIPE Warrants from $1.21, $0.90 and $1.00, respectively, to $0.15, removed certain maximum ownership provisions and removed anti-dilution provisions for lower-priced security issuances. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Conversion Agreement resulted in modifications or exchanges of the Notes and PIPE Warrants, which should be accounted for pursuant to FASB ASC 405-20, &#8220;Liabilities&#8221; and FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No. 96-19, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments". The combination of the adjustment to conversion price and the automatic conversion of the Notes effectively resulted in the settlement of the Notes through the issuance of shares of the Company&#8217;s common stock and amendment of the PIPE Warrants&#8217; terms. Since the Company is relieved of its obligation for the Notes, the transaction is accounted for as an extinguishment of the Notes upon issuance of ordinary shares and modification of the PIPE Warrants&#8217; terms. The loss on extinguishment associated with the Conversion Agreement amounted to approximately $17.2 million. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On January 19, 2010, a holder of approximately $1.8 million of the Company&#8217;s formerly outstanding Series B Notes and Series B Warrants (hereinafter referred to as the &#8220;Holder&#8221;) of the Company&#8217;s common stock disputed the effectiveness of the Conversion Agreement and the Warrant Amendment.&#160;&#160;Accordingly, the Holder did not tender its Series B Notes for conversion. After negotiations with the Holder, on March 19, 2010, the Company entered into an Exchange Agreement with the Holder (the &#8220;Exchange Agreement&#8221;), whereby the Company issued the Series B-1 Note with a principal amount of $1.8 million (the &#8220;Series B-1 Note&#8221;) to the Holder along with 283,498 shares of the Company&#8217;s common stock as settlement of the accrued interest on the Holder&#8217;s Series B Notes and 666,666 shares of the Company&#8217;s common stock as settlement of the outstanding dispute regarding the effectiveness of the Company&#8217;s Conversion Agreement and the Warrant Amendment.&#160;&#160;The Company did not capitalize any financing costs associated with the issuance of the Series B-1 Note. &#160;As of June 30, 2011, the Company has an outstanding convertible note with a principal balance of $1,540,261 consisting of the Series B-1 Note, which was recorded at a carrying amount of $1,443,000. The Series B-1 Note bears interest at 6% per annum and is due on March 19, 2012. During the nine months ended June 30, 2011, the Company issued 784,768 shares of its common stock to settle&#160;the accrued interest on&#160;the Series B-1 Note. </font> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div> </div> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><br /> The Exchange Agreement resulted in modifications or exchanges of the Holder&#8217;s rights under its former Series B Note, which should be accounted for pursuant to FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No. 96-19, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments", and FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No.06-06, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments". The loss on debt extinguishment associated with the Exchange Agreement amounted to approximately $1.3 million. </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The costs associated with the Conversion Agreement were directly derived from the execution of the Company&#8217;s plan in improving its liquidity and business sustainability. The related loss on debt extinguishment was a cost that was integral to the continuing operations of the business which is different in nature to the continuing interest payments and change in fair value of the compound embedded derivative and warrant liability. Accordingly, the loss on debt extinguishment is included in operating expenses in the accompanying consolidated statements of operations. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company evaluated the Series B-1 Note for derivative accounting considerations under FASB ASC 815 and determined that the Series B-1 Note contained two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the &#8220;compound embedded derivative&#8221;). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account &#8220;gain (loss) on fair market value of compound embedded derivative&#8221; in the accompanying consolidated statements of operations. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On <font style="display:inline;font-family:times new roman;" >March 19, 2010, the Company entered into an Exchange Agreement (the </font>&#8220;Exchange Agreement&#8221;) with Capital Ventures International (&#8220;CVI&#8221;) whereby the Company issued a Series B-1 Convertible Note (the &#8220;Note&#8221;) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum. On May 11, 2011, the Company executed an amendment with CVI (&#8220;Amendment&#8221;) whereby CVI waives the following Trigger Events: (a) the migration of the Company&#8217;s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, the Company&#8217;s liquidity and financial position raises substantial doubt about the Company&#8217;s ability to continue as a going concern.&#160; </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The loss (gain) on debt extinguishment is computed as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="100%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" colspan="6" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Three&#160;Months&#160;Ended&#160;June&#160;30, </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" colspan="6" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >Nine&#160;Months&#160;Ended&#160;June&#160;30, </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of the common shares </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >85,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >25,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >155,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >18,863,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of Series B-1 Note </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,108,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Unamortized deferred financing costs associated with the converted notes </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >594,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of the CED liability associated with the converted notes </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(13,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(26,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(74,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Accreted amount of the notes discount </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(95,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(25,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(184,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(7,544,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Common shares issued in conjunction with Series B-1 Note </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >- </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >100,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="52%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Loss on extinguishment of warrants </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >- </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >- </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >- </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >3,502,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="52%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Loss (gain) on debt extinguishment </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(23,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >- </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(55,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >18,549,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >During the three and nine months ended June 30, 2011, $100,000 and $200,000, respectively of the Series B-1 Note was converted into 1,000,000 and 1,666,667 shares of the Company&#8217;s common stock, respectively. As a result, the Company recorded a cumulative gain on debt extinguishment of approximately $23,000 and $55,000 during the three and nine months ended June 30, 2011, respectively. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >During the three months ended June 30, 2010, $25,000 of the Series B-1 Note was converted into 166,667 shares of the Company&#8217;s common stock. There was no gain on debt extinguishment during the three months ended June 30, 2010. The Company recorded a cumulative loss on debt extinguishment of approximately $18.5 million as a result of the Conversion Agreement and the Exchange Agreement during the nine months ended June 30, 2010. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" >&#160; </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The following table summarizes the valuation of the Notes and the related Compound Embedded Derivative, the Series A and Series B Warrants (including the Advisor Warrants), and the Series B-1 Note and the related Compound Embedded Derivative: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="90%" style="font-size:10pt;font-family:times new roman;" ><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Carrying amount of Series B-1 Note at March 19, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,815,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of compound embedded derivative liabilities </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(1,573,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Loss on debt extinguishment </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,293,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Amortization of note discount and conversion effect </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(4,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Carrying amount of Series B-1 Note at September 30, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,531,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Amortization of note discount and conversion effect </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(88,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Carrying amount of Series B-1 Note at June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >1,443,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of the Series B-1 compound embedded derivative liabilities at March 19, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1,573,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Gain on fair market value of embedded derivative liability </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(1,131,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Effect on debt conversion </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(20,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of the Series B-1compound embedded derivative liabilities at September 30, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >422,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Gain on fair market value of embedded derivative liability </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(263,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Effect on debt conversion </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(26,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of the Series B-1compound embedded derivative liabilities at June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >133,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of warrant liability at September 30, 2009 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2,068,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Loss on PIPE warrant extinguishment </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3,502,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Cashless exercise of warrants </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(157,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Gain on fair market value of warrant liability </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(4,511,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of warrant liability at September 30, 2010 </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >902,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="82%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Gain on fair market value of warrant liability </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="15%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(853,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="82%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Fair value of warrant liability at June 30, 2011 </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="15%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >49,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Series B-1 Note </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-style:italic;font-family:times new roman;" >The material terms of the Series B-1 Note are as follows: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Interest Payments </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Series B-1 Note bears interest at 6% per annum and the principal of $1.5 million is due on March 19, 2012. Accrued interest is payable quarterly in arrears on each of January&#160;1, April&#160;1, July 1 and October 1<font style="display:inline;font-weight:bold;" >, </font>&#160;&#160;beginning on the first such date after issuance, in cash or registered shares of common stock at the option of the Company. If the Company elects to pay any interest due in registered shares of the Company&#8217;s common stock: (i)&#160;the issuance price will be 90% of the 5-day weighted average price of the common stock ending on the day prior to the interest payment due date, and (ii) a trigger event shall not have occurred. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Voting Rights </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The holder of the Series B-1 Note does not have voting rights under these agreements. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Dividends </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Until all amounts owed under the Series B-1 Note have been converted, redeemed or otherwise satisfied in accordance with their terms, the Company shall not, directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on its capital stock without the prior express written consent of the required holders. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Conversion Right </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >At any time or times on or after the issuance date of the Series B-1 Note, the holder is entitled to convert, at the holder&#8217;s sole discretion, any portion of the outstanding and unpaid conversion amount (principal, accrued and unpaid interest and accrued and unpaid late charges) may be converted into fully paid and non-assessable shares of common stock, at the conversion rate discussed next. </font> </div><br /> <div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Conversion Rate </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The number of shares of common stock issuable upon conversion of the Series B-1 Note is determined by dividing (x)&#160;the conversion amount (principal, interest and late charges accrued and unpaid), by (y)&#160;the then applicable conversion price (initially $0.15 and currently $0.10 for Series&#160;B-1 Note after the execution of Amendment on May 11, 2011, subject to adjustment as provided in the agreement). No adjustment in the conversion price of the Series B-1 Note will be made in respect of the issuance of additional shares of common stock unless the consideration per share of an additional share of common stock issued or deemed to be issued by the Company is less than the conversion price of the Series B-1 Note in effect on the date of, and immediately prior to, such issuance. Should the outstanding shares of common stock increase (by stock split, stock dividend, or otherwise) or decrease (by reclassification or otherwise), the conversion price of the Series B-1 Note in effect immediately prior to the change shall be proportionately adjusted. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Redemptions </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Series B-1 Note permits the holder the right of redemption in the event of certain specified triggering events such as: </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The suspension from trading or failure of the common stock to be listed on the principal market or an eligible market for a period of five (5)&#160;consecutive trading days or for more than an aggregate of ten (10)&#160;trading days in any 365-day period; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s (A)&#160;failure to cure a conversion failure by delivery of the required number of shares of common stock within ten (10)&#160;trading days after the applicable conversion date or (B)&#160;notice, written or oral, to any holder of the Series B-1 Note, including by way of public announcement or through any of its agents, at any time, of its intention not to comply with a request for conversion of any Series B-1 Note into shares of common stock that is tendered in accordance with the provisions of the Series B-1 Note; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >3) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company's failure to pay to the Holder any amount of principal (including, without limitation, any redemption payments), interest, late charges or other amounts when and as due under this Series B-1 Note except, in the case of a failure to pay any interest and late charges when and as due, in which case only if such failure continues for a period of at least five (5) business days; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >4) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160;(A) The occurrence of any payment default or other default under any indebtedness of the Company or any of its subsidiaries that results in a redemption of or acceleration prior to maturity of $100,000 or more of such indebtedness in the aggregate, or (B)&#160;the occurrence of any material default under any indebtedness of the Company or any of its subsidiaries having an aggregate outstanding balance in excess of $100,000 and such default continues uncured for more than ten (10) business days, other than, in each case (A)&#160;or (B)&#160;above, or a default with respect to any other Series B-1 Note; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >5) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company or any of its subsidiaries, pursuant to or within the meaning of Title 11, U.S. Code, or any similar Federal, foreign or state law for the relief of debtors (A)&#160;commences a voluntary case, (B)&#160;consents to the entry of an order for relief against it in an involuntary case, (C)&#160;consents to the appointment of a receiver, trustee, assignee, liquidator or similar official, (D)&#160;makes a general assignment for the benefit of its creditors or (E)&#160;admits in writing that it is generally unable to pay its debts as they become due; </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >6) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >A court of competent jurisdiction enters an order or decree under any bankruptcy law that (A)&#160;is for relief against the Company or any of its subsidiaries in an involuntary case, (B)&#160;appoints a custodian of the Company or any of its subsidiaries or (C)&#160;orders the liquidation of the Company or any of its subsidiaries; </font> </div> </td> </tr> </table> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >7) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >A final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company or any of its subsidiaries and which judgments are not, within sixty (60)&#160;days after the entry thereof, bonded, discharged or stayed pending appeal, or are not discharged within sixty (60)&#160;days after the expiration of such stay; provided, however, that any judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount set forth above so long as the Company provides the holder with a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory to the holder) to the effect that such judgment is covered by insurance or an indemnity and the Company will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance of such judgment; and </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:72pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >8) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company breaches any representation, warranty, covenant or other term or condition of any transaction document, except, in the case of a breach of a covenant which is curable, only if such breach continues for a period of at least ten (10)&#160;consecutive business days. </font> </div> </td> </tr> </table> </div><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><div> </div> </div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><br /> At any time after becoming aware of a trigger event, the holder may require the Company to redeem all or any portion of the Series B-1 Note at an amount equal to any accrued and unpaid liquidated damages, plus the greater of (A)&#160;the conversion amount to be redeemed multiplied by the redemption premium (125% for trigger events described above in subparagraphs 1 to 5 and 8 above or 100% for other events), or (B)&#160;the conversion amount to be redeemed multiplied by the quotient of (i)&#160;the closing sale price at the time of the trigger event (or at the time of payment of the redemption price, if greater) divided by (ii)&#160;the conversion price, provided, however, (B)&#160;shall be applicable only in the event that a trigger event of the type specified above in subparagraphs 1, 2 or 3 has occurred and remains uncured or the conversion shares otherwise could not be received or sold by the holder without any resale restrictions. </font> </div> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >Rights upon Fundamental Transaction, Change of Control and Qualified Financing </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Series B-1 Note also contains certain provisions relating to the occurrences of a fundamental transaction limiting the type of entity that can be a successor entity and requiring the successor entity to assume the obligations of the Series B-1 Note.&#160;&#160;In addition, the Series B-1 Note contains certain provisions relating to a change of control or qualified financing which permit the holder the right of redemption for all or a portion of the Series B-1 Note. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >1) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >Assumption. </font>The Company may not enter into or be party to a fundamental transaction, as such terms is defined in the Series B-1 Note, unless: </font> </div> </td> </tr> </table> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >&#183; </font> </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The successor entity assumes in writing all of the obligations of the Company under the Series B-1 Note and related documents; and </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >&#183; </font> </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The successor entity (including its parent entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an eligible market. </font> </div> </td> </tr> </table> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >2) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >Redemption Right on Change of Control. </font>At any time during the period beginning on the date of the holder&#8217;s receipt of a change of control notice and ending twenty (20)&#160;trading days after the consummation of such change of control, the holder may require the Company to redeem all or any portion of the Series B-1 Note in cash for an amount equal to any accrued and unpaid liquidated damages, plus the greater of (i)&#160;the product of (x) the conversion amount being redeemed and (y)&#160;the quotient determined by dividing (A)&#160;the greater of the closing sale price of the common stock immediately prior to the consummation of the change of control, the closing sale price immediately following the public announcement of such proposed change of control and the closing sale price of the common stock immediately prior to the public announcement of such proposed change of control by (B)&#160;the conversion price and (ii)&#160;125% of the conversion amount being redeemed<font style="display:inline;font-weight:bold;" > . </font> </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160;3) </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;font-weight:bold;" >Redemption Right on Subsequent Financing. </font>In the event that the Company or any of its subsidiaries shall issue any of its or its subsidiaries' equity or equity equivalent securities, or commit to issue or sell in one or more series of related transactions or financings, including without limitation any debt, preferred stock or other instrument or security that is, at any time during its life and under any circumstances, convertible into or exchangeable or exercisable for shares of common stock, options or convertible securities (any such offer, sale, grant, disposition or announcement of such current or future committed financing is referred to as a "Subsequent Financing"), the Company is obligated to provide the Holder written notice of the Subsequent Financing and the Holder, at its option, may require the Company to redeem the Series B-1 Note up to the Redemption Amount. </font> </div> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(A) In the event that the Gross Proceeds of the Subsequent Financing equals or exceeds $15,000,000 (a &#8220;Qualified Financing&#8221;), the &#8220;Redemption Amount&#8221; shall equal 100% of the Principal Amount then outstanding.&#160;&#160;For purposes hereof, &#8220;Gross Proceeds&#8221; shall mean the aggregate proceeds received or receivable by the Company in respect of one or more series of related future transactions or financings for which the Company is committed in connection with such Qualified Financing. </font> </div> </td> </tr> </table> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td> </tr> </table> </div><div><table cellspacing="0" cellpadding="0" width="100%" border="0" style="font-size:10pt;font-family:times new roman;text-align:center;" ><tr valign="top" ><td style="width:36pt;" ><div style="margin-left:0pt;text-indent:0pt;margin-right:0pt;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </div> </td><td><div style="text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >(B) In the event that the Gross Proceeds of the Subsequent Financing is less than $15,000,000, the Redemption Amount shall equal a pro-rated portion of the Principal Amount equaling a ratio, the numerator of which is the amount of proceeds raised by the Company in the Subsequent Financing and the denominator which is $15,000,000. </font> </div> </td> </tr> </table> </div> </div> </div> </div> </div> </div> <div><div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 20 &#8212; SUBSEQUENT EVENTS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On July 2, 2011, the Company issued 8,600,000 shares of restricted common stock to the Company&#8217;s employees pursuant to the Company&#8217;s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.&#160;&#160;The issuance of the shares of&#160;restricted stock was not registered under the Securities Act in reliance on the exemption from registration provided under Regulation S, as promulgated under the Securities Act. Shares of&#160;restricted stock were issued only to non-U.S. persons in offshore transactions&#160;who met the conditions under Regulation S. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Out of the 8,600,000 shares of restricted common stock issued, the Company issued 1,000,000 shares of restricted common stock to Yihong Yao, the Company&#8217;s Chief Financial Officer, pursuant to the Company&#8217;s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter. </font> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" > </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><div><div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" > </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><br /> <font style="display:inline;font-size:10pt;font-family:times new roman;" >On August 2, 2011, the Company paid the short term loans of approximately $302,000 to BOC. The remaining short term loans of approximately $706,000 will be due to BOC on August 15, 2011. </font></div> </div> </div> </div> </div> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 19 &#8212; FOREIGN OPERATIONS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company identifies its operating segments based on its business activities. The Company operates within a single operating segment, the manufacture of solar energy cells and modules in China. </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >The Company&#8217;s manufacturing operations and fixed assets are all based in China. The Company&#8217;s sales occurred in Europe, Australia, North America and China. </font> </div> </div> <div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >NOTE 9 &#8212; OTHER ASSETS </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Other assets at June 30, 2011 and September 30, 2010 mainly consist of the following: </font> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-size:10pt;font-family:times new roman;" ><tr><td valign="bottom" width="70%" style="padding-bottom:2px;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >June&#160;30,&#160;2011 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" style="border-bottom:black 2px solid;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >September&#160;30,&#160;2010 </font> </font> </div> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-weight:bold;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr><td valign="bottom" width="70%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Land use rights </font> </div> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="13%" colspan="2" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Cost </font> </div> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >773,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >746,000 </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr><tr style="background-color:#ccffcc;" ><td valign="bottom" width="70%" style="padding-bottom:2px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Less: Accumulated amortization </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(24,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="12%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >(11,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >) </font> </td> </tr><tr style="background-color:#ffffff;" ><td valign="bottom" width="70%" style="padding-bottom:4px;text-align:left;" ><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >Total other assets </font> </div> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >749,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >$ </font> </td><td valign="bottom" width="12%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" ><font style="display:inline;" >735,000 </font> </font> </td><td valign="bottom" nowrap="nowrap" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >&#160; </font> </td> </tr> </table> </div><div style="display:block;text-indent:0pt;" ><br /> </div><div style="display:block;margin-left:0pt;text-indent:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-size:10pt;font-family:times new roman;" >On February 8, 2010, the Company acquired land use rights of a 68,025 square meter parcel of land located in Yizheng, Jiangsu Province of China, which will be used to house the Company&#8217;s second manufacturing facility. For each of the next five years, annual amortization expense of the land use rights will be approximately $17,000 with an estimated useful life of 46.5 years<font style="display:inline;font-family:times new roman;" >. </font> </font> </div> </div> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="justify"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">NOTE 16 &#8212; NET INCOME (LOSS) PER SHARE</font></div> <div style="display: block; text-indent: 0pt"><br/> </div> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">The following table presents the computation of basic and diluted net income (loss) per share applicable to common stockholders:</font></div> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left">&#160;</div> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"> <div align="left"> <table cellpadding="0" cellspacing="0" width="100%" style="font-size: 10pt; font-family: times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td colspan="6" valign="bottom" style="border-bottom: black 2px solid"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="center"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">Three Months Ended June 30,</font></div> </td> <td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td colspan="6" valign="bottom" style="border-bottom: black 2px solid"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="center"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">Nine Months Ended June 30,</font></div> </td> <td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom" style="border-bottom: black 2px solid"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="center"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">2011</font></div> </td> <td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom" style="border-bottom: black 2px solid"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="center"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">2010</font></div> </td> <td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom" style="border-bottom: black 2px solid"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="center"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">2011</font></div> </td> <td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" style="padding-bottom: 2px"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom" style="border-bottom: black 2px solid"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="center"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">2010</font></div> </td> <td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Calculation of net income (loss) per share - basic:</font></div> </td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="white"> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td colspan="2" valign="bottom"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Net income (loss)</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(1,311,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(658,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">530,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(23,740,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> </tr><tr bgcolor="white"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt; padding-bottom: 2px"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Weighted-average number of common shares outstanding</font></div> </td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">161,543,403</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">156,502,573</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">160,990,033</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">128,327,753</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt; padding-bottom: 4px"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Net income (loss) per share - basic</font></div> </td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(0.01</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(0.004</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">0.003</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(0.18</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> </tr><tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Calculation of net income (loss) per share - diluted:</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="white"> <td valign="bottom" width="52%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Net income (loss)</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(1,311,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(658,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">530,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(23,740,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> </tr><tr bgcolor="white"> <td align="left" valign="bottom" width="52%" style="padding-left:7pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Less:&#160;&#160;Gain on change in fair market value of compound embedded derivative</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(263,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:7pt; padding-bottom: 2px"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;&#160;&#160;&#160;Interest expense on convertible notes</font></div> </td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">136,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="white"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Net income (loss) assuming dilution</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(1,311,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(658,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">403,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(23,740,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> </tr><tr bgcolor="#ccffcc"> <td valign="bottom" width="52%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="white"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Weighted-average number of common shares outstanding</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">161,543,403</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">156,502,573</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">160,990,033</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">128,327,753</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Effect of potentially dilutive securities:</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="white"> <td align="left" valign="bottom" width="52%" style="padding-left:7pt; padding-bottom: 2px"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Convertible notes</font></div> </td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">9,935,073</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Weighted-average number of common shares outstanding assuming dillution</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">161,543,403</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">156,502,573</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">170,925,106</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">128,327,753</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="white"> <td valign="bottom" width="52%" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160; </font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="padding-bottom: 2px"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 2px solid; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 2px solid; text-align: right"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 2px; text-align: left"><font style="display: inline; font-size: 8pt; font-family: times new roman">&#160;</font></td> </tr><tr bgcolor="#ccffcc"> <td align="left" valign="bottom" width="52%" style="padding-left:3pt; padding-bottom: 4px"> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="left"><font style="display: inline; font-size: 10pt; font-family: times new roman">Net income (loss) per share - diluted</font></div> </td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(0.01</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(0.004</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">0.002</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td align="right" valign="bottom" width="1%" style="padding-bottom: 4px"><font style="display: inline; font-size: 10pt; font-family: times new roman">&#160;</font></td> <td valign="bottom" width="1%" style="border-bottom: #000000 4px double; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">$</font></td> <td valign="bottom" width="9%" style="border-bottom: #000000 4px double; text-align: right"><font style="display: inline; font-size: 10pt; font-family: times new roman">(0.18</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="padding-bottom: 4px; text-align: left"><font style="display: inline; font-size: 10pt; font-family: times new roman">)</font></td> </tr></table> </div> </div> <div align="left">&#160;</div> <div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt" align="justify"><font style="display: inline; font-size: 10pt; font-family: times new roman">During the nine months ended June 30, 2011, 1,273,333 stock options, 55,229,796 warrants and 10,440,000 restricted stocks were excluded from the calculation of earnings per share because their effect would be anti-dilutive.</font></div> <div style="display: block; text-indent: 0pt"><br/> </div> EX-101.SCH 9 soen-20110630.xsd XBRL TAXONOMY EXTENSION SCHEMA 01 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 02 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 03 - Statement - Consolidated Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 04 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 05 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 06 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 07 - Disclosure - LIQUIDITY AND GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 08 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 09 - Disclosure - FINANCIAL INSTRUMENTS link:presentationLink link:definitionLink link:calculationLink 10 - Disclosure - ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS link:presentationLink link:definitionLink link:calculationLink 11 - Disclosure - ADVANCE PAYMENTS AND OTHER link:presentationLink link:definitionLink link:calculationLink 12 - Disclosure - INVENTORIES link:presentationLink link:definitionLink link:calculationLink 13 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:definitionLink link:calculationLink 14 - Disclosure - OTHER ASSETS link:presentationLink link:definitionLink link:calculationLink 15 - Disclosure - SHORT TERM LOANS link:presentationLink link:definitionLink link:calculationLink 16 - Disclosure - INCOME TAX link:presentationLink link:definitionLink link:calculationLink 17 - Disclosure - CONVERTIBLE NOTES link:presentationLink link:definitionLink link:calculationLink 18 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 19 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS link:presentationLink link:definitionLink link:calculationLink 20 - Disclosure - COMPREHENSIVE INCOME (LOSS) link:presentationLink link:definitionLink link:calculationLink 21 - Disclosure - NET INCOME (LOSS) PER SHARE link:presentationLink link:definitionLink link:calculationLink 22 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 23 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 24 - Disclosure - FOREIGN OPERATIONS link:presentationLink link:definitionLink link:calculationLink 25 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 soen-20110630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 soen-20110630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 soen-20110630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 soen-20110630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R3.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Balance Sheets [Parenthetical] (USD $)
Jun. 30, 2011
Sep. 30, 2010
Allowance For Doubtful Accounts (in dollars) $ 443,000 $ 42,000
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 400,000,000 400,000,000
Common stock, shares issued 172,710,388 170,338,954
Common stock, shares outstanding 172,710,388 170,338,954
XML 15 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Sales $ 12,203,000 $ 16,355,000 $ 38,390,000 $ 51,799,000
Cost of sales (12,762,000) (15,051,000) (38,080,000) (47,637,000)
Gross profit (loss) (559,000) 1,304,000 310,000 4,162,000
Operating expenses:        
Selling, general and administrative 1,394,000 2,475,000 5,799,000 7,243,000
Research and development 63,000 54,000 216,000 287,000
Loss (gain) on debt extinguishment (23,000) 0 (55,000) 18,549,000
Reversal of payroll related tax accrual 0 0 (5,817,000) 0
Total operating (income) expenses 1,434,000 2,529,000 143,000 26,079,000
Operating income (loss) (1,993,000) (1,225,000) 167,000 (21,917,000)
Other income (expense):        
Interest income 0 1,000 4,000 5,000
Interest expense (67,000) (59,000) (247,000) (5,383,000)
Gain on change in fair market value of compound embedded derivative 181,000 717,000 263,000 1,115,000
Gain on change in fair market value of warrant liability 628,000 1,393,000 853,000 4,369,000
Impairment loss on investment 0 (1,000,000) 0 (1,000,000)
Other expense (60,000) (485,000) (510,000) (929,000)
Net income (loss) $ (1,311,000) $ (658,000) $ 530,000 $ (23,740,000)
Net income (loss) per share - basic (in dollars per share) $ (0.01) $ (0.004) $ 0.003 $ (0.18)
Net income (loss) per share - diluted (in dollars per share) $ (0.01) $ (0.004) $ 0.002 $ (0.18)
Weighted average shares outstanding - basic (in shares) 161,543,403 156,502,573 160,990,033 128,327,753
Weighted average shares outstanding - diluted (in shares) 161,543,403 156,502,573 170,925,106 128,327,753
XML 16 R23.htm IDEA: XBRL DOCUMENT  v2.3.0.11
RELATED PARTY TRANSACTIONS
9 Months Ended
Jun. 30, 2011
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
NOTE 18 — RELATED PARTY TRANSACTIONS

At June 30, 2011 and September 30, 2010, the accounts payable and accrued liabilities, related party balance was $0 million and $5.8 million, respectively. The $5.8 million accrued liability at fiscal year ended September 30, 2010 represents $4.8 million of compensation expense related to the Company’s obligation to withhold tax upon exercise of stock options by Mr. Young in the fiscal year 2006 and the related interest and penalties, and $1.0 million of indemnification provided by the Company to Mr. Young  for any liabilities he may incur as a result of previous stock options granted to him by Ms. Blanchard, a former officer, in conjunction with the purchase of Infotech on August 19, 2008.

Both the Company’s obligation to withhold tax upon the exercise of stock options by Mr. Young and the indemnification has a three year statute of limitation. The statute of limitation expired as of December 31, 2010. As a result, the Company released the $5.8 million on December 31, 2010.
XML 17 R1.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Document and Entity Information
9 Months Ended
Jun. 30, 2011
Aug. 08, 2011
Entity Registrant Name SOLAR ENERTECH CORP  
Entity Central Index Key 0001307873  
Current Fiscal Year End Date --09-30  
Entity Filer Category Smaller Reporting Company  
Trading Symbol SOEN  
Entity Common Stock, Shares Outstanding   181,670,962
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2011
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2011  
XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 19 R12.htm IDEA: XBRL DOCUMENT  v2.3.0.11
INVENTORIES
9 Months Ended
Jun. 30, 2011
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
NOTE 7 — INVENTORIES

At June 30, 2011 and September 30, 2010, inventories consist of:

   
June 30, 2011
   
September 30, 2010
 
Raw materials
  $ 3,133,000     $ 2,639,000  
Finished goods
    33,000       1,444,000  
Total inventories
  $ 3,166,000     $ 4,083,000
XML 20 R25.htm IDEA: XBRL DOCUMENT  v2.3.0.11
SUBSEQUENT EVENTS
9 Months Ended
Jun. 30, 2011
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE 20 — SUBSEQUENT EVENTS

On July 2, 2011, the Company issued 8,600,000 shares of restricted common stock to the Company’s employees pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.  The issuance of the shares of restricted stock was not registered under the Securities Act in reliance on the exemption from registration provided under Regulation S, as promulgated under the Securities Act. Shares of restricted stock were issued only to non-U.S. persons in offshore transactions who met the conditions under Regulation S.

Out of the 8,600,000 shares of restricted common stock issued, the Company issued 1,000,000 shares of restricted common stock to Yihong Yao, the Company’s Chief Financial Officer, pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.

On August 2, 2011, the Company paid the short term loans of approximately $302,000 to BOC. The remaining short term loans of approximately $706,000 will be due to BOC on August 15, 2011.
XML 21 R17.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONVERTIBLE NOTES
9 Months Ended
Jun. 30, 2011
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Discussion of Hybrid Instruments and Embedded Derivatives [Text Block]
NOTE 12 — CONVERTIBLE NOTES

On March 7, 2007, Solar EnerTech entered into a securities purchase agreement to issue $17.3 million of secured convertible notes (the “Notes”) and detachable stock purchase warrants the “Series A and Series B Warrants”). Accordingly, during the quarter ended March 31, 2007, Solar EnerTech sold units consisting of:

 
·
$5.0 million in principal amount of Series A Convertible Notes and warrants to purchase 7,246,377 shares (exercise price of $1.21 per share) of its common stock;

 
·
$3.3 million in principal amount of Series B Convertible Notes and warrants to purchase 5,789,474 shares (exercise price of $0.90 per share) of its common stock ; and

 
·
$9.0 million in principal amount of Series B Convertible Notes and warrants to purchase 15,789,474 shares (exercise price of $0.90 per share) of its common stock.

These Notes bear interest at 6% per annum and are due in 2010. Under their original terms, the principal amount of the Series A Convertible Notes may be converted at the initial rate of $0.69 per share for a total of 7,246,377 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest). Under their original terms, the principal amount of the Series B Convertible Notes may be converted at the initial rate of $0.57 per share for a total of 21,578,948 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest).

The Company evaluated the Notes for derivative accounting considerations under FASB ASC 815 and determined that the notes contained two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative” or “CED”). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account “gain (loss) on fair market value of compound embedded derivative” in the accompanying consolidated statements of operations.

In connection with the issuance of the Notes and Series A and Series B Warrants, the Company engaged an exclusive advisor and placement agent (the “Advisor”) and issued warrants to the Advisor to purchase an aggregate of 1,510,528 shares at an exercise price of $0.57 per share and 507,247 shares at an exercise price of $0.69 per share, of the Company’s common stock (the “Advisor Warrants”). In addition to the issuance of the warrants, the Company paid $1,038,000 in commissions, an advisory fee of $173,000, and other fees and expenses of $84,025.

The Series A and Series B Warrants (including the Advisor Warrants) were classified as a liability, as required by FASB ASC 480, “Distinguishing Liabilities from Equity”, formerly referenced as SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity”, due to the terms of the warrant agreement which contains a cash redemption provision in the event of a fundamental transaction. The warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account “gain (loss) on fair market value of warrant liability” in the accompanying consolidated statements of operations.

In conjunction with the March 2007 financing, the Company recorded a total deferred financing cost of $2.5 million, of which $1.3 million represented cash payment and $1.2 million represented the fair market value of the Advisor Warrants. The deferred financing cost is amortized over the three year life of the notes using a method that approximates the effective interest rate method. The Advisor Warrants were recorded as a liability and adjusted to fair value in each subsequent period.

On January 7, 2010 (the “Conversion Date”), the Company entered into a Series A and Series B Notes Conversion Agreement (the “Conversion Agreement”) with the holders of Notes representing at least seventy-five percent of the aggregate principal amounts outstanding under the Notes to restructure the terms of the Notes. As of the Conversion Date, approximately $9.8 million of the Series A and B Convertible Notes were effectively converted into 64,959,227 shares of the Company’s common stock along with 1,035,791 shares of the Company’s common stock as settlement of the accrued interest on the Series A and B Convertible Notes, and the remaining $1.8 million of the Series B Notes were exchanged into another convertible note as further discussed below. In connection with the Conversion Agreement, on January 7, 2010, the Company entered into an Amendment (the “Warrant Amendment”) to the Series A, Series B and Series C Warrants with the holders of at least a majority of the common stock underlying each of its outstanding Series A Warrants, Series B Warrants and Series C Warrants (collectively the “PIPE Warrants”). The Warrant Amendment reduced the exercise price for all of the PIPE Warrants from $1.21, $0.90 and $1.00, respectively, to $0.15, removed certain maximum ownership provisions and removed anti-dilution provisions for lower-priced security issuances.
 
The Conversion Agreement resulted in modifications or exchanges of the Notes and PIPE Warrants, which should be accounted for pursuant to FASB ASC 405-20, “Liabilities” and FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No. 96-19, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments". The combination of the adjustment to conversion price and the automatic conversion of the Notes effectively resulted in the settlement of the Notes through the issuance of shares of the Company’s common stock and amendment of the PIPE Warrants’ terms. Since the Company is relieved of its obligation for the Notes, the transaction is accounted for as an extinguishment of the Notes upon issuance of ordinary shares and modification of the PIPE Warrants’ terms. The loss on extinguishment associated with the Conversion Agreement amounted to approximately $17.2 million.

On January 19, 2010, a holder of approximately $1.8 million of the Company’s formerly outstanding Series B Notes and Series B Warrants (hereinafter referred to as the “Holder”) of the Company’s common stock disputed the effectiveness of the Conversion Agreement and the Warrant Amendment.  Accordingly, the Holder did not tender its Series B Notes for conversion. After negotiations with the Holder, on March 19, 2010, the Company entered into an Exchange Agreement with the Holder (the “Exchange Agreement”), whereby the Company issued the Series B-1 Note with a principal amount of $1.8 million (the “Series B-1 Note”) to the Holder along with 283,498 shares of the Company’s common stock as settlement of the accrued interest on the Holder’s Series B Notes and 666,666 shares of the Company’s common stock as settlement of the outstanding dispute regarding the effectiveness of the Company’s Conversion Agreement and the Warrant Amendment.  The Company did not capitalize any financing costs associated with the issuance of the Series B-1 Note.  As of June 30, 2011, the Company has an outstanding convertible note with a principal balance of $1,540,261 consisting of the Series B-1 Note, which was recorded at a carrying amount of $1,443,000. The Series B-1 Note bears interest at 6% per annum and is due on March 19, 2012. During the nine months ended June 30, 2011, the Company issued 784,768 shares of its common stock to settle the accrued interest on the Series B-1 Note.

The Exchange Agreement resulted in modifications or exchanges of the Holder’s rights under its former Series B Note, which should be accounted for pursuant to FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No. 96-19, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments", and FASB ASC 470-50, "Debt/Modifications and Extinguishment" formerly referenced as EITF Consensus for Issue No.06-06, "Debtor's Accounting for a Modification (or Exchange) of Convertible Debt Instruments". The loss on debt extinguishment associated with the Exchange Agreement amounted to approximately $1.3 million.

The costs associated with the Conversion Agreement were directly derived from the execution of the Company’s plan in improving its liquidity and business sustainability. The related loss on debt extinguishment was a cost that was integral to the continuing operations of the business which is different in nature to the continuing interest payments and change in fair value of the compound embedded derivative and warrant liability. Accordingly, the loss on debt extinguishment is included in operating expenses in the accompanying consolidated statements of operations.

The Company evaluated the Series B-1 Note for derivative accounting considerations under FASB ASC 815 and determined that the Series B-1 Note contained two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative”). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account “gain (loss) on fair market value of compound embedded derivative” in the accompanying consolidated statements of operations.

On March 19, 2010, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby the Company issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum. On May 11, 2011, the Company executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of the Company’s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, the Company’s liquidity and financial position raises substantial doubt about the Company’s ability to continue as a going concern. 

The loss (gain) on debt extinguishment is computed as follows:

   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Fair value of the common shares
  $ 85,000     $ 25,000     $ 155,000     $ 18,863,000  
Fair value of Series B-1 Note
    -       -       -       3,108,000  
Unamortized deferred financing costs associated with the converted notes
    -       -       -       594,000  
Fair value of the CED liability associated with the converted notes
    (13,000 )     -       (26,000 )     (74,000 )
Accreted amount of the notes discount
    (95,000 )     (25,000 )     (184,000 )     (7,544,000 )
Common shares issued in conjunction with Series B-1 Note
    -       -       -       100,000  
Loss on extinguishment of warrants
    -       -       -       3,502,000  
Loss (gain) on debt extinguishment
  $ (23,000 )   $ -     $ (55,000 )   $ 18,549,000  

During the three and nine months ended June 30, 2011, $100,000 and $200,000, respectively of the Series B-1 Note was converted into 1,000,000 and 1,666,667 shares of the Company’s common stock, respectively. As a result, the Company recorded a cumulative gain on debt extinguishment of approximately $23,000 and $55,000 during the three and nine months ended June 30, 2011, respectively.

During the three months ended June 30, 2010, $25,000 of the Series B-1 Note was converted into 166,667 shares of the Company’s common stock. There was no gain on debt extinguishment during the three months ended June 30, 2010. The Company recorded a cumulative loss on debt extinguishment of approximately $18.5 million as a result of the Conversion Agreement and the Exchange Agreement during the nine months ended June 30, 2010.
 
The following table summarizes the valuation of the Notes and the related Compound Embedded Derivative, the Series A and Series B Warrants (including the Advisor Warrants), and the Series B-1 Note and the related Compound Embedded Derivative:

Carrying amount of Series B-1 Note at March 19, 2010
  $ 1,815,000  
Fair value of compound embedded derivative liabilities
    (1,573,000 )
Loss on debt extinguishment
    1,293,000  
Amortization of note discount and conversion effect
    (4,000 )
Carrying amount of Series B-1 Note at September 30, 2010
  $ 1,531,000  
Amortization of note discount and conversion effect
    (88,000 )
Carrying amount of Series B-1 Note at June 30, 2011
  $ 1,443,000  
         
Fair value of the Series B-1 compound embedded derivative liabilities at March 19, 2010
  $ 1,573,000  
Gain on fair market value of embedded derivative liability
    (1,131,000 )
Effect on debt conversion
    (20,000 )
Fair value of the Series B-1compound embedded derivative liabilities at September 30, 2010
  $ 422,000  
Gain on fair market value of embedded derivative liability
    (263,000 )
Effect on debt conversion
    (26,000 )
Fair value of the Series B-1compound embedded derivative liabilities at June 30, 2011
  $ 133,000  
         
Fair value of warrant liability at September 30, 2009
  $ 2,068,000  
Loss on PIPE warrant extinguishment
    3,502,000  
Cashless exercise of warrants
    (157,000 )
Gain on fair market value of warrant liability
    (4,511,000 )
Fair value of warrant liability at September 30, 2010
  $ 902,000  
Gain on fair market value of warrant liability
    (853,000 )
Fair value of warrant liability at June 30, 2011
  $ 49,000  

Series B-1 Note

The material terms of the Series B-1 Note are as follows:

Interest Payments

The Series B-1 Note bears interest at 6% per annum and the principal of $1.5 million is due on March 19, 2012. Accrued interest is payable quarterly in arrears on each of January 1, April 1, July 1 and October 1,   beginning on the first such date after issuance, in cash or registered shares of common stock at the option of the Company. If the Company elects to pay any interest due in registered shares of the Company’s common stock: (i) the issuance price will be 90% of the 5-day weighted average price of the common stock ending on the day prior to the interest payment due date, and (ii) a trigger event shall not have occurred.

Voting Rights

The holder of the Series B-1 Note does not have voting rights under these agreements.

Dividends

Until all amounts owed under the Series B-1 Note have been converted, redeemed or otherwise satisfied in accordance with their terms, the Company shall not, directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on its capital stock without the prior express written consent of the required holders.
 
Conversion Right

At any time or times on or after the issuance date of the Series B-1 Note, the holder is entitled to convert, at the holder’s sole discretion, any portion of the outstanding and unpaid conversion amount (principal, accrued and unpaid interest and accrued and unpaid late charges) may be converted into fully paid and non-assessable shares of common stock, at the conversion rate discussed next.

Conversion Rate

The number of shares of common stock issuable upon conversion of the Series B-1 Note is determined by dividing (x) the conversion amount (principal, interest and late charges accrued and unpaid), by (y) the then applicable conversion price (initially $0.15 and currently $0.10 for Series B-1 Note after the execution of Amendment on May 11, 2011, subject to adjustment as provided in the agreement). No adjustment in the conversion price of the Series B-1 Note will be made in respect of the issuance of additional shares of common stock unless the consideration per share of an additional share of common stock issued or deemed to be issued by the Company is less than the conversion price of the Series B-1 Note in effect on the date of, and immediately prior to, such issuance. Should the outstanding shares of common stock increase (by stock split, stock dividend, or otherwise) or decrease (by reclassification or otherwise), the conversion price of the Series B-1 Note in effect immediately prior to the change shall be proportionately adjusted.

Redemptions

The Series B-1 Note permits the holder the right of redemption in the event of certain specified triggering events such as:
 
1)
The suspension from trading or failure of the common stock to be listed on the principal market or an eligible market for a period of five (5) consecutive trading days or for more than an aggregate of ten (10) trading days in any 365-day period;

2)
The Company’s (A) failure to cure a conversion failure by delivery of the required number of shares of common stock within ten (10) trading days after the applicable conversion date or (B) notice, written or oral, to any holder of the Series B-1 Note, including by way of public announcement or through any of its agents, at any time, of its intention not to comply with a request for conversion of any Series B-1 Note into shares of common stock that is tendered in accordance with the provisions of the Series B-1 Note;

3)
The Company's failure to pay to the Holder any amount of principal (including, without limitation, any redemption payments), interest, late charges or other amounts when and as due under this Series B-1 Note except, in the case of a failure to pay any interest and late charges when and as due, in which case only if such failure continues for a period of at least five (5) business days;

4)
 (A) The occurrence of any payment default or other default under any indebtedness of the Company or any of its subsidiaries that results in a redemption of or acceleration prior to maturity of $100,000 or more of such indebtedness in the aggregate, or (B) the occurrence of any material default under any indebtedness of the Company or any of its subsidiaries having an aggregate outstanding balance in excess of $100,000 and such default continues uncured for more than ten (10) business days, other than, in each case (A) or (B) above, or a default with respect to any other Series B-1 Note;

5)
The Company or any of its subsidiaries, pursuant to or within the meaning of Title 11, U.S. Code, or any similar Federal, foreign or state law for the relief of debtors (A) commences a voluntary case, (B) consents to the entry of an order for relief against it in an involuntary case, (C) consents to the appointment of a receiver, trustee, assignee, liquidator or similar official, (D) makes a general assignment for the benefit of its creditors or (E) admits in writing that it is generally unable to pay its debts as they become due;

6)
A court of competent jurisdiction enters an order or decree under any bankruptcy law that (A) is for relief against the Company or any of its subsidiaries in an involuntary case, (B) appoints a custodian of the Company or any of its subsidiaries or (C) orders the liquidation of the Company or any of its subsidiaries;
7)
A final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company or any of its subsidiaries and which judgments are not, within sixty (60) days after the entry thereof, bonded, discharged or stayed pending appeal, or are not discharged within sixty (60) days after the expiration of such stay; provided, however, that any judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount set forth above so long as the Company provides the holder with a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory to the holder) to the effect that such judgment is covered by insurance or an indemnity and the Company will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance of such judgment; and

8)
The Company breaches any representation, warranty, covenant or other term or condition of any transaction document, except, in the case of a breach of a covenant which is curable, only if such breach continues for a period of at least ten (10) consecutive business days.

At any time after becoming aware of a trigger event, the holder may require the Company to redeem all or any portion of the Series B-1 Note at an amount equal to any accrued and unpaid liquidated damages, plus the greater of (A) the conversion amount to be redeemed multiplied by the redemption premium (125% for trigger events described above in subparagraphs 1 to 5 and 8 above or 100% for other events), or (B) the conversion amount to be redeemed multiplied by the quotient of (i) the closing sale price at the time of the trigger event (or at the time of payment of the redemption price, if greater) divided by (ii) the conversion price, provided, however, (B) shall be applicable only in the event that a trigger event of the type specified above in subparagraphs 1, 2 or 3 has occurred and remains uncured or the conversion shares otherwise could not be received or sold by the holder without any resale restrictions.

Rights upon Fundamental Transaction, Change of Control and Qualified Financing

The Series B-1 Note also contains certain provisions relating to the occurrences of a fundamental transaction limiting the type of entity that can be a successor entity and requiring the successor entity to assume the obligations of the Series B-1 Note.  In addition, the Series B-1 Note contains certain provisions relating to a change of control or qualified financing which permit the holder the right of redemption for all or a portion of the Series B-1 Note.
 
1)
Assumption. The Company may not enter into or be party to a fundamental transaction, as such terms is defined in the Series B-1 Note, unless:
 
 
·
The successor entity assumes in writing all of the obligations of the Company under the Series B-1 Note and related documents; and

 
·
The successor entity (including its parent entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an eligible market.
 
2)
Redemption Right on Change of Control. At any time during the period beginning on the date of the holder’s receipt of a change of control notice and ending twenty (20) trading days after the consummation of such change of control, the holder may require the Company to redeem all or any portion of the Series B-1 Note in cash for an amount equal to any accrued and unpaid liquidated damages, plus the greater of (i) the product of (x) the conversion amount being redeemed and (y) the quotient determined by dividing (A) the greater of the closing sale price of the common stock immediately prior to the consummation of the change of control, the closing sale price immediately following the public announcement of such proposed change of control and the closing sale price of the common stock immediately prior to the public announcement of such proposed change of control by (B) the conversion price and (ii) 125% of the conversion amount being redeemed .

 3)
Redemption Right on Subsequent Financing. In the event that the Company or any of its subsidiaries shall issue any of its or its subsidiaries' equity or equity equivalent securities, or commit to issue or sell in one or more series of related transactions or financings, including without limitation any debt, preferred stock or other instrument or security that is, at any time during its life and under any circumstances, convertible into or exchangeable or exercisable for shares of common stock, options or convertible securities (any such offer, sale, grant, disposition or announcement of such current or future committed financing is referred to as a "Subsequent Financing"), the Company is obligated to provide the Holder written notice of the Subsequent Financing and the Holder, at its option, may require the Company to redeem the Series B-1 Note up to the Redemption Amount.

 
(A) In the event that the Gross Proceeds of the Subsequent Financing equals or exceeds $15,000,000 (a “Qualified Financing”), the “Redemption Amount” shall equal 100% of the Principal Amount then outstanding.  For purposes hereof, “Gross Proceeds” shall mean the aggregate proceeds received or receivable by the Company in respect of one or more series of related future transactions or financings for which the Company is committed in connection with such Qualified Financing.
 
 
 
(B) In the event that the Gross Proceeds of the Subsequent Financing is less than $15,000,000, the Redemption Amount shall equal a pro-rated portion of the Principal Amount equaling a ratio, the numerator of which is the amount of proceeds raised by the Company in the Subsequent Financing and the denominator which is $15,000,000.
XML 22 R8.htm IDEA: XBRL DOCUMENT  v2.3.0.11
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Jun. 30, 2011
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Principles of Consolidation and Basis of Accounting

Prior to August 19, 2008, the Company operated its business in the People’s Republic of China through Solar EnerTech (HK) Corporation, Limited (“Solar EnerTech HK”) and Solar EnerTech (Shanghai) Co., Ltd (“Infotech Shanghai” and together with Solar EnerTech HK, “Infotech”). While the Company did not own Infotech, the Company’s financial statements have included the results of the financials of each of Solar EnerTech HK and Infotech Shanghai since these entities were wholly-controlled variable interest entities of the Company through an Agency Agreement dated April 10, 2006 by and between the Company and Infotech (the “Agency Agreement”). Under the Agency Agreement the Company engaged Infotech to undertake all activities necessary to build a solar technology business in China, including the acquisition of manufacturing facilities and equipment, employees and inventory. The Agency Agreement continued through April 10, 2008 and then on a month to month basis thereafter until terminated by either party.

To permanently consolidate Infotech with the Company through legal ownership, the Company acquired Infotech at a nominal amount on August 19, 2008 through a series of agreements. In connection with executing these agreements, the Company terminated the original agency relationship with Infotech.

The Company had previously consolidated the financial statements of Infotech with its financial statements pursuant to FASB ASC 810-10 “Consolidations”, formerly referenced as FASB Interpretation No. 46(R),  due to the agency relationship between the Company and Infotech and, notwithstanding the termination of the Agency Agreement, the Company continues to consolidate the financial statements of Infotech with its financial statements since Infotech became a wholly-owned subsidiary of the Company as a result of the acquisition.
The Company’s consolidated financial statements include the accounts of Solar EnerTech Corp. and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. These consolidated financial statements have been prepared in U.S. dollars and in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents
 
Cash and cash equivalents are defined as cash on hand, demand deposits and short-term, highly liquid investments that are readily convertible to known amounts of cash within ninety days of deposit.

Currency and Foreign Exchange
 
The Company’s functional currency is the Renminbi as substantially all of the Company’s operations are in China. The Company’s reporting currency is the U.S. dollar.

Transactions and balances originally denominated in U.S. dollars are presented at their original amounts. Transactions and balances in other currencies are converted into U.S. dollars in accordance with FASB ASC 830, “Foreign Currency Matters,” formerly referenced as SFAS No. 52,  “Foreign Currency Translation”, and are included in determining net income or loss.

For foreign operations with the local currency as the functional currency, assets and liabilities are translated from the local currencies into U.S. dollars at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Translation adjustments resulting from the process of translating the local currency consolidated financial statements into U.S. dollars are included in determining comprehensive loss.

Property and Equipment

The Company’s property and equipment are stated at cost net of accumulated depreciation. Depreciation is provided using the straight-line method over the related estimated useful lives, as follows:

   
Useful Life (Years)
Office equipment
 
3 to 5
Machinery
 
10
Production equipment
 
5
Automobiles
 
5
Furniture
 
5
Leasehold improvement
 
the shorter of the lease term or  5 years
   
Expenditures for maintenance and repairs that do not improve or extend the lives of the related assets are expensed to operations. Major repairs that improve or extend the lives of the related assets are capitalized.

Inventories

Inventories are stated at the lower of cost or market. Cost is determined by the weighted-average method. Market is defined principally as net realizable value. Raw material cost is based on purchase costs while work-in-progress and finished goods are comprised of direct materials, direct labor and an allocation of manufacturing overhead costs. Inventory in-transit is included in finished goods and consists of products shipped but not recognized as revenue because it does not meet the revenue recognition criteria. Provisions are made for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of net realizable value.

Warranty Cost

The Company provides product warranties and accrues for estimated future warranty costs in the period in which revenue is recognized. The Company’s standard solar modules are typically sold with a two-year warranty for defects in materials and workmanship and a ten-year and twenty five-year warranty against declines of more than 10.0% and 20.0%, respectively, of the initial minimum power generation capacity at the time of delivery. The Company therefore maintains warranty reserves to cover potential liabilities that could arise from its warranty obligations and accrues the estimated costs of warranties based primarily on management’s best estimate. In estimating warranty costs, the Company applied Accounting Standards Codification Topic 460 (“ASC 460”) – Guarantees, specifically paragraphs 460-10-25-5 to 460-10-25-7 of the FASB Accounting Standards Codification. This guidance requires that the Company make a reasonable estimate of the amount of a warranty obligation. It also provides that in the case of an entity that has no experience of its own, reference to the experience of other entities in the same business may be appropriate. Because the Company began to commercialize its products in fiscal year 2007, there is insufficient experience and historical data that can be used to reasonably estimate the expected failure rate of its solar modules. Thus, the Company considers warranty cost provisions of other China-based manufacturers that produce photovoltaic products that are comparable in engineering design, raw material input and functionality to the Company’s products, and sold to a similar target and class of customer with similar warranty coverage. In determining whether such peer information can be used, the Company also considers the years of experience that these manufacturers have in the industry. Because the Company’s industry is relatively young as compared to other traditional manufacturing industries, the selected peer companies that the Company considers have less than ten years in manufacturing and selling history. In addition, they have a manufacturing base in China, offer photovoltaic products with comparable engineering design, raw material input, functionality and similar warranty coverage, and sell in markets, including the geographic areas and class of customer, where the Company competes. Based on the analysis applied, the Company accrues warranty at 1% of sales. The Company has not experienced any material warranty claims to date in connection with declines of the power generation capacity of its solar modules and will prospectively revise its actual rate to the extent that actual warranty costs differ from the estimates. As of June 30, 2011 and September 30, 2010, the Company’s warranty liability was $1,481,000 and $1,125,000, respectively. The Company’s warranty costs for the nine months ended June 30, 2011 and 2010 were $324,000 and $411,000, respectively. The Company did not make any warranty payments during the nine months ended June 30, 2011 and 2010.

Other Assets

The Company acquired land use rights to a parcel of land from the government in the People’s Republic of China (“PRC”). All land in the PRC is owned by the PRC government and cannot be sold to any individual or entity. The government in the PRC, according to relevant PRC law, may sell the right to use the land for a specified period of time. Thus, the Company’s land purchase in the PRC is considered to be leased land and recorded as other assets at cost less accumulated amortization. Amortization is provided over the term of the land use right agreements on a straight-line basis, which is for 46.5 years from February 8, 2010 through August 31, 2056.

Impairment of Long Lived Assets

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. When such factors and circumstances exist, management compares the projected undiscounted future cash flows associated with the future use and disposal of the related asset or group of assets to their respective carrying values. Impairment, if any, is measured as the excess of the carrying value over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. No loss on property and equipment impairment was recorded during the nine months ended June 30, 2011 and 2010.

Investments

Investments in an entity where the Company owns less than twenty percent of the voting stock of the entity and does not exercise significant influence over operating and financial policies of the entity are accounted for using the cost method. Investments in the entity where the Company owns twenty percent or more but not in excess of fifty percent of the voting stock of the entity or less than twenty percent and exercises significant influence over operating and financial policies of the entity are accounted for using the equity method. The Company has a policy in place to review its investments at least annually, to evaluate the carrying value of the investments in these companies. The cost method investment is subject to impairment assessment if there are identified events or changes in circumstance that may have a significant adverse affect on the fair value of the investment. If the Company believes that the carrying value of an investment is in excess of estimated fair value, it is the Company’s policy to record an impairment charge to adjust the carrying value to the estimated fair value, if the impairment is considered other-than-temporary.

On August 21, 2008, the Company entered into an equity purchase agreement in which it acquired two million shares of common stock of 21-Century Silicon, Inc., a polysilicon manufacturer based in Dallas, Texas (“21-Century Silicon”), for $1.0 million in cash. The two million shares of common stock represented approximately 7.8% of 21-Century Silicon’s outstanding equity. In connection with the equity purchase agreement, the Company also signed a memorandum of understanding with 21-Century Silicon for a four-year supply framework agreement for polysilicon shipments.  The first polysilicon shipment from 21-Century Silicon was initially expected in March 2009, but was subsequently delayed to March 2010. On March 5, 2009, the Emerging Technology Fund, created by the State of Texas, invested $3.5 million in 21-Century Silicon to expedite production and commercialization of research. The Company’s ownership of 21-Century Silicon became 5.5% as a result of the dilution. This first polysilicon shipment that was to be delivered in March 2010 was further delayed without a specified date given by 21-Century Silicon. As a result of the continued delays in shipment, in July 2010, members of the Company’s executive team, including the CEO, visited 21-Century Silicon and conducted reviews of the production facility and technical development.  The review indicated that 21-Century Silicon’s production facility and technical development were significantly below expected standards. Based on the findings from this visit, the timing of the first polysilicon shipment is unknown and it is unknown whether it will even occur. In addition, management of 21-Century Silicon expressed the need for more funding to sustain operations. Moreover, 21-Century Silicon could not provide the Company with updated financial information concerning 21-Century Silicon’s working capital condition and future cash flows.  The Company considered the above findings were indicators that a significant adverse effect on the fair value of the Company’s investment in 21-Century Silicon had occurred. Accordingly, an impairment loss of $1.0 million was recorded in the Consolidated Statements of Operations for the fiscal year ended September 30, 2010 to fully write-down the carrying amount of the investment. The Company may also be obligated to acquire an additional two million shares of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million common shares (at $0.50 per share) as the product shipment has not occurred.  On October 7, 2010, the X-Change Corporation announced that it has acquired 21-Century Silicon, Inc. The terms of the acquisition are anticipated to involve a change in control of the Company and the appointment of new directors. The X-Change Corporation is anticipated to issue 20 million shares of its unregistered, restricted common stock to the shareholders of 21-Century Silicon in exchange for 100% of the issued and outstanding stock of 21-Century Silicon. As of the date of this report, the X-Change Corporation has not issued its shares to the Company.

Income Taxes

The Company accounts for income taxes under the liability method per the provisions of Accounting Standards Codification Topic 740 (“ASC 740”), “Income Taxes”.

Under the provisions of ASC 740, deferred tax assets and liabilities are determined based on the differences between their financial statement carrying values and their respective tax bases using enacted tax rates that will be in effect in the period in which the differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
 
Valuation Allowance

Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, the Company considers all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.
 
Unrecognized Tax Benefits
 
Effective on October 1, 2007, the Company adopted the provisions related to uncertain tax positions under ASC 740, “Income Taxes”, formerly referenced as FIN 48, “Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109”.  Under ASC 740, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority based on the technical merits of the associated tax position.  An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company also elected the accounting policy that requires interest and penalties to be recognized as a component of tax expense. The Company classifies the unrecognized tax benefits that are expected to be effectively settled within one year as current liabilities, otherwise, the unrecognized tax benefits will be classified as non-current liabilities.

Fair Value of Warrants

The Company’s management used the binomial valuation model to value the warrants issued in conjunction with convertible notes entered into in March 2007. The model uses inputs such as implied term, suboptimal exercise factor, volatility, dividend yield and risk free interest rate. Selection of these inputs involves management’s judgment and may impact estimated value. Management selected the binomial model to value these warrants as opposed to the Black-Scholes-Merton model primarily because management believes the binomial model produces a more reliable value for these instruments because it uses an additional valuation input factor, the suboptimal exercise factor, which accounts for expected holder exercise behavior which management believes is a reasonable assumption with respect to the holders of these warrants.

Stock-Based Compensation

On January 1, 2006, Solar EnerTech began recording compensation expense associated with stock options and other forms of employee equity compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation”, formerly referenced as SFAS 123R, “Share-Based Payment”.

The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula and a single option approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The following assumptions are used in the Black-Scholes-Merton option pricing model:

Expected Term — The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding.

Expected Volatility — The Company’s expected volatilities are based on historical volatility of the Company’s stock, adjusted where determined by management for unusual and non-representative stock price activity not expected to recur. Due to the limited trading history, the Company also considered volatility data of guidance companies.

Expected Dividend — The Black-Scholes-Merton valuation model calls for a single expected dividend yield as an input. The Company currently pays no dividends and does not expect to pay dividends in the foreseeable future.

Risk-Free Interest Rate — The Company bases the risk-free interest rate on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.

Estimated Forfeitures — When estimating forfeitures, the Company takes into consideration the historical option forfeitures over the expected term.

Revenue Recognition

The Company recognizes revenues from product sales in accordance with guidance provided in FASB ASC 605, “Revenue Recognition”, which states that revenue is realized or realizable and earned when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and collectability is reasonably assured. Where a revenue transaction does not meet any of these criteria it is deferred and recognized once all such criteria have been met. In instances where final acceptance of the product, system, or solution is specified by the customer, revenue is deferred until all acceptance criteria have been met.

On a transaction by transaction basis, the Company determines if the revenue should be recorded on a gross or net basis based on criteria discussed in the Revenue Recognition topic of the FASB Subtopic 605-405, “Reporting Revenue Gross as a Principal versus Net as an Agent”. The Company considers the following factors to determine the gross versus net presentation: if the Company (i) acts as principal in the transaction; (ii) takes title to the products; (iii) has risks and rewards of ownership, such as the risk of loss for collection, delivery or return; and (iv) acts as an agent or broker (including performing services, in substance, as an agent or broker) with compensation on a commission or fee basis.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are carried at net realizable value. The Company records allowance for doubtful accounts based upon its assessment of various factors. The Company considers historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect customers’ ability to pay.

Shipping and Handling Costs

The Company incurred shipping and handling costs of $318,000 and $1,414,000 for the nine months ended June 30, 2011 and 2010, respectively, which are included in selling expenses. Shipping and handling costs include costs incurred with third-party carriers to transport products to customers.

Research and Development Cost

Expenditures for research activities relating to product development are charged to expense as incurred. Research and development cost for the nine months ended June 30, 2011 and 2010 were $216,000 and $287,000, respectively.

Comprehensive Income (Loss)

Comprehensive income (loss) is defined as the change in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners.  Comprehensive income (loss) is reported in the consolidated statements of shareholder’s equity.  Other comprehensive income (loss) of the Company consists of cumulative foreign currency translation adjustments.

Segment Information

The Company identifies its operating segments based on its business activities. The Company operates within a single operating segment - the manufacture of solar energy cells and modules in China. The Company’s manufacturing operations and fixed assets are all based in China. The solar energy cells and modules are distributed to customers, located in Europe, Australia, North America and China.

During the nine months ended June 30, 2011 and 2010, the Company had one and three customers, respectively that accounted for more than 10% of net sales.

Recent Accounting Pronouncements

In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820) (“ASU 2011-04”). The amendments to this update provide a uniform framework for applying the principles of fair value measurement and include (i) amendments that clarify the Board’s intent about the application of existing fair value measurement and disclosure requirements and (ii) amendments that change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. These amendments do not require additional fair value measurements. The Company will adopt ASU 2011-04 in the second quarter of fiscal year 2012. The Company does not believe the adoption of ASU 2011-04 will have a material impact on the Company’s consolidated financial statements.
 
In June 2011, the FASB issued ASU 2011-05, “Presentation of Comprehensive Income” (“ASU 2011-05”). ASU 2001-05 amends Topic 220, “Comprehensive Income”, to allow an entity the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 does not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income, nor does it change the option for an entity to present components of other comprehensive income either net of related tax effects or before related tax effects. This ASU is effective for the Company’s financial statements for annual and interim periods beginning on or after December 15, 2011, and must be applied retrospectively. The Company will adopt ASU 2011-05 in the first quarter of fiscal year 2012. The adoption of ASU 2011-05 is not expected to have a material impact on the Company’s consolidated financial statements.
XML 23 R14.htm IDEA: XBRL DOCUMENT  v2.3.0.11
OTHER ASSETS
9 Months Ended
Jun. 30, 2011
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Assets Disclosure [Text Block]
NOTE 9 — OTHER ASSETS

Other assets at June 30, 2011 and September 30, 2010 mainly consist of the following:

   
June 30, 2011
   
September 30, 2010
 
             
Land use rights
           
Cost
  $ 773,000     $ 746,000  
Less: Accumulated amortization
    (24,000 )     (11,000 )
Total other assets
  $ 749,000     $ 735,000  

On February 8, 2010, the Company acquired land use rights of a 68,025 square meter parcel of land located in Yizheng, Jiangsu Province of China, which will be used to house the Company’s second manufacturing facility. For each of the next five years, annual amortization expense of the land use rights will be approximately $17,000 with an estimated useful life of 46.5 years.
XML 24 R19.htm IDEA: XBRL DOCUMENT  v2.3.0.11
FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Jun. 30, 2011
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
NOTE 14 — FAIR VALUE OF FINANCIAL INSTRUMENTS

In September 2006, the FASB issued SFAS 157, “Fair Value Measurements”, codified in FASB ASC 820, “Fair Value Measurements and Disclosures”, which defines fair value to measure assets and liabilities, establishes a framework for measuring fair value, and requires additional disclosures about the use of fair value. FASB ASC 820 is applicable whenever another accounting pronouncement requires or permits assets and liabilities to be measured at fair value. FASB ASC 820 does not expand or require any new fair value measures. FASB ASC 820 is effective for fiscal years beginning after November 15, 2007. In December 2007, the FASB agreed to a one year deferral of FASB ASC 820’s fair value measurement requirements for nonfinancial assets and liabilities that are not required or permitted to be measured at fair value on a recurring basis. The Company adopted FASB ASC 820 on October 1, 2008, which had no effect on the Company’s financial position, operating results or cash flows.

FASB ASC 820 defines fair value and establishes a hierarchal framework which prioritizes and ranks the market price observability used in fair value measurements. Market price observability is affected by a number of factors, including the type of asset or liability and the characteristics specific to the asset or liability being measured. Assets and liabilities with readily available, active, quoted market prices or for which fair value can be measured from actively quoted prices generally are deemed to have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. Under FASB ASC 820, the inputs used to measure fair value must be classified into one of three levels as follows:
 
 
Level 1 -
Quoted prices in an active market for identical assets or liabilities;

 
Level 2 -
Observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and

 
Level 3 -
Assets and liabilities whose significant value drivers are unobservable.
  
Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment.

The Company’s liabilities measured at fair value on a recurring basis consisted of the following types of instruments as of June 30, 2011:

   
Fair Value at
June 30, 2011
   
Quoted prices in
active markets
for identical
assets
   
Significant other
observable inputs
   
Significant
unobservable
inputs
 
   
 
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
                         
Derivative liabilites
  $ 133,000       -       -     $ 133,000  
Warrant liabilities
    49,000       -       -       49,000  
                                 
Total liabilities
  $ 182,000       -       -     $ 182,000  

The method used to estimate the value of the Series B-1 Note compound embedded derivatives (“CED”) was a binomial model with the following assumptions:

   
June 30, 2011
   
September 30, 2010
 
Implied term (years)
    0.72       1.46  
Suboptimal exercise factor
    2.50       2.50  
Volatility
    60.60 %     66.30 %
Dividend yield
    0.00 %     0.00 %
Risk-free interest rate
    0.14 %     0.34 %

The fair value of the Series A and Series B Warrants (including the Advisor Warrants) were estimated using a binomial valuation model with the following assumptions:

   
June 30, 2011
   
September 30, 2010
 
Implied term (years)
    0.68       1.43  
Suboptimal exercise factor
    2.5       2.5  
Volatility
    65 %     78 %
Dividend yield
    0 %     0 %
Risk free interest rate
    0.13 %     0.33 %

The carrying values of cash and cash equivalents, accounts receivable, accrued expenses, accounts payable, accrued liabilities and amounts due to related party approximate fair value because of the short-term maturity of these instruments. The Company does not invest its cash in auction rate securities.

At June 30, 2011, the principal outstanding and the carrying value of the Company’s Series B-1 Note were $1,540,261 and $1,443,000, respectively. The Series B-1 Note contains two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative”), which are measured at fair value both initially and in subsequent periods. The fair value of the convertible notes can be determined based on the fair value of the entire financial instrument.
XML 25 R15.htm IDEA: XBRL DOCUMENT  v2.3.0.11
SHORT TERM LOANS
9 Months Ended
Jun. 30, 2011
Debt Disclosure [Abstract]  
Short-term Debt [Text Block]
NOTE 10 — SHORT TERM LOANS

At June 30, 2011 and September 30, 2010, short-term loans consist of:

   
June 30, 2011
   
September 30, 2010
 
             
Short-term loans
  $ 1,008,000     $ 1,312,000  

On March 25, 2010, the Company entered into a one year contract with China Export &amp; Credit Insurance Corporation (“CECIC”) to insure the collectability of outstanding accounts receivable for two of the Company’s key customers. The Company pays a fee based on a fixed percentage of the accounts receivable outstanding and expenses this fee when it is incurred. In addition, on March 30, 2010, the Company entered into a one year revolving credit facility arrangement with Industrial Bank Co., Ltd. (“IBC”) that was secured by the accounts receivable balances of the two key customers insured by CECIC above. The cost of the insurance on accounts receivable is recorded as selling, general and administrative costs in the Consolidated Statements of Operations of the Company. On May 5, 2011, the Company terminated the credit facility arrangement with IBC and on the same day, the Company entered into a revolving credit facility arrangement with Bank of China (“BOC”), which is also secured by the accounts receivable balances of the key customers insured by CECIC above.

If the insured customer fails to repay the amounts outstanding due to the Company, the insurance proceeds will be remitted directly to BOC instead of the Company.  The amount drawn down as of June 30, 2011, amounted to $1,008,000, of which $302,000 and $706,000 are due on August 2 and August 15, 2011, respectively. There have been no insurance claims submitted to CECIC. There are no commitment fees associated with the unused portion of the credit facility. The interest rate of the credit facility is variable and ranged from 3.78% to 5.30% during the nine months ended June 30, 2011. The weighted average interest rate on this credit facility during the nine months ended June 30, 2011 was 4.42% per annum.
XML 26 R13.htm IDEA: XBRL DOCUMENT  v2.3.0.11
PROPERTY AND EQUIPMENT
9 Months Ended
Jun. 30, 2011
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Text Block]
NOTE 8 — PROPERTY AND EQUIPMENT

The Company depreciates its assets over their estimated useful lives. A summary of property and equipment at June 30, 2011 and September 30, 2010 is as follows:

   
June 30, 2011
   
September 30, 2010
 
Production equipment
  $ 9,816,000     $ 8,130,000  
Leasehold improvements
    3,879,000       3,709,000  
Automobiles
    312,000       366,000  
Office equipment
    363,000       348,000  
Machinery
    3,065,000       2,916,000  
Furniture
    41,000       40,000  
Total property and equipment
    17,476,000       15,509,000  
Less:  accumulated depreciation
    (8,477,000 )     (6,635,000 )
Total property and equipment, net
  $ 8,999,000     $ 8,874,000
XML 27 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
ORGANIZATION AND NATURE OF OPERATIONS
9 Months Ended
Jun. 30, 2011
Organization and Nature Of Operations [Abstract]  
Organization and Nature Of Operations [Text Block]
NOTE 1 — ORGANIZATION AND NATURE OF OPERATIONS

Solar EnerTech Corp. was originally incorporated under the laws of the State of Nevada on July 7, 2004 as Safer Residence Corporation and was reincorporated to the State of Delaware on August 13, 2008 (“Solar EnerTech” or the “Company”).  The Company engaged in a variety of businesses until March 2006, when the Company began its current operations as a photovoltaic (“PV”) solar energy cell (“PV Cell”) manufacturer. The Company’s management decided that, to facilitate a change in business that was focused on the PV Cell industry, it was appropriate to change the Company’s name. A plan of merger between Safer Residence Corporation and Solar EnerTech Corp., a wholly-owned inactive subsidiary of Safer Residence Corporation, was approved on March 27, 2006, under which the Company was to be renamed “Solar EnerTech Corp.” On April 7, 2006, the Company changed its name to Solar EnerTech Corp.  On August 13, 2008, the Company reincorporated to the State of Delaware.

The Company conducts a substantial part of its operations under a wholly-owned subsidiary in Shanghai, China named Solar EnerTech (Shanghai) Co., Ltd.

On April 27, 2009, the Company entered into a Joint Venture Agreement with Jiangsu Shunda Semiconductor Development Co., Ltd. to form a joint venture in the United States by forming a new company, to be known as Shunda-SolarE Technologies, Inc., in order to jointly pursue opportunities in the United States solar market. The Agreement was valid for 18 months and expired on October 27, 2010. After its formation, the joint venture company’s name was later changed to SET-Solar Corp. Since the agreement expired on October 27, 2010, SET-Solar Corp. became an independent company and transactions with SET-Solar Corp after that date are not considered as related party transactions.

On January 15, 2010, the Company incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement its existing production facilities to meet increased sales demands.

On February 8, 2010, the Company acquired land use rights of a 68,025 square meter parcel of land located in Yizheng, Jiangsu Province of China, which will be used to house the Company’s second manufacturing facility.
XML 28 R9.htm IDEA: XBRL DOCUMENT  v2.3.0.11
FINANCIAL INSTRUMENTS
9 Months Ended
Jun. 30, 2011
Investments, All Other Investments [Abstract]  
Concentration Of Risk and Foreign Exchange Risk Disclosure [Text Block]
NOTE 4 — FINANCIAL INSTRUMENTS

The Company’s assets that are potentially subject to significant concentration of credit risk are primarily cash and cash equivalents, advance payments to suppliers and accounts receivable.

The Company maintains cash deposits with financial institutions, which from time to time may exceed federally insured limits. The Company has not experienced any losses in connection with these deposits and believes it is not exposed to any significant credit risk from cash. At June 30, 2011 and September 30, 2010, the Company had approximately $82,000 and $82,000, respectively in excess of insured limits.

Advance payments to suppliers are typically unsecured and arise from deposits paid in advance for future purchases of raw materials. The Company does not require collateral or other security against the prepayments to suppliers for raw materials.  In the event of a failure by the Company’s suppliers to fulfill their contractual obligations and to the extent that the Company is not able to recover its prepayments, the Company would suffer losses. The Company’s prepayments to suppliers have been steadily decreasing due to the change in the industry practice from requiring full cash advance to secure key raw material (silicon wafers) as a result of the financial crisis in 2008 to requiring less or no cash advance during fiscal year 2009 as the economy is recovering from the crisis. The economic crisis may affect the Company’s customers’ ability to pay the Company for its products that the Company has delivered.  If the customers fail to pay the Company for its products and services, the Company’s financial condition, results of operations and liquidity may be adversely affected.

Other financial instruments that potentially subject the Company to concentration of credit risk consist principally of accounts receivable.  Concentrations of credit risk with respect to accounts receivable are limited because a number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk.  The Company controls credit risk through credit approvals, credit limits and monitoring procedures.  The Company performs credit evaluations for all new customers but generally does not require collateral to support customer receivables. All of the Company’s customers have gone through a very strict credit approval process. The Company diligently monitors the customers’ financial position. Payment terms for our solar module sales generally range from 0 to 60 days. In some cases, these terms are extended up to 200 days for certain qualifying customers of whom the Company applied rigorous credit requirements. The Company has also purchased insurance from the China Export &amp; Credit Insurance Company to insure the collectability of the outstanding accounts receivable balances of a key customer. During the nine months ended June 30, 2011 and 2010, the Company had one and three customers, respectively that accounted for more than 10% of net sales.

Foreign exchange risk and translation

The Company may be subject to significant currency risk due to the fluctuations of exchange rates between the Chinese Renminbi, Euro and the United States dollar.

The local currency is the functional currency for the China subsidiary.  Assets and liabilities are translated at end of period exchange rates while revenues and expenses are translated at the average exchange rates in effect during the period.  Equity is translated at historical rates and the resulting cumulative translation adjustments, to the extent not included in net income, are included as a component of other comprehensive income (loss) until the translation adjustments are realized. Included in other comprehensive income were foreign currency translation adjustment gains of $800,000 and $98,000 for the nine months ended June 30, 2011 and 2010, respectively.   Foreign currency transaction gains and losses are included in earnings. For the nine months ended June 30, 2011 and 2010, the Company recorded foreign exchange losses of $0.5 million and $0.9 million, respectively.
XML 29 R10.htm IDEA: XBRL DOCUMENT  v2.3.0.11
ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS
9 Months Ended
Jun. 30, 2011
Accounts Receivable, Net Of Allowance For Doubtful Accounts [Abstract]  
Accounts Receivable, Net Of Allowance For Doubtful Accounts [Text Block]
NOTE 5 — ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS

At June 30, 2011 and September 30, 2010, the accounts receivable, net of allowance for doubtful accounts consists of:

   
June 30, 2011
   
September 30, 2010
 
Accounts receivable, gross
  $ 10,537,000     $ 6,588,000  
Allowance for doubtful accounts
    (443,000 )     (42,000 )
Accounts receivable, net
  $ 10,094,000     $ 6,546,000  

The following table summarizes the activities of the allowance for doubtful accounts as of June 30, 2011 and September 30, 2010:

   
Allowance for doubtful
accounts
 
As of September 30, 2009
  $ 117,000  
Addition
    -  
Write-down
    (75,000 )
As of September 30, 2010
  $ 42,000  
Addition
    421,000  
Write-down
    (20,000 )
As of June 30, 2011
  $ 443,000
XML 30 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 31 R18.htm IDEA: XBRL DOCUMENT  v2.3.0.11
STOCKHOLDERS' EQUITY
9 Months Ended
Jun. 30, 2011
Stockholders' Equity Note [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]
NOTE 13 — STOCKHOLDERS’ EQUITY

Warrants

During March 2007, in conjunction with the issuance of $17,300,000 in convertible debt, the board of directors approved the issuance of Warrants to purchase shares of the Company’s common stock. Under their original terms, the 7,246,377 Series A warrants and the 21,578,948 Series B warrants are exercisable at $1.21 and $0.90, respectively and expire in March 2012. In addition, in March 2007, as additional compensation for services as placement agent for the convertible debt offering, the Company issued the Advisor Warrants, which entitle the placement agent to purchase 507,247 and 1,510,528 shares of the Company’s common stock at exercise prices of $0.69 and $0.57 per share, respectively. The Advisor Warrants expire in March 2012.

The Series A and Series B Warrants (including the Advisor Warrants) are classified as a liability in accordance with FASB ASC 480, “Distinguishing Liabilities from Equity”, due to the terms of the warrant agreements which contain cash redemption provisions in the event of a fundamental transaction, which provide that the Company would repurchase any unexercised portion of the warrants at the date of the occurrence of the fundamental transaction for the value as determined by the Black-Scholes Merton valuation model. As a result, the warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account “gain (loss) on fair market value of warrant liability” in the accompanying Consolidated Statements of Operations.

Additionally, in connection with the offering, all of the Company’s Series A and Series B warrant holders waived their full ratchet anti-dilution and price protection rights previously granted to them in connection with the Company’s March 2007 convertible note and warrant financing.

On January 12, 2008, the Company sold 24,318,181 shares of its common stock and 24,318,181 Series C warrants (the “Series C Warrants”) to purchase shares of common stock for an aggregate purchase price of $21.4 million in a private placement offering to accredited investors. Under its original terms, the exercise price of the Series C Warrants is $1.00 per share. The warrants are exercisable for a period of 5 years from the date of issuance of the Series C Warrants.

For the services in connection with this closing, the placement agent and the selected dealer, Knight Capital Markets, LLC and Ardour Capital Investments, received an aggregate of a 6.0% cash commission, a 1.0% advisory fee and warrants to purchase 1,215,909 shares of common stock at $0.88 per share, exercisable for a period of 5 years from the date of issuance of the warrants. The net proceeds from issuing common stock and Series C warrants in January 2008 after all the financing costs were $19.9 million and were recorded in additional paid in capital and common stock. Neither the shares of common stock nor the shares of common stock underlying the warrants sold in this offering were granted registration rights.

In connection with the Conversion Agreement, on January 7, 2010, the Company entered into an Amendment (the “Warrant Amendment”) to the Series A, Series B and Series C Warrants with the holders of at least a majority of the common stock underlying each of its outstanding Series A Warrants, Series B Warrants and Series C Warrants (collectively the “PIPE Warrants”). The Warrant Amendment reduced the exercise price for all of the PIPE Warrants from $1.21, $0.90 and $1.00, respectively, to $0.15, removed certain maximum ownership provisions and removed anti-dilution provisions for lower-priced security issuances. Given the above, the liability associated with the PIPE Warrants at the pre Conversion Agreement exercise price was considered extinguished and was replaced with the liability associated with the PIPE Warrants at the post Conversion Agreement exercise price, which were recorded at fair value.

There were no warrants exercised during the nine months ended June 30, 2011. During the nine months ended June 30, 2010, a warrants holder exchanged 1,147,394 warrants for 450,878 shares of the Company’s common stock after a cashless exercise.

A summary of outstanding warrants as of June 30, 2011 is as follows:

   
Number of
Shares
   
Exercise
Price ($)
 
Recognized as
Granted in connection with convertible notes — Series A
    7,246,377       1.21  
Discount to notes payable
Granted in connection with convertible notes — Series B
    21,578,948       0.90  
Discount to notes payable
Granted in connection with common stock purchase — Series C
    24,318,181       1.00  
Additional paid in capital
Granted in connection with placement service
    507,247       0.69  
Deferred financing cost
Granted in connection with placement service
    1,510,528       0.57  
Deferred financing cost
Granted in connection with placement service
    1,215,909       0.88  
Additional paid in capital
Extinguishment in accordance with the Conversion Agreement
    (53,143,506 )     N/A  
Loss on debt extinguishment
Issuance in accordance with the Conversion Agreement
    53,143,506       0.15  
Warrant liabilities
Cashless exercise of warrants
    (1,147,394 )     0.15  
Additional paid in capital
Outstanding at June 30, 2011
    55,229,796            
 
At June 30, 2011, the range of warrant prices for shares under warrants and the weighted-average remaining contractual life is as follows:

Warrants Outstanding and Exercisable
 
               
Weighted-
 
         
Weighted-
   
Average
 
Range of
       
Average
   
Remaining
 
Warrant
 
Number of
   
Exercise
   
Contractual
 
Exercise Price 
 
Warrants
   
Price
   
Life
 
$0.15
    51,996,112     $ 0.15       1.10  
$0.57-$0.88
    3,233,684     $ 0.71       1.02  

Restricted Stock

On August 19, 2008, Mr. Leo Young, the Company’s Chief Executive Officer, entered into a Stock Option Cancellation and Share Contribution Agreement with Jean Blanchard, a former officer, to provide for (i) the cancellation of a stock option agreement by and between Mr. Young and Ms. Blanchard dated on or about March 1, 2006 and (ii) the contribution to the Company by Ms. Blanchard of the remaining 25,250,000 shares of common stock underlying the cancelled option agreement.

On the same day, an Independent Committee of the Company’s Board adopted the 2008 Restricted Stock Plan (the “2008 Plan”) providing for the issuance of 25,250,000 shares of restricted common stock to be granted to the Company’s employees pursuant to forms of restricted stock agreements.

The 2008 Plan provides for the issuance of a maximum of 25,250,000 shares of restricted stock in connection with awards under the 2008 Plan. The 2008 Plan is administered by the Company’s Compensation Committee, a subcommittee of the Company’s Board of Directors, and has a term of 10 years. Restricted stock vest over a three year period and unvested restricted stock are forfeited and cancelled as of the date that employment terminates. Participation is limited to employees, directors and consultants of the Company and its subsidiaries and other affiliates. During any period in which shares acquired pursuant to the 2008 Plan remain subject to vesting conditions, the participant shall have all of the rights of a stockholder of the Company holding shares of stock, including the right to vote such shares and to receive all dividends and other distributions paid with respect to such shares.  If a participant terminates his or her service for any reason (other than death or disability), or the participant’s service is terminated by the Company for cause, then the participant shall forfeit to the Company any shares acquired by the participant which remain subject to vesting Conditions as of the date of the participant’s termination of service. If a participant’s service is terminated by the Company without cause, or due to the death or disability of the participant, then the vesting of any restricted stock award shall be accelerated in full as of the effective date of the participant’s termination of service.

On July 2, 2011, the Company issued 8,600,000 shares of restricted common stock to the Company’s employees pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.  The issuance of the shares of restricted stock was not registered under the Securities Act in reliance on the exemption from registration provided under Regulation S, as promulgated under the Securities Act. Shares of restricted stock were issued only to non-U.S. persons in offshore transactions who met the conditions under Regulation S.

Out of the 8,600,000 shares of restricted common stock issued, the Company issued 1,000,000 shares of restricted common stock to Yihong Yao, the Company’s Chief Financial Officer, pursuant to the Company’s 2008 Restricted Stock Plan, with such awards to be evidenced by and subject to the terms and conditions of the form of restricted stock agreement previously adopted by the Company, except that the vesting of such restricted stock awards shall be over three years, with one-third of such shares vested upon the one year anniversary of the date of grant, and the balance to vest in equal monthly installments thereafter.

Issuance of fully vested restricted stock to the Company’s former Board of Directors

On January 12, 2010, the Company issued 400,000 shares of fully vested restricted stock to the Company’s former board of directors on their resignation date. As the former directors no longer provide services to the Company, these awards were properly accounted for as awards to non-employees in accordance with FASB ASC 718.

The following table summarizes the activity of the Company’s unvested restricted stock units as of June 30, 2011 and September 30, 2010 is presented below:
    
   
Restricted Stock
 
   
  
   
Weighted-
 
   
Number of 
   
average grant-
 
    shares    
date fair value
 
Unvested as of September 30, 2009
    23,150,000     $ 0.62  
Restricted stock canceled
    (10,000,000 )   $ 0.62  
Restricted stock granted
    400,000     $ 0.31  
Restricted stock vested
    (400,000 )   $ 0.31  
Unvested as of September 30, 2010
    13,150,000     $ 0.62  
Restricted stock canceled
    (80,000 )   $ 0.62  
Restricted stock vested
    (2,630,000 )   $ 0.62  
Unvested as of June 30, 2011
    10,440,000     $ 0.76  

The total unvested restricted stock as of June 30, 2011 and September 30, 2010 were 10,440,000 and 13,150,000 shares, respectively.

Stock-based compensation expense for restricted stock for the three and nine months ended June 30, 2011 were $0.7 million and $2.0 million, respectively. As of June 30, 2011, the total unrecognized compensation expense net of forfeitures related to unvested awards was $0.4 million and is expected to be amortized over a weighted average period of 0.14 years.

Issuance of common shares to non-employees

On February 1, 2010, the Company issued 400,000 shares of common stock to the Company’s third party financial advisors. These awards were properly accounted for as awards to non-employees in accordance with FASB ASC 718.

Options

Amended and Restated 2007 Equity Incentive Plan

In September 2007, the Company adopted the 2007 Equity Incentive Plan (the “2007 Plan”) that allows the Company to grant non-statutory stock options to employees, consultants and directors. A total of 10 million shares of the Company’s common stock are authorized for issuance under the 2007 Plan. The maximum number of shares that may be issued under the 2007 Plan will be increased for any options granted that expire, are terminated or repurchased by the Company for an amount not greater than the holder’s purchase price and may also be adjusted subject to action by the stockholders for changes in capital structure. Stock options may have exercise prices of not less than 100% of the fair value of a share of stock at the effective date of the grant of the option.

On February 5, 2008, the Board of Directors of the Company adopted the Amended and Restated 2007 Equity Incentive Plan (the “Amended 2007 Plan”), which increases the number of shares authorized for issuance from 10 million to 15 million shares of common stock and was to be effective upon approval of the Company’s stockholders and upon the Company’s reincorporation into the State of Delaware.  

On May 5, 2008, at the Company’s Annual Meeting of Stockholders, the Company’s stockholders approved the Amended 2007 Plan.  On August 13, 2008, the Company reincorporated into the State of Delaware. As of June 30, 2011 and September 30, 2010, 13,726,667 and 12,860,000 shares of common stock, respectively remain available for future grants under the Amended 2007 Plan.

These options vest over various periods up to four years and expire no more than ten years from the date of grant. A summary of activity under the Amended 2007 Plan is as follows:

   
Options Available
For Grant
   
Number of Options
Outstanding
   
Weighted Average
Fair Value Per
Share
   
Weighted Average
Exercise Price Per
Share
 
Balance at September 30, 2009
    12,060,000       2,940,000     $ 0.39     $ 0.62  
Options granted
    (250,000 )     250,000     $ 0.13     $ 0.20  
Options cancelled
    1,050,000       (1,050,000 )   $ 0.39     $ 0.62  
Balance at September 30, 2010
    12,860,000       2,140,000     $ 0.32     $ 0.55  
Options cancelled
    866,667       (866,667 )   $ 0.20     $ 0.32  
Balance at June 30, 2011
    13,726,667       1,273,333     $ 0.32     $ 0.60  

The total fair value of shares vested during the nine months ended June 30, 2011 and 2010 were approximately $21,000 and $36,000, respectively.

At June 30, 2011 and September 30, 2010, 1,273,333 and 2,140,000 options were outstanding, respectively and had a weighted-average remaining contractual life of 6.40 years and 7.66 years, respectively. Of these options, 1,270,833 and 1,542,917 shares were vested and exercisable on June 30, 2011 and September 30, 2010, respectively.  The weighted-average exercise price and weighted-average remaining contractual term of options currently exercisable were $0.60 and 6.38 years, respectively.

There were no employee stock options granted during the three and nine months ended June 30, 2011.

In accordance with the provisions of FASB ASC 718, the Company has recorded stock-based compensation expense of $0.7 million and $2.0 million for the three and nine months ended June 30, 2011, respectively, which include the compensation effect for the options and restricted stock. The Company recorded $0.7 million and $2.2 million for the three and nine months ended June 30, 2010, respectively, which include the compensation effect for the options and restricted stock. The stock-based compensation expense is based on the fair value of the options at the grant date.  The Company recognized compensation expense for share-based awards based upon their value on the date of grant amortized over the applicable service period, less an allowance estimated future forfeited awards.
ZIP 32 0001144204-11-046535-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-11-046535-xbrl.zip M4$L#!!0````(``I,#S]'QM3+/<,``),("0`1`!P`<;"S']N:2YTMJ!"-I+@AT`\A6_OKK'D`"!`($>'U/ MI2JUL9B7_DU/=T]WSS"\__O+RB0;)AQN6]^>J1?*&6&6;AO<6GQ[]N7IIC4\ M^_N'/__I_5]:+?+SQX?/Q+!U;\4LE^B"49<9Y)F[2S+YO25+@YZ(=J%`8(PNI8:O!= M@VCE?MLOW%4]Z/I9DW75T6C4EJ6[J@Y/JPB=JNV??_C\J"_9BK:XY;C4TF-8 M^!'LR?KUF;U**N+;8W\#OL2+!Y9@_]-I3N(#+W""E) M!ZK$9MU-G?6>/^N[JKKM6:[8QNLZ3+]8V)MV4!B(H=K2U%TS3X"DZEGM@M*4 MA@;CZ6V@(*4Z>]&7Z?6Q)*4!MS;,<=.;^&4IC2S*=2>]C2Q*:>)P/;T!%*15 M=]QF4"CXS'.9$VF&,NZDMI$E M*;1>S"-J^?-GM!5H\]!H7#K2'#RP.9%&Y#)0C..FIKT6]AHL(0?R$:,F.T!0 MWYXY?+4V=\^64I70I+80K=+7E(L7QSAKAW;YRK9<]N*21Z:[:+IC5ED/"CDH M=%#Q5^V'R:^:TOK.DSTJ9_O:L"QP=[O_S0U\,N=,$#G6^-#"B;ZZ_?[L@P(F M4E,&PX'VOIULC!VVTRD`)[AM['^#H13N-1@@>(3@6DH7YF??/EJ^`VW$&N"B M$B48EH9/]B3;,1X=9]KHOX9IRJB%;'@+3!L[OT[GR+9'MGY[;/.797?'@U&, M!_O2:CR(:YOZICB0T#:UK+:IKZ-M;YII2EEM:XQI.VU[DVR+:=L!#^K2-I\' MRK`U]A9OGP=#^*\I'NRLKC)ZLSP`D]N0U4WJPMM>>:KH`KJ`7RR>X?]Y6(*, M>5Q"!.ZKQAU/,$^!"9+%H:=AV7A;^PCI<_MG@F) MKP3?`W@^1JG<8KF*P>2+A@_;X\)I9]HI;:=T694^LBW8#F1@O/`%MQQ!XRU3D*\E]:SE,CM790XXEA723J^ M3/I5;N"94XS6CUJU%$!>,B/S!DMSO#89@2-ZW2Q&N&>F.1\>0 M=CH]Y:LCW?ESQY"J`W7TU9'NO*ZC/.WW.]60CG69R'4>F,Z@^LQD=\P-5HA: MQ+/;CP$\1J\>7(6$4049Z)X$[%ZP->7&Y&7-+(?5QRFU,X@#2B54$4DAWO14 MI1R06VL#3V`Y!X[5P(FN,M1B`*+]GT:WT+@UM=\O1%V,YL>O7@*L2A MX6@T.@E71(;N;$NO35H&6B]+5O=T*@(IQ)E!PHSD`KF&F-+AX,K4SQ15B2MP M%JGJ<(H)C5(:C5]6AS49#1+6S.^Z++%BAK.O):0@A5C@E=W3;;U+[&`XZJ7Z M?W%*5;$48L1H.!J6Q'+E.:Z]`I4Q-G@LIM8%14N$%.FD*J,IYI/UM+)@@'G" M8\9G3F?E+=PG)E8?;2'L9PB=Z["OJJ;&E2N%3"4418/?81D4 M0&6#QVTP)K9=5K\QCBKX45IUH2K&IFXW87P*8[MF`N(@EV]8(V8HYAYD4ZH' M43%>:5K":RD&JQ'VJ*-^PHNI%T0QCO1ZO6X)$!'A^FQ;"]3&J)#5P9:>IF;) M3C`Z.4JP-7.EE+1\7GH"\_"<5N(?9E%TZ3J,J MBD),"8**?"0IBEF'C]CI*8,LQ3^);'5[$U?EW=9D79M0:L('39(XG7RQH0\Z MAJZ MM_*D&RVS-[C7+]B260[8H%M+AS#ML^TX=\R=SI_H2QV:->@=Q.QE(#2&OF`H M6Q_Z!^92;C%C0H6%WGJDJVLVYSJOPYJW1IJFQ<4XGVZ=*`NQM37J#)4J**5@ M+VW38,+!?*R;?MJE9'JITXU/]B&5*A@*AGF#41D0D?5B;!F-L.4POYA'M#Z` M)^8DRP`-K8\]= MVH+_SHS2_,PX-H>NAY+I-B:IU@(NA8'-@[MU'*\^KH&GK6G#4:][!)A/L3*H MXMP"_WN@*MIP6`U4L;.9M;,K<3*S.KQZ&9R]JL3KZE>'PS M7TNXIPD*98DGW_8[?N)HD-@HKT@\^<;8\8-7'45K;N0Y0<%02YQ@.4+\RG8@ M%/ADVX9T19C8<)TYC^"-5)_^GM)+)@>SB%6`5$8HNH.^-F@>4CE1&23/6S;/ MI3P!4H;)A:H(I$\"0LM[8<\S@K!2PJ,I\41"I/,R-$M)AYJ8B1-IEIG^5J\W MJG^<>8<2E2(D'YEIP@KQ"6\(H2;,^]A8<4N^KX(IX>#L9N69[G0'B46B$-V: MD):1#PC`M:^'M)11T1(GD;\B3W,.!A^LTJ61/C"'4:'C&?5K6.-,6YY^JTL\ M$PGPH\2JH2HCBIWAX+5@E9&[OO9UF)63@%&3N;R"L#Y1;CF8+P67V9J\X.MG M'G>66'LZOV:SZLM@6$982MH[TVNE*&K7%*H%,IN_EE5ID>YW$X=@DB?+T2]FKOC*H'4"I%;&K=9ME0"[]$\CO=VPJ M2T!+]5^62X&PIW(*B%)&I:..$@?Y:D)1RN=61Z.,V:B3%7EO.I3BPZV\2PS- MA5]^"Q0%/*D>:!V\GI1&YF0HI5(VS4(I(R*OQY*<78T36.(_J\W_'24@Q+HO M2[F4.&@'[^Q5HEW*D1TT-^J\E^$*DYZL9@S?DML?TT(O`RT'N!@'975D=`<) MXUT:0?WPRTB4JJJ]MX:_E!,S5-\:_%*BG0@/*\$'"R@8==@U\_]_:]U0+N3N MXW3^Q5HR8Q%M?6LYKI`7+%1WI51ME#1,IV)I<$2E,I]:/VGFW^"(2AGPSO#M M#ZB,\@Q[CX,0J=B*67U&\9RJE_9)$?J1"$/$M[9 MEAV/4.IR,%O=8 M9[JCWXLO`+'NR]$ME^'0Y`GH>BB7RVIHJMK,D',RG5K!\89G9\/381^IP_7R M,YUQ.JV%Q],BAW)2J9T&YZ@`I,'I2#CJL!$T1X4B&TWTZ%YCO"E^D%"K@.:: MFYZ;<=:L"=$)Z)T*J0'QJ8BH`1&JE4<%$"F^&'5*(?HGXXLE/!MO8#5:L#L/ MHDPQG1^QY-GH/H]I=,;1*2]%(9ZP6<+8CKXSE#K#`:]MP$^6V;3 MP??5'N[YO`WPV>*=`5[!8Q%:@^`#[2AV#K4QJ<]"4?<`&I/\UQI`8]+_=68@ M?P`#9=2!8*)?RP"NY0>4.)77.E?.)PR[!Y<[[7JO0#4G]SM2U$)4]SE4//8[ MG%)19BA2\H,?)D2HM9ZI*C325QTETZG%B0Y M:7F\,KP<$O]=WN^Y9=2V^=M)WA!Z0*(R@!PYZ9:@/U[A;>2_2\9,YS?,)Z6ON^&^:U?`:0_*RVX*4&T*;\_YWMS+6P[SVX5M[E;G:5P;)PP;Y M5!M`F7-.6U.2IS.JHHS?NUM]$>AV\Q#&*=:,+BW9MUMT89 MQHT2;QH6;>M2@GSBZ4)QT8X!SN-SI]P_VM$Z`#.(O=].? M[+$.H:5@F7=U5S_!DSA;59QT8X#S+MCJ)0.^DQ`+6V?,<&Z$O4J)Z&OE\<&] MZT4I-P>XE)T^$7&&[/NG1>JU%*UN(@HO3KLQQ'D>\R!Q_>YID&-S$UZ=6\N+ M7*J:B-$R2=6%)^=(^[!_\&&%?#P/$*?Y]@'W/.KD3S=&7U%JP!_"O MIE;ZQ[&J*VWBG'H)V@UBSEMM!K6`3J_A?WDOZ>U67].3]W&7(-X@Z+R@6.L4 M^4)?-FR9E9@D7D.]2MQ%_G&+-RSA'6I8MKM#J(9EOA<:D4HX7F,@>8&"HGRE M<3PRS,!]Q.=UO.L=&)PJ,%YA&+G'FFO!WPR3U9X6X7$S"(KQYSAM&7TYW-^S MB7]#"X+BVP+PAZ(K!!`$%("9]AFIS^;>\XA-_W+$--2BQ+?*=9V[]Z5/[ MRKO!.<&O!Q+H^9'.Y7>['?"QP=A(FK:O'81:AJ0N6(RH:\>I7#,@CG>80I.Q MMP`.$563%(;DKZ',=)3$Z'8%ZCL8GNPQ4C?X?'BDTM\N]OCW?STM6?BI<<*L M!5T`/@[(R8:"S72WB&_F.3`;>*<'\,OE)OD!KY5!?/US\KQDEB0>]C)C8#,( M1T\[R`;;.W.!#*-DO;1=>V.;+N5Z;(#W/T7Q$D>.%V](6FR)SDPS49EH)K:.!4[*D[CE.#+3&C#W.#"6^0X_\ M"%D@*\HYG>-GJZ&E[8\^0`-U#9@_L3T'#LAZ=+T6]EIP[!'Z#[IT,Z!9=,4N MR)B`%EC(^A6,'<1KQMQG!GS.$[8T^3^'@3PO;1#]EOULR>FE&/DQXG@SZ(A3 M(6?Y2-_G^Y%L_"$'$N#K`4B!KT?/2PY/H\*`[6#4,P8Z@&,S2*8\^VBC4CT% M=0#.F4F]`WI1&CY+#2ER2`,)9G<=%__I@<;%^RZHN1=_6.8D0O*]K,C[;$M5M#SOV3/&[_GO?IR MW_A^`8\7)QS5TB&SK6R%)W2I')#NHST/+-%O%LB07+HEDI:4DPE!(;%LTUY` MJ'!.;BT=4$#_MI`>@NU#`/]A[0G'`^U?@U%PT=?&Y%T,R!Y?@,A?R&`6?V.N MORQ%>`-`-C"5!H(FZI!`O.PN'6G.VN2X%&"O=(?X"*KS@PYF3$=B MZ!&`/*^9%.H0E!RD*ZCEX(J$RBXE)=X'H7*@6P1/&J*?^&_@T.X.-^INTP_HQ"! M9?>M,XB9XZW7IB]-*,#LA??'JK> MBJ$Z@IJ!1X[EL@DP0,I&(0DX#QS%9PX.,QADZ4?#)"]MI)SE&CL,EXN(BX\" M$TC)]K@,Q'\%.9#BN8U=.N0S!S890`[J?[+E$5\8E[`J9T$:E2UL=&+VHK2D MR41')Y;H^'S[XY?;Z]NG7V26X]/T]NX3N9K>74T>[DBSFOO_0G>CCO.2HJL?(]G2QD``JF'ZM%YASGSF(+>0,.T3%1/#?M9\>?^$@H)5GO-,K[M/;H MJ-G@X4J!FOO;ST`:Q\O\FUZ6%(#/,,.QQI/J8I]7H8[CK4*YI:[,JN"R<01( MN+Q(6[Q:F](%Q[[`>3`#@R_E6::\)?-,:=AW)6;D$&G@V5OH8R-9\/Y9-"FV MD_2<(1JV=%I!#4W/0(<85ET#38=?#+P5;&XRW9^&-4PL;N20N2>]>"8WF9V0 M*R`%-KX>&$P,#D$W83S2'B3&%\@H7?GOOJ37C8Y8\GE%,?GA>*;K2Q%V`3*" M]UWX65*.D3FP&Z4:UM\_3'F^*;\.?!;NZ"`;TFCXKEC4E#LN6T,EO MF%M%R9#6W,8=&U"4!7[(@/CC<`*)PHX=M`WR#QJ>21<4I4;.X-YRZ#!*F$<1 M!)D@I#.3.TO?J#SOBOV0"@W'DJ^=4*N6%+R\59@)#`^&^E:'6]+N7$#T#,+M MF_YDPF"78L8$,SA\`!/?:O/<,```8[CRD0D&1LUVN50J:9*#_+PTIGJH-1`Q ML`@2%MPT?$&N/19F[,#`;:06@0UW?,;&@>'2)PW00M[([X-)9WBP?J+%I&") MT"MVD9DPIN34RF',N0#H034<0J(6+);_L)\9Z#-*0AAO!^[ND6;^`*+8]J,( M5X-S*`%QW+GGXX2.Q9"?0G$K[ MXZ].60L3&"I@JN=XU22QLF7E`F5HSXUQRR`A/C.#. M@__:,XQ??B`!)(+_I[UW;6[<.!J%O[O*_P&U9_T^VBJ((:F[G:1*J]4FRME= M;5:R<_+I*1`82K!!@,%%6N;7OWV9&0Q`\":)%"^3BFV1!.;2T_?NZ6;303I1 MP$!$Y":4?MMIG750RX$A\URQZIGP1J2`5X].QUX%MI;.@#E(`#!=`_94>+AT M9`8X`%/=0Q(5P"-I?:?.YW\MM*J3UHGQRLS5F*<*2P%[?!\/09WH4("NP5XG M3;[H*T+]!MG+O8<8$_454C0?*[53:LD!2PQ#3L@N-C@6.*\TB0@*>)*$*&R= M(WX^YO=J2W=1TH,=?/U-KDLKH^3'$B+8QP>!,_3[SM['J]MWFB,T$DE/`-9C M-12UA3J$ZF`HUY\!IZ)EHC/08,"`ND')-QX]&AUI,1F,^-!IJ5Z(2,"\!EF$ M%Z+KR?\#4)?8TM]2`>JCZWQ%)^&=%S&B7R%+C8.6A3&7C"+?J8^!!%,BHR"(-] M`HF$+/%,9LZ1\!YPATQ71):LD#QR-`NVZ&/<"^`K#]23OZ'[,'F46$]>TBF, MOX)3\!IZ$$I?CZ09A@>N!ED9R&=XJA]^1Z=>^2R)"Z1;=+VR\D;#F7QP#FVD MZM\QE(F%U8=25VC63A[#(+\'%:']DZEIT/N+ZAFG?;_?<8Q<,8>2KO9J^0/X965D MV#!,)L5>K!,J4#Z#K3.$O]C"0$[QMN.>=H[<[G%'B9TP(ZZJ(\<2O%TBX!ZP M)E2?9(4#L#Z.?R(21]-[,"EN^QDL%!3(I2JD3^D[J+HYF]H>@#@H@U"X!1-^ MY^KG1BC2ACU@MVP_]I-("HU;V#W&Y2\QRI+][.QY[^B)07B7:J5J(ON3SFYM M5UW?7KQ_KR0.?/CG>]?9Z_&(*&C0`*R.1P\#]F(XRN/3UN"3:?0*WAR^ZQA> MGCW_'9F?">9]5;=2VG[DDD<>KQ1&&?$FPT]##029[P/O)\60UZ]_8#DF8XA-8"\7M"6%8`VZW.$:ES\$>;<,:GC%,0 M9%X*XCK^339V`)9W2ADNKVRF&*%#8AG6RH?!!!T"I3J>*FT?O%Z=,3%@\ M27)85L7YY2IK65<**HG$W`)L'"CEZ+"-E,*Q,++M(^E*EP>*CW4/W/8A&`KP M'N*Q'EC;-E.DK7):2V-$^2;8N@$`+-DKM(`XLFX"'`\P"H8`*SQCS*MQ9:=S MXNSCB0Q"Z3O"<[V@(P#CU0<6;S`SX"3A.^@X0I[(]F+3`ROA[ M!.>>LG/2JX;P508%QKF),B52>9-HP+2N/2)-7C/3(R8LC8]80;)A6OJ-)ZW7 M*^_0H$.VYJ8^:'6UEYKC_S@Q0[9?8`!JY'P`59U\MC+Z>=@HD,BZP"!&\AE>4Z/_3R217@ECZG- M3*XW*M]`M)>FRFLH!\"S"I6C4$Y)X@*8)G!:M_$J36'H(R=$ MPN]3JH-`(GYDKJRR=+EY1HNI!\32I`$L+2`?H)\R3:S;:4H3T_'3_#'1V$8B MB/:I9!)>@\#/W<[^!>EV(^<&F*B/X6Y8XMM.JZW?1E/:R^XK7G62S!1.`'Q) M>L"+5%::7$#MG,S5F'(Q`X4EQQ,Y8IE)7[Z;L#(2DJ4'8YA$HTS^I*Q%"L\K MB' MF51UWR=>&E!"9(C,*$DQ=0HO`@-64[A&AC[(RU?.S1RJ/B?'W:(1>1-T^A5E M@/`+=Z":DAFF3@<)'29FK;/&120C'.+MVXSX=3^,F%"&PTB%0![5KC0/^!L& M6&(EK$RMM&E2;>5$XH['UP4%)E/"9CQ`T[=9AR82S,;I3*6^=8QGI;E05#,0E/6=1Q"4P M4E04D8\BYC@.1?/(;GO$KY(>62Z5`\!@7H(^4*_([Y-49U"!]BKD0I2%F/2; MUJ2"VB7HX8P>2`8^)XFHEC`D\4;;=3.4!94;3%LM+R^IKZHSCO$`">:`]:7! M,!)\S0Q[Q?@Z7*J3B?"8:UOMV@#G?);++`F.?BB*%5(<&O\0QMUL0^S4$*+; M.BB33=`GCB4"''*11XD'^H4IQ\9?-S2K9SL(QU#ANAH%A95P^@7KPHQVL($3 M4[>CG`(,',ET7_9_U$`G8W9>HW1"&+*%'NO M:*)]56=A7M<,AS\(QD;.#JK\((`0D=.05`MBGP$:*&5DEBRA@!Z6J=&+.F06 M#Q?(/,J929&5VKXEHLGB:?#"UP3T,!!3]C+I_)=)#RHYEC>_?OY\_NW?>'GT MYNIO7ZX^7EV=OP4#N@^T>2[M\[?_V\E8-1P][+)/V`. M>!7WDQP?5,^9-Q\I%I#<"0I8L.NU/K_K-`Q6N>[K_.L>+5T3B$$8L,OC,7;4 M.Y/%T^1439G%J.P:+;?8323?HF^41W-L_9P/40="F=N1H>3-V7RA;#AYZ804 MFH12&S"#C&2W#I7H-^KA,GGT8/6?HX]\9(2?.&>S=M&TT^:;IF@*<(B2+^!6 M[!US`_7X:7V:ZLG\JCT"8\MIRI;3LP"1D#,!$]@H^JR'NN!Y`VB/WK$;9%(!.>8\?5T=C32L<+QB9"HB.Z% MV:M",Z\;).2Z\F)RP9EYS246:I=1G;S(^87,!733^W`XP3V@Q_%RO*"9#"B/ M0&4/Q'4Q4!(O*-FI)&X='.&<(UAF+(/-M#C.`)`HG1FQE*RZ)@-3*&2KDAH\ M1E@S`98'5FNWB+38O15,X1(/F.];1:J@*C),00.G7,4XRKMK>G)H1#<_GM^\ M=\YO+IS33GN_TZZ6Q#"TM6J,E'R'Z"I-11^8"8@@?D3K8A$,SQ0A\<%%"CP7Y%:8:3J\Z5ZU519`L5AJL)1F_`,!9 M2.N'U1W?B?=":]+8*Y,?&WQZ"Y'6*V3K+9Q/M\&4N^`U'G6YA4]4-EL95_[X M9CCI";GAX@\Q9_^D2S,;OBI<>+!&%BHV'L;%.\A[?D@1XTATD M&.S7UDU+9L8KU8:VE@;DJ"0ZH6?87T3^&1]OVB$'T3:@2@!"N]$T`NC-OYV? M?ZVHASLI6YYEEO_*.?"7,C"5[20$%Z5Q1G,M4N8A;WR(:FOD(P/U$8%5C*52 M74DEQZB`82:SA=25/GG7C%V8TI;$4*7.(\G&[NF5U]0H#2C,_"C)9(*DKW*@ M\HGOY&,!T]G;+A/SQM?&V>^R5@==.U(7<,LWB/[)(8WIDCE?)F63F9-N@K"/ MI9=D/FB2&0#;!EZPROOG%RJT1'\8-6)WT-'Y)+B-A>2PY(-*@Z6+)1CAPGM# MJ*G**R&!H&32K(S,T>45ERYQ@$3D.(=,"9$Q+"+\E"[E!B$;!3HC'?B&+-)3 M4AI-+#/;,'`&'(@NE]'%%)I^&VAEQ7*3&Z;X;(1\3%(8J[S48$GF26IROXA] ME8VHP,M>*N>;B$%/[85(2$:Z->J,430MMFI64$R%]MU-OG)?2I[Z&@R%=C<) M9J$S-NT-\@,K:\0H*`KK3`SSHVHQI*1G98+R`%C]"%/#T<0,#@YRXDQ8@XP\ MF/(D28])U>V(7-U&JDS;8*24CA$,G1LVB")[S0L^>SG>9W;-@,0$!\D-C(H> MD9*TC[KN7(>`/_V,^4:A_\N;'W]H9A`-]Z?&5DN`8Q=+Q:5#FF9JA"H`)BH' M597/P+)66,\@I4(:EAQFD0,`'S&!#L!@2=H?S(EGFN/(Q-L&ANA.5-#Q7K(\ M41&45Z0J(W-9CCK.2]U>J+Q%2MY`KZ,7TD5R^;M*,F2S3J7,R_03SLLLT)#V6K)D55,[Y7GLQK&SFD*8Z/A) MQ;V\5[V[A/G,/`7N>,6IO"I,MY-P?`F=;FB"4T<]"8T)SXD[T,UT%"OHLZB4 MT"H[V+<<.=TJCL@YSZT(HJRH8?IG+5_>J/F>%*V59[JOP(JNWH7_^5-G@SU#`<'Y0Q/]V$LM"RM]4S(S,N# M&6ON;MZ2CX_F6?/&NZ-^)^GV\-B#FDFN6BC;L=`]0<3ZR5+$HW#Y[_CV\F(XL.6S3L7;:EA2>8/[( M>E$E5EEIL97D807%PB`[+_)DD/3":$:BA*6%#3M82PN+N[2+-`ZQRIJEA&TZ M5DL)"X/L$];FN$\B7=[9ZDK;=L3D7,;T'"XG3,$ M0%&HT)/Z@$[>F5[CQ9)(G"W+)[G$N&,0J4 M:B?`I`IG]^,/9HD/B@6H,U81`Q5SQ7X"'.2D&&49R6TYG^D2?V6F>2L@O?19+)&GRZ+IDL2*:B M_/LJRL\1."0.*ED>EG5!=5W/B+(=,/@GFXQ@4`M+[&-V@?>HRS?P,D*C0,>P M2/U[CVXH8"F)1[JS^YBD?P!T]ZGX.8;A9>G.,+N'M^Z2)%`Y0$"<(8W4=P*J MO:6GRESU#15TY(28&#/-DK+O1_5Z)\88[X47\%KP9IV\QNG`6B@-@.L6FJ'[ M^JHPAQ0;\V62U)=YG<;Y_`9R].!\1?5K>M\`E M2YE(D.E"AX\,2G57PO/]M)"J19D[(/L+/2JP,Q=2A7-T&1TNCJ8(D$IJ*?*= MG(1*%QBQ,&"U=0?E58V&H4]L,T.+0Q9MRQ\3[E.@EX.+!69+O8_"N.1MW%H= MN"3`@FY6T@Y!CXUY`+JS\2AH"-!4:J.J%B>R>0=1<-D2H]-NM7^B$;KXEXOI M44/AO%!-+TP:P]-$QRP:6:QSHW\9T2+Z6:<=3Y+3>&DE5# M=9JIP@K*1M-8("'6RQ*N1:5@IV_'ZLKZ7M-)4EU&*@NK>0!K[C(QT),=8F*N MCS'B7[GL)%D"H#O)JFO4>_LQ=LL\7W6=N?H<9R3K,R93>I)&8$*C\:@&_:@$O=HSU=925?A3>2AT;]5D:GC:139V M`YOZ$V=5G.=#8D5%0Y+2^?>9Q$J=3"@;C.$`#/D^R9.')`+^X)?`T7=IN!:: M+(F"U4/@($3*S7BPQ!L-IDCS5OU$R,NKYXT8,)J-C$*,Q'T\9[KWV0%M;*D;C>ZU;5YA#4F M(MLM2MCC3^3!H&HT)6XH,LQ$#>"RP(UD\MQ4IQ%Q*X!13[)LC%3?K!$0[AW= MFS+*U/&1@SZM:\55U7`Y%O4A)[(2$:,A`8$O1H=-G*3<-6TBHH*W*-)`6$@@ MD!`U)Z-SE+VVF%9&XVU\1CR@5WNW)WMVR4(R"5UC;,91.GL#/^=#3K>&F;38 M20CDZKWP+F7?JVIYFSN1$*.'M7E(]LVHZG(+D!IP!T.!5S*QR)?1H!*6-L(R M-%)XU8N>L'@M58_:7EF]Z6K>U"I?G/ MJ-\I51?S#&_?TX.46O&+F#&3JPB37I&K8JT9B1W95WT14H"FL;#UV\7U2)M M6(HDDB4_:,1O%RC=N;J-]!7B=\; ML/1O%ZZ\OR<;*X%&(1ZPPI$L(.^2! M`*?0H+%6:]/B$-HY606!TC-T[Q**(LDCXU`%+IY=>ZSMJ-"`O"9!JHEY20), MG#27S9D!],:GRB4)?0N"(U9-U;^-8E]<-*YZG8)JQAD%^Q%*A\9BC*K7 M.2^KU'%IL@-J`G)T;",;BWOK!QA:4N7G/R6`WY^HZ<%S6>6.":>GLE?4X,1C M1BH<=1F-N(T.DR<20UB>$'8MPI:KJB,:_&I4!_?#%.@7G7Q\33E`ST=I6-5= MYNR!H(ETG>J>TOF= M[27L\I/YL@B[]'12'0E9GSW+$I^[2^LKK/(IY":RP,PPR0H(2.=G!CW,.[I2J]O&I1W3NL.8KJR M*LQ:=;@M+Q#8N8[NU5'7<9@*J8F5X8#D@`[OM2_N'##PEYD75S,*)\'I$XD`J#BN_H&P62 M-)LUA'$?*)R0F5U#05^:[MV1ABPJ;K M6TTYOJ*"OY78:3_L+P05+-7>Z['+)J=)%)M8_XOY^+`1:N3^1 M66,ON]O[J:T_R6'2L)Y'2J(*97TS;62$J@,\(.V92PK!HZR&AMU:J>A\`$;6 MB'U+ZEE0Z9UK]2HUZ<6W$8*7`X%4>.?:EJ^XFE\%;PCC5 MH!)^?WM@M-F$]35L)N1#FNH^HZOAB!JUU6IWJ53PYI*"+Y$_HNBIK:A^U MCGYJJI<=A%%A9!E,.1\2C`AB]M3)[)/J26"(`LN&R`[I"OZ(:M@!W'0B4KSI M#H:($:[C"Z=`3GVU9;L'&IHDL%H@'@18<7#L'-L94+!G:J2"Y*NY,N M$=DGY9:]6XQ0^]NSG,H M->E&5HF]'LJ.RNA44-9, M$V(7T7@$F=NRHEQZQ/3A_0!QMJ*DEQE7-0.D^4B>T9>[U%&VJO?V'.W&Y^_+ M70(==`#5@/?$S`;X?_L7JENQ;N2%1C28 M9E*;.\L*[`/>@$_H7"CBLL,OY1KD:-_IH(\Q5Y0>$<:C6C!3,79,<3BJ(Q%'.$HM$`ODQ,DHZXH?RAFA0Z;P+TR>%X`C1\ M5[67*WT"R[,U'GJEG*!:A&-;$$-6,RY[_-7.EL_(I7L-*8E1[_NT>KCF#353 MD>=D.D$A4:.Q%&AQ#558ZT%()8FJD4I<"VB#V2%OA]*DO1>E*G[W&2 M,>N0T^*!QC+5U5,_UZDC,OZ+V\(NRGD>J2LEI7HZ#Z0H.;Z4O^6**Y=5\"=) MFM4ERX1YNMYYC?52,3U@!-P-F M1L-NY_@SJ@JW\$1:-[C&DH_T1!C;&4(4+;C<8U&11B79,L M%DIACGHK;`,@'<>L\R+ON:/0VY6,ESYH;UQET2INEF>US`E/Z[*E,=K$",T+ M+7P%M9Z$3NQ:AJ)PGJ;SD3?PX)!0'"2LNJ.USF'!BA@;5W`FL'^ZN=&<#[(6 M&H?EI4^O;!L;0A7T2>>]B$4_?*T,/GNP3ZTZ0DH6ZGY)Z5KAF.))+405)$/5 ML-70:%5&'+6F]K$UM=2^J"<3/<+FC]9[9]LCDQNR7GUQ#D\K0QBF$K*E7]4: M?4?D5J\-IIGYGFD5%TYM?J7E28WL]EID$)@Y)! M:E`HS=WX"192I+$S0-[FI$#?#\*_Q#1B!,!T!O" M&K7TA6/^([H//1!YN7+XZ41RF)O$=0%6:(HBK&):E#$'.(6P[.UN9$R:^S(! M=#X+!B2-C.1/I9CWE8.N3.[QG*/V3P[M,KQ/.'>])TC`JCU6\VW(!ZMNR['G MKFS!*9,V$(#Z,J[N'$_9[J#R1WR1.JD?1D;"<0``54E*L"=91:>Z!KI,AL$R M-B,*DU&2?249I:.O;=8L(J%($F_'LT&D&I_![.S9QAN%U(`C-XT@ES-#'L-, MJD:3)UVH##B-.6*A@8"_$ MOEO`HTI]=I`$(D(RDDE6][JR1:9=Q>2;_UU>*U7W4LO>@\"9,,7<3*`QA"6;R_N[\!HU3XG3"`C`OE."+&3D%PP)?$?7HRWYDIED.V( M8[?>`)XK?K!+2+7\4H!62M78[1P91QR6M6OX9B&:"IS)"YPW&0F=+T&:9N"FI=*B[G%^]:: M%W9_F9C86AJS^(9.M<[&@FV3,LP(RV4I)$:1!B/YQQ_,')/=U'.>=(Z_::-C ML=/4QHJ*2FM_D5%@J[1HIJ40T@&[,B"!TIUN%E7KL!I:,5VVBHL,2R<@UT(? MA48KJK,D&2.2-GI\X"M<@:JDHY`&U`U,/_U07KZ)P@$E"5,EIK+\T91R4B8@ M1EQ/##:J:[R5%ZXL0LZ+D!^4Y5M'QT8N7C?UL7Q?IBI=L##39UZWJ3.^"09V M7<1E6#B1K=IO4[IV/W+^ M*])D'RSX(84I,RK;15%1OC\%J(?L*!58H)-4+N!7]H1G$KKV+7U,TKZ0]>W- M\Z6B#T:%T'[Y7)45Y]X?0G:35@R9>0$Y04HQ)%4]8YQ2*ZVH)[MY>L_RC\A6 MZVG,2AZEF^B;1=J24Q7 M"(&??Y%1[+"L;]LK1GAA">_2?>?W=>(*;.47>6TL0F>X2N'EC:O*L6B1TFV% M?_%->0T?*ISOL<>^6M2>RB4HIZV&0ZA:#'"JCZJG):-X"16V!4!2P$&_5.YQ M@-T-KF+R>G.]'%:P,2DT0B010[Z:7[WRYCK9"-3Q`96'R1*^7DC%`?3=/QE# M+HMD&AB@EXO1UH@SL,JI)BQS)]GO@DY5KX(_>`3F1RYF9@I);4=EJHR`.J7L MGNZ\]8QD//+BW*5T$RNE)@;LQ-'&G3XX+!A49(:3I8%?`"D-N;H>/L!I%46/ MOP1VLW\XQG+PE@?R`#78WV@I%&S_JEIK.'A9K/]R%H1!:5LF\<\*BFKXO?`=VIBT2MW^0P'%.)M?X$EX ME'66/,PC8>3144U<>@(>0;Z%VFPF29U]'E@:6MT1=G5T46F^5`$1EXVFCV1+ M=*%2FER1_`^/:,Y$B1HI>0TBPD"Z5+NGA' M.^>TR\8QWI5%?K7WG!`,[QJ!0DV?4Z":\F70D!.QFAO[U-4T%Y%*0,41,"U, M71A%;E.D6K3C`S(-"/:%47>_O+8LB[_+Z)OBJJK.CRSFHT=+$505=C+]?@\MQ7=FWTII M29;7967*5*U:A:R\ZZFX/5<,*FU<,PU+EH)LJM:LJS.9;_*=.S+,J4F94<"R M-Y*FKRK!G*=AK^#7L'T._=98)F?&]KFL1.G#\,W*,EFELHQ1"Z,:$.=R;TV3 M<\L'?\H2:N`U^V3*2OCX#L81`5.D!NY+CT\D;^Q1U)RKM=D*2`X ME?NJK$EEN>,B)H"J8LMW;\O+P!D#UG""XN^ZJUVIF%3--2-6127;8F5Q2LM?(M*V-Q@>/OHM*?&QWT MNA:G,?*,95`]"L606=\R?`;469B'O"RPR+OKG&,G,SA;SW6^`.^]=\[Q1IG/ M"8@\KT7;&6C[8?$"^/7B70%='>.KZY@S81R:J:_*.VF50M=F8]2?5*]C[EZV MDR?W3'.1RI0;EU:_I@E7*;/5]^>K3N5\]HPK!F6E.HHWR4M>YS>_$CWLMP]= MQ[B*]YD[;!`7WN,22J?=]KM:#27];K4?U"V58@"J8_%`T1RL>4EE(G492<\I MXA!%LE%ZE_+3L!RO(F,9.(IDH8DRT7I@+)!;3[&39R]\5^[97`05?P"6#1#G MW.?$2X-:Q4;JRN?UL)2KK#T7A64+>(JC4<-+5NQ:DZ93OR"KJ!=:V'A. MA;)Y?E95#8Y_-8+0U+"NP2MB\*<)+.RHUM*.?FCC#TP0F2PD!V^-78&:,ANU MI:!05Z6KM+Y)0IXZ6C^'Q9.<6R@U&<>N-,7EW?I,J1CU>CO5)Y+)QK8(Z3=3 M!Y<%J#&V5E9$F[`>AXK;4#'33&"[VIS[EB`1J;K3!N68!U@2LV1[E(D*3ZKX MF*[R4/HAIFR$[H@*:C&#@\S8ME%"HKS3#P=APC*FF"29/.82RX1)\SC+,UP4 M]#@E54&/=*D(+FI`:28][G/?\*N\>(00A?_H.@C:/]O$VYK8F=Q)K*X,4(9P M.-`7D'H">`+E\')*@M='5OT!=#,L$VS<7SQ2I7#)!I(`5EWJ4Y&;S7'G$!)' M.E6<-?S8*AI5:[E?95><6F.][ MY-M__?&'/ZLW/JJYK\I[VA^TPJ%?(2*&#]]$_R]O+OCO_SW[?/F_!^U]8+3[ M")PW?QUW44UW7&VL)?'E^O;2.:PD4G^\^G+^Y>+J_)-S]>7F]MNOGR^_W-XX MUJ1X8LT)L[X:^CV&"2K2W,_"Z)AD5E:GHO!QGFJI+=,L*&6+QM#%#JC@._>+ MA3_*"P:871$\<-ZN:O-,!>Z)ZTB?>$-N1\L>]"+N/[S$@16$,H9_(*@^D;SQ M85;\AP7EA4Q[X;`]1T'"`2?TX7\Q[P4[2B$C%8&\PPJO4C-'NF4V9Z=W#!/( M)EKCO60R42X3D:`L%Y$;$D%5W<#A*JAI8"+M@%OFG.?3>JZ7HK"Q^3HYEJH= M=-Z>=LN8*/]=%:RVG3>@*ZZT1!3PP#2!2FL*H<!24"5&9L"K=5ZFI2]5^PWB-<>K6Y0?7NJ9Z$6T#T0VZA':9>J6]OW7#05\9341REVLBG<`W4_R,CIGL^P6:R=TT-BTJ6Z@,>`?8ZKDQ[IQEE46F=SLC+,%(6)RK*LU,9*R=+ MU5'SS$BQJN,+LG_=B*D9N?N5JQ94C"&::S)$US)M>[;5I-,Z754&EVR\:O@H M"N&$`BI;[XW(!N(6,I$"'N;86-X]ZS8'9\Q6E`M5EXIPI%'#-"]`)M,U3)E0 M4-Y+B"BEHTE;;,Z>,,;.ZH/7*T\UY1>C_%&WZE6E+<^)"^J^@S?E17*7>L-[ M*:""D!L1E6@^\/X03C&<28L4NT3T1H\.<$=/M__"R_S"7/@\_92P54M6V6U^ MGR;%W;WZCI0<4-#+S&G66&1P-`XQ(1OO3J0)Z'*8SC9S6GG-0D\K]-UVZ;_` M,IF`025PT`M5UDB9)GBEC,!$3PVQ\IC0:1756].88"X77$Y.DN8NH3LS#!K/ MH8LFW%*F#BB&1-8DTW!12;E^#XH%:01VWG<`;<:GN#-U8/NH]KM2Y>6`N09)SS!41 M-$$)1._Q'1Q9\902ZOL4Z"EA!Y!^O)?"2->54%ZD\"Y)T3&IL,^(KS0T$XZR MI(28TM$"UJ-9A5-2CX+KSN5WP@)Z1_WC7/!45_HE@\&P1BX]KI7KCA)?S-X^ MT^X8L$Z&RH("!!;?6--(]D+"Z_G94W,D**V9G'N6KZHJR3_*_#;=2(J](W%0 M271;P/EH=8NZ;V/$=:";?50JK9#`;I@(_:A`ZT<+__)\**_):#%#O`5YXS<1 M#\*X%[J4[Z-#-;_&H>[5A^%6D$NIU0_G.D-,H8K*,Y)-R/NR7*WYDPZ*$)_' MRYF@H6,C\";%XWQR>R%%='S3#>OEP-G+A-\:"CS>AY&^3\RCJ;LJ#4-1(!M4 M!+R35ANH;!P4E!)!%GIK6OXEIR&"%@65VL9%8.R&/UJV9]]17 MSKB64PE&FE=VQHN"3PF-R11@OAZO[PJ/KX:F4/444"4I%S)E=+J0,&?BL$,^ M&+K>=-INE]ZZL],7N-O4>'SE7Q\;ERAOL_.Z"$?9#UJ_((6U)+#):0MKR3Q# MB]#WW_MU420G1MBTC:[0!)]VZTQ]4=OS(L)JOBC:G#$Q,XQV%:,G+$E'+Q@[ M6P<.^OPHV4DE2G;UY;?++[?7WZXN;ZQ$FN5MGAH=<,J@0"B1#X6*\D(D_=>K MKSGYBGY.1@IE-@\]+`7ZES?M-_1YB(E@\C/=9_C+FY/V3V_4D$_2>O-4_T7% MU6%!?WG32W(P61HGD6O8YT=^[@Z_+[VKS03FE0>S5]YYH84_S[B8T9]GKHT< MP$[`W`64@!^[>E<]%!.IVE0/*Q(ZL#6'$B>J9MW+DS;ZXD2Z2AMMR@3\4#6A M#+4TXF3Q]0;_N4-_W=.M'NEZAPO@H:6GG:+GIH#[16B:ENB MFH6+ZD,I:U.-<(!A=VE2Q,$^H&.2_OQ_?+_?]WU31,\EF"<#8!WJ"BUT!<6, MK#\;F\:QY[GW/U^'WZX&]F^?L=;NRD%\X'8.#M`G\(15S^8RJX'X\M#$(O=& M(W?7/3XXVPGD7D@\]NE_"XO'A52&39.8'\,XS.Y%X-PE2;`,D3D=>AO$:*;K M]^M$%//SH[GWM-1SFL>:F":L7Y:]O:B%L%Y6MB4\2WB+$E['/3P\M+2W,F.\ M!H+#K=(V;NFRK!%06;["<;A5?`]V0X5W([&B$WLAPV?^O;PZPSMP.\?'K\3P MIE/[.N)J62O1TIVEN^?0'2@9IXLJ^16!K#Y@$'RB,!G+1IF66F*FH'S%FE]I M/OH:X>WO.,"T+2JS:A-1OF`BRFDE$>7KM^NOE]]N_^V&%[ M"W)2EJD<53J=#%-!':(S74L_+UM]A:G1U[[(!);AQRM7>/O!R8H![(!RVH<2 M:3F=46$L9A?.D_I"O=HSV68DLPDO-N%EZ:S$!NAMPLO&Q.8M/5EZL@DO&^AC MVQZ'VE>^&H]Y_%J]LWDO-C5@XFK/W-/.%._6%J4&6.3>.>0^=3L'[9U`[E7D MO6R/E/PDO(P:GF#IR#1YF*,>N64E:[GHUT@4/3W9C5PZB^7KLNC7P/*3]FY@ MN;4O%[HD6\`>DUX8+255PS*2[6,DG>Y.L!&+X^NRZ/EQ?'I?SX6P?%J&T!9A MN34S%ZJ!V>]CN5GKB%UGE%X_B7EL[R%:'-]R'#\\W0D+-`ZQH] M/;QN6]K(V\.''7MUV!*>);S5$]Z4/*B=(CQKDB]^0;_YVIBUTM=0B5X[^Z5S MXAZ>[(8!8]%\71;]"FA^Y![9C*GGV^D3ZT=LEZG^2639SR6XR[\\7S9Q$4%Y MZ3M,8FO26\MB/2V+O5,0\"=;;UV\L]:\I;FUH;EC]_A@2NQK%VAN%8;\#A3? M:[;M7>P$MWR=PQ8%6X?;F!M4%.S4/3N;8F4ME>]M7C$^2W26Z%Z$Z$Y/%BWY M6Y'.ZL-BE?AF5]BKMH3$YJ"WWO>&NGWK4XEOE?55OF`9ODZGUA#RXOKSI7-[ M_O^F"O>I^U^;VGNKZS*-[>CCQ,F][U1@3C:B18T)OL4;Y&&&)5>PG6Q?`%F# M7H4_9M@46CT-+V/QODQUO0^>V7W6Q4ZN8I@[/A")%\9RMD$8AX-B@-.U[!DO M<,;`([!T#M=7[!49#)A1]^;Q+M]X(/##@Y>&29'ISKK8SYH[BN,#=R)&1(BH ME;/1GURV;);GJ)I@@[&28P%L3:PGO]"!%EB*%`^3FS[;(YUUI+_F813^E_M` M)WT^O-9-JX$NL=F=C-V3']]*4NHT_>FF0-367+WKP%AG M\&/]`>=U*.' M\U!K[:#EG%,;ZSG:81ODE3F!Z`M\GP`K*ZI26%&>2(BR"C^P+_,(*F@,:FO/)>U08^O7;A>O`W@#U8\"_H1<2!<#7#E7T M&P+NP-!)D-<\7UWU.2K\P3O.$P0G3M>1G\&_$" MO_!)/B3&I)A$M_T+;,$7^*KH]Z7`AB5Z=U0Q2#_7 M^05E/(E_F!=/O,1N0CQJ$PZK@5_'4-1&)&G"\NH4E5HAG8WT7JXUJQ#[H2 MA[YPJ10U\$9C,!8F<-!I$NE*U7AVJD(A_JX4+=1^"Y>.2]-0:SE7?9/%XYG2?_HDA11;P*6&0>C1L<-I$8'">8`<\4SX M-)R+>5$LYQ8F[T[0#Q@4,BD MP)1-XKL$I9WX#J_$4G7MD?V!7WL%:&YI2'*-F!'24:A83I.*A;C(>AS@2UKJ MOR"TCQ&GJ*Q\*@8H'('.8].LPG[&`#`:ET/ MK#!4&7XA;M.(\_!:!G`.^R"^`:Y*(3?8>`R'X72ZTD:?CN23O%G3_%.F'^OF M'LX"M0Z@/O1XY:/S.*`OWZ.J\=4;$=&MH6_K-;I,=`XJ[JV;V^N+__OWZT\? M+K_=F)8T=IRX_?=.ZES/@O&_P"CS9I5&W%;(+0*H#\"G@+=]]E+_OI07:)J0 MG@0T^GL1L]9#4ANY2IAE!>I.J*F\[9RX!VW*T9?//Z#2@]9$('HY:QB]!"4] M/!V$P.78JAE2_[7,[+=KYPNAWWZ.34/3L\ M50^]-QY*A=(HR7("H?*VT^JR\?ZVW3JK^3PY2(U.#=1VQ\'=Z8(V"(IE$)#J MZ^J''#X*U%3D;^1T&X#(R5@E0L4N$^E#Z`O2:$A/9C7V#O^MG+7UHP%H@L9, MJJJI!>)9R&,Y#Q["#-Y61^*"KA3"DF#4,$=S$;7BVFSFJ1VU$H@_/`5;"SX*WO8\9!S.09509@$/W" M9%[)P6C@(A1^`U)N__3LN-KI7.Q@`0UA*]@?HH=F`=P\2)*Z1I8]L':B@GTI M# M'2]#&RP0@R&Q$1T,TJ$#@?W$R&IU^D4<>#@*LE$8-_-\9E,\IG1KL*%M,I/' MI(@"F$6S!%9U%4&C(RPU'=XE?^5Q`NDQP+\3GYRF4DR03=>\*LWQT/@*'+06JU!>F]B>\LKLW"M>O8^8<7%^B]ZW0QHM0^ MK2IX&9:/[QZZ!YU3MW/:,?0Q]-)5=:^X\J24C1#/IT\7]-)Y&B1%JG^_(MPC^8E&BB^(&U>0G72MXU;[)];. MD#(`#4C1\IP.?N^Q]CER^J+"(:OF'#%A MTKC"K&16M%HE5S&\E^4R"8+%KR7Y621_-4D)0>6"4MW.E4'DHIJL,.S$'4^Y MX!`4H0U'%<_AM8`X0UWN29YP8'/W=+([."^5JHZ&4KS0WY`FCM8&_D M%.GZ'6,9(T5SDQ!.>&":2;&>%#G&.\F*U?9NZ=<9MWJ;5[;G)U&D?5HU('R] M^GK9*/B9&8S!"*W/PI>^IIK`)094JL&5H9F3D+O-95\;.X)0#M7W!;HTNT@TPQ]_*!,-7ZHK^@O>*UAE&_6SHQ6T43\\LVW4 M7[OM<]NV?9X^@FELTAUA!2E-4R(;=@:NALG>ZSOSY=6@:S M6V1S*34ZRU::X?,5[:42(??>3B@C85G,O)39/9FW2,KN4>,WG6]J%/%ZNE!; M5E434X'>GA(F?Y-.WH:(1#T0FE431:7S;@DE3C:SM,+F%+9H1N1E@EJG.2ZE MRLCF0-XB^18C.<8!=AR_335G>V0DWC>A+#>Z(XN"<.B-T,&W)*5D@8JO5BEI M4DK>6Z5DXUC'ZOEU>:]BQ[FVQ?(MQG),2]AQ_+9:R:I<)1.P9@>U%".A0&=# M-F@J%RO15'[\86UIEG/ MYI18W<,RY@U@S+IFTXYS9XOD6XSD6#YLQ_';:A_6\V&U#\N8UXLQZR(F.\Z= M+9)O,9)C$9X=Q^^YM8\??]@H@;CRX,O..T`N=;&3`;?0&:N\.JD6D%5(-HYM MK)Y7[QT=N)W#`_>H?;S!+'MJ:W*+W6NRZ-5C]Y<_3;A3N!%8;=T@DR#S"9L. M8HM'+/DO*A+2ND*6`_(K5133:B"61[_DJK="`;$^D8T"]6OX1#I'.X[?VZF* M_*O6?B*<5$/KM5PA"Q6_V33H7]0+:QH=018XA[E9W'1@;A"OGEXX:'.8RMD3 MMK348YH^GG2ZZ"JSS1M_60GQHM6O5N^5V1J2VTBB>CWH+TUC>C5Z>&DE:JLE M^Z9<\ZD=PN%6'<*U47?;RZLUUY>O71UN+*MO4D5@-TZ0%+U(;!"[F:%>->_I M-?4K>3W]Z,CM=L_,]X+D*LPCVO0>1>G?8P&C@A3'GDL=YZOEY`5IW%/;%BW53J4.S MA-0JFZ.8=DU!C"Z3^ MOY1BN0)9;`6O%;R6W5IV:]FM9;<67S<"7\_9W;3KV/I\Y6!-?)C/@M4W=%^6 M`)O4EO5IX>1U%9U64;&,WS+^93#^\AK]6O-^B[`;@;#?5$#,ZBI65]&!JM?0 M4"R9+Q$^7XI!3Z0OJH1N.+U;Q-T(Q)W><]ZBJT77M4+7BT1G%>TZQCY=H5J' M)*(5ZUTS)JCRPA+^7S$1;M9QO(@6-SDO:*V0;D'.LPZ8ML;I:C;O;%GW#2SA M;"7A$#^V5&.IQE+-`E3S*>Q;HGF*/CWYAN\"!51,E7M[KO.^G7RGWA9E6^-% M=[NKK\K6<<_.CMU.IVNCR!;-YV`M&X7=MAK;`G@]7J)^_=:]YL!^!13OM#K; MW_]Z(?5O@0(O6ZO^'9WLOYWGU=Y^X[VB`:H/<]7$>=$"):^F_STSSS7+T]#'#I!;;BF>Z]@Y+^Y@"J=SAL5XVJ>N\SEM.9]$XOP;;(T[5_;"&`R] M>,08?-KMG/R2.1?WH>@[E]^%7^3A@W"N^_W0%ZGK4.B!>HSFB>/Q03C70^HT M>H$]-J+(HP]8O^<&*_LXE%`3]HJ\TFV#>W'\0WBQ\SZ"%^'1P(41^TDZ$*F3 MJ`EAFF&:/(2!H&)!>^$[6K1OSI7TX<6,EI+P4CP]36]$2^F)_%&(F/9/>Z=O M/V>M&!5(5 M)%VZJ'OD=H_:;KO=5N6/X!$_&0Q@,-X(E4.*1OBPL5]<7VV'+4L'L^D`09AY M`P%G/`(LBYTK6-A0T.KPV`9AG@NASJF)(MXG>)!>`.`77)D*"_J]>[[5_H4?Q%?]?YY9W$:SQAQ&Q\)51M:V`AC2B2EM-5L`40L"><.]D` MN(J.E6V(P3!*1@)&&Q8I3I;CTTAT]?%Y8(UFF<6S67AVJY""<$!RK:SQ<#UG MX'T/!\5@GI/FDVCHZNP]`DZJRFFY.7O+J2X&*Z,%`^`]&;-OX%`363]\)^*, M.:LF#63-6='SYR<5>.!#F,)RDS1SB7?>>[`*!Q9`N^ZT2YUI)+P4&.:W^IX? MX`LG>8#=P7OW@(D./ND,11HF`8U9Q/@,O#".N2E)C+X(\3M\MN2A7J;6CSP? M_O!R21DD,W")80R_P)J^>FD>^N&0X0%PC,)!*(E,$Y/K!&JK/%,29T644R&[ M*J#HYQ"^!F!F0/Q>&@I^)X&G8)\@]Z*0I_Y0I%3*&-Z2.P8<>+P/021)//'\ M_Q0AGJ=)S!5$D#('I_L=%HB_(\!D^3PN6IVQ'C!4.T6*N/>B"`X,1#_^H>07 MTE1FB-M[4.1(6%>VB-_B!"4RT\,N+-^/BD")-!J-%I3`&62%L:V8P`L0%:%< M`;`#(*8X,&$%]*I%<,9UMXDL8(BAW*LQ:JM$M_*O*]R*N?'RZ)U[.&P@79Q) M-DTG4L8=IL++`!OV>!V`/MC/"3'KB.G'2 MI+Y79(*.*9YP5A+5ZZH(_E-'%CF^.09CU61D':IM235-;KCE MU`&_.%CPJ%%'DZ!!R!=";;_A-!I6:@!4;11QFPZXSDV0U4I0@Z3U?.`D(J5U M`<3Z!7Q=`D;T^\BF'YX%(BMN9ZMU_RBBD=,U"XTJ[$!A"V=SZAZW%]"A%M.: M)CT]63%TF4$15Y+"FS4W0=S-9RQ'#F?0($Z#.*)%BZ)$B5>HO$W7W4`7@0F2 M(@-H*0VV2DU@V'WWQ3!G45@C"%IN,T5D)4F0F"Z%=";WFL1B/[\/62$PF;R4 MV\4P80J$!UFZ>W$<8G-&+QW5.0TIN*ZN#=OS(E*H)*-"2A3_P6JP<*CY/6PV MC+,@_#C)`41W2K\J5;(; M,*%3:K3EG/NTQ%2`@*./B.Z`747\?T%N.DC(_D$JD&O";N"NDS7OC(L.! MWP=%=$=\:-*<+;;#9VT"UJVH)HD!=@#4.(GW?VW=M%#]R!#C0N10_>P^@6=A MB:`EDC9J%$5]O$^<@>#C&"9][6#UU6*4O@"DV M3'$XV#J+/J31EG.>:9Y$IJQZ)4Z<"+@N?*?DU5*A]OQ\V[4_/FW;&]>3?AYEUI/I50GY(> M\?0KYVLMOK8X-%W?5`75NIW5L/6R9NU?1YADX*E]]FSDLQ=J5[[HU5^H[1ZX M';Y5LO77:BV:OVX]A%?`[G;K>,>NB\\2J0L4#-I.D3IV>XSO>XG`RLLUQ.VU MXRA[G;9*C]Y@QO+.RDDK)ZVJ8GR?-O:BG!'#ESIVMU]EZG5=Q3G/YG+ON\8'U.N\8S6V4@']-%_.29/XVN9A?)OA\N%5J M0,WK7*E'MWQ=X'!C^5*3W(3=.$%2]"*Q5C3R/&6@>5.OK@UTVN[AX?*U@3*N MOA`76+M#WD(*?+4#68ZRL,*#:+=.CE>A+*P;C524!?5ADYME+K\0;I[D7C2M M)]:L*K8Z>LWUI$NV38^5P4I9-MM5O9;"!Q&-;+7X66=$A3GW>U[&W1;*/FOB M._[-#:;&3DTUD..>`7@0,"^I6(=M0%5A3/161)SNE:914UD<66Q(-4:#F=NMSB$W5+!X&#^K:X'J M`\*5\>LEX[<`N$L4;=>Q\U'T4NX_L%#[@7E[47&/$&PF-G+ZNN^*%SR$68)- M%&_7H2O`^N/`X@3VK!HJW")Y&XCGY0&W(*LZ'[#(0Y&!81&2,=UV^\2Y_$^! M9?ZO8JPPA.WWOD9>O),@7P0UK^*F+@8(T"KGJO4^G@#NIM[')^.]CZE]DH=M M&[+*),"*Z#HB,20\VR)/@)6:S;VS6NM5L]DJXH3NI0):C51?J-VLUC5*GCN) MQU9X,3:2]8K\/DE)$T'6J;O$55KOGABM=U5[WYCJ>E)+)RE.<>,#;X3JC90% M#8,`S^5F46'L8[-1Q;(!0@H(NMDS-:_]/H1=N[16HV4F:9/#(O7O:8B&QJ(P M%2A9!0$\AS$%O"<[FN*CW."U`ALU'(@5[-&)$,?M>%'&*EN`V"HJC;FX2YR: MWN@&C%MF23<'4KG$J:DLKOHO4#]4RZ#1Q!Y'( M,EX^]ES1G;^\,'6HCI=L7DN-Z55C6D=V\FINV\GH*#_P,G93_CU5#3JBJE6G MS$S&.UJ--4@VV,R"K'Z,]ZCW&WF0*[O>*A)C1C1&L)-(GYHU&EP%\+QSU,!C MJKP$-H*VCVQFIQ&.FKMY0VSYY$73.%.%>*@!MFH+U_1T*F!S23I,9#O),):* MY4TN,?P#V&B@!(K&AI@6S6>C^6?/P'#)2)J.XCR.L>'>9R%4M\`;XR@G-UBL M'CAA2(TX2LG3=(:PQ//B#J"`WAN#$!6YF2A"S8PG8DB3CV""]\C%R4ZZQ^[Q M\0E[CKKNZ?$TBZ?JCU"=J+T'+XRH.Q"27K]`B<`,V>QZ/PZ(F8C[VEW+;`.P ME_1[9D+K!]3>DIQ%#UZ*G3REAPCP98AP/J:4MZCXCE M$\3BQ]IJHEK)'<:HHYCN+C8%(=&UY66R3UGV\EW`YN6KDWT@"_7@.CM800^N MH^F9&LN.3-@>7+"1]JY5#_[QAZ?%MZ5[IP3ZN9)<<\6[E\V!U[#B\L?$<#;\ M#?GJ(I!:PVRIUZ=6RW9VBX2F]8R9ZF^VW.>ZR+,<%$`@$LMV+-NQ;&[;LV;+GY0'L4D82 M#9Z,(47+HBV+?BG.MM"]IP6N/Q\U7U??\$M.[[V((JQ>/A9:LLV/UO)Z__1% MGZV^JE;7;1]O>J$06U5KHT"]>BSONF?3[M19)+=(_D(7X5:/V^W6P011;]': MHO4&H[4M]K1PE8^>ZFM%M+9PUQ.EU8R1[W8VO&FP+(5K4;C1K-AZS MK?9GM;]F[:]S8-':HO76H75W^[GU*D(X6UW!5EDY7.]].07?MZ:.YK;4KCU[ MPI9>OUB=VYZF@KXLCUOSBIV6]"SIK9#T]G:#]FS5Z/4XAY=1LU^U5>%RHF16 M*FW41BR)V%+K2P[";7<(;DK*H>WDN9;^F'5S@I453C;3%?;C#];':_%\]JJ[ M;LKZ"MM*[X:%=U*J/7>B"61:;FC*_'JK!N)5*Q8]0&; MF8R;7E-MS+I-6>YIJ[K`W>HVZ=4^D[+3F>Q\'A0I-GZC'H/A]/;MV)D*$T^Y M?3,U??L>#KP<.Z.][7:HC1HU=#\XQK]KO=RGFLKVO/)?SO-YF]@IW9)/1&6^ MZ69C=#Q)V4JBUL0.7[KW`J-M_;YJ6\_][1`??%ANZODY-@>,PCXASG'KL&TT M*3MI'1_SQ]I).]?4*+)L?\9+;KNG[X/M M32[0QS"_)PACS\\P(_@#.7P\OWGOG-]<.">=6BO/>P\[ON+[V'X9SVV_1WV? M?7A`Q!GW@!7?\6_B,T`V)[IC+0F4;JML:(LM-QUUHR(0-%1U(=3] M5D^C4`PG@G%R8!>YV@?WU"Y;ELH]-JV_^^3UMY>]_IE'$F8._RI;^E;5B@D983J$ZOL*:^"'.]FND< MI/KISW\JLOT[SQO^3#7J90==;AM]'@?TY7O.IU#W7R[T_T%.-75-^>W\T^_7CK7'YV/5U_. MOUQH2GNLG.K^X@,%!V`^I[W,I6$Z[[7D&(DYGT$5E M8.:=@>C#EC.3D>6),^!!'"_+A!PF"KU>&(5Y*$!OPT;OO2C,0+,%W;F?>@/Q MF*1_$(OB=U'W*,=T)<\%VJ:&[6!;(VL#%3(H5^=X/=#4"7(%2[]R@%9E[]2L MM^1;C_J2\ZA&"\B1R7N%$H*-$ M\U!(@I&!@`"Y%V95M<,+0/K">Q7`PFO7?IX0L%1[=<9]M/Q0D68M00K,I@[O MY=:&24:8ZX*O$?&>$`;/`/D4M[..FA7L1H/$+. M1*RXF3#@V#]/?A>Y%N$:#-$#;'5B:@_*G`Y0%"UBUF6UY38:$B,DBD($4_3$ MK@M2>$%-@I=!90/`^YF#ZC$(#!]IB?2[\5=[`L=75-9RSIOIE:R;5'A!B)X2 MU2W9Y7;J\-__%`GNQ`06$0'R`X:P`20?]$B3M*EQNZ?\,'(H.<8=L'-@3#@K M<(M``&B)-=Q[P!KQ2.^0R0<"N1I"9\IQX9X\4F0K;_Q>!'?$R-1Q-@FMEO,K M]8NO2EV$:1@/"P`8O6Q(2Q,G@`QPOWX$\%?R&QY%[DN&`BXD`J$55=K.OQ+3 M6"[1&OZG>;:GW?:+]+OOM+'W'`?%Z7NU^`56:P!DK(]7GNH80IX,*_E@Z%7#-$\(9^J4(9;!LX\B*GO'S@R00T3[0&7RC)WJ\3S*]-7PK*3=,6AW^G`&<4<-$AR)K.P$.DM;? M^(7FL2S+LJPM8%D'F\JR)AEW?VV2G^$+ZW=G13T_2Z4P-SE"")B33 M'J(2^0)8\>,/BZML\^8JS[N\%^K6_IS5'L!R_02/%W[L+OFNY9C*OE0`8:BW M!!+%?,N/0-8UJ&W)KE_PU5B\U$]64Z9_FA/9D>]6X^U^<:D\L:()VEGUVEGZZE'TL_EGZ> M3#\'EGZ6:VNMM=*YOHN;Y*%:GY4NU7]@L<%B@\4&BPWK`7"+#3N%#0W*CM:B MG].8L.)[WIX&$!_PSIA']]54;K%X@?C$1A#?RE'X[7-6VVU>[E*;K!\<4`'. M'6`;%H]7ONQ70.A)M_TL*J_/XC81IA:5+2J_.BI;[6)M\7@AHV2!/G5;:I3\ MRTNIPJUYV]&:)&N\[%?@'H=GN\(\+#[O`CY;?^EE)7&JA[MN;%JJZI4;4RPI430'A.E+$G-P+EN\$28%5Y3,@W=;13MQ= ML=ALL7E[L-E:A@M!];-FOPC4ZAUO,-2P2[P82'VPS$MLLZB=D M4?>],&U,ESYW/#`$5>ZT(^OF9LY>&/M1@0E1]/1Y\!!F2:I_?^<\@AC5V=B8 MGTT9T676-$[F86ZTS9^V^=,VU]/F>MK\:4M3EJ9L_O3:8*/UH=C\:6M[OK3M M>7RZT;:GS1=;UV6_3O[TP2Y@LXV?V_QIRT&6L?!NZV@7&(A%9HO,6X/,UBZT MV=.68;Q(WNEF\PL;3%^S9;\""I]LMCO#YDV_(#!MWK1E%=-\GUO,*2P&6PS> M;`RV5MW"&=..S9BV+&-VQO1FATBLW%NS9;].QO0V(['-F'Y"QK3OI>D(LY0I M:SK#M&G?R^XI79K^$/\I0O@-5INYCN?[H#_DF9,*7\#7`%SZ,BU$X(CO0Q%G MPGQLZ(VJSYC]GW`*;\`/!H7`LM>IB"C->NBE^.8L.#6:R1O;S!ZG>=.)0W6I>,:IF'LAT,O$AHD"P>G^N->',!)W@O&?;ADD]/)]$L'`3@C4)E*<%8<+0KHD`(04`D;N MX7-JR]WV+],*O>O'.K^\9'"<(D MNP4Z>(\D]-A`Q+17WP,<`JE3=I^5;/KE^O;2Z1QIA.QT?W$NKC]__7;Y]\LO-U>_ M73I77^#SI;/WZ?KFYMUR.>6VR%ZDZ!AE$XE=$_6`'!#WG#U`UNQ=J7$2E_,R M>;LH^_G5X#Q%95WH-M'9*6B1R[Y,=-0M)]F\NT1K=.WAY8R';M>\]7"L=VDO M/50O/=S>HW/J,SQVGSF7,8I]I52M\/+#&M]]L+1E:>N)M/4%_K2D]32,;(@S M6#F\%B0,:W3UWK6N-9E9LSL==R#3@<# MR"^;-K-2B$_`8XNY6XVYQT>GFXNW/_Y@,7=7,??HH+VYB/NB.++.:[/X.Y'S M=@_;W,P1?A3--CN.M$/'/S MK;FWM%2N-GT\?NCPJ#O9(_.R;/!%H\2;FDEAZ6PWZ>STQ)*9)3-+9LLFL_:4 M`(.E,TMGZ[.E'W_8:$H[FY)&L5.$MHJ@7PT$AU-!L&EQP(O)%_R7;R4?;C*[ M@\4[05+T(K&BHWJ9A(/YM[+4?(33H[.E)2,L1+`ON:MGIH99(K%$4B&2HY/E MI?E:(K%$L@U$TG$/EIB;^6I4LEP[TY++KI(+)H(>'TX).VPJPZS8V-,6FET.JOMBOC&V$91TOP'T- M5/&YMP>M8P>6&:DZEF^[K5/U1:UXYCS&ZE@%QEF%%6M%&`79)SYYZL[%UZ@8.-)O6#CYZO;SY=?;F^<\R\?X/.7VZLO?[O\ M?,:U6W7@5J?!>5O(A->ZG.]Y$``?21#1%PD0HG#NPK71<#XM4BSPH/Q M\L3QG-^3$/Y,)X$V\D"^>WF2CASO+A6"OGP,\WOG!E-2[KVPU(Q^C4,JTIN/ M7"<@)OA!^,0ORV"EAC MF,D3)SZ;./U"%C06&0J_,+NG50*GU:M7);"174>"F#+\/''7'K)?68?Z.G:^ M)`_,]CM=9ONN62G9\>`=+&B&WTT`DE/"1NX\+]_!]2,4##3NPX$Y?91'(UAA MAKLDRN&/KMQ++$L(1Z.QN:/(P:Y2!F`="<_#EO/>+!=,J\>WJINZ]YJ@'"=. M)#)8#^S+^?;Y/0C"\L"42-M[>]@Z4O+LG2-E(LDS@&R:T/O"W)"L?2SAD&(9 M]%2PO,3*RKJ\,0K&L!_Z.#@<=A+CL>*N`Z<8PN^]4?5@4&:/GT#+.2E8V/IU!LYH2Y!E27'-:\9FAC>+F*H2PYM^DJ:@ MR](#<@#DBW+_>DH'D0(@`+S(G7XP?E)$@9,)\0?Q9/`S;H6`R91U8F^W3A2Q3^83YF:YKX':'>,A,D_\GCLWX'S( MC5*5S=Y6)&S(QY7= M>RFQ?V10_,,4)I7$=*0H<1$=J87!%]DB0_C(>H1DKW!N,S3>FA:%O.\!F*GB:#ULYX`M M4\;V!D-CHX4\8J:)/^(@ZDMQCE#O MA]_I*#*!XK(BAU'_2_E8&C"'>_,@*T=)DTW&NH8Q/Y[?O'?.;RZ<$Y0];RIH M_J%\5?DPJ2(=.3<@%_R$[L`X M;SNMMGX;6_I0(ZT,%:B',"DRT.5@(WZ196R>:3)I_T(-B`XJSKJ;8@``HUY6 M-P`AM#'10W+.](M\^FL"D".3"&[B&+*$W+J]=YR$$`0[[;H"=]!R@2(4'$%CB M44\'8BJ0_;BD%!Y)60O:"8`D,GD62S\>`181P._$.N^]O&'BRA86FH>[367E ML41H&T7)([$ZV@:UMO)2;*)T59H`J!3%WIU0WJ`&:,`(@':9=,2@C4;(-4## M2VG?(`LRP&8TVE"(D](.$WV&9^!,4[=I7#93T`10RDY>T8)`ARB&[",SNS+! MW`,V"F`07Z3D:)@!R\^5#53 MH-9A$HTRN?[L7AJU9,W]$2>//%Q8^0;L1A*GH?(X/8`=F?@@WV&^PRN+*=>6SOLF MA__H6-"UQBA"/#Z-#"D`'6,..PD;XD[DD\!^8H\I4/I^@,=1Z>DF+5P)FQ(. MQB;-(QIX0(%11K9^T@,IH=0@R:UKIK7)NA7#9@Z^!^<'1O11&[5Z_O+=!.(C ME]T,_!L(D2O6]A_0I)%3*"^@A)O1!PV@C$9\U0TXAQFO[/61R`WQA#93\Y;E M7KW,Y)KEHM5P&K'0B7P-2(]'>&*ZD/_?OKS9>9&DPR25X<(XAK/S%2^5_@2] MKG%(NL#U?$G8``K-SNF5C)D!ZJ<@R;`;8*X,%+`AD0`=7]\N1:];FD0UDM(= M`\%:1>-),524_$&(#IY$^7`;-]0P=Y8!X7;;#?(?G79%G(J[,,,FT0$%1/,T M)$9?40YD>S]ZE7O\91,P+41.+W>)9-9IM[5KB)82T!;-)HE3]`^%4/@VTK1A ME\&6\RDGJQ!#SHE;E1N7>]$H:_7,>?3,DC%VNZ:J66*/%HNHV57#2'O*^?$. MP-YRG4]Y0-P;]*E44,2!?`9ONSJ6@:?T]O"D#&ZH]H_XFO;:2>[S/@&%!*?] MH"BDB:J\(K]/4M@UO:<=QY^+..3&G7]#'2,FBJLWJ=1/E\\86N@[Y?$.@_VP MM':]<5Y(RW][T#5VA0H*<'R3(,K(1\^+0&,1+/J.6A7PH/@`7`"=!H63C([@ MSLJ3ZC`#)%5-&0IC,37M.95LAWWD$H`-&Z<(&075*B$U(Y3$I`I+B;$3$7`1 M[$0$;Q$H$`Q-)3!!`4D#!BO0!] MF"R-&7.FG!',5OA"JBH-DS(]P721N",4&J)LSS)J?ZI\+<+Y^NW"B;S'JIHY MYG6OX$[%>6ZNRFM@YGK0_\F"F""M7PC_N[L?00U'63(_C_?$>D@'`)C MY[J),5'XI1(\E&F3973X5Z1'HP=S4!I-E>4J%])=ZL52:%8.I,+\"'NMR)A' M9/S#BPNT]&5TMD;@F/W%XAI5`L#&!'!P'Y1K5"Z+'E@Q(;X,T/]W^-][@<[K M?X1PNEGA?$5#3Y+ZQ3TP0#8<@39DQ""7S88IHC-F`(>L!!!UEA(H\R*!&BYL M`8S;)OL$"$CH*="2&\&F7,^VD')^N$ST^#;[D'KL/2P9-6`-_!1I=!B MA@9AX`3OAN8\.D]C$`E`LRGG[SWB5T90U106@(XH\EC& M*A`;8D(%UB@79&Q-RB`KP:M<'M,A:K;:;I"V`,H*;"WESD>Y'T4O)=(];4S" M4>91A$P76];+J`KF96+`QA>,$J1UY:H].M/KM!CP+6KVPU#PD_0Z?'%\ZK9! M,AXB;\TVT>G>NHW]DI]5.S3#; MQM\PK386VRKT]!MY'F")5SAM[$E?U)XQW,5O5]7W,8VME@BG?!R@,U(JY/O] MCF/B&45$ZN8E?ED9&38,DY7&H;3SD(W&;*R63L>W'?<45*SN<'!>#1LWB&@<"/:[3Y-#C&`FY=6!/LZN-6\,AL;V'W=[#`RP=TY?[L['GOZ(E!>">=/5/< MTI%4`W7.U_7MQ?OW2L>'#_]\[SI[O7?*TQVA#[_F/<"'`7O11/)&TLDKP:?4 M&@GO4DL07("I;85,$W<&DK#9:1W"4&FHM1WO(U?KU;R[: M0@2+`YQ1CM-`,>@@5$FT51N1D)2L8RVL\7M"6';/M%N=(W+,P!_L=#8=TBYJ M;[]3"AHJH"EMN+R/P3YH'^@`U4?I6(95B`=./D7=NT^N9:E=CB^^A8M!S-)* M'XE.OE,,B25%+\>!BWSBN%Z/I3&) M;9E`21DD=PDGFU!4:8I'W%1>2[HVH8[J:\<].FPC<6O/L$JL['B'O2]Z#60=I^@(W74XKP?-OEY_. M;R\_.%_/O]W^V[G]=O[EYOSB]NKZR\UR59?Y?-?,7*G&4S8"ZO8C M2D>#AI`ZH>< MOB5C.4..%X)4_YRVG'\#+._*9,MR%_IZ2B-?HR0]`6H/0YJ`:,9_,8(%8!C$ M.D*I4@""^O4$6+=>2).&0SEC\)QQM`YJ&-Z($[OJN8$J]:6V7\.#>!\.:/M9 MRWF/.`$2,H`]L,^N\59AABN4)=>#G1TY[Q$SGIH)V+G9EYG,.9M)3W0DV[`+B#*40/($A'_ M_"\O14KY5%+;EX3S)^F*X;B\/\_^][J/$A\X'DK\]ANGB$-^YM>;#V\HLC/P MHNPO;]IO_GK6!M)H__E/,^=Z@05I%63:@A9:RS>!>K@77?>_>J,4K"`)X5OO M^SF*!4X\&EO1044EF@X@M9[94SUW56=KN:J#FOJX'JNJ*[735G5TVCDI<7R^ MM2F*O9("]JL7!B]Q:$WC/F.^Z1L_.:5MSYKS?)"D>?A?8J#7?7@*+$GTOYQ3 M8OE+[GKZ3"^ZINF0Z70KD)F]+D(=F7>;?:-(+NJZ7T1^W3]'YPNJLA^3]`-: MP_TB4H]:TXQ,LZ.*979^<7']*Q8@^'9Y<7GUV_G[3Y>N\^7RUKG^Z)Q_^G3] MK_,O%Y?.Q^MOSH?K7]_??OSUDW[%JG!+,=U2C=$NC$AJNZ>PF@*.@<3K\A7* MGLTHDC6]A]TR3V5R80VJ-\-WSH:>'\9W2/?T6=;,H<^RHLYINRRI\Z3[>$9% MU(G%B4[:KUJ(>(*[:Y45E%?0[G[&1@Y@)WZ"*`$_=N`//*#\@3YFK$O("E6M77!?Y]='0TM-NT9.6OY.):K[RXCM-5`M5 M'U^@GQ<)YDU6^9JTN#LL:+.$FN*;T*9N`WN4=YK;7B^UE&O;/3J8TJIGBSH! M6NS>.>P^=H].I[3MV"+D7D@L+M"48VY[=1-%YG3GQA+DYG1E:X.8S:;W(FKB M29O3BFCO\/!@ZYL1+:5G@:6X5]_2AE+<]G>-G;^:^TN;W?,T3-A$_6)"8&7Y MBL7A5K&Y36H^,8N]K;[[Q%S\K=-VVV>'K\3BEM:PXLW1XO&UD]Q(N#/7!-HR95I6\O/+%F0X9E0J$03*9V:%:!>C;MC/R.9KNA#?G MCMATCWG2/4XG][2UZ1XK$G+'-CP]CRC2WM#*)8_R@V(6BX2H=PE^T]W&3S?V M;`A_7E\",=L-ENA\\;4N:MMG-H"_,2'.H]4'\#N[$;U?5H!SXYF&K`)KF<0: M(NW:<8M]RR>>HUQL:2+$OW2=;IOSL`,1V*.-C,">'-D(K%6`YK6:)J726X7( M6DTPWK1T#JL,;3_/L$;3BI'VQQ\VV6PZ['8LOWBNCF&-)VL\6>/I=8RG;ML: M3ROV"DU/KUD*HULB=!N*LMHTUBU.IYO!YM8TG6[Q>S$+))U5/\E"8L^I!E66 ME`H>\-FO7!H;2P-3*VA;-NH+EHTZKI:-^O`;%8;Z>O[OSY=8/NK\RP?G^O;O ME]]>+2%M4S35N:M">8R/JE8[-P_A>NRRX-,VU'LZL?6>=B,!T-:GF4MXVGI/ MMMZ3I:>7HR=;[VF=0QBF8-X>,_UK*E2#';S@D7J/#C:.2T,OLG6@-B<@NOI* M.=W3*>D56Q3AL*B]Q& M53F+XNNRZ-6C^&';YL@MJ;+1=*-[TR0IQ:ILM<1=2'[9R-IMW?:4&Y(OR]=> M+?EE^0[JW:.\'W]8JTUM).UUSLXL[;U6@>;MRD"[37(OFI*:8-/1MC@=;3.K MNQUU7BOM=MUJNUF2LR2W&H7#[9XL6L?TV3F@,](WS9:F-_=)FM^*=/!!]/(U M3/!<90+`%\SN[+0KZ9TW?[_^=NO<7G[[['RZ/O]B6WV^6%)GAIBWGP/J.5'B MQ=DVI7(>&^GJ3^(K-I5SZ=1N4\]>!(Q/RM+-4F1=OC8[^IV8C6IVX=?*MS\&&-G>7E MU5D/^9IMQ!+0RQ/006=Y27MK3D`+>/&MWSC_Y3IV/GNI?^]TCY2'&!L$720# M4$9'#MGM(G#".$\5AVS]E3+O]N^Y>+RXNK"_VY\\L[!V8,\35!*P)U M+1(^G&08A?FHQ(6D[R1%GN5>C%A9MC`JFRU28G_^F*CF1W)O.MQP\DOF_"%& MC@^`3@8BS5K.K0&"H3?*8.M](9R>EP$L8.'P,?P.?PY%BJX-[T[HSDKC\QMK M-1<:!X[X/A1Q1EV:PHQF>+P7L0/P@H]A[!,$@C$/8.^#I M`X^/2Y&0CLEGYN4PP$T._^$,%)C_&O"!,#NKX5K+(3H;.4QDG>J9H:(-!(3C M$:97#\@9/Y?W%YSOP@O*O(%P`F\T%1$FGO_X\'36L'ZF:O.HWU]7CMH%=`T! M$P&B7I0E3SGP28?MF&<\,RQ5Y<@&%UZ8[U9LM@:V3N(0>&O[IV<+\].Y^/,\ MIE?CIPV51U<&%0,F*-P`=`VC#$4"W==B_!K(1DL5`1`4`A\S2,&M\85AFOA" M!!E@>Q0Y/0%##L(.&^UL>/BDTQ/;P_XS@41^=N3]C%_`$&(FP.J/R_N`"Y.EQZ0 M'SJ:M:0B&PIL^2>B4:NR0ACAW@-^UA,@9>+$@(D?>>$@*Q_.BIZ$"2R2:)$X M+0R`RX!7_60`#_"].2&P8V"6^"'Q,&(B"*8B+E!>HE:`TEX"K\9_F(.'Q*U@ M&\`_Q80GD<\\>"".D)'@SHEO!4X?\,'YVKZ-$>``6?C>VH)A%='U%\T]#$O&P==C]"94&6'Y< M#*8SMGJ.R?34$3.YY$.8`=UD`//K_M]'O30,0/W*TT*EI5P.>B*`%7X0*;!E M1)2R&-E34U`6^7/3>-*B\1DSK:5;26NYN/[RV^6WVZOWGRX=_/UF0FQC21D8 M6R$AE,52,JL3ZH\&_[Y)(E!U+V-,N@(^6E.!2#WA-JC#`@8`9=[Q[E+!J@]: M&UD&_/5MYZ1UX,`"(LFTE%H#E`',(0^1_<1)#L/L(>$;^M$7_+:B#".;"D3N MP6S4F#5'$M.S/Y+NE7.75F.<&R!,&/Y<)O'0A_?.O^33Y@0M!\L)IBCY(A!T M!C_Z3^&EL'W)BVH0.^A,`!EHM@'P[3#7>4$X7M+_>0*B+A4SM9MBD1P@U,W> M..R(H>^?D!`T+7*=I]IGDB?#2MB@HB,>'$]2)U<:)9WBI*\L]Z1;7^X+Z-"O MSX0E?$X/)L%G;G`U0&9E+._M4:NM.1*8H4.@+#.1JJ MFE\19R)V4O*\B]<,,M>70)XWL;:?5[9#R M0L^\P^^83PQ`[6'6M@@6KM)19]F+92^6O4QD+P>&PC,G>WF_"'LYLV$\YFQQ%68A'M-Y*2;3VB3^LFG&^^V] MR-11]C`NI?UL7NX<&[XQ#L-(ER?@"T:Z6LZOL(<4S=LP=1)8?A@#`F'X)&,G M;Q-6X??S*,<#;X3.8&GEHRLPEX[C,,<0F/),`@X=GY4X1-%%#U`1KR7#SV.J M-'Q7D6%[[.15SN($H93D&.Z+BD!,>HNB:G*)Y*<(.*QYK^]`$RY+:+Y[.5`U M$>$"H#HZF0RJ;L<].CEUSPY/7QE6B_@VGA]2FB-JL\$47F5:9B!=@-)1Z"@G M8Q*>2Z#=T"ID2&%*=#\%.IY:$#I_/+]Y[YS?7#BGG2/E6Z/@*0TJL9!]<^C' M]OB'Q\01TN5M3M877EX`!K@ROP"1.2.?WY#B%<2!G%0$8L!?`,D\A)&XHW6F M!7G:.-)T#^(:EA<"(@)!P+0X'$?L,T=\Q^MU=5\A8.P0\U";EF9X^(!VS;%P,)`2D33#42WY2/5[1*F-N[NTO%G91H(+$Z;?>HJR46D!2MKT'3K(@^G/>HC&%#@^H`"UPYQN\$@I(@C M/(LPXYE'E--$OD,NONL:+60X;&QF0>&#IX=NNWNTF$C>4>*[U=K:)'IR]EA3 M4C&A.D*\RP<1'D[>7 MF9'23`N0.!'O]`LZV_)MMW6D7#IF]E+'\":G8@BB3E"Z$Q&&,L`HM:G3ZC8^ MB2MJQ*DF)L;$,FF=F)LXP`2D_V+F[@.;Q/`/D"\GQD9A7P_-E@,H&IB?"R27 MWR?2KO"&0,;?0VRBP=%ZT>]SCE4M4XA?XC755\K0?7EQXH(Z<<,KTF*9T41I_'^`4JTFN4[)JF\4OJ[O& MF.=:6DR96#]4T51G(FR+E&V^KG*QJ\(17JJY9P;6<\5<+HF^8"4>GO6.C43;/*Z M(M/D)SJ,XT/W[.C,[79-Q]M<:K,7);!I`C0JM4?NR5EGX3$P MD3S/(S$PX8U>`EX?!5>"QII0;+) M\HGZ;1`3=FZY>X/V+@Q>VT`XFDJ`N7N_)RFRW=*+49XF$4!$2@GQ71DE,&E$ MGV%INXZKW\TKVY-761B-:T#X>O7U=?,DNT^*"/F6,E*DJW]8I(@\E-59 MVJSMH_UNU:8T+$'3.L'YRM=.VOMHBK[!?.L_?:XLF:S'[\KRQ?V]F6377E[= M?J2[0R+."L;[*\HW15OW['B_LYYKS.'GQU*4%%,4Q3A.`8 MIBW\1CN)>WC)R)`?K&VJ[%?#`<[L0PDAK\CA8,&"KOC(S?,QQ;)YOG0[:4PL M2J7B/DV*NW%_X:*"%[5FS0R;.)WQ+JLM+>%J'(.PKY,\IAW:WC4 M:)>C7*XMH.F*1B.)FA=4:II;YZ0TV:SQL9CQ@10N&VNK@!'J)#4`CZMY332@ MF4R#3O)^W-]NN@3Q%@^@6A^3PU-E->-)CZ6A_YT66='"YB5+!%NA3'G-'F*1 M-=D(!N9)EC.FYACWF(PHOIGZCJ_Q@F'R@,+$N2!#!HFY!AHDTI*9@>E"T(C% M79*'DK5K$N%!C8NWY3E.TW,5?S9V5QMR3`$>?Z5^VQ)FD)%R`X;EU#T]<`_/3I=J-U7QD09K0/GCXV,7_GF1 ME50N%C)*.VA"I]JE/@&WQR=[`7PW@^D*QWUO&.;`R/Z+\GI4\WXU7\NK1WEJ MYVW>:CQONK]HHM\]BSH33F.FYA@>RDO`C(CNT6';[1YWJO=-FA:FE+Y'S[S! MG9/+/4W)6C,QW#T\I)@3R\0Z<6#R438]^PC$NKQO6:'[;LOY,/>U/[>)6$]. M#]V38Y-6QA)=\T1B8WD6$RBC^L#86=K4EF6FMC0P^<7LFP:61AM3"2^(&"SK MJZSN:0;0IELR[LHML_;Q?OMXN8:9TM8#_'D.E;T!YZ8I[&4PQN:W/,F+,5F0 M-HIT\L+J0@*4HJ3NJ$L7G5_D,[1[6#-%B\,!>AJE0 MYP"<15^<#",Q3H$M2TN=AEN/%'^B()DNV8)RY0Z+H$@]#\/:84R9;LE8;1.] M`ET%!"B!"`LS-)W8XVC!V$A:>%6:]TBD?D**69D17D;3:O=B\QETQN5V,*>4 M^+;<*[I_56Z*#5@OWUO8E"9:U]N6D3!:GV-+4D=M=N@*LT.7>WUL`TGZ.G;F M&7+J&,_TMQ#=U$YM;G>+3"%C\]KY#7Y%@@?]#:9E-SI\72E@]]M5]?W)WAK/ M9#GU\&]C58FZ$P8FDW9U7-[N:/;TN,#ZT,`VJG4UFK6L54PUBW49LTZGR;QE MW88S=DN?/,,1UFL"JSG&JT!&N_.P+@VG`B51E#PBI=["5N]@-9>8Y)#][.QY M[^B)07B7>K.TJDAZ%[0N=GU[\?Z]XL/PX9_O76>O]TZE'T6HOE3'HXE)HVHVLTP6E$3L?HQK/GOR,?#4?D*UMQ])45YOB>5K("70\)SJUT#Y7J MC5K]A()KC$@4QR30#(]I$T0\E[C#2S,FGE+J"JC9FO,^D#QL>Z!VS[LM/`]Q&,],,D0+$[G3D$W4UWO MZS3589)QTG7JA:A9HDC-,3Z.V79)`XHZ2N;"'JH>[Z98#:A%,,O+))O*7J543L-]WN M,C?N:=>K#$^H);RN_;->9+DOU,'E*>O7O26.R[WL4#^@&1,HF@?14H+Y,[GT MR\^7*"?+CV/MMYY[-W]F(>XI./CJ784L35F::J*I+V%L26H)*%DI.V&%[9HR MAJYE#),8`]G$EKPM85C"&".,MB4,2QB6,*S$L(1A"<-*C!>WE#0B/:<5Z%'7 M\(]N3^//CTWQ>QW6R18OT#FE_5\#]%;3M?"9_:1GG_I++OOM,U9[MGHHGQY1 M2:`GK'E*X\'50GR9B&(1?-,1O&L1W"+X-B-XY\ABN,7PK<;P4_?T^&!7D'PA M"ZA/_[,6D+*`ZIGAUOY94RQ?.R:SOPN\Q2+Y&BW;(OD:(8M%EI3@E@[=F1E MKD5RB^06R3=LW>L.;HOD:X0L%LFW!LF/S@ZM[63#27,EU%U5&IN"`KQG-;B-^+V.C);2\G6;9C MO>A6MFX"N"V2KQ&R6"2W2&Z1?$W7O>[@?HV"#>WVQIM(ZW0U::$J?IMF/GV2 M;1Y%M5=+TE=-(I>34#<=IAO%C*97V%PKU?3QIHOT%V9[+UK* M\U7QU9+>^FW*DIXE/4MZEO0LZ5G2LZ2WWJ1WX!ZUNU,,[!TCP96$*VM`.-P^ M$WQZZ]05F."'6\8183_4'S@2*SK&ERKK.O]F7IT5[G6G7:!;+B.$A0O ME9-D"XJ%K3YX<&KCIN!4\[=N[I:;ZJ7.GWBP!89[CC7]>Y'E87^T)+A^*%*LM(DW M(O/[5`C'BP,GAJ&<08(]U1V!K=0=[*#N8.-T;);I.F]5W@0^_;;+'UPG%=E0 M^'GX(**1NF=93R5^]#*C#$T8YXG3H;?51R`')U^I9SGCD>?E5$N6L.`-_Y2.`!_.P7@R+R\`T'?0J37`JP M`F\X3)/OX<#+<6]OI3%'VYR]2'C!.IN+2&)I,7C^-.@-M(YF3,A_:=DY;1PX`-\),?Z\DD'*?"(P, M?SV_@\71,(C'^./E=__>B^^$\9.QF>F8WGX.;K\@,HY)D67/OT21B,C13Z(H M>:0S0"GG9,4`5@.#9'0H6![,HVL=\H"_T*UW=:*IB*@^&*(8NIZ=RT%/!'AV M'X!2'@C#7)-RSNE514;.OU3:TUX8^U$1*%PX#Q["+$GU[^]=-^0Y^EMD2?E9[9-K2I)^F$+Y2V=[JE5YP`Y4:( MAV6UAS&4RYW/7NK?.YTSYDWV>M-&]77K'+U"GK![VMG\2_&O'*;<4I93+<3I M*P$FE``+M`#3U3E#6WMS?=%__;C/7L<].MGV^IO+NI^PI5SGTQ3#S[(6RUKF M5FRZ9YO/6=9)L=GJ*U#GW*Y)^Q2PBEY91`^->;]T(8E^7_@K2].*Y"PW?+:Z!%6K>JW_T< M.]OE\;YD)[9*?#+-B=5KAO,Y0QZZ6R]N".LYW-M0>[QYOOD%H#=U`7E0!S8+RF9!K??BK'%GLZ"L?^DEM1K96M%P(C5XM-MGUK5D M/=HSUMMUV\?3[I;L+L^QH3953>7KU==+S7)L516KWSQMX;/Z7NTNJ['JS867 MW4<"V(WX+E(_S,32&TA;)K.53&:O,5@_;EO9L)D-FZUSV.S0 M/>I,2Q*WD3.K<;V$0\FF2%J'TLSUGED;SRIB5A&SBM@.*F*G1Z\7C-\I-6R' M$I@:-3.;FV1SD]8_-\GVX)S`%M6'S>[!N2!0'P4-TDNB8'$HU^O4365YFP+` MQ7M"SH(AO?ISF,/X_AQ0Q69YV`4Q#;W(@?\,LDE-(;U48&M$[JR7O6K/N76& M_U1H7\4`8I'ESE=OA+'S&7&M[87BHOT'3HC:B9 MX7\*+X5OHQ'\"@21TBJPA+`'0\`4__!B>&)4"H2.ZYS#(J+*-_\H8(`.+?+: MSQ/TKG4613T&C5O'GW*>\J^>@(.+L>@GK!2AT@]3V%96P)H##RF[#WN";6:% M%_O"Q;WY7@8;2IT4WLT0#H'1^=7L\(J@QS&3H=E.4_9F;3E7E<^.B(0/2)\G M"%$'O]%0QM.`B1LGG*?5[,_.7OBNW#2^HG:$:`#_?H2C!\1QSMH_J4&/]@-8 M!\,5.\@^B-2[4\_+9RJ[%7%@`!)?AF`6,'.-CU^%H/]+<'4).<;#F&9ZYS, M]1Y`#>@X0>X'";ZFT/.!`9PR@,&.AQ?AK0RXB.I^G%G4?0KJ?@@?0EA78-%V M#F#]&N=AY"#CY$+6("8>@8%K?!S#8D+>GA!QV=@TH M\_(PZX>D`CB>C]W%28H\AOD]CAVFK"B[%=&FV;CK!&$*8@YD/`P+T)*?U'3X MWV$!.H>'*4ZI$P@_0MT:_E1"D:1O(/&!G@&9F(:]@F4L:"^P8=\;HI8O!1,N M+BERI?7`.^+[,,5TJL=R:[GW-CZ?\4(8I9IOYG$>WZXLE,TWS]MOZR$HD99Q$,OK'0S MD87]][3IXR(/(XO&>*&TG."[AM^QZ;P#+"J]$]D[9P!\J2=*SHFO)TZ_B(#' MT>/X9IS$^UZ6`K(Y2P%OPSAP[G,PHQ()UPCM7HQVO=UU M<"VJO8*]WV/M=8*%2J2+*%D,D]A$O`D*+[H&!$IX6%+@]$8LB9'B]K[7+,SI M=%\S)84H(Z"RE..*`V"=ZU8"[S8?G`V'8F'(DRW0=>(+T$V9`* MG/2KS!D^8Q``]X":43,^%#&EFEF;H5O?F=5&;+5U/4;+,L[`/R,EJ9 MC[M/!$+3AGDH`.R=D(IX#]7@1$I/?IC1;VL\*ZN,O7P#RV5`'KXML4Z7&`UL M MLV(RSP'FJZ8"5#>G(\@L+44494//!U#]Y4W[#7V646+ZK(+([?9/;QR.JM/W M:O$+K-8`AR]0[IL9+:D.9^?)L)+I(B>BA?Q\TAU.2%I9^'26P!MEM"CX9Y"D@M4$ M_/\=*%%WRN@$;7"OTS:51/-]]%>!IG%PS'$-7L,,PEFO%`5+O\NDW^[FT6]3 MV&_OW"``1<7H8\'_>J9*J7Y$(P[H%+X>C?D_9]J/Z%I%J3R=]DHSJME<8Z4] M=?;>&R/$21YBQ%7Y:%%!3M%T1-,**'EJ9`8-3#\J:`FPP4>/]C8L>C`[QL'! M'O4%6W"XL#0I[NYI5'@*E1'O#I4'\L@H_Y>K?D/3-29]!",_Y+\:#$&')A^X M1\!#PQ:Y5=6@QI'&=7<88`)P@#R^RN_5MU9)_QAS MD=4FI.$>[T,P='C`&)-P^FSZJ(&!%>5A#)QI3`D#)A,)#SF6U,:<7I'!:649 M<6_+/"SS4!G+F\4\2ET"M"('68E,(%+N4(PAJ60DT?>**"^)6WW!Q,STB`6C M14"44^^!PW"FC69X5WM> M1#H,NBZ!)?+8>I/(VC@%3ZZG9%Z@MQ6H"E5M0:5_5CF7*X\2'R$>2:F(Q"(K M:G(=2%XO>6#8>7H%I&PIU[K40'ETJVM9=MG,?XXVBUW>SD7:+EA1*<9.B`S@ M.64"8K*\\#B7MN_<8G2?XF*_MFY:,&X@*0K3@4#[BKS4^2@PO`06'1"S@/WA M[\`A@%5$WB-1.!NC42CZ."9RHB2MV;AH,2$O`YO->4@B4,B\E+*$8+X*53HS\KD])O32;=^>%,>8WY^PX@G^/#7XQ97"PLPPVC7]%(=C;8`23B:O!D_3[H1\B?/8^&%,-O#]HLV"A M(O3D,#23`ED/?NJ'N3H^'QAF2)!#3G=I)^YZ!D%&DNG3!#@3X>YW=0 MP+(@]$DQHY/*2G:A0KK"4)=Z7OQ'6@QS?T0\C*BIPJ["K(G-S*E5361%%>V% M60^R"!\@EL#+];L'T^9`%G%148XP`Y+>5FQJ_#+#E`&7RQ$L"2^3A$\VC83[ M(2:D_%X$=\JWJ_[.M'!4%A_@ZB")07HI"P7%7]4>Z1Y)>R1%-40Z81>D6;1E MV#=3+@7'HVQHJ3MEX76I59D7)64LHL#2SB&&U="D1Z4F5Q'I,TOT8PAXIP2`)^,*LC+)R"6RC+W8 M<"YB!JW#\4%.HU2>N!Q>R3S6-X/$+Y!>W,E1`UX`_ZUG*1DN4"U@K%L-",AW MYH@'C$=US>R,BJMM1M[@"]'S,S"VNI#&3S5JW\"4[RHO,^]NL#`G.YTT@T>5 MR5N]<%NYI8$W&V0F0$5@@"3BVUITQTRJ/K6[&&,%$G+R!;,\AC&QH`([49LN M6$@[`_N/>0/OCIQ.4<&"&70U]%;C1!7#JCGEG'.5]%VV01'EX3`*RPQD,_*7 MBD%8#`#ENT<_L;IHP@:='IF?ACU<+.D1J#T5/5!.O+O4&]YG3@?GXS3S4_D, MC(*2@(9CVN?!WC7[YI^P@_\421Y*A7;LFKJE MZST\TNI#ALX\!C1*T@#F(@_FG4R!IO7AI>Z)&Y2O-BB1%;!H12$;K[A\ M+&+@*2BE(^>V%+:N<\$9\H`R%S!@FD1T\O\$3L58\Q%,RQB5ONU(\EY]61(O MRNBJ7TZDI%*WC=RE5"@;CDV=,DZ9R1P)X^Q,18FR.93Q1\2.3<7Q@N&(^8(/ ML@<9""I`:-SC#6#^F:D;99QZ?^P1E%-@R@Q8""8]`)^73TFV:C75&;DJ;\RX MC0)R7L!XZBH'^2D946&M_]%XVM=XRGH@I]?/DUU/>J"4Z#/DN;T0O>EFX<'Q MFIN%&Y9/OZ@0DQY+9"Q$?6,49=J9J(FC*D&'S2FC24K7N,@Q1FQA`G/$,"/; M?5S`C"YP]NGVIM2?QC)G^0[@C`LS2_'0K.FMI=WF"Z\)T08BWS`V]C2^(.%S M>C`)/AO!$V^;U"G6I2HY!Z1T]">I5XH)3JY?PTI9WCWAB^MTC:A\S#R!\!%8"%=>>X((D1 MMF(PJ&9;C$VRM#B-*F_;YZR!EP[8U*,!PS0)"JY5L_?]7=VI+F?O":JJJ2(@ M5"RV7@M(!T$F52>JAXJ,54V(DS1=?9]<7Z5V;$;-E?JI-4QE#LLUQ#6*-MU8 ME5A!-5RP*M@X#JH4."=\O!9'5U$HA69`\8U$#HTA5H$383%8H>_+92SH M*.+!G@+#2H7`[PWY^.&99E),D>4'UA\9P[,D?%4]0BG MCRC')U6;3(9Z[^:P)7R=/;JM4U"&41\#\RA'7)"=7DRE?#,0`*&J7M8H)&2U M/8)OD?,]9#ROO!*I"E&IDI"DHSX39E+8%X+5YF7 M4BU3>D_#X%IJ\IMT2H2A0W:DS]:SFC2J8JB$J4%RYR327L.2M-)GS:7/1LD> MO%?=+!#^EB99YGPU4HDGDAU9%YGD9/3TV\X1YF]3#O>>YRCKJ]O^I2$?0__: M^45R!^/Y,9HSGI82B8T;2M*2J_RJ:T>:H M/'UC*56(C*\#+T]6KV^7F=AF`A'_3518KZ)9*?XY7?I);CQ9")+HX!2"&LGV(M+M_0M(MTII8T.P MN2@!]E-BV#7'W9B,HC=(BW4HYL'CQV"$I'RQO%]>#"`I8Y1*4E+& M"[.&VLSQ;(T9$`H3RVDB/8NQV25Q_Y?Y].<_%=G^G><-?_[`A?8!S-?]OX]Z M:1A<:4,N.X^#RT%/!($(/H`X??#P%D1V"\CX'C7KOZ+>_&M/?_4<3[6$7\S5]Y@1/O)2PU7K3BROY?KF\O MG6Y;:TJ=[B_.S:_O;R[_^>OEEUOG\C?X]XU-N9T)Q^N8>^=U527ZJM9&5==/ MW6.I59<^`95I3@'3:I578X1*``0X5I2,!+QOE@*9]'2WW3X%/J=GN:'AOT98 MDZ=4&?%&2I#)VPZ":JC[S(NX&)"NJD\YOI3*1M7\U04JS81!;1W4]B6;\:F" M^^BV>0B3(J.ZYV#=C_$\=>.J9/A`Z;FL;$++'1^=UZ\O*^!-3'@3JP.,L!.B MW"LHY?MX83(H;]+R2>`$V*1I*&-0J+WCB^A6P;HAF5>6YU3Q*>F'44Q8U50" M(#U0;\98BA$XU/R>+DR``1-%?`>9KA)3W*G1FKFMW>"DU&B%-.5C8W!X]+@A MFM&KT$SR4*>0HI9[_K;&2\8,NCZ,)8LH,"#_A-W-&E7W1W,&$ MS>H:)56PQ`6KCV^+1XG'M.L-0=!]#P<WQ^J?2OMLHE5%QI=A?GWD M@G(7?']LA'9=E&"9C@7ML&VUMSIG%7OKX_6WRZN_?7&NOUY^.[^]NOZR9(-K M"]01\WH.RN`<_=V9C!=2*5>D/B$+_O2\C/-,\7==.`$5Q@=239EL=1"=!L`Z MSUQAQ7,PB0>#N_61F6W`J@JL&B,;=F0)5@_$XGUW(W9EDN0;)$$1<>(]J"FQ MMV2E<[O.N**HE?`F36H#)W3WM:: MIZ[R=CDQU"H_O;[]^^4WY_SFYG+9KJN54-D2,\@)H32UY`Z@B7`.VJQL$&[? M@'DAJ`N)_+KMH'(#F@LU*,SRTIZ1B9,_OQK()\-LH;C2"8:5%@\EF8$C(U2D M0DB]),^30>,D<@W[_,C/W>'WUPH$5:[L3%AYYX46_BRJ+W?RC(TJW7GN^\6@X*M^W@"OCOR78M1+$)_3H;E!;&>ZFWB=B&1^[C3WGIK. MZ<U->\""#>+2M,8TEN*TANM037Z>PVP:W"_*[M M_'"KE(W;!,N-)T82S_(5C,.MXG:P&R=(BEXD5G1D+V3VS+^75V=S)X=GK\3F MIA/[&F.J)3E+3X5 M8`N9NT]PYDD7.3.!MRUKUP3@KS`* M\U'+P4)1JFTGU>@`X#I];*DI+T!Z<4S5/PR_#?9@%G&FKV+7=Z\66+O;U3F1 M5[NPBS$,`D@7$1<^%2&[R(!F)QF%HQ]NKZY>>=\O?SFW/S]_-MEY7RJIS,3-'5`O"FY4@-36CJL\;4%`+T05&_- M.P8.)_3+CK^9*JD\+')=`KKG950Z.7"","J0Z&*!=XWA,>'L`4IG[["6`-]K M-IM;YDGE[CE7^HX61^G2N51E9H^/H92HPRUKL&'I3V:$92FP"_P:'K"^\R%=%YI/^ MU/CS/L>KIT69+2GM(BG90[:';`_9'K(]Y(TXY`F:S^-]F(LWKXD+UHMBD=,> MLCUD>\CVD.TA;\0AOY07165<'W7'KVV1U^1@6,_OWCA7RY>Z;V5!1XI<(JUZ M(@`[/RUK^<^(/T^M)_0T-)YST6^?NM:SYK4R\)>TV+V.>\#U%I[-+5X/X@U8 M;?%XQ_#X^.C48K'%XLW&XJ.#]H8C\0(X8K%YR[%YKWO@GAQN.D;/8,OS>S:? M:XO\XDQ*IMQ@`^5?E+8G@GWO0:3>G7#B@KJJ)7U]VUAVP2[R+/=BW/^2;)B7 MO"#T&CRHEI[Z?]KT/Z/(VW/2*U>\K;.G;FNI#*USW'&/#@_;KZ!.Q:!&\]N7K$]>[C9_,VH+;HR:GD) MM]N"VUFN9Z[=:C=<87YQEG:X2I;VO1**6>%=JDEH9TG(9`^G=-M(Z$7"[!.,3D77?KR"_P]/;]AV2G3RXBUKVK- M+YKFL/)\ZPT&O,5CB\?;`'B+QQ:/MP'P%H\M'F\.X)<192I?VLBXT4)%6R;&\P_*.;0*\Q6.+Q]L`>(O'%H^W`?`6CRT>;P[@;=S!TJ*EQ74'O,5C MB\?;`'B+QQ:/MP'P%H\M'F\.X&TI.5M*[E7XQU:6>[&EY"P>;P,>VU)R%HLW M'HMM*3F+S=N#S;:4W,O9(B>;;XM\$EGVLT%U^J^_>6'L)+'CWWOQG8`9G+X7 MIKC*/\!\`4@50I:6&R9%'#ABT!-!(`(G$&GXX.7A@[!FS3IQ]C7B0?L;S'E> MQ;%G4=BBL%4'+4(O52\\/MANI=!RY*U&X%W@R"N+LIPTU1#;@B+9399.TU]7 M<2Y2D>6.^#X4<2;($DKB!Y'F82\2@$JYR)9DW]0/I`[^M:1X6TUQA<4KEL'J M-J*&XESX9^GF];=EZ6;=#LI*'TM%+[.OSL'QD@S%3:$E2SV;]-#:39$;+'99@Q.B*S9*@5K2W_V-N%6W":T>&SQV.*QQ6.+Q^L.>(O'%H\W M!_`V!C&ON?0O@?.)8-][$*EW)YRX&/1$*J_\#)*8*R9G3E+D6>[%N/EQV-N@ MQ-HM^C4\")WCCGMT>.`>+J5KV1K"WJ+VSJ#VT;%[U.ZZ1R<6M2UJ;Q=J'[?= ML[.VVSZPJ&U1>[M0NWOJ'G1/W).C74!M6YMM?IA>]OO"S]',&28Y+";THF@D MTZX>A),)OTC#/!29[1"SCFNV_A/K!]P&<%H\MGB\#>"T>&SQ>!O`:?%X&^(R MVUK5X,)6)K"WV^SMMO4\*$LW:[4M2S?K=E!6^E@J>IE]G;EG!T=N>RFAV$VA M)DL_FW`TM16V;+&A1>TM1 M^Z3MGG6/W$[[V**V1>VM0FV;+-@8BEO`]GF.JV&5)1)><]V;X2%YA8#[*APD M:Q"27XZCY!6PT!+/:^_*$H\E'DL\EG@L\5CBL<1CB6>5X:WQ!,O#S4^P'*_( M/10IQ[F68F+^7F1YV!\M"X(?BA13 M)/-[X<0PA#.`%^XS1\#B`NPL7$:^F"R\LN9\RC`D!7? M_:C`J?JP)%J%[T5^$7DX,J9W"B^%==UEAO';$[Y79`*?#E-'VD4_HS_AB_^?U!+`P04````"``*3`\_14E"C;,(``#<@0``%0`< M`'-O96XM,C`Q,3`V,S!?8V%L+GAM;%54"0`#Y!])3N0?24YU>`L``00E#@`` M!#D!``#M7=USVC@0?[^9^Q\R])D0DIO.-=-)M]'B,.1H"?\HC$-@MEYJ_7T]'2\&#'OF+)) MZ_3DY*R5$#96E.<+CE/43V<);;OU[U^W]\X4?-3$A`>(."]<<1_2QT41!IHY3HJI)#_:B9D3?FHV3YMGK6/%]QM2!LPZL$0QD?1 MZ\^#Y0PN&AS[,T^*'3V;,AB+9Q2(X&^W3SZ>G4CN#_JI''R/[X_F#G52K_0D6I2EC1:_,8)DC/@HPB7DS0E" MLY8T9@N\@"=/(O,V3]HQ/!_BQ]\ZG$/`NR$3$@?)"SPT`B]Z[;=\NM:!I>PB M/NT05_YQ]2/$<^0)*7@GZ"+&EF+E_8V\$!32F_%O0M]A:041-4^&;0BZ$I#,I`/(:1T^` M)]-`^*V#0]AQ'!H*88?@@!!\Y,$=!`;S3L5F/V!JK6.H'QZ^Y$IT#.&Y*--D/3(7,A&V5+,'042*3+[`4AK%=O]=YOL'GG3CBMB M_0-:O*Q@_9K0,-J/C4[S&*WVB4UP]8,I,--\)H?8?ECR-$R@T`?[UD96^Q83 M76V&>_B\:/L$O-JY6ICRY,Y/JW+1`:,S,6N7`P^10.33,I>>R1FK#K!*-HL1 M4:MK8Q*ZYNCN*''*>/,U>HLA*5#0QNSS$F;2>?,2G;#K"W M&(VP)X0`@VB60UQ50V*`EF99?0%#I7.ZV.A%G8A-=6V,S]V0!]07#M*=RQZW MP7PJXJ@).(4*VQB M:!AK`I1.??-VTT%+%(;GP@YS*!64E&PUP4NM>H+6GO*'[#Z]?/+M'\08(H&1 M[34,EEM=IVYB;WTN\%XKQK8S*Q(/[E+V4LU:,)&+_(9B]EKEVM?BT2TE$YE" MK,D1X+9%W<'X'PET]H(6ZN5MJI+H`6]9`-C:"AQ`@3,"]0HS(KMN:4I

#W8IDK"]5" M)MM!4>FK]V;-ZE*J:OQ'?P9,J$0F\<4C5=Z1I3VX+P%/C#FYD89$GL"WX_J8 M8!ZPJ-,9RZ5R,68#5#K)"R')^!]#:]CHEH;`01A&WAZ]%![4H]$!<#V`:KYZ MX*;1W<;FS(VH5KGL+@#ODZN%U#+$?+KR7);NA_J57:!+LUZ@/ M[G6V*VXJG[U9`V=\R;IF-L;G/>2%-8`A1\OW&B$S%T1M:^0RTG25S=C=W%M5 MLS;7R(7S=9W41O/7"/,HA,T_?$CF8([6=>C1WC`0NE%5(%KAT'M!WX7BUEY>Z?GSX0" M2?*61`DEO@4<-0"O2%>#.SH5..'H#,T=)32=4^FCHH;1?J!TFIO?TOEIN[[R MBX+7'GWB/>)B!DZP[09P=J!#[`5GWWKXDDW*,&!TCH4J7Y>/'-P>>:X?.H[P MG[IS)B4&.?3BW:$DK7!IEH1D<]UN*&UCW7<),S'=<60/!2PILIJCDE;9QH+O M)7F6)Q;ZX]3WEYX_OJ39P3$8H.9`FIK)RI+R?BI"TE>1,KOR6+"(X[HE6,!0 MG0LK_(GO).BE`9"+O5.J_!ZEFK#FR M.K-8^9V'5WPJ8C_AU.RXA*K0K""4OIZ>S:[>5M?0L>IFT>JVVY^8N`:;33G$ M-0] MS;4C]MOO@9W:U6=_WP7[R250Z2VR4\ORK8Q&V5^I*345AY)DK@M:LS ME94]_5,WI:#=8'UUL&Z:)H'4X!QSI9`F/YZCWE!2\[TZ,%-&B9$\4V1H^[@; MD)6BX+=SM9DU3'<\:Q)WB"';RPNH_KI@7:< M'Z$P<>'O%RD;CL:#V+C6%&!F&Y'FYM(?8:G``PMY'0"77POCY)P$,`6\Q"AU M1[R,P7;ZHLP;=:7/G=]=7&G>()4NK>0G�I<4\-BX;!53*99,VAHU'^X8P MBSU[?VR*73%/S;%3&&.W"Z0M^;J12%'%/_X'4$L#!!0````(``I,#S\O!Z1> MF0X``-[5```5`!P`&UL550)``/D'TE.Y!]) M3G5X"P`!!"4.```$.0$``.U=WW/B.!)^OZK['U+9YPP!9G9GIG9NBPG)%+79 MA$HRMW=/+F$+T*V16$DFL'_]23;FEVU9M@42=WD*`;7<7[?+G\_G)W]?'REW_\_6\_APC_,0(,7HCVF'VY MG'(^_]QJO;Z^OEN.:/B.T$FK@SB^7OB0]XC*!4KXO"%O*_J[39E?SJ MJMVYZK;?+5FPT4NT"?CF,KL=?&@E/UY*>;TWT183WC/ZR*P[C'5*%2KKG!&(10_M]O6/W>NXES[Q(P&/]W!P MBSGBJP$>$SJ+AZC+BT-T4BM&0D`AAI1#?_K.)[-6C$_944,EGSG@4';^.+Y# M6`R^"(1#PI#L^R8$C*$Q@D$E=36[;*CX#<'B^B@0UPJ^@E!.&\]3"#D;2IWX M%'+D@["2XII=FK/X0,RQ,UC7N&MI<^K<`#:]"\DK&^``4>CSNIIE.XJ5%&,\ MPO%M<"\TVM,5+CG$@;S1DF]ECXT?C3AB(?[>A4(9(Q":.S#$@\(8L%$\,D3L M:@+`O"6MU8(A9^DWL?VNKMOKH."']=?>Q@`"'1R(CRR]2@A&,(RO[14W]JX3 M*]G0^`6,MG>*2MNXH=<^]&>/[NLL1N:TM_4@72GJ&5,RTS!7>DE2HNP%H0&D M7RZ%1,2$)F0N=9:#0S+P?_8)YN(.O`UC,?&4P(G\L/T])`P&7RXYC6!-)S'H MOYN012N`*/&/^'#H%O&5E]S%3W""&*<`\PRV]#V=@]'R] M4WN_/[&]7RB0;,KS:C8B88&E]]IX/YZ!C0\U3JW[P*X0]'XZ`S]HP4B=\^.)G9/&Z"^BVP(W[#;Q/IZ!P0\43DW[ MTXE-VQ,Z!%*/NQ`4W>)[;;Q/9V#<0XU3ZWZT=.,.(44D4,Z]]E)7JD>R?J_YV4635"3)HU7?!IK77/H?U MJ$+YC?D+%J6M?4[K2"R7)J/ZQG>]\5VN\%WUG=1C#'+6&TENR.<*)^TW=)[Y M*E3;-.]5W_22M^_A0/ZY_3-""Q`*2*S';P"E*[&(^"<((]5CHR5OE2W+&C_? M2;I("A^UDS\UOD\BH>(3]*%05PP$#Y"O>2?5,Z00LTJMZ3JJ!(`[S]:0PCE` MP>UR#C&#Y9[);6^5>--U29'FIIGF^KX8X(50B="5N%<4+MAM9I6.T[7\@<*F MN>7Z!H^'RUX@0M\7L-P^JN5/@5K0*C>GZY12"*8IZ?IN>N132!-0V"3U=.>J0\T-DU'-YF:R5PLN5?#$"29)"+BF\MH M7CT]J,3L,G_Z,[4:@6E:V\C(]$"P7V5PVK:W2P?6&*#V53=-@]?W1A_.)?O$ M*CBD2,0N0ZCK$Y7VIEGRIG-'Z:3AM<]A!;[5U3@%7M_"]PB,4"A,!ID8+N,W MK5,2"NV8'#KY2H.UTNW":[N>V5('D3MKP)0X&(*5WE(D7\!KVUR25S*]FD#) MPG*&V[J)&"`/.4N!RA^D2=Q2-8+`#5^OARI?Q MVC;7^&:>KV)D[@R'_0B^D"<8RKT/0T#UO%8LY+5M<@$&W*:&Y@ZS]CPEE+]` M.OM**"6O"$^4;V&SK;VV3?+`@*<*,+G#JMT0O!"K;"3?31`.]2,.M:#7L4DQ MF)C,2N&Y0\OU(44+P-$"5IK65&)>QR8;86*(+`%G@N#+[E>3WWB_`RHWCFCY M0BW@=6SR#PV\4`[+'?:NTC.3!\8F86'@2YTQY#"UD M93FW=B8NO1G+ZYPY77&`9>,+^PQ%+;9=88/.F3,4:F@;Q]FG*':VI94FD!XT M]3IV]RLI+5P4,60A.,.D]X(`)9<>`A0,\`V8(P["'9U5'&VIL->UN]^IAKOT M0#E%KD>S**8EXT0!H>B\+8`^2/XQ>P5%/N57KRNG;W4M7Q M;76$[A#R3Y`+P\#@%E`L.%V[945J>"@?A#M,?%G4U2!MP^N>.=.A`W`S#1:X\C2[(37+M+WMAM35^&TW MI,.[(<.0O,I;_([0/HE&?!R%V3U/&@D65?HYG[V4%5&Y$\?O+##$L/5(8]1! MO&(<0AJ7;]%;)Q=).U^4K!H6=P+S3)6=7L2GA**_MC.9VF.'4LZ7,-/#X$[@ MG=%SP%A4S3N)A/-USLKU=R?XKEB=2T?,^1IIFB!*\EQ.7F1D75GX+8)^BZ#/ M/X)^!B$4P>`"X@BJ-_0=M#R;*#BKMTMQ+A,#RC="@IA6@'2!?,B>2:B>CHN$ MSBBJ54!P)YC]1@EC0TK&2CIYI]79!*O[.KL3G#[.(055 M,^^YGR"#PBZRA%-?S(LAB7>UE_M/*6>UVD@-MY6!<2=(^"8LP.2K6+$PPK=+ M"3-";)HL1OIPI)R;RF2M5B6IX38=0"8"B()<11E'4@;"Q_$0K`34<+T)Z@4L MXZUL(*]ZN::DU3HE%5RA#\?AN*)*/&&W7$F-AR07@3N!Q$:];9:)CCNVK=VO M7%RBO#M;MQX()OLZKN\9C<"[5-;]`L>5H+A3DTF6LF-<8DN4'6`.J?A&X:PB M$;OU3O3LGN\S%2)G8NU4J?+H^J"EW0HGS?R2`>).,'TK<,MJ@]L]+S*BE..R M""S.>F`PFPN]T_=YZ3RB]':^A-T*+(U<60S( MH:6"S$PO1*E:-2@%[19@:>*U(P*&*?11&7)EU52!AMS!*$Z_L`'"G*L#O M$$VF0JO>0HRG$_@02?R/XTP>4MD35*D?NV55JOBP,BR'RI$6Z+Z^#:MDV57L MR6Y%%@/N50%S[LPO>0K-74A>V4#H2*'/WS+SWC+S_@+6'E*R0.() M^;KZ+G09X,T;A9XO5MC)CC0-JKYR9V>3WU<+FCN$9+U%DE7.OI;!==90#O'V MO>`_T9H1D95.Q4CAH_CTK*VZ+\3<\WF,RUE-1C1YDQS)..Z,`7TX%X$+`O+R MBIMDMYG=L\Z.Y)!\]Q_`=F:(V+X!D2GFC^.]\V(VA\64)&>5=V#W;+63>EK; M(.X\NBG?!`-9/P5B5O80YPO8/:OMI$XN-(#+KPMK%8"OTHW=T^%.>@-4-(L[ M+PU[,R)T^RN^7^4[,P[P1-8^+3]92"EH]WRZD[J^U!#NO'D\;M:UW0/P3CZI MEQK#G9>6!C,#K)ZG=]HAO=@$[B1-)B4,?T4XT$B7S#:V?!;?2?V9C]Z=]]O[ M\\@=PD"8`T_DME*YH;2/6%+E1GM.+N["\GF`%J=GM4T<>K5N-Z73)LMVVMNC MEG'<>=7O7!+H_P^%U\Q*#N449(%L[+&NC:Q!]NMW8C=1V/8]HK**0\<@9!7/ M%MFK=#=DQ>UF&5?TC*Y[\V$Z0^]G%1Y2*)8Y@.XX'>C**?`%+Y=A9K0.[B0YPN7EAJVZU)^]0V&XB])$>OSR0[G#BQ7/X^L2W'D[.DMC80N^(J$;] MVDVF/G)LI(G?'?I=HX8H712GO0[L7NJ9DUG%;U-J0+:F06PT-*' M,&!WPCHY^5BZ'M?OQ>[!G69=7@VU.RME?2L8&<;MG@AJU.750+LSKA?HO7G[ M9V("5W1F]Z11`Q-X"39WUN-[8]*44"[/ZR[)9"J4L7OV:$U7:(S5AQB=F8V? MX'P=1LCMMWK>*Y2Q>Q2I4>\I,3H_K^9@-C*ZVCV/U*B#JX%V9UZ]'8^ASQ_' MMTM_"O`$/HF9YA%+*"+ZDW]D!+@0L:$ZP:!*-[:/+:U0&Z(B*G`JW5NG&]EFG%&'HH78E1IO1L=AUYN\>@-G=D#AQW MTGN?H_D\V<@/PK0FQ`"/"9W%^8P:BQ?-'KSNN9PK40&0.[F]:<:QS$%6OC/: M-O.Z5H\ZJV#EHO<_^UB<672D!@YSX2^8'AX1%5*=X=-.NO:Y- MYJCJ6-H4J8ELZX(\C,,M.3=$*$BYW);U0#AD7U?RN$1YC*S\;7-27U[,VJ@_ MKVN3"#+BI)SE:\CHCL085__P74$L#!!0````(``I,#S_?C]9NIB<``)!!`@`5 M`!P`&UL550)``/D'TE.Y!])3G5X"P`!!"4. M```$.0$``.5=;7/DMI'^?E7W'U"Z5&6W:K2KM7V)[8N=TDI:6\EFI5O)SJ52 M5RG.$*-AS"''?-%*^?6'%W*&)$B\D)QN;-T7KSR#QG0#3S?00*/[#W]\VL;D MD69YE";?G;QY=79":+)*PRAY^.[DI_MWIU^?_/'[?_^W/\11\LLRR"EA[9/\ MNY--4>R^??WZTZ=/KYZ66?PJS1Y>?W%V]N7KNN&);/GM4QZU6G_ZLF[[YO7_ M_.7]W6I#M\%IE.1%D*P.5+R;/KHWWWSSS6OQ+6N:1]_F@OY]N@H*(8&1+S+8 M@O_?:=WLE']T^N:+TR_?O'K*PQ,^!ED:TX]T3<3/?UL\[^AW)WFTW<6<;?'9 M)J/K?A[B+'O-Z5\G]"$H:,C[__J4_83L_S^JCT\(;_33Q^M]+Z*',G]=YJOOR='X.X;+OV;WS6Y>\]_5F6Q.Y3?M/J21(Q'"`YO:1:E MX54RCM4.-2C/=T60%1.X;M`#\7V?%D$\BN,&)1"O'^BXL=W308TIL\1TW)@> M*&?DM5#Y=![(PPCR=83__9[]?HLS^E30).3F3W[**36V7-I`O@:(I2E=M3J+ M^6*09FTY\Y0F3)8W;\Y^]^69D(1_\H_+=%5N:5*<)TSMBZAXOD[6:;85B\GY M,B^R8%74'0G61??_L*=]_7TM=(O'C.9IF:VHD\!RW-O,!$L'9OCBRBCYTLY& MXZ>[D^]K,A(D(9&$I$%)_E[3_N\?Y._/)P[;="S3/=@]D>H\:V,IR%8U;^Q/ M@UA5B]>KE.UD=L5I:\+66;IU!4_-2NHZ)*^M]:*YRU@'^5)(4^\UN+Z\IG&Q MWWT(#3H]>U/O6JJ/_\$6GX)RKNZ#Y<'"-!1FH"&`=@RRV`7-O@'YNV@"COCY M.(5`L7[J:\AJYQT!GVSEH=?LS]P&HX?&&#AMLJI!`&]&1#M\P$YG&06Y"B@& MT=M%A"N"<[IZ]9`^O@YI),'+_NABEGWT#VG9/]*'B!OTI/@0;/NLZF!3`+QJ MV.Q.?;4"']H1WA`:K;,S#(%5$QAJI!J0<%R<7C#-R(+XFNW@G_Y,G[5`[;8% M1:K*Z,#,5PV):$E84SRPSL][9:@EK?+Y(`-$\U(W0[/Z,["+JR][86!:FW[,'`L?-YG M`;]'NGO>+E-EO"OFVVV`,-EEK#N]U?=$-L"`X30.H9#7.\%-S/7-[I'WHNEV MFR9W1;KZY6X3L-FY*0M^MN;U6"@[9[\3\M]Z%P=#YK;=!@AG7<:Z$[G_GO`&&$B;QB$4UGHGN`FVOMD] MMDW;AVUH'/G^ML!6KLOHH#F1#5'=][EYAK:&O:#H,XM]B#@V8N5)@?SE=^RS MONLH?7M@Y/8Q/(B$ZABG`H1HCHG@N7F'1O(@6/K0/(04&$3SLR][/!]:HZ"Y MR:P)#^)(TA,DS\,W#HH5@`QCN(L.A&B!F_6[*`F25<0T*LTC0U"8$SE&1(%> MG.$+^W1-]H2DID0,#4,3#"4ZP0*$@_$*9@3":=5YGM,BM]"?3D-`35%85)PP MT<`#Z)LYO;N[NK_#!'#_?'>AVCO9<*"\"/+->1+R?ZY^+:/'(&9:DY\7%T&6 M/4?)P\]!7.KB&>WH`2%L*Y!R!D:#R)0)VB!1%O+&87<*>\58&;K059TH%K&]`,MJL`-W69$1P:Y-=&SKRS_ M57-R:+\@C&)!*AJTC:`>*XPUX7!ONOA.=QE.;]O M[#`QH6Z'I"[XK6`$IPXW?/&5)WMF%>AI#`C[7E:[\!"-B&R%#FX'CHK<8.HA;Y0L3C"P-(MT\Q[HE`F-L7VAZRJ-TJ!:(UT'.`VH![L MW*QT"5>-;K-T1[/B^98-I"M&2@WKV6?=7)E\T71!#(#"DU M":KG-%(0(0$]2(#F5,T^$1[[`ATJ): MXV0HD(93Q$NZX[%CN8,N#I(`JJ.&;25JMFKJD5*.X!Y')V=@%%+_3&#NJJ`! MR=#>OM'-A_?O!_U07']^T)''=^`=68/WU_6..CCTWT?!,HJC(J(YVY2*Y].; M-`YIEO,-:O%L$5-LW06@^CB(U85+@U1&KS2(?TLDN0=1RE,DO#Y_>_W^^O[Z MZHZ;]Y=7'.R;A?_]T??\W3$5QQ617E1P!"1\G=QL\VUUA M#A`@Q,8I+`_&1U4M\8^>G3G?R9:XX6CC!]H##TP/\*'0LUYT`[Y3*/,BW3)G M4,8Z6=SZ#%%`OD489%I-`"=;DKHINF:.X#UHQZ&AQF_KX:)$;&NQ`KKV9"4- M&VNCU?(S0`.[`@TRWF,;>5O2:(R.]C'\4QFLB.5)S33B?BQ(>M3WK$E:R`,> M#9;T/OU(8U&&)LCL-%9#!'D\J&-=.;DJ*2E24C4G57MTM762H;N%%(YC4*E& MW%2-K!)S)[M$.E><<7X\4'*SIB@GCR8U`4R(L$FSXIYFV[=IEJ6?HN1!6S^A MIS5DNH->9I4D`+S5:<&:D4,[M$0&KBS':9`@Z>6$X?5`#35(5I(H#,(8T.U+ M$P:A(N(OGM*"VA_*&`@AG4"3"(H_=2`@@L*;TYI)HB2<8O]V,8QRL1JC.HE6 MX%)\11MD05Y.9]%CP-]H.GF-6C+02VHM^^H-:MW<*_=QO!2-?2?6]?416(>] MT#8K@'JI;43_A)J*?PTR7G[&2A\-!%#5$W4L=R%0M?5"`4)V-Y%(_D`I&,H-A0LI2!H23?4+81")EO)S(9D)RNRHQ?VA:;H"`/ M3#-ST5[>"8H_L^AA4W`O=\?$V_!*UKE,BLXZ6,EDZ3F_1B11(G(@9*'XI4]1 ML1'T?#.^YX/7V\Y*&;A:YF40Q\^DW+$NJL/KBJL=747KB'G4P9;O5EZ1:A!R MPGZ9K-C_B"\+L@ZBK!*64?+?Y%R09YY^,)7\)[Q*94QXA"D;9S8VJ^<5W]1% M:^;.)`\T>X56C--HL5H5.$WF"B4PPKSEP=WH6*F-#R;5B>'VTR#TS`TGZ#VS7?R4H.D,V3GFO90XGOF`$`ZN.7[$[#1QO';/=1C3^.<: M@"$[Z)9!Y'I*;#?=$.O<[ZGCZ\DD67QV>FV"N6T0-:OKJT6ZF0;/`=8BHM<' MQH/V%!%\\X31F1[I#&OY_O_L#P=K]DLD3>C>&U[2YS0)/S^G>-C`VAHR%-?8 MSB=&))C1^/:)P>E?0^DSDOBBQ: MEH6(B6++R6T@#G/P7\^XB=;S/N9;W/H5KD]B/'H$TRC4::P`T&T*>H*CL*F> M<33+J%:YX:_SO*3SITZW/JBQY5KNWT[)5V=G/'.SR-Y<;?*"LMBD6?0ON=WZ MS=FKL[,W/&!1;KH6Y,WOOUC\_LW9XLNOOQ:!CF]^S_[^\NO%-__Y5=U%)$9! M9HL]U&']G-)#3YM_#_++3!7`HV0R4T7Q)W/,D/%33QI[+1_@_FI4CI MQ@_^6%^(#_,FBBS%7+7$C`0AVL,]K$GT8,.+*KU/JPSF.'BT!HTSVST/0D?8 M;+C5Z2,M@BBAX560SV%J]KRZW-'>;UD-.U$.YU MT+1K('_N?@:O./.6-%0T1GH:[!G3#@9X;MQX973G%\X?0SMLF\S7B]XELK2+ M5.DG]2AQI3ZF93!AI0?!+K;B*,$E0BA_+#&H2#ZEW;2(KM&ISX30WXLTR=,X MXB&,8647[WA08RYMYH86T2J(-7$U8WJ!"@]V%J[GJ<6^@WK9(+(+TNH#,>[& M'TG!8CS'@;85]3D*L8`7(W61\'=I=EF5"%?+25ND&73J!_)2Q%%`Y22D546] M[H'TEA+'SE(XFZCO>D5]$24D3.,XR/+YS^)<+@G@I]0K?P5%?G]L9)8I\^`M2-5$A`FCA?S8\8H4VC-B(#W8$0^`5`D- MZ44HY`XX+V[6/Z1I*&ZG:?88K6A^E\9ZEW60"'3WJV%=W8OD(@I?-*_>54L" MPBGP=KXC9,CQE''.,9_]3OSX0>:,(YBMEZ=A]LHB3@W/.5-Q9_.[;/K`-(;M!5)\6TD MX8)4I&(;U2:N%0;->YPLVT-#MJ!%C.1R`LR6#RZJDYXIGJN+DD$^^,TI&X<- M8^B2N=5QNN-G56:;H:<#?>:K%T!]HBC;"ZPU*+#-PB0YP@,%UM/>>6?!`W6W MT@SU3:A9+0!]QR!*) MT\BL$C1_2=*$M`GYT00G1?-,1\C$FW-)0O8UVS M&.5+RVD"]=MMS8'BS5O:@@F/LOB9?I8'\W[X.F<5SX/E*FJ M7\984$(]OK(20ET*)1&Y69.*;%\>G1&2BA+EC=4T@9@>[RJ!ZD+U!1,H.))` M5N401DETOZ%5'0.PSWCU/55)F_&Q#E#^@NS03)QTR'XAE`#%43#Z>"'-$G;;%3FP.+JSDP+J)\V@G11U*39`ZDB>^G!K=X8F62>SUJ1 MJQ7II7+#!Z/,D),"J>366M-5>5N5@8S&?J1YP;TWR<]U4E"&!WTX]@`):#SV M(-MJ3'/=M(+3@M2M\0*R';B77PTDI(:-PM9#10W#UN($$N/RA\V7:]V6H(CN M,CD(!>0+,P=.Z9$XM5I]W$<4^>![^L#"FH->K5*M0)]*P2G_U79)PY!GAJT+ M&_-#=;[9ODG4[_3/--S[`C0@8P3MXJMN1PX-%X1W4SE8XLZHKPWBHY`YY!8B M,ME6&_8I+_X@J]-N@^P76E3).63-W%U:)B&A]1B$^XYQ;!SVI"-;3$_G'M(, MC[9O74,]UKB!OAS-:)#32RK_O4[>L9D2&65NUC\E&QH^-%F\WA>LUITK3N@4 M]OWI>-%[7GF*3LB+NKN7'/:\QRJOD@@$J#LCC=YX"?N"?9='#XFXAPIR\B/[ M<>FL[YLAOG2=;Y@L#<.G3L'Y&?/9NFX?/10>^)GP1/O0\Y)XFG$`-([;'6-- M1H8GM+"*G:AW0[R5K3#H'+91HOV#;IG-7YL^/<@:&$RFZ"7EWV@ M52XJ>Q`+>&9;%?:J\\2^#?)HI=&O_O:09Z\##"M';75UMGWBX@41;=$.3RT9 M5Q!\R$],3LF24UEF+P8Z%YTZ(1Z$$FFU0#F]TZ@`GN)>1G%9:+/*#E$@*N^! M:1NT5*U]4>!AYO4J'$HZKY5XU,1XJ,@=K3"ICM!*N9"/YNL026K MFLZVM1&07R,9#HR)]<#.C%+8KO49HZWH-JDRD2ZYL5U[PK=+&B$G`AAY#S.C MO%KKU-SC^&B?CC[!_MHHDP);6BF#]D+6`Z^2#]^L+X)\\RY./]ED0].2@=8( MU[*O%D:N\T4S_'$"(B@\>$)Q=$%`\R!9@$HMZ6Q$%.AY.6?B-DL?HY"&;Y]_ MRFEXG>P?0IVOBNA15J"U>'[DWAGLR;N[J'TNNT!AW0U9/I,7O"?"$UT<7L$= M>O-`YV8178B]%LK'%:'QW#;8DZ/F+1R/Y9ZS]G%`!BP1&_ZSK.[+[]./E`]1 M%-/6)<%].I]J'^7G(`O.'F>XE"*>AY_A5W7['R+JM1[[^O,S)#C#F.V',5%. M3-G7_,,5'\I=BB]LU/'5%VEHNKQ]!;.UEW2'8-`U)O,IC&NK6:`MJ7# M7A?,S:^Q]-:!19':)N-*4SR+E(3TUS)"3*?HP+H'SG0?5+LZV8-3V#R(\@4! MKQ]RL[ZMIOJ6C6IQ54^U1LLL.P#.B&@E4F]$]>%%#:?FZ*_IB>B`7!T-_P[9 M$4?)UTW!%^6[M$Y>Y9&&0\V?!TD4<:81.K&BO7WIRZYH;5P`SPZK^`T:7J1; M'MAHVHH,$$">%PZQK!RP\8:G2]Z2-)NBG0]:,\Z+)U:,KX[)N%WB]ZGC[<'F M10]SY1Q3AW',)XB7)>6^CLA@>!MDW'6Y*+-,OZUQZ@;UF:%6/,N'A:P/>3XA M4U=6W2Q(U9$_CP6=A#U?K7ABTIRGYA31TJ(J!$]@R62LW\,).>N8+;?PE;R%\U%6S*(C8[YWE.M6__#(209Z4F M$10D-@CD6\":A$@:M./*J9*DXG%.T"L$Z)&A%:J4PS\;2,&IQFT0A=?)GZ,D MM$AIUM,84`5Z6>V"A31%U4J!2! M&IA8'X9)%]^#&,$R]^^BA(UCE#SPHIF\7.9EE,M%VMKP:[I`6P*T8IE,Z)Z8 M"&I9Y::F]V-AF"1?DA:4G\D(@JH"T9JRS4=(UGO15^D1+(/5)A-J)CUP7UUU M4;]<&A41T\7=W\Y=!+N(#;O%#;Y#)ZCNK48T2^?V<'=>=>'!Q?DD.2]$QI>< MR]:XS!:;.*&$#6@FS?:L$C2_Q)'36K&+AF85ASS`9A4&TP3<%M1G?,&;%) M9VP@134!BAB6ZE_1X:=!=A;H/'P4GN].>L9R/16G/OXH_HQ"X*I]OY:85;Y7 M13#5G2>K2MBO1=JR5'HZ5$5O"V"IY0TB?S3<),G^VYE7\VD7/5/''STM^KS3 M@&N6>K39;)-459Y0\5/M7B2T/.<)?N^#)ZV#X=@!5/U/%Y&Z9%N:<9V*5F4\[[$QWD04Y')DO$;1@4I:+9EQB+EMV]DE]''*"WS^)FD M;/;$7K-(9<7-LM@P+>1G'Q.*B8IA+O<[@0:^:Y/X.0'%SI@?F7VPFJ?.QK-5 M^M35^G(M.G#DMO=4B'%/>551;$]WA2EID/JS%[402G*/I_1'91[YK'E` M.RS.F/M5PX>SY5L9VW6>A(+)_6GX^\.1_ZA#9YM^O3B-MAL`UV/JVT;(G$3U MX=*HT;,_IF7:<'1#!1=]<8)B,.K=&=O"MHH>8(](2^%_+HH!.1V?>J/EGT:5TL^\&T-&R%DCT2V.+%8]O:T,=>H$T MHD["*6I843PJ_]THW:E'==#1ZS]Y=9IS1+G\=`NGNX.^6)7]ZZXYSF]TG>%;&;VHCM;F M\`;PWYS>+[I]_F-!98M%=8,9"3G8Y-FQ3W-MI=T:>UJM&BP'(L. MXP8W@K<^Y9%OA+?WPE\P"/`VS;+T$]>1,@E%<;*]"'$:)$CK]6Q3X,&K9J,> M:/?X/4H`I\(?:?TBA5*%"KL(<-=161[EBQGT M,=O@'_G@\WYN8>PG`M+^&)6X:W],&NSCWG^6/;^?>_UY]OC^;^S=XRCZ]O=> MG2^`2>FG$S/=>8&OMKQ>TU5QL[YZDH]G/K*%XB;AW)XG(?^''Z\^!C'5IX1R MZ@:R+K.;>$I-8$'.5^JZ`\)[X*]^A#GB)^WBCT8W:%6V2",2?7@:&>,JG9MT0@]!:R;4.YV ML:AU&<1UKW"5,EX\(1%_ MFXUZ2>*(.:6J@1/@()\(R@RW/.>M1E]:S4`?\+784]_C5=F&^?=XK^JL>,1] MXJ7.LOIB2YEBV-TE5XD/3![VY^&&/PE[_&^>,C5.\S*C%J9^+!U'&)76DAD>A!6)EY-3N8_UXW9^+M7HV^'- MH!<3TA-=/?'?*Z-\4Y4M3QD/6<%+"7Q("YJ_?;ZN,LCS[[;;-!&UF?I.N*;U M!Y6\:(+`ROE(JRN.V]6A,Y$\/.^FX%^)'DDNND3)?N2/_#C9D_R17TUJ!)97 M9ZK6M]+L3%1Y(.-U1WD^M[?\\SEL5[,['TU76]P9D"L[)&]/WQ#>J?>VZ[,; M@-FMU^PCD!]&@'__>9BO'KT?;;U4I9^2&-+%-.$:'EM,77MF+WSDVR[%XPC& MO=%.>]T[DF8U7I;>K$6"&UD5C7E9W.$:TC$3&92VF=DW/*755;8#T3N_);#2 M0'<1[EO)4JL2+L4FX(6CR%521/R]H7P&+,J]!/R40QQRO$@S4;^S_N"E;%<- MA^PB$VLRSY::,]9IR%.G!DSG&5U0%:FJCT\RT5(,X: M.Q7!4YJDV^=7^S.I*.?UK:)$]AXUKBZ"95HR)N*X^<`I"7L#D(3T">%<9KN, M,U!EF0WJS+)2(AE25OXEG#2V-43Y0JR^V^"??'.3I6&YDHLTHQ7?`A7L[S@6 M'U;AS3(_9\23>+(=PRK:!3'K(?N%\G`?]D%J&K8K39[Q<;-NMURU?D M>BUW.G+/)5/JR3W7-F4,L]T$VV0FM,-J8PL5Q'G*FH?12A#*]/A\)!XIB;8\ M3W[M='%>T\/,LY^@P6JS[UG(P\F70V/V1)B65>?)ID"5,\OSEJ\:M8%YMRWB/A[EH<)-0MJOB>Z8E);\R M1ZN(UA$-_ZM7EE5:QB%O*$Z!GF6D>9F++D6^?I*73#"V+SQA>]`P%=S3^/ED M04XD&Y3]1"P^8`R?R(G?%RLZ>47N-VP$J+SPXUM-,N$N: MKS*VL>,@Q]N\N5MYM_6H:^(G+$CO([9G#!G@V0_]D(K:IDR^3!>(94<'M?A8 M"-"U5'L2`31!1"HJ[-T:F#1@NF`+L)8&6*+K"+@W[K_,A-C(URW26K!@[[&F M"=2,>]%(@@Y\O>VWA1=@/7N9_)NQ0@>RV(BG(,\$-<6U!%0XTSMT)D$J8NPL:(:/<^-C#U:LT=)5H:M!S`1BC4J30+!1^"XH5./S M'2`(IUK[`6^,]V$7;;."V?8`J%SV0MGAS]*M@-*N\>()1R(IY!$2WR)^C/)? MY#."-*/,^#>>X/-O//*G1@*VJX9N:)T422+K)1T*R'V@QAN0?@#9@;=?9<VS;=8CP)T^CWQ#,/ MQGUUZYJU;E/Y]690RWRH,"OJD//+X_TH\89A/4I[BJ"H;G-#>=6KEBK_;&PC M!I!\-H_Z$_09S,D4`RF+@]8E7.I2F<;MG8$,S,P9V5<`6%5#W531; MB+9*\\U`%GPBVZ!@FX`@SA>'2CX';F1<@ZR1!Z=)E]5SF(LT M+_*+8!<50M-6OC$27"]+HE(%; M=KMH.-RR:[_\IL]K5"`MP$Q*TS4/\V@,G.WHY<9F!380`FJ^403E/>X0,#U8 MJ6?`/*URA#+FC**`C$^V/FC,`_ZVD0+&.5UB0XMD.?8JW1+ M[X,GQXN<82K04VP=\^KA+V]-6'._C/MH*?PP[A8(4D^M3?!!50"[BQP-&:X* MZ"]`>G7``_-_=$&0=<+B*L>(*,CM?18]BN0VC:%BOQ?B!@G9C)*J%Z.E/U`=`B,!;*/!>I-']\7F91 MV.;Y:KND84C#@TQ63_XG=0MI$Z:)WY<;3G;'X^]DAXI6U'V21J=>K-6?Q6"` MVH89E$,Q#M,U`["H]Z]E5#S_A18;7E+S\)(["?^41DGQ,_L?GFG/8H_@VA-D M:6]G(96C"UZP99/&(LSI+*9ZAGCH8J^(?)D17YPN M>3^'$'(?UEROA(8]5AT':O7`=12B`;./!%'VL(MH$/`,ZXL%R M!"`*MFZ8T^=8X`K:!;/VL/`<*+,'@;\(&#F]2+<[MIV@2<[/,]^GN2]6OA\& M_9X,FB5OC9Z\^.!>L(TQ-Y)"EC@WBZ''376+)4\`/+#J8`)!:H0MV)2BXG9( M`[3P5?6*6YH)O\7&U@^10%K]8;85^U\U):RM]$I]6`N.Q#_HJF"`CK(^Z'&# MAWF;)6*8!A'U.AO:!QL/5H,CBH")?:/A-^$'=)^TC?:'S!>I2$%-DY5KX(5; M/[`[*"W8?-;TXR6SUX%O=;+BN7DC;;%:&DD!==%"C"X>*Q(B M:&QOXZ&T#4H>2'VRA5I7@RQQAJ\S;@N;2R\>:)*=D=>`T+/U#%M.'S3/81ES M1RO@A:>L0W%19AE;6&WN=H8H("\Y!YE6[@2K,AMU4P^6IZ,P#WJ1J8>,& MJT=W!DD@XSF'V58+>M9-B6SKP9IQ)/9!8RP-P%%B*?6HP4.\56CS(`TBYK5Q MNRIJ/%@2CB5^)`Y&0A!Y%Z$!2L>[7%R!%?1(@0-):$?53$@6[W`\LL%CL+G[\ MV\O"?[?"+"0T^'S5>O_AZAT.7.J18/;YZNOX_OK[J[_]]8]_^-$GP:\3%.)W M?'P0?KZ:1]'RAYN;;]^^O7^9,/\]9;.;VP\?VC?9P*MTY`\O(3D8_:V=C6W= M_.>GQV=WCA?HF@1AA`)W!R70Y,&U/GWZ=)/\+Q\:DA_"!/Z1NBA*."BDZYUT MA/C7=3;L6OQTW;J];K?>OX3>E9`!HSY^PM-WR>=_B-9+_/DJ)(NE+\A.?ILS M/.6_41QP^%;KPW?M#P+Z3SWJQ@L<1)W`NPLB$JW[P92R14+SU3N!]^M3_X#X MD/J(X0"S"+OS]RY=W(A1-TI$-]6(?(Y0A`7RX?2>!%P;!/DC&A*!N^NC,"13 M@CTC+Q;WE?D"_FT?,Z M!2XKW`UT?>1T43B_]^FWL!]XA&$W*DO9*:**1`[9#`7D]V3&#@= M+C%+?@N-*"W&5I'Q/W@>/WW] MZ6XP?C8B,Q=!1:(V;(9/V,5DA28^'F!N`1V?3W^Q@-Q3UJ/Q))K&?C;4B.8R M^*NRY*T$YA%:"VL.N84,^=K'S,B6X*A(6C]8<724F4[0?;B*)(P8Y>M$M!:; M\6\Q60K^C&C)15!U?13"[80A-IQ=^W!5EY4Y9=$8L\4C18;K\1%HY3DBML4Q M>C&<(1E4=;^$>]81$99*(\-Y>@)0UPI=V3F;'.A95H'H/_DQT MCVF$_%(4[T&>B5:^)I>B=`MW+IEB%N)R,MU!UDAK=$JGL2!W$N2K%-^L0[YF M):OH(R?C@$#\$N'`$V&P]%>!H'+@+@FP4O?@0[X(:5)6M$J+7QP5\LZ$NT%( M!'!21+[@-$'O:,,Z']+U6XO&C2P2.4]1.$F$'8?7,X26-X+V&^Q'8?9+PLWU MA]8FSOJGS<_.-H0T%@?='.+S!SJME-)]'7;8(=6(N1D^_M<3!1X&A31+@4B$#G5L0/0GRG@%F3BWQ,?LRZG9$:9>MH?C'2^:X38\RG/)-X^L\3'#(F;_.?U8D)] MB:P/QCA_:824CVG.Y/L19BFGBP4-GB/J_IH$TL)A'(ET!D&B>EU7`#K?-T(3 M6HQDZOGSF=63>>1CCE:BB/TASJ=&B/R(Y$RXWYU9N!U.@R?HN/>1;)H?C'%: M'QHAWQ.B,PG_!6CZ;F-^"F\E=ZS3@CD.EYW1)\1GDO\>2/*I]Y22=<]_RSO$ M*L<[K0LYR&IJ()>!3`N?0+4@?%A]'6Q'.ZUFG%$5Y.\.3/D*N#F.6!ZS6UL4 M4S.?#RK6E$.5(OQI`OX6`36=[FIAO@5!WX*@%ZRX-`]*8^TX'-B`<*B4\+H4 MML)L0G?7?.?5F\@V%CDC_`^1L+1"?I)%$G418VM^%DURA!3JU(('#K^>:BY? MP[J\6*'XW-S830A49;X*,.`XKZZ:"UB0!]N;I-X1PTM$O+N7)0Y"7*S7W/'` M$61=AI0H'[PX!CTKIZ.R)9'O)ODKJ23:+C\:/B&+WL MEIAB"U0#`@>W=55:R(3\WJ%)2MY+_2]6[.E@X+"YKC)S"9??3!@J,-K/%X0X MK&@X.P>\`P?CM=V;8Z+EUQU-,KFL\F?DHS1A+"O_46^+*C#H8+^^?Z/F07[; MTB0%[ZTV`QJX)LOJ;CST[4&)I?60>/G]39-TV<-+$<$,#=0I`X&^C=#5J(I^ M^750T_;,PLW2:34CUK.C5G%7U!SM/!(T(3Z)"!858$E:R9SZG*\P+4/4",SJ MHG!:EY_.5X8G.^(^67!KA-9ZQ\Y\`*<%&_HQ4IPZS'?*F!7QVVX<1G3!G8BT M68#&:48"X;1@HT4UJ%K!F356S6).Z$Y46H:=#^.T8&-)]=BVG#<[PKZ]&(_I M7N&TEL[E0$X+-N94@]+5S-D1/=YV\_A"&:/?2#!3)D"A9PI4= MD>/C)B7:?IH:T+F%#675L8D7,EA;Z!DX-L+(BNMGA8VV:)`38P5H.-YC-E M1\1Z;_=YI,%,N!_[NY#>QIP'Z=S"ALOJW9EE'-86X;Z\K5GS]D()Z=PV/IRF MP6%]D?37WJ25.BV$<6X;&S'3XFVKQ\I!L\O8KO7V:>>V\6&Q(VZV>JP<"0/4 M8ZF[+(7T;AL?!U,SMU5ZLP-A>_7QA24(1T.=-G35M%(_,A_KE`DK[JDZGD=2 MLD>(>/V@BY:$+R9[_*KN,`J!G39T]5X)9>NQ9])U676B98'+:T,6`96:&.8]V7'<]X0B1`'MWB`4BXK\GB!Z>$I>HMOMB M8*<-76A88C+HL57;Q==%.7E&SIW3AN[O5D*[^6S4=LMU&4>O7!^W0A*:TVY\ M-$V'Q>W67_LT.%_G"\T'H:H&=_0^4]33UPS+6V\+G>Z^QC*5+I1O+2[>6ES` M*T[U;)1)H:<1GB8UR##DRXKPQMZ9G2]K0Y8(S$M".+MW9G1"5S+H!K0N-N/& MCK#&2?_.3AS-*2._[QPEM;Z/H1K0)%F/"SOB$2<\]L,P-M-M"M&`+LS%'-B1 M7&O8=5@'K`'=GS79>,7T6I!NBYL'?L_>K$5\=4N&QE6E!.+MB*EI`G+YO1TG MWXZ3EZPXY&-^+EKA(,;J'A9'(QMT)#REW))#7\AWF`=*O22$B]F*N#A\IK[: M/Y0!->J(IV"B^LE.\:+@>37\P,0SKXQ.E?>.>Z,:='P[I+JVXQK@A=/F"==@ MMFD!J-.'5@K3H`.;B@<[CFS/V.Q$BBDDX3X_U/3Q1[LA%L,"M%TLH78>EZIMX_O/>%>_FA>?/ M0N0/IR.TYOC]3?7^&+TD'1Q0W@MKFI#0[1@--&G`4?5=^V)LU!V$A-'FW6*"11?]7=6U.`:(W8B?`4[^3WU]8(P+NOECE1E1 MBED[4E:XJ!A&(>[A],]^<(\(2]*OAM.OP1Q[LWW>^P$79O*`HLJ=*X\4NJ]D MM76E"M=VA%[[BR7G.4NFR'9/Y5S)AX#N-UEI(LA9JGXDN(2-)JDRE$I(=Q/S@P8;3D[3;(NLUP@/=0-)D!A@S9D=_.0G;F_EODI-NB`FZ^60-?^-->%0\T^+2P"4^/F!U3.M;&E[C<\!)_'5. ML5<2CQT9ICW,B75)HE_%%-L?!EP5\%KJS)\\1XQ;L3SMKH%%4=IP>O"H\O9% MY8+4XF($P)4$YYTGVB*Q(RDC"T!C3[3EQ$%8M(#D`P#7'9QWBDA%8&O.1:EW M^TS0`%N9%^A[!/TG@ M:=0)G`Z&K@$Y[VS(Y]^.Q)3#[?.>!(B+,IB)_A^B\T>/A&EC3VUO1(X"NJP$ MTB]12\6.;!C@6@;8F.YY)U140_K.9<[`K2PW M#SSIM8/41`)=7P,]PU1RJ>\%RPN++I[V4S>:2Z?@T,4YAGK5G1SYC%:^R+K, M96;$,#^6>CJ5OVI0Z*J=5YH,ITS:<1]URJF(203\:^I';Y5PT"4^KS0'CCB\ MT(9)IW0G/E1'^.UC]*)<].T'ZC.A6CGJOHE?""UV'],H>I:8$+"D1UCR_U9+" M#5VD5'.&KP'7-O1@EG"O0.;<-J>,\EFY-CJCM?]+$XM\!= MBVJ=,&9\U[;"-&(;JF7[<6Z!>QO5.5W,V+;8:=G>RM?AM"B0B=?A&^ZT%'!G M1Y;WP3HZIRP:8[8HR*V4PCAMV`!K245J[##'7%I1-_2$EQNW2_0GT=.]%,9I MPT9=:]6]DDN+WH+2%UHMFX/3AHW"UCI'S-BVP:6XFTZQ&PVG=R_N'`4S_,1G M[S`00N#NMOA#N-PK[HRK,X],T#CMYC0],.6KMHH>P"F1S]T(,T*]XT"S8DJ8 MH'':S6GX9,J7'74[^5QW^'+)V)JOC,EEIO%L.()WVLV)BFHS5-O5RC*98IQ& M%ED]!YKSH*$V0[55VZ1SX"Z`*BF/ETL_D0[RLV9?_6!*V2)5DT;+-3T,3KLY M+]4;L&1'L4U6/B0*BI37\KMA3ALV\&BB(]D5^R$W5D0+,E$,:.#RO^Y"IX&7 M<^81Q3X^#6.F\P!35=1.NSG!QCIXA2Z>DJ3X'=<5=REGCD6B-'U`(QQ^6??# M,.8L8O%_BP4-GB/J_IIW5JR$S_D(&X:L1<6'LZ>R/("7H!IFS#,6&:Y?Q.]U M3)@]=,Y'V-#E)%7U"XJV8(C)J"EZ5VS"7]A6/\M32Y6PQ`K<&-A9IG'T9< MOIXK=#Y#>>S__+7?ZX]_Z0QZ#\/^X*$[''3OG@:5[>.1\)7&(]&:B_&!)MT; M^*["5.$:+;@ZK$'VC4(C*`2$G/L:DLN;\CH\V3#3G^/%`K$U]VO(+"!3XHKL MOK1@@3,]HCYQQ?7TN7O(G%"@T]=9"@3Q@(1*G"J+,D,`_."$4N2R&*TN8S:8 MUWU_T!ET^YW'_N!Y_/3UI[O!^/G`T*TW*RF*K MFV(^WD)S4X/58E+YGR@VFP(X4-,H%%ON]"_FR(8IOM]4!<#I$Y]>&]T4*Z`` MW+L<:G1\.A78!3ARS=9YS:FWD9&27/B3?,4\COV-@W5MFY"0IS1%E41 M,X`AYM*C8X1J0&`#K*X'B7D64!0(35]ZL% MM<+HN0#@MB,1IRQD+F/"!E-(F_Z.TD:10($>D$VKTCDAR,/`C MDDJ^TB.2DA\;S.0XN_#\>T9.#W:^R_\=>[/RJ>D5L`)8FR`B#L,D3>SOZPD3 MC[CL4WWZ4(+656\5M.`[617]2:RYHCQLL'9Q)HW68\:=0RXJL]2\FJK1$PI^ MPM%?H'9Z;0W,D##.!!5>N819P$=VR@" MO8A]J-@@--BPP28.WD(:899LI&>W"\0"[L-OOZ]C(1(0`%LY)D7'2*0PT-8A M%ZO$3E2TI`-^;B"ER=0Y4$`B+L<$B)82%)(3!T`$(J9UGL088X[U;003MCK^OU;HM'P0B=GY$BE:07`8#;",*L'-D550)``/D'TE.Y!])3G5X"P`!!"4.```$.0$``.U;;7/; MN!'^GIG\!XR^M)TY659\2<^>.#>T3#F-J93SJU;KZ]>O9R*),2>, M<$FBZ5F4S%IOSMOMYOF[YH52&Y,98;*;\-DM&>,TEM>-+RF.Z9B240.]?@4M M8>)*)(0=H/7U*Z1Q:Y"O%V<)GX#<>;OUZ;X7Z*8WT%+X*J;LMS7$TY#'!>:B MI:J'6)`R1$F,Y!)4!KQM995KXO$._9]Z8&!3.=T!H$Q(S*+U!E6 MMG3MBIXK1B98DM%6&YZ?X\QI%LDJ=YC!F6"5]TX7V- MT82Q=&96-)*\I5QM@5`3I`BGT1J6R/W#:=W:?E,E,VK6Q8PE$DN8G#^\Q_,Y M9>-$%:O!?:4LA`!"ZF'@.WMF3=V@VR1*U2QLL9'-))4+!S3RF;;00!0HW2FQ MM#TB8\JH;M=Y&S51@2H_8C9"F0I4TO&^M:F@T)D*,O+8!_T,(1:@0R/49)FC M': MHU/L^R4Z.UA,NW'R53AL1&$AE17"JQ)&[M_6YUYI1%KE"7+O\0EF]-_:%BRJ M+I8I)]YXU1^S`.P7,T;AG5IQJ8CB1(`\O'C^G>4Z_[!"QW.1Y=XBUPH'OHV\ M+O+ZMJ_+@Q,,0\_Y^\"Y=<+/P,F=Y[AW'<_MV+Z;L;^UUDCZ7S=)7\(UXUH! MRC6<(-5!.IMAOO#&`9TPV*]$&+:3D3ZX43;IPR0149)W^YJRQC#\M!F&8'!_ M;_F?55\/G#O7Z3H=RPV1U>EX`S=40>E[/:?CV*VO!U$WZ;I$,Y M3N-"-./^.4!3:-KGFZ')>WV`?+MC.P_63<_^`;EVJ$:'U>MYOT#@;-3U?'3K M#6["[J"WA)QB`$>/BNX^7NA="ZS`'FS+>1ZD+97&0+0K@;A]T%3WK<]Z>.@U MP@L_VOX)\NRP1_`EXOYI3N-]GL"64"[4_IYUDF>6[.HCQ$_% M5%F\&AFL'`4=M^/=VRBT/IT@=YT$%A8NJ=I1);)8;2JE1B8KYSLXRSW`_.C` M'@JY7GB2"X]:4^0BY#""<52ZN#"4&TFMGM9"K_.WCU[OUO:#/^E5)_Q\@KQV M,>4/.$Y)Z<;?84)R_2M*3O(^(2/CU=.:Y?CHP>H-]'70_\]NQ4PQ`W^FA`GZ M2'J)6$X5F\4FDM]4SETPY_9]^Z/M!LZ#7 M3$$J(]A<922YMB5MKC617CF.^W;-"^Q;U M+74F"WW8_5J=4[VX[R:%"19['M#O-#Y3H MFQ^8S5M%XQNM;^`/$'ZH/^LQ>E'>Q'AXJ#<`(?&+=$^>Q*CK&$' MV%]Z=*#]`G>8?7/V<$W+!4"9?%O#V,Z$W2TVM3TCL$5B*8J2YDI57:]W)+KN M:HL!EC\?T093+G&=1I1QQN8[[`J(=C3&]F1]>R78#TTV'6]WT`4&]#@V; MJ","8\Z_/ZP1"7-WM"/_)$DW9'?FNS44DN,B65)MQWZM)Y[MZ?3W/5=01MG$ MD62FSAL-A'.IZX;DJ=KQ:2G88]%D%&K<*.5Y:CZC<:RR0PI9`6 MI//""`7U#=3Z@"K^_8(YQTSV*![2F*I]7$>O&&6G=LB4/9DE,.8P7YA\&>-8 M&)W)MFJRJ!IFJ=#7C8B3$96_DXMNPJ(:7I;%O@='ZR6H&WKMH<`7U']]HKY3 MQ+$W[N,%S+-Q?LL6XB4'KW=Y6A^1)WL0P2QWB:@F4^9I]`GLEB_)G M!OP;.-RCT#]AQ*L,QKL$J(+_J"`KFML:;XU9!]:6%[1@J[(:)' M:7E!P7Z&'Z9^<)R:%]=%S`GTIFZP3_(EA=K<5F,X]XK^[T/6RJY6/KQ^]1]0 M2P$"'@,4````"``*3`\_1\;4RSW#``"3"`D`$0`8```````!````I($````` M`L``00E#@``!#D!``!02P$" M'@,4````"``*3`\_14E"C;,(``#<@0``%0`8```````!````I(&(PP``&UL550%``/D'TE.=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`"DP//R\'I%Z9#@``WM4``!4`&````````0```*2!BLP``'-O M96XM,C`Q,3`V,S!?9&5F+GAM;%54!0`#Y!])3G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(``I,#S_?C]9NIB<``)!!`@`5`!@```````$```"D@7+;``!S M;V5N+3(P,3$P-C,P7VQA8BYX;6Q55`4``^0?24YU>`L``00E#@``!#D!``!0 M2P$"'@,4````"``*3`\_U;SP<;,4``!K2`$`%0`8```````!````I(%G`P$` M&UL550%``/D'TE.=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`"DP//R:EU/HH"0``%D8``!$`&````````0```*2!:1@! M`'-O96XM,C`Q,3`V,S`N>'-D550%``/D'TE.=7@+``$$)0X```0Y`0``4$L% 3!@`````&``8`&@(``-PA`0`````` ` end XML 33 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
ADVANCE PAYMENTS AND OTHER
9 Months Ended
Jun. 30, 2011
Advance Payments and Other [Abstract]  
Advance Payments and Other [Text Block]
NOTE 6 — ADVANCE PAYMENTS AND OTHER

At June 30, 2011 and September 30, 2010, advance payments and other consist of:

   
June 30, 2011
   
September 30, 2010
 
Prepayment for raw materials
  $ 285,000     $ 673,000  
Prepayment for equipment
    18,000       402,000  
Others
    207,000       199,000  
Total advance payments and other
  $ 510,000     $ 1,274,000

XML 34 R21.htm IDEA: XBRL DOCUMENT  v2.3.0.11
NET INCOME (LOSS) PER SHARE
9 Months Ended
Jun. 30, 2011
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
NOTE 16 — NET INCOME (LOSS) PER SHARE

The following table presents the computation of basic and diluted net income (loss) per share applicable to common stockholders:
 
   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Calculation of net income (loss) per share - basic:
                       
                         
Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
Weighted-average number of common shares outstanding
    161,543,403       156,502,573       160,990,033       128,327,753  
Net income (loss) per share - basic
  $ (0.01 )   $ (0.004 )   $ 0.003     $ (0.18 )
                                 
Calculation of net income (loss) per share - diluted:
                               
                                 
Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
Less:  Gain on change in fair market value of compound embedded derivative
    -       -       (263,000 )     -  
    Interest expense on convertible notes
    -       -       136,000       -  
Net income (loss) assuming dilution
  $ (1,311,000 )   $ (658,000 )   $ 403,000     $ (23,740,000 )
                                 
Weighted-average number of common shares outstanding
    161,543,403       156,502,573       160,990,033       128,327,753  
Effect of potentially dilutive securities:
                               
Convertible notes
    -       -       9,935,073       -  
Weighted-average number of common shares outstanding assuming dillution
    161,543,403       156,502,573       170,925,106       128,327,753  
                                 
Net income (loss) per share - diluted
  $ (0.01 )   $ (0.004 )   $ 0.002     $ (0.18 )
 
During the nine months ended June 30, 2011, 1,273,333 stock options, 55,229,796 warrants and 10,440,000 restricted stocks were excluded from the calculation of earnings per share because their effect would be anti-dilutive.

XML 35 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income (loss) $ 530,000 $ (23,740,000)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation of property and equipment 1,901,000 1,842,000
Loss (gain) on disposal of property and equipment (5,000) 51,000
Stock-based compensation 2,013,000 2,221,000
Accounts payable and accrued liabilities, related parties (5,817,000) 127,000
Amortization of other assets 12,000 0
Loss (gain) on debt extinguishment (55,000) 18,549,000
Impairment loss on investment 0 1,000,000
Payment of interest by issuance of shares 54,000 210,000
Amortization of note discount and deferred financing cost 94,000 5,146,000
Gain on change in fair market value of compound embedded derivative (263,000) (1,115,000)
Gain on change in fair market value of warrant liability (853,000) (4,369,000)
Changes in operating assets and liabilities:    
Accounts receivable, net (3,301,000) (6,075,000)
Advance payments and other 816,000 441,000
Inventories, net 1,078,000 (962,000)
VAT receivable 650,000 (84,000)
Other receivable 448,000 236,000
Accounts payable, accrued liabilities and customer advance payment 38,000 7,175,000
Net cash provided by (used in) operating activities (2,660,000) 653,000
Cash flows from investing activities:    
Acquisition of property and equipment (1,750,000) (463,000)
Proceeds from sales of property and equipment 38,000 9,000
Net cash used in investing activities (1,712,000) (454,000)
Cash flows from financing activities:    
Borrowing under short-term loans 4,864,000 1,141,000
Short-term loans repayment (5,207,000) (412,000)
Net cash provided by (used in) financing activities (343,000) 729,000
Effect of exchange rate on cash and cash equivalents 387,000 15,000
Net increase (decrease) in cash and cash equivalents (4,328,000) 943,000
Cash and cash equivalents, beginning of period 6,578,000 1,719,000
Cash and cash equivalents, end of period 2,250,000 2,662,000
Cash paid:    
Interest 78,000 0
Supplemental disclosure of non-cash activities:    
Extinguishment of convertible notes by issuance of common stock (200,000) (5,729,000)
Extinguishment of convertible notes by issuance of Series B-1 Note 0 (1,815,000)
Issuance of Series B-1 Note 0 1,535,000
Acquisition of other assets $ 0 $ 732,000
XML 36 R22.htm IDEA: XBRL DOCUMENT  v2.3.0.11
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Jun. 30, 2011
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
NOTE 17 — COMMITMENTS AND CONTINGENCIES

Research and development commitment

Pursuant to a joint research and development laboratory agreement with Shanghai University, dated December 15, 2006 and expiring on December 15, 2016, Solar EnerTech is committed to fund the establishment of laboratories and completion of research and development activities. On November 12, 2010, the Company amended the agreement with Shanghai University and extended the funding commitment from five years to eight years, and consequently the agreement will end on December 15, 2014. Based on the amendment, the Company has committed to fund no less than RMB 30 million ($4.5 million) cumulatively across the eight years. The funding requirements are based on specific milestones agreed upon by the Company and Shanghai University. As of June 30, 2011, there are approximately $3.2 million remaining to be funded in full by December 15, 2014.

The Company will continue to invest in research and development as it grows its business. The payment to Shanghai University will be used to fund program expenses and equipment purchase. Shanghai University needs to obtain the pre-approval from the Company before incurring expenditures on the program. If the Company fails to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If the Company is unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, the Company is not in breach as it has not received any additional compensation requests for pre-approved funding payment from Shanghai University.

The agreement is for shared investment in research and development on fundamental and applied technology in the fields of semi-conductive photovoltaic theory, materials, cells and modules. The agreement calls for Shanghai University to provide equipment, personnel and facilities for joint laboratories. The Company will provide funding, personnel and facilities for conducting research and testing. Research and development achievements from this joint research and development agreement will be available to both parties. The Company is entitled to intellectual property rights including copyrights and patents obtained as a result of this research.

Other than capital expenditure related to purchase of fixed assets, expenditures under this agreement will be accounted for as research and development expenditures under FASB ASC 730, "Research and Development” and expensed as incurred.

Capital commitments

On August 21, 2008, the Company acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash as previously discussed in “Note 3 — Summary of Significant Accounting Policies – Investments”  above.  In July 2010, members of the Company’s executive team, including the CEO, visited 21-Century Silicon and conducted reviews of the production facility and technical development. The review indicated that 21-Century Silicon’s production facility and technical development were significantly below expected standards. In addition, management of 21-Century Silicon expressed the need for more funding to sustain operations. Moreover, 21-Century Silicon could not provide the Company with updated financial information concerning 21-Century Silicon’s working capital condition and future cash flows. The timing of the first polysilicon shipment is unknown and it is unknown whether it will even occur. The Company considered the factors above as indicators that a significant adverse effect on the fair value of the Company’s investment in 21-Century Silicon had occurred.  Accordingly, an impairment loss of $1.0 million was recorded in the Consolidated Statements of Operations for the fiscal year ended September 30, 2010 to fully write-down the carrying amount of the investment. The Company may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million shares as the product shipment has not occurred. On October 7, 2010, the X-Change Corporation announced that it has acquired 21-Century Silicon, Inc. The terms of the acquisition is anticipated to involve a change in control of the Company and the appointment of new directors. The X-Change Corporation is anticipated to issue 20 million shares of its unregistered, restricted common stock to the shareholders of 21-Century Silicon in exchange for 100% of the issued and outstanding stock of 21-Century Silicon. As of the date of this report, the X-Change Corporation has not issued its shares to the Company.

On September 22, 2008, the registered capital of Solar EnerTech (Shanghai) Co., Ltd was increased from $25 million to $47.5 million, which was approved by the Board of Directors of the Company and authorized by Shanghai Municipal Government (the “Shanghai Government”). The paid-in capital as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be originally funded by September 21, 2010. In August 2010, the Company received the approval of the Shanghai Government to extend the funding requirement date by nine months to June 2011. As of June 30, 2010, the Company has not funded the outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase the remaining balance recently. In order to meet the registered capital requirement, the Company is in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. The Company has not received the approval from Shanghai Government as of the date of the Company's Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to the Company in September 2011.

On January 15, 2010, the Company incorporated a wholly-owned subsidiary in Yizheng, Jiangsu Province of China to supplement its existing production facilities to meet increased sales demands.  The subsidiary was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.  In order to fund the registered capital requirement, the Company will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. The registered capital requirement outstanding as of June 30, 2011 is $23.4 million.

On February 8, 2010, the Company acquired land use rights of a parcel of land at the price of approximately $0.7 million. This piece of land is 68,025 square meters and is located in Yizheng, Jiangsu Province of China, which will be used to house the Company’s second manufacturing facility. As part of the acquisition of the land use right, the Company is required to complete construction of the facility by February 8, 2012.

Convertible note

On March 19, 2010, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby the Company issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.  On May 11, 2011, the Company executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of the Company’s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. Notwithstanding the above, the Company’s liquidity and financial position raises substantial doubt about the Company’s ability to continue as a going concern. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041.
XML 37 R24.htm IDEA: XBRL DOCUMENT  v2.3.0.11
FOREIGN OPERATIONS
9 Months Ended
Jun. 30, 2011
Foreign Currency [Abstract]  
Foreign Currency Disclosure [Text Block]
NOTE 19 — FOREIGN OPERATIONS

The Company identifies its operating segments based on its business activities. The Company operates within a single operating segment, the manufacture of solar energy cells and modules in China.

The Company’s manufacturing operations and fixed assets are all based in China. The Company’s sales occurred in Europe, Australia, North America and China.
XML 38 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
LIQUIDITY AND GOING CONCERN
9 Months Ended
Jun. 30, 2011
Liquidity and Going Concern [Abstract]  
Liquidity Disclosure [Text Block]
NOTE 2 — LIQUIDITY AND GOING CONCERN

The Company has incurred significant net losses during each period from inception through June 30, 2011 and has an accumulated deficit of approximately $92.8 million at June 30, 2011. The conditions described raise substantial doubt about the Company’s ability to continue as a going concern. The independent auditor’s report on the Company’s most recent annual report on Form 10-K for the year ended September 30, 2010 also contained an explanatory paragraph stating that the Company’s recurring net losses and negative cash flows from operations raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s consolidated financial statements have been prepared on the assumption that it will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

During fiscal year 2010, significant steps were taken to reach positive gross margins including securing sales contracts from recurring customers and establishing new customer relationships, which had improved operating cash inflows. In addition, the Company engaged in various cost cutting programs and renegotiated most of the contacts to reduce operating expenses. Due to the above efforts taken, the Company has been generating positive gross margins throughout all quarters in fiscal year 2010 and first quarter of fiscal year 2011. However, since the second quarter of fiscal year 2011, the gross margin has been negative, mainly because of the devaluation of Euro dollar against RMB natively affecting the Company’s return, usually 45-60 days after the cargo was shipped, and decrease in average selling price of solar modules from $1.91 per watt in the first quarter of fiscal year 2011 to $1.58 per watt in the third quarter of fiscal year 2011, coupled with a decline in sales volume from 8 MW in the first quarter of fiscal year 2011 to 7.7 MW in the third quarter of fiscal year 2011 because of a down-turn of European markets, which forms more than half of the Company’s revenue. Europe has been playing a large role in creating demand growth in the global PV market through its feed-in tariff (FIT) programs. However, since the beginning of the fiscal year 2011European markets has been slowing down significantly due to the waning economy with its failed expensive aid packages to Greece, Portugal, and Ireland. As a result, even Germany, the long-term and strongest proactive player in the PV industry, has cancelled its mid-year tariff reduction, leaving module shipments well in excess of demand as well as low sales orders. In addition, the Company’s lower production volume resulting in higher fixed production cost per unit and lower gross margin.

On March 19, 2010, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with Capital Ventures International (“CVI”) whereby the Company issued a Series B-1 Convertible Note (the “Note”) to CVI with an original principal amount of $1,815,261, which is due on March 19, 2012 and bears interest at 6% per annum.  On May 11, 2011, the Company executed an amendment with CVI (“Amendment”) whereby CVI waives the following Trigger Events: (a) the migration of the Company’s listing from the OTCBB to the OTCQB, (b) the failure of the Company to timely pay the interest payment due on April 1, 2011 and (c) any other Trigger Event that may exist as of the date of this Amendment. According to the Amendment, Section 3(c) of the Exchange Agreement is amended to reduce the conversion price of the Note from $0.15 to $0.10 per common share, subject to further adjustment upon certain specified events as defined in the Exchange Agreement. As of June 30, 2011, the outstanding principal of the Note is $1,540,261 and the related interest is $23,041. Notwithstanding the above, the Company’s liquidity and financial position raises substantial doubt about the Company’s ability to continue as a going concern.

As discussed in “Note 17 - Commitments and Contingencies”, (i) Pursuant to a joint research and development laboratory agreement with Shanghai University and as of June 30, 2011, the Company has a commitment to fund Shanghai University’s prescribed research and development activities for approximately $3.2 million to be funded in full by December 15, 2014.  If the Company fails to make pre-approved funding payments, when requested, it is deemed to be a breach of the agreement. If the Company is unable to correct the breach within the requested time frame, Shanghai University could seek compensation up to an additional 15% of the total committed amount for approximately $0.7 million. As of June 30, 2011, the Company is not in breach as it has not received any additional compensation requests for pre-approved funding payments from Shanghai University. (ii) On August 21, 2008, the Company acquired two million shares of common stock of 21-Century Silicon for $1.0 million in cash. The Company may also be obligated to acquire an additional two million common shares (at $0.50 per share) of 21-Century Silicon upon the first polysilicon shipment meeting the quality specifications determined solely by the Company. As of June 30, 2011, the Company has not yet acquired the additional two million shares as the product shipment has not occurred. (iii) The paid-in capital of Solar EnerTech (Shanghai) Co., Ltd as of June 30, 2011 was $32 million, with an outstanding remaining balance of $15.5 million to be funded by June 2011. As of June 30, 2010, the Company has not funded the outstanding remaining balance of $15.5 million. With the decision of Board of Director, investor will not increase the remaining balance recently. In order to meet the registered capital requirement, the Company is in the process to file an application with the Shanghai Government to reduce the capital requirement, which is legally permissible under the PRC law. The Company has not received the approval from Shanghai Government as of the date of the Company's Quarterly Report (Form 10-Q) was filed with the Securities and Exchange Commission. It is estimated that the approval will be granted to the Company in September 2011. (iv) The Company’s subsidiary in Yizheng Jiangsu Province was formed with a registered capital requirement of $33 million, of which $23.4 million is to be funded by October 16, 2011.  In order to fund the registered capital requirement, the Company will have to raise funds or otherwise obtain the approval of local authorities to extend the payment of registered capital for the subsidiary. (v) On February 8, 2010, the Company acquired land use rights of a parcel of land at the price of approximately $0.7 million. As part of the acquisition of the land use right, the Company is required to complete construction of a facility by February 8, 2012.

As of June 30, 2011, the Company had a cash and cash equivalents balance of approximately $2.3 million and short term loans outstanding of approximately $1.0 million. Operating cash outflows amounted to $2.7 million in the nine months ended June 30, 2011, mainly due to payments to the Company’s vendors based on contractual terms. There have been no significant changes in the payment terms of the Company’s major vendors in the three months ended June 30, 2011 compared to the same period in the prior year. If the Company is unable to successfully generate enough revenues to cover its costs or secure additional financing, the Company’s liquidity and results of operations may be materially and adversely affected and may not continue as a going concern.
XML 39 R16.htm IDEA: XBRL DOCUMENT  v2.3.0.11
INCOME TAX
9 Months Ended
Jun. 30, 2011
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
NOTE 11 — INCOME TAX

The Company has no taxable income and no provision for federal and state income taxes is required for the nine months ended June 30, 2011 and 2010, respectively, except certain state minimum tax.

The Company conducts its business in the United States and in various foreign locations and generally is subject to the respective local countries’ statutory tax rates.

Utilization of the U.S. federal and state net operating loss carry forwards may be subject to substantial annual limitation due to certain limitations resulting from ownership changes provided by U.S. federal and state tax laws. The annual limitation may result in the expiration of net operating losses carryforwards and credits before utilization. The Company has net operating losses in its foreign jurisdictions and those losses can be carried forward 5 years from the year the loss was incurred. As of June 30, 2011 and 2010, the Company’s deferred tax assets were subject to a full valuation allowance.

Under the New Income Tax Law in the PRC, dividends paid by PRC enterprises out of profits earned post-2007 to non-PRC tax resident investors are subject to PRC withholding tax of 10%. A lower withholding tax rate may be applied based on applicable tax treaties with certain countries.

The New Income Tax Law also provides that enterprises established under the laws of foreign countries or regions and whose “place of effective management” is located within the PRC are considered PRC tax resident enterprises and subject to PRC income tax at the rate of 25% on worldwide income. The definition of “place of effective management" refers to an establishment that exercises, in substance, overall management and control over the production and business, personnel, accounting, properties, etc. of an enterprise. If the Company or any of its non-PRC subsidiaries is treated as a “resident enterprise” for PRC tax purposes, the Company or such subsidiary will be subject to PRC income tax. The Company will continue to monitor its tax status with regard to the PRC tax resident enterprise regulation but does not anticipate a material adverse impact to the financial statements as a whole.
 
There are no ongoing examinations by taxing authorities at this time. The Company’s tax years starting from 2006 to 2010 remain open in various tax jurisdictions. The Company has not recorded any unrecognized tax benefits; and does not anticipate any significant changes within the next 12 months.
XML 40 R20.htm IDEA: XBRL DOCUMENT  v2.3.0.11
COMPREHENSIVE INCOME (LOSS)
9 Months Ended
Jun. 30, 2011
Equity [Abstract]  
Comprehensive Income Note [Text Block]
NOTE 15 — COMPREHENSIVE INCOME (LOSS)

The components of comprehensive income (loss) were as follows:

   
Three Months Ended June 30,
   
Nine Months Ended June 30,
 
   
2011
   
2010
   
2011
   
2010
 
Net income (loss)
  $ (1,311,000 )   $ (658,000 )   $ 530,000     $ (23,740,000 )
Other comprehensive income:
                               
Change in foreign currency translation
    452,000       87,000       800,000       98,000  
Comprehensive income (loss)
  $ (859,000 )   $ (571,000 )   $ 1,330,000     $ (23,642,000 )

The accumulated other comprehensive income at June 30, 2011 and September 30, 2010 comprised of accumulated translation adjustments of $3.6 million and $2.8 million, respectively.
XML 41 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Balance Sheets (USD $)
Jun. 30, 2011
Sep. 30, 2010
ASSETS    
Cash and cash equivalents $ 2,250,000 $ 6,578,000
Accounts receivable, net of allowance for doubtful accounts of $443,000 and $42,000 at June 30, 2011 and September 30, 2010, respectively 10,094,000 6,546,000
Advance payments and other 510,000 1,274,000
Inventories, net 3,166,000 4,083,000
VAT receivable 249,000 870,000
Other receivable 252,000 690,000
Total current assets 16,521,000 20,041,000
Property and equipment, net 8,999,000 8,874,000
Other assets 749,000 735,000
Deposits 80,000 102,000
Total assets 26,349,000 29,752,000
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable 9,898,000 7,895,000
Customer advance payment 353,000 2,032,000
Accrued expenses 2,670,000 2,596,000
Accounts payable and accrued liabilities, related parties 0 5,817,000
Short-term loans 1,008,000 1,312,000
Convertible notes, net of discount 1,443,000 0
Derivative liabilities 133,000 0
Warrant liabilities 49,000 0
Total current liabilities 15,554,000 19,652,000
Convertible notes, net of discount 0 1,531,000
Derivative liabilities 0 422,000
Warrant liabilities 0 902,000
Total liabilities 15,554,000 22,507,000
STOCKHOLDERS' EQUITY:    
Common stock - 400,000,000 shares authorized at $0.001 par value, 172,710,388 and 170,338,954 shares issued and outstanding at June 30, 2011 and September 30, 2010, respectively 172,000 170,000
Additional paid in capital 99,874,000 97,656,000
Other comprehensive income 3,555,000 2,755,000
Accumulated deficit (92,806,000) (93,336,000)
Total stockholders' equity 10,795,000 7,245,000
Total liabilities and stockholders' equity $ 26,349,000 $ 29,752,000
XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.11 Html 9 113 1 false 0 0 false 3 true false R1.htm 01 - Document - Document and Entity Information Sheet http://www.solarenertech.com/role/DocumentAndEntityInformation Document and Entity Information false false R2.htm 02 - Statement - Consolidated Balance Sheets Sheet http://www.solarenertech.com/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets false false R3.htm 03 - Statement - Consolidated Balance Sheets [Parenthetical] Sheet http://www.solarenertech.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets [Parenthetical] false false R4.htm 04 - Statement - Consolidated Statements of Operations Sheet http://www.solarenertech.com/role/StatementOfIncome Consolidated Statements of Operations false false R5.htm 05 - Statement - Consolidated Statements of Cash Flows Sheet http://www.solarenertech.com/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows false false R6.htm 06 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS Sheet http://www.solarenertech.com/role/OrganizationAndNatureOfOperations ORGANIZATION AND NATURE OF OPERATIONS false false R7.htm 07 - Disclosure - LIQUIDITY AND GOING CONCERN Sheet http://www.solarenertech.com/role/LIQUIDITYANDGOINGCONCERN LIQUIDITY AND GOING CONCERN false false R8.htm 08 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.solarenertech.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 09 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://www.solarenertech.com/role/FINANCIALINSTRUMENTS FINANCIAL INSTRUMENTS false false R10.htm 10 - Disclosure - ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS Sheet http://www.solarenertech.com/role/AccountsReceivableNetOfAllowanceForDoubtfulAccounts ACCOUNTS RECEIVABLE, NET OF ALLOWANCE FOR DOUBTFUL ACCOUNTS false false R11.htm 11 - Disclosure - ADVANCE PAYMENTS AND OTHER Sheet http://www.solarenertech.com/role/AdvancePaymentsAndOther ADVANCE PAYMENTS AND OTHER false false R12.htm 12 - Disclosure - INVENTORIES Sheet http://www.solarenertech.com/role/Inventories INVENTORIES false false R13.htm 13 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.solarenertech.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT false false R14.htm 14 - Disclosure - OTHER ASSETS Sheet http://www.solarenertech.com/role/OtherAssets OTHER ASSETS false false R15.htm 15 - Disclosure - SHORT TERM LOANS Sheet http://www.solarenertech.com/role/ShortTermLoans SHORT TERM LOANS false false R16.htm 16 - Disclosure - INCOME TAX Sheet http://www.solarenertech.com/role/IncomeTax INCOME TAX false false R17.htm 17 - Disclosure - CONVERTIBLE NOTES Notes http://www.solarenertech.com/role/ConvertibleNotes CONVERTIBLE NOTES false false R18.htm 18 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.solarenertech.com/role/EquityTransactions STOCKHOLDERS' EQUITY false false R19.htm 19 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS Sheet http://www.solarenertech.com/role/FairValueOfFinancialInstruments FAIR VALUE OF FINANCIAL INSTRUMENTS false false R20.htm 20 - Disclosure - COMPREHENSIVE INCOME (LOSS) Sheet http://www.solarenertech.com/role/ComprehensiveLoss COMPREHENSIVE INCOME (LOSS) false false R21.htm 21 - Disclosure - NET INCOME (LOSS) PER SHARE Sheet http://www.solarenertech.com/role/NetIncomeLossPerShare NET INCOME (LOSS) PER SHARE false false R22.htm 22 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.solarenertech.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R23.htm 23 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.solarenertech.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R24.htm 24 - Disclosure - FOREIGN OPERATIONS Sheet http://www.solarenertech.com/role/ForeignOperations FOREIGN OPERATIONS false false R25.htm 25 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.solarenertech.com/role/SubsequentEvents SUBSEQUENT EVENTS false false All Reports Book All Reports Element us-gaap_EarningsPerShareBasic had a mix of decimals attribute values: 3 2. Element us-gaap_EarningsPerShareDiluted had a mix of decimals attribute values: 3 2. Process Flow-Through: 02 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: Removing column 'Sep. 30, 2009' Process Flow-Through: 03 - Statement - Consolidated Balance Sheets [Parenthetical] Process Flow-Through: 04 - Statement - Consolidated Statements of Operations Process Flow-Through: 05 - Statement - Consolidated Statements of Cash Flows soen-20110630.xml soen-20110630.xsd soen-20110630_cal.xml soen-20110630_def.xml soen-20110630_lab.xml soen-20110630_pre.xml true true EXCEL 43 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F,SEE,C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-/3E9%4E1)0DQ%7TY/5$53/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D9!25)?5D%,545?3T9?1DE.04Y#24%,7TE.4U1253PO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D-/35!214A%3E-)5D5?24Y# M3TU%7TQ/4U,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D9/4D5)1TY?3U!%4D%424].4SPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159% M3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I!8W1I M=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+97D\ M+W1D/@T*("`@("`@("`\=&0@8VQA2!&:6QE3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^4VUA;&QE3QS<&%N/CPO6UB;VP\+W1D/@T*("`@("`@("`\=&0@ M8VQA2!#;VUM;VX@4W1O8VLL(%-H87)E M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q M,3QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'!E;G-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XT,#`L,#`P+#`P,#QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F,SEE,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E7)O M;&P@'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@V,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N(&]F(&]T:&5R(&%SF%T:6]N(&]F(&YO=&4@9&ES8V]U;G0@86YD(&1E M9F5R'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S(&%N9"!O=&AE M2`H=7-E9"!I;BD@;W!E2!A;F0@ M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS."PP M,#`\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'1I;F=U:7-H;65N="!O9B!C;VYV97)T:6)L M92!N;W1E2!I7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAAF%T:6]N(&%N9"!.871U'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F M=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/E-O;&%R($5N97)496-H($-O2!C96QL("@F(S@R M,C`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`@("`\=&%B;&4@ M8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\9&EV/CQD:78^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M:6YD96YT.C!P=#L@/CQB6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP M<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E1H M92!#;VUP86YY(&AA&EM871E;'D@)FYB2!T;R!C;VYT:6YU92!AF%T:6]N(&]F(&%S2!A;F0@8VQA2!R97-U;'0@9G)O;2!T:&4@;W5T8V]M92!O9B!T:&ES('5N8V5R=&%I;G1Y M+B`-"CPO9F]N=#X-"CPO9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB6QE M/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z M,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D1U65A M2!E;F=A9V5D(&EN('9A'!E;G-E2!H87,@8F5E;B!G M96YE65A28C.#(Q-SMS(')E='5R;BP@ M=7-U86QL>2`T-2TV,"!D87ES(&%F=&5R('1H92!C87)G;R!W87,@65A28C.#(Q-SMS(&QO=V5R('!R;V1U8W1I;VX@ M=F]L=6UE(')E6QE/3-$;6%R9VEN+6QE9G0Z,'!T M.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM6QE/3-$=VED=&@Z,3`P)3MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.CAP=#MF;VYT+69A M;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM M87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/D]N(#QF;VYT('-T>6QE/3-$)V1I&-H86YG92!!9W)E96UE;G0F(S@R M,C$[*2!W:71H($-A<&ET86P@5F5N='5R97,@26YT97)N871I;VYA;"`H)B,X M,C(P.T-6228C.#(R,3LI('=H97)E8GD@=&AE($-O;7!A;GD@:7-S=65D(&$@ M4V5R:65S($(M,2!#;VYV97)T:6)L92!.;W1E("AT:&4@)B,X,C(P.TYO=&4F M(S@R,C$[*2!T;R!#5DD@=VET:"!A;B!O2`Q,2P@,C`Q,2P@=&AE($-O;7!A;GD@97AE M8W5T960@86X@86UE;F1M96YT('=I=&@@0U9)("@F(S@R,C`[06UE;F1M96YT M)B,X,C(Q.RD@=VAE2!#5DD@=V%I=F5S('1H92!F;VQL;W=I;F<@5')I M9V=E2!T;R!T:6UE;'D@<&%Y M('1H92!I;G1E28C.#(Q-SMS(&QI<75I9&ET>2!A;F0@9FEN86YC:6%L M('!O28C.#(Q-SMS(&%B:6QI='D@=&\@8V]N=&EN=64@87,@82!G;VEN M9R!C;VYC97)N+B`-"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^/&1I=B!S='EL M93TS1&1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE2!A9W)E M96UE;G0@=VET:"!3:&%N9VAA:2!5;FEV97)S:71Y(&%N9"!A2!H87,@82!C;VUM:71M96YT('1O(&9U M;F0@4VAA;F=H86D@56YI=F5R28C.#(Q-SMS('!R97-C&EM M871E;'D@)FYB65T(&%C<75I2!H87,@;F]T(&9U;F1E9"!T:&4F(S$V,#MO=71S=&%N M9&EN9R!R96UA:6YI;F<@8F%L86YC92!O9B`F;F)S<#LD,34N-2!M:6QL:6]N M+B!7:71H('1H92!D96-I2!I;B!397!T96UB97(@ M,C`Q,2X@*&EV*2!4:&4@0V]M<&%N>28C.#(Q-SMS('-U8G-I9&EA'1E;F0@=&AE('!A>6UE;G0@;V8@2X@*'8I($]N($9E8G)U87)Y(#@L(#(P,3`L M('1H92!#;VUP86YY(&%C<75I2!I6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP M<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D%S M(&]F($IU;F4@,S`L(#(P,3$L('1H92!#;VUP86YY(&AA9"!A(&-A6QE/3-$)V1I28C.#(Q-SMS('9E;F1O3IT:6UE65A2!G96YE3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F,SEE,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=CX\9&EV('-T>6QE/3-$9&ES<&QA>3IB;&]C M:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[9F]N M="UW96EG:'0Z8F]L9#L@/DY/5$4@,R`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`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`^/&1I=B!S='EL93TS1&1I M'0M:6YD96YT.C!P=#MM M87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T M:#TS1#8U)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I M'0M:6YD96YT.C!P=#MM M87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL M93TS1&1I'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT M('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP M<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C4-"CPO M9F]N=#X-"CPO9&EV/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1T M;W`@=VED=&@],T0S,R4@6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI M;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D%U=&]M;V)I;&5S#0H\ M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS M1#(E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1'1O<"!W:61T:#TS1#8U)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F M=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQD:78@ MF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1'1O<"!W:61T:#TS1#8U)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@ M/CQD:78@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#8U)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD M96YT.C!P=#L@/B8C,38P.R`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`Q)2!O9B!S86QE'!E2!L:6%B:6QI='D@=V%S("9N8G-P.R0Q+#0X,2PP,#`@86YD("9N8G-P.R0Q M+#$R-2PP,#`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`R,2P@,C`P."P@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&%N(&5Q=6ET M>2!P=7)C:&%S92!A9W)E96UE;G0@:6X@=VAI8V@@:70@86-Q=6ER960@='=O M(&UI;&QI;VX@7-I;&EC;VX@;6%N=69A8W1U2!P=7)C:&%S92!A9W)E96UE;G0L('1H92!#;VUP86YY M(&%L2!3:6QI8V]N(&9O65A2!T:&4@4W1A=&4@;V8@5&5X M87,L(&EN=F5S=&5D("9N8G-P.R0S+C4@;6EL;&EO;B!I;B`R,2U#96YT=7)Y M(%-I;&EC;VX@=&\@97AP961I=&4@<')O9'5C=&EO;B!A;F0@8V]M;65R8VEA M;&EZ871I;VX@;V8@2!3:6QI8V]N+B!!2`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`^56YD97(@=&AE('!R;W9I"!A"!R871EF5D(&EN(&EN8V]M92!I;B!T:&4@<&5R:6]D('1H870@:6YC M;'5D97,@=&AE(&5N86-T;65N="!D871E+@T*/"]F;VYT/@T*/"]D:78^/&1I M=B!S='EL93TS1&1I'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$9&ES<&QA>3IB;&]C:SMT97AT M+6EN9&5N=#HP<'0[(#X\8G(@+SX-"CPO9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UEF5D+"!T:&4@0V]M<&%N>2!W:6QL(&%D:G5S="!I=',@=F%L=6%T M:6]N(&%L;&]W86YC92!W:71H(&$@8V]R&5S(&EN('1H92!P97)I;V0@ M:6X@=VAI8V@@6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F M=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.PT*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI M;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D5F9F5C=&EV92!O M;B!/8W1O8F5R(#$L(#(P,#&5S)B,X,C(Q.RP@9F]R M;65R;'D@2!I;B!);F-O;64@5&%X97,@+2!!;B!);G1E"!P;W-I=&EO;B!O;B!T:&4@:6YC;VUE('1A>"!R971U"!P;W-I=&EO;BXF(S$V,#L@06X@=6YC97)T86EN(&EN8V]M92!T87@@<&]S M:71I;VX@=VEL;"!N;W0@8F4@2!A;'-O(&5L96-T960@=&AE(&%C8V]U;G1I;F<@<&]L:6-Y('1H M870@F5D(&%S(&$@8V]M<&]N96YT(&]F('1A>"!E>'!E;G-E+B!4:&4@0V]M M<&%N>2!C;&%S6QE/3-$9&ES<&QA>3IB M;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI M;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E1H92!#;VUP86YY M)B,X,C$W.W,@;6%N86=E;65N="!U&5R8VES92!F86-T;W(L M('=H:6-H(&%C8V]U;G1S(&9O'!E8W1E9"!H;VQD97(@97AE6QE M/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"CPO M9&EV/CQD:78@'0M:6YD M96YT.C!P=#L@/CQB'0M:6YD96YT.C!P=#MM87)G:6XM M'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$ M)V1I'!E M;G-E(&%S6QE/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM M6QE/3-$=VED=&@Z,3`P)3MT97AT M+6%L:6=N.G)I9VAT.R`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`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`R M,#$Q+3`T(&EN('1H92!S96-O;F0@<75A65A2!D;V5S(&YO="!B96QI979E('1H92!A9&]P=&EO M;B!O9B!!4U4@,C`Q,2TP-"!W:6QL(&AA=F4@82!M871E6QE/3-$9&ES M<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA M6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP M<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/DEN M($IU;F4F(S$V,#LR,#$Q+"!T:&4@1D%30B!I"!E9F9E8W1S(&]R(&)E M9F]R92!R96QA=&5D('1A>"!E9F9E8W1S+B!4:&ES($%352!I7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE M/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"CPO M9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X M="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E1H92!#;VUP M86YY(&UA:6YT86EN'!O2!S:6=N:69I8V%N="!C2!H860@87!P2`F;F)S<#LD.#(L,#`P(&%N M9"`F;F)S<#LD.#(L,#`P+"!R97-P96-T:79E;'D@:6X@97AC97-S(&]F(&EN M'0M:6YD96YT.C!P=#L@/CQB'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S M=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I6UE;G1S('1O('-U<'!L:65R6UE;G1S('1O('-U<'!L:65R'1E;G0@=&AA="!T:&4@0V]M<&%N>2!I2!M87D@8F4@861V97)S96QY M(&%F9F5C=&5D+B`-"CPO9F]N=#X-"CPO9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I2!S=6)J96-T('1H M92!#;VUP86YY('1O(&-O;F-E;G1R871I;VX@;V8@8W)E9&ET(')I28C.#(Q-SMS(&-U2!C;VYT2!P97)F;W)M M28C.#(Q-SMS)B,Q-C`[8W5S=&]M97)S(&AA=F4@9V]N92!T:')O=6=H(&$@ M=F5R>2!S=')I8W0@8W)E9&ET(&%P<')O=F%L('!R;V-E28C,38P.VUO;FET;W)S('1H92!C=7-T;VUE M7,N($EN('-O;64@8V%S97,L('1H97-E('1E'1E;F1E9"!U<"!T;R`R,#`@9&%Y'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I2!M87D@8F4@2!R:7-K M(&1U92!T;R!T:&4@9FQU8W1U871I;VYS(&]F(&5X8VAA;F=E(')A=&5S(&)E M='=E96X@=&AE($-H:6YE6QE M/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"CPO M9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE2XF(S$V,#LF(S$V,#M!'1E;G0@;F]T(&EN8VQU9&5D(&EN(&YE="!I;F-O;64L(&%R92!I M;F-L=61E9"!A2!T2!R M96-O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQD:78@6QE/3-$9&ES<&QA>3IB;&]C:SMM M87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/D%T($IU;F4@,S`L(#(P,3$@86YD(%-E<'1E;6)E6QE/3-$=&5X="UA;&EG M;CIL969T.R`^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`@=VED=&@],T0X,"4@6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N M=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG M:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L:6=N M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E M:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X M.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z M8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM M'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$8F%C:V=R;W5N M9"UC;VQO'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI M9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/C$P+#4S-RPP,#`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$=&5X="UA;&EG;CIL M969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R M)2!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X M.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ M:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)V)O'0M86QI9VXZ M3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT M('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XH-#0S+#`P,`T*/"]F;VYT/@T* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<"!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E M>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I#MT97AT+6%L:6=N.G)I M9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)V1I6QE/3-$)V1I6QE/3-$<&%D9&EN9RUB M;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X M.R`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`-"CPO9F]N=#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS M1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE6QE/3-$9&ES<&QA M>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"CPO9&EV/CQD:78@ MF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UEF5S('1H92!A8W1I=FET:65S(&]F('1H92!A;&QO M=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S(&%S(&]F($IU;F4@,S`L(#(P M,3$@86YD(%-E<'1E;6)E'0M:6YD96YT.C!P=#L@/CQB M'0M86QI9VXZ;&5F=#L@/CQT M86)L92!C96QL6QE/3-$)V9O;G0M#L@/CQF;VYT('-T>6QE M/3-$)V1I#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II;FQI;F4[(#Y!;&QO=V%N8V4F(S$V,#MF M;W(F(S$V,#MD;W5B=&9U;`T*/"]F;VYT/@T*/"]F;VYT/@T*/"]D:78^/&1I M=B!S='EL93TS1&1I'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R M.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z M8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!S='EL93TS1'1E>'0M86QI M9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F M;VYT/@T*/"]T9#X-"CPO='(^/'1R('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO M'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S M=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R('-T>6QE M/3-$8F%C:V=R;W5N9"UC;VQO#L@ M/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT M+6%L:6=N.G)I9VAT.R`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`P,`T*/"]F;VYT/@T*/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R M('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO'0M:6YD96YT.C!P=#MM87)G:6XM M'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$ M)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$=&5X M="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&1I=B!S='EL93TS M1&1I'0M:6YD96YT.C!P M=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE"!S;VQI9#MT97AT+6%L:6=N M.FQE9G0[)R`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,34E('-T>6QE/3-$)V)O'0M86QI9VXZ3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XH,C`L,#`P#0H\ M+V9O;G0^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/BD-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/CQT6QE/3-$<&%D M9&EN9RUB;W1T;VTZ-'!X.W1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE"!D;W5B;&4[=&5X="UA;&EG;CIL969T.R<@/CQF M;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ M3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT M('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XT-#,L,#`P#0H\+V9O;G0^#0H\ M+V9O;G0^#0H\+W1D/@T*/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQD:78@6QE/3-$9&ES<&QA>3IB M;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/D%T($IU;F4@,S`L(#(P,3$@86YD(%-E<'1E;6)E M'0M:6YD96YT.C!P=#L@/CQB'0M86QI9VXZ;&5F=#L@/CQT86)L92!C96QL6QE/3-$)V9O;G0M#L@/CQF;VYT('-T>6QE/3-$)V1I#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II M;FQI;F4[(#Y*=6YE)B,Q-C`[,S`L)B,Q-C`[,C`Q,0T*/"]F;VYT/@T*/"]F M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W3II M;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE#L@/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II;FQI;F4[(#Y397!T96UB97(F(S$V M,#LS,"PF(S$V,#LR,#$P#0H\+V9O;G0^#0H\+V9O;G0^#0H\+V1I=CX-"CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T M.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/E!R97!A>6UE;G0@9F]R(&5Q=6EP;65N M=`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X- M"CPO='(^/'1R('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO#MT97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$ M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T M.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/D]T:&5R#MT97AT+6%L:6=N.G)I9VAT.R`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`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ;&5F=#LG M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V)O6QE/3-$)V1I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!$:7-C;&]S=7)E(%M!8G-T'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\9&EV/CQD:78@6QE/3-$ M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T M.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D%T($IU;F4@,S`L(#(P,3$@86YD M(%-E<'1E;6)E'0M:6YD96YT.C!P=#L@/CQB'0M86QI9VXZ;&5F=#L@/CQT86)L92!C96QL6QE/3-$)V9O;G0M#L@/CQF;VYT('-T>6QE/3-$)V1I#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II;FQI;F4[ M(#Y*=6YE)B,Q-C`[,S`L)B,Q-C`[,C`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`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)V)O'0M86QI9VXZ3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II M;FQI;F4[(#XQ+#0T-"PP,#`-"CPO9F]N=#X-"CPO9F]N=#X-"CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`X,RPP,#`-"CPO9F]N M=#X-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T* M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F,SEE,C'0O:'1M;#L@8VAA2P@4&QA;G0@86YD($5Q=6EP;65N="!;06)S M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/&1I=CX\9&EV('-T M>6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E M;G0Z,'!T.VUA3II;FQI;F4[9F]N="UW96EG:'0Z8F]L M9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA M>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/E1H92!#;VUP86YY(&1E<')E8VEA=&5S(&ET'0M M86QI9VXZ;&5F=#L@/CQT86)L92!C96QL6QE/3-$)V9O;G0M#L@/CQF;VYT('-T>6QE/3-$)V1I#L@/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II;FQI;F4[(#Y* M=6YE)B,Q-C`[,S`L)B,Q-C`[,C`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`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N M8G-P.R0-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$R)2!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M86QI9VXZF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C@L,3,P+#`P,`T* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`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`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T* M/"]T9#X-"CPO='(^/'1R('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL M969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/C,T."PP,#`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`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`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE M/3-$)V)O'0M86QI9VXZ M3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT M('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XT,2PP,#`-"CPO9F]N=#X-"CPO M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F#MT97AT M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L:6=N M.G)I9VAT.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/C$U+#4P.2PP,#`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I#MT M97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)V1I"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF M;VYT('-T>6QE/3-$)V1I#MT97AT+6%L:6=N.G)I9VAT.R`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`-"CPO9F]N M=#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN M;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT M+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V)O6QE M/3-$)V1I7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/&1I=CX\9&EV('-T>6QE M/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z M,'!T.VUA3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@ M+SX-"CPO9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@=VED=&@],T0W,"4@6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ M8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW M96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ M,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG M:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G M:6XM'0M86QI9VXZ8V5N=&5R.R`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`^/&1I=B!S='EL93TS1&1I M'0M:6YD96YT.C!P=#MM M87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1I3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@/CQF;VYT M('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1'1E>'0M86QI M9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F M;VYT/@T*/"]T9#X-"CPO='(^/'1R('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO M#MT97AT+6%L:6=N.FQE9G0[(#X\ M9&EV('-T>6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X M="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/DQE#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@ M/CQF;VYT#0H@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE M/3-$9&ES<&QA>3II;FQI;F4[(#XH,C0L,#`P#0H\+V9O;G0^#0H\+V9O;G0^ M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/BD-"CPO M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE"!S;VQI9#MT97AT+6%L:6=N.FQE M9G0[)R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M('-T>6QE/3-$)V)O'0M M86QI9VXZ3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XH,3$L,#`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M'0M M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V)O6QE/3-$)V1I6QE/3-$<&%D9&EN M9RUB;W1T;VTZ-'!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I'0M:6YD96YT.C!P=#L@/CQB'0M:6YD96YT.C!P M=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT M('-T>6QE/3-$)V1I2`X+"`R,#$P M+"!T:&4@0V]M<&%N>2!A8W%U:7)E9"!L86YD('5S92!R:6=H=',@;V8@82`V M."PP,C4@65A2`F;F)S M<#LD,365A3IT:6UE'1087)T7V8S.64R-S$Y7S-B.&1?-#@Q,U\Y8F4S7V)F,F0T,&$T83=A M,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]F,SEE,C'0O:F%V87-C3X-"B`@("`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`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ M;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I M>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V)O6QE/3-$)V1I#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE#MT97AT+6%L:6=N.G)I9VAT.R`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`U+"`R,#$Q M+"!T:&4@0V]M<&%N>2!T97)M:6YA=&5D('1H92!C2P@=&AE M($-O;7!A;GD@96YT97)E9"!I;G1O(&$@2!A'0M86QI9VXZF4Z.'!T.V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;CLG(#X-"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^#0H\+V1I=CX\ M9&EV('-T>6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X M="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/DEF('1H92!I M;G-U2X@)B,Q-C`[5&AE(&%M;W5N="!D M2XF(S$V,#M4:&5R92!H879E(&)E96X@ M;F\@:6YS=7)A;F-E(&-L86EM2!D=7)I;F<@=&AE(&YI;F4@;6]N=&AS(&5N9&5D($IU;F4@,S`L(#(P M,3$@=V%S(#0N-#(E('!E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M,SEE,C'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\9&EV/CQD:78@6QE/3-$9&ES<&QA M>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/E1H92!#;VUP86YY(&AA6QE/3-$9&ES<&QA>3IB;&]C M:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/E1H92!#;VUP86YY(&-O;F1U8W1S(&ET6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E M;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E5T:6QI>F%T:6]N(&]F M('1H92!5+E,N(&9E9&5R86P@86YD('-T871E(&YE="!O<&5R871I;F<@;&]S M2!F;W)W87)D2!5+E,N(&9E9&5R86P@86YD('-T871E('1A>"!L87=S+B!4:&4@86YN=6%L M(&QI;6ET871I;VX@;6%Y(')E69O65A65A6QE/3-$ M9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"CPO9&EV M/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE2!04D,@96YT97)P"!R97-I9&5N="!I;G9E"!O9B`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`@("`\=&%B;&4@8VQA6QE/3-$9&ES<&QA>3IB M;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#L@/DY/5$4@,3(@)B,X,C$R.R!#3TY615)424), M12!.3U1%4R`-"CPO9F]N=#X-"CPO9F]N=#X-"CPO9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP M<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D]N M($UA6QE/3-$)V9O;G0M6QE M/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT M('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#L@/B8C M,3@S.R`-"CPO9F]N=#X-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0^/&1I M=B!S='EL93TS1'1E>'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$ M)V1I&5R8VES92!P6QE/3-$9&ES<&QA>3IB;&]C M:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"@T*/"]D:78^/&1I=CX\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P M,"4@8F]R9&5R/3-$,"`@'0M86QI9VXZ8V5N=&5R.R<@/CQT M6QE/3-$)V1I6QE/3-$=VED=&@Z-S)P=#L@/CQD M:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0S+C,@;6EL;&EO;B!I M;B!P6QE/3-$)V9O;G0MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M M:6YD96YT.C!P=#MM87)G:6XM3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#L@/B8C,3@S.R`-"CPO9F]N=#X-"CPO9F]N=#X- M"CPO9&EV/@T*/"]T9#X\=&0^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ:G5S M=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE2!B92!C;VYV97)T960@870@=&AE M(&EN:71I86P@2!B92!I6QE/3-$;6%R9VEN+6QE9G0Z,'!T.W1E M>'0M:6YD96YT.C!P=#MM87)G:6XM6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G M:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/CQB&ES="`H=&AE("8C.#(R,#MC;VUP;W5N9"!E;6)E9&1E9"!D97)I M=F%T:79E)B,X,C(Q.R!O6EN9R!C;VYS;VQI9&%T960@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE&-L=7-I=F4@861V:7-O28C.#(Q-SMS(&-O;6UO;B!S=&]C:R`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`Q.2P@,C`Q,"P@82!H M;VQD97(@;V8@87!P2`F;F)S<#LD,2XX(&UI;&QI;VX@;V8@ M=&AE($-O;7!A;GDF(S@R,3<[2!O=71S=&%N9&EN9R!397)I M97,@0B!.;W1E28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!A6EN9R!A;6]U;G0@;V8@)FYB2!I'0M:6YD96YT.C!P=#MM M87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T M>6QE/3-$)V1I&-H86YG92!! M9W)E96UE;G0@&-H86YG M97,@;V8@=&AE($AO;&1E&-H M86YG92D@;V8@0V]N=F5R=&EB;&4@1&5B="!);G-T2!R969E&-H86YG92D@;V8@0V]N=F5R=&EB M;&4@1&5B="!);G-T&-H86YG92!!9W)E96UE M;G0@86UO=6YT960@=&\@87!P2`F;F)S<#LD,2XS(&UI;&QI M;VXN(`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`H)B,X,C(P.T-6228C.#(R,3LI('=H97)E8GD@=&AE M($-O;7!A;GD@:7-S=65D(&$@4V5R:65S($(M,2!#;VYV97)T:6)L92!.;W1E M("AT:&4@)B,X,C(P.TYO=&4F(S@R,C$[*2!T;R!#5DD@=VET:"!A;B!O2!T:&4@:6YT97)E2!O=&AE&-H86YG92!!9W)E96UE;G0@:7,@86UE;F1E9"!T;R!R961U8V4@=&AE(&-O M;G9E&-H86YG92!!9W)E96UE;G0N($%S(&]F M($IU;F4@,S`L(#(P,3$L('1H92!O=71S=&%N9&EN9R!P'0M:6YD96YT.C!P M=#L@/CQB6QE/3-$9&ES<&QA>3IB;&]C M:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/E1H92!L;W-S("AG86EN*2!O;B!D96)T(&5X=&EN9W5I M6QE/3-$)V9O;G0MF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE#L@ M/CQF;VYT('-T>6QE/3-$)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI M;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II M;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE"!S;VQI9#LG(#X\9&EV('-T>6QE/3-$ M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T M.VUA3II;FQI;F4[9F]N="UW M96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ M,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2`@6QE/3-$)V)O M6QE/3-$)V1I#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O M;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F M=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE#L@/CQF;VYT('-T>6QE/3-$)V1I'0M:6YD96YT.C!P=#MM M87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II;FQI;F4[ M(#XR,#$P(`T*/"]F;VYT/@T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@;F]W#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0M'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$=&5X M="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG M;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E("!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$=&5X="UA;&EG M;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P M.R0@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)2`@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/C$U-2PP,#`@#0H\+V9O;G0^#0H\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B9N8G-P.R0@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)2`@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C$X+#@V,RPP M,#`@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO M9F]N=#X-"CPO=&0^#0H\+W1R/CQT6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G M:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT M('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I M3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I M3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/BT@#0H\+V9O M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E M>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE("!S='EL93TS1'1E M>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I MF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/CQT6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE("!S='EL93TS1'1E>'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/BT@#0H\+V9O;G0^#0H\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE("!S M='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE("!S='EL93TS1'1E>'0M86QI9VXZF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE("!S='EL93TS1'1E M>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M6QE/3-$=&5X="UA;&EG;CIL M969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M("!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/BD@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2`@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X- M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B@W+#4T-"PP,#`@#0H\+V9O M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/BD@#0H\+V9O;G0^#0H\+W1D/@T* M/"]T'0M M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE("!S='EL93TS1'1E>'0M86QI9VXZ MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/BT@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$ M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$ M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE("!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$8F%C:V=R;W5N9"UC;VQO'0M:6YD96YT.C!P M=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)V1IF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X M.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/CQT6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X.W1E M>'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X.W1E>'0M86QI9VXZ MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V)O3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B9N8G-P.R0@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)2`@'0M86QI9VXZ3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[ M(#XH,C,L,#`P(`T*/"]F;VYT/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E("!S='EL93TS M1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1"=B;W)D97(M8F]T M=&]M.F)L86-K(#1P>"!D;W5B;&4[=&5X="UA;&EG;CIL969T.R<@/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$ M)V)O6QE/3-$)V1I3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E("!S='EL93TS1'!A9&1I;F#MT97AT+6%L:6=N.G)I M9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M("!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#1P>"!D;W5B;&4[=&5X M="UA;&EG;CIL969T.R<@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O6QE/3-$)V1I M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/BD@#0H\+V9O;G0^#0H\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2`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`F;F)S<#LD,C,L,#`P(&%N9"`F;F)S<#LD-34L M,#`P(&1U2X@#0H\+V9O;G0^#0H\+V1I=CX\ M9&EV('-T>6QE/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\ M8G(@+SX-"@T*/"]D:78^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I2`F;F)S<#LD,3@N-2!M:6QL:6]N(&%S(&$@'0M:6YD96YT.C!P=#MM87)G:6XM M'0M86QI9VXZ:G5S=&EF>3L@/B8C,38P.R`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`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B9N8G-P.R0@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q-24@('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X- M"CPO=&0^#0H\+W1R/CQT6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2`@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B@Q+#4W,RPP,#`@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/BD@ M#0H\+V9O;G0^#0H\+W1D/@T*/"]T'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X- M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO M=&0^#0H\+W1R/CQT6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UEF%T:6]N(&]F(&YO M=&4@9&ES8V]U;G0@86YD(&-O;G9E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)O'0M86QI9VXZ3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XH-"PP,#`@ M#0H\+V9O;G0^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$<&%D9&EN9RUB M;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$8F%C:V=R;W5N9"UC;VQO6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[ M=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D-A3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2`@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2`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`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$U)2`@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B@Q+#$S,2PP,#`@#0H\+V9O;G0^#0H\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/BD@#0H\+V9O;G0^#0H\+W1D/@T*/"]T#MT97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$9&ES<&QA>3IB M;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/D5F9F5C="!O;B!D96)T(&-O;G9E#MT97AT+6%L:6=N.G)I M9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M("!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT M+6%L:6=N.FQE9G0[)R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$U)2`@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D M9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$8F%C:V=R;W5N9"UC;VQO6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F M=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D9A M:7(@=F%L=64@;V8@=&AE(%-E6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C0R,BPP,#`@#0H\+V9O;G0^#0H\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^#0H\ M+W1R/CQT6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`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`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`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`L(#(P,#D@#0H\ M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N M8G-P.R0@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q-24@('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^#0H\ M+W1R/CQT6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'1I;F=U:7-H;65N="`-"CPO9F]N M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$ M)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I M'0M86QI9VXZ M;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X- M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2`@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B@Q-3'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$8F%C:V=R M;W5N9"UC;VQO'0M:6YD96YT.C!P=#MM87)G:6XM'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)O'0M86QI9VXZ3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI M;F4[(#XH-"PU,3$L,#`P(`T*/"]F;VYT/@T*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E("!S M='EL93TS1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$ M=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG M;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$=&5X="UA;&EG;CIL M969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1"=B;W)D M97(M8F]T=&]M.F)L86-K(#1P>"!D;W5B;&4[=&5X="UA;&EG;CIL969T.R<@ M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.R`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`H M>"DF(S$V,#MT:&4@8V]N=F5R2`H>2DF(S$V,#MT:&4@=&AE;B!A<'!L:6-A8FQE(&-O;G9E2`F;F)S<#LD,"XQ-2!A;F0@8W5R2!T:&4@0V]M<&%N>2!I2!P2!S=&]C:R!S<&QI M="P@'0M:6YD96YT.C!P=#L@ M/CQB6QE/3-$9&ES<&QA>3IB;&]C:SMM M87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/E1H92!397)I97,@0BTQ($YO=&4@<&5R;6ET3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO9&EV/CQD:78^/'1A8FQE(&-E;&QS M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`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`H02DF(S$V M,#MO6QE/3-$)V9O;G0M M6QE/3-$ M)V1I'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T M>6QE/3-$)V1I2!O2!S:6UI;&%R M($9E9&5R86PL(&9O2!O9B!A;B!O'0M:6YD96YT.C!P M=#L@/CQB6QE/3-$=VED=&@Z-S)P=#L@/CQD:78@F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UEF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE2!O9B!I M=',@2!O9B!I=',@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=VED=&@Z-S)P=#L@/CQD:78@F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE2!O2`H-C`I)B,Q-C`[9&%Y2!J=61G;65N="!W:&EC:"!I2!T;R!T:&4@:&]L9&5R M*2!T;R!T:&4@969F96-T('1H870@'0M:6YD96YT.C!P=#L@/CQBF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=VED M=&@Z-S)P=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE MF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE2P@8V]V96YA;G0@;W(@;W1H97(@ M=&5R;2!O&-E<'0L(&EN('1H92!C87-E(&]F(&$@8G)E86-H(&]F(&$@8V]V96YA M;G0@=VAI8V@@:7,@8W5R86)L92P@;VYL>2!I9B!S=6-H(&)R96%C:"!C;VYT M:6YU97,@9F]R(&$@<&5R:6]D(&]F(&%T(&QE87-T('1E;B`H,3`I)B,Q-C`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`-"CPO9F]N=#X-"CPO9&EV/CQD:78^/'1A8FQE(&-E M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O M6QE/3-$)V9O;G0MF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM M3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF M;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#L@ M/B8C,3@S.R`-"CPO9F]N=#X-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0^ M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE M/3-$)V1I2!A2!U;F1E6QE/3-$9&ES<&QA>3IB;&]C M:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"@T*/"]D:78^/&1I=CX\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P M,"4@8F]R9&5R/3-$,"`@'0M86QI9VXZ8V5N=&5R.R<@/CQT M6QE/3-$)V1I6QE/3-$=VED=&@Z,S9P=#L@/CQD M:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E1H92!S=6-C97-S;W(@96YT:71Y M("AI;F-L=61I;F<@:71S('!AF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ8V5N=&5R.R<@/CQT6QE/3-$;6%R M9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C(I(`T*/"]F;VYT M/@T*/"]D:78^#0H\+W1D/CQT9#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ M=7-T:69Y.R`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT M('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#L@/E)E M9&5M<'1I;VX@4FEG:'0@;VX@0VAA;F=E(&]F($-O;G1R;VPN(`T*/"]F;VYT M/D%T(&%N>2!T:6UE(&1U2!A8V-R=65D(&%N9"!U;G!A:60@;&EQ=6ED871E9"!D86UA M9V5S+"!P;'5S('1H92!G2!P6QE/3-$9&ES<&QA M>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"@T*/"]D:78^/&1I M=CX\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T M:#TS1#$P,"4@8F]R9&5R/3-$,"`@6QE/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P M=#MM87)G:6XM3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.S,I(`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9#X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI M;F4[9F]N="UW96EG:'0Z8F]L9#L@/E)E9&5M<'1I;VX@4FEG:'0@;VX@4W5B M2!O9B!I=',@2!O9B!I=',@;W(@:71S('-U8G-I9&EA2!E<75I=F%L96YT('-E8W5R:71I97,L(&]R(&-O;6UI="!T M;R!I2!C:7)C=6US=&%N M8V5S+"!C;VYV97)T:6)L92!I;G1O(&]R(&5X8VAA;F=E86)L92!O&5R M8VES86)L92!F;W(@2!R97%U:7)E('1H92!#;VUP M86YY('1O(')E9&5E;2!T:&4@4V5R:65S($(M,2!.;W1E('5P('1O('1H92!2 M961E;7!T:6]N($%M;W5N="X@#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^#0H\ M+W1R/@T*/"]T86)L93X-"CPO9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB6QE/3-$=VED=&@Z,S9P=#L@/CQD M:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/BA!*2!);B!T:&4@979E;G0@=&AA="!T:&4@1W)O&-E961S("9N8G-P.R0Q-2PP,#`L,#`P("AA("8C.#(R,#M1=6%L:69I M960@1FEN86YC:6YG)B,X,C(Q.RDL('1H92`F(S@R,C`[4F5D96UP=&EO;B!! M;6]U;G0F(S@R,C$[('-H86QL(&5Q=6%L(#$P,"4@;V8@=&AE(%!R:6YC:7!A M;"!!;6]U;G0@=&AE;B!O=71S=&%N9&EN9RXF(S$V,#LF(S$V,#M&;W(@<'5R M<&]S97,@:&5R96]F+"`F(S@R,C`[1W)O2!I6QE/3-$)V9O;G0M MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X- M"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^/&1I=CX\=&%B;&4@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$ M,"`@'0M86QI9VXZ8V5N=&5R.R<@/CQT6QE/3-$;6%R M9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`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`P)3MT97AT+6%L:6=N.G)I9VAT M.R`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`^/'1A8FQE(&-E M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Y-24@6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN9RUB;W1T;VTZ M,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG M:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G M:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM M87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA#MT97AT+6%L:6=N M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E M:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X M.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z M8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM M'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F M=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O6QE/3-$)V1I M6QE/3-$8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$ M)V1I'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C$N,C$-"CPO9F]N=#X-"CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@] M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I'0M86QI9VXZ M;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C(Q+#4W M."PY-#@-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F M=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/C`N.3`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE'0M86QI M9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$=&5X="UA;&EG M;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$ M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T M.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/D%D9&ET:6]N86P@<&%I9"!I;B!C87!I M=&%L#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^#0H\+W1R/CQT6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI M;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D=R86YT960@:6X@8V]N M;F5C=&EO;B!W:71H('!L86-E;65N="!S97)V:6-E#0H\+V9O;G0^#0H\+V1I M=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T* M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/C4P-RPR-#<-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$=&5X="UA;&EG;CIL M969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/C`N-CD-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/C$L,C$U+#DP.0T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,C6QE/3-$=&5X="UA;&EG;CIL969T.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,C6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL M93TS1&1I'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT M('-T>6QE/3-$)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I&5R8VES92!O9B!W87)R86YT#MT97AT+6%L:6=N.G)I9VAT.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`- M"CPO9F]N=#X-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/CQD:78@ M'0M86QI9VXZF4Z.'!T.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CLG M(#XF(S$V,#L@#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^/&1I M=B!S='EL93TS1&1I'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I'0M:6YD M96YT.C!P=#L@/CQB'0M86QI M9VXZ;&5F=#L@/CQT86)L92!C96QL6QE/3-$)V9O;G0M'0M:6YD96YT.C!P=#MM87)G M:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE&5R8VES86)L90T*/"]F;VYT/@T*/"]F;VYT M/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@;F]W3II;FQI M;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI M9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N M="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C,E M(&-O;'-P86X],T0R(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="UW96EG:'0Z8F]L M9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$ M)V1I'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R M.R`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`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`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIL969T.R`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`^/&1I=B!S='EL93TS1&1I M'0M:6YD96YT.C!P=#MM M87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF M;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE M/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ6QE/3-$)V1I6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,C(E('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$=&5X="UA;&EG M;CIL969T.R`^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I'0M86QI M9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/C`N-S$-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$=&5X="UA;&EG M;CIL969T.R`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`Q,BP@ M,C`Q,"P@=&AE($-O;7!A;GD@:7-S=65D(#0P,"PP,#`@2P@=&AE65E6QE/3-$;6%R9VEN M+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM6QE/3-$=VED=&@Z,3`P)3MT97AT+6%L:6=N.FQE9G0[ M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z.'!T M.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CLG(#X-"CPO9F]N=#X-"CPO M9&EV/@T*/"]D:78^/&1I=CX\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3MT97AT M+6%L:6=N.G)I9VAT.R`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`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="UW96EG:'0Z8F]L M9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$ M)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M6QE/3-$)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N M="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`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`^ M/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F M=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/C(S+#$U,"PP,#`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$R)2!S='EL93TS1'1E>'0M86QI9VXZF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X-"CPO='(^ M/'1R('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I'0M86QI M9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF M;VYT('-T>6QE/3-$)V1I3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/C`N-C(-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T M.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/E)E'0M86QI9VXZ'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M86QI9VXZ;&5F M=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/C`N-C(-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E M>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E M;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E)E3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B@X,"PP,#`-"CPO9F]N=#X- M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED M=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I'0M86QI9VXZF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C`N-C(-"CPO9F]N M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@ M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I'0M:6YD96YT.C!P M=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I#MT97AT+6%L M:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)V1I6QE/3-$)V1I M6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I#MT97AT+6%L:6=N.G)I9VAT.R`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`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R M)2!S='EL93TS1'!A9&1I;F#MT97AT+6%L:6=N.G)I9VAT M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C`N-S8-"CPO9F]N M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@ M=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\ M8G(@+SX-"CPO9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE2X-"CPO9F]N=#X-"CPO9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB'0M:6YD96YT.C!P M=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT M('-T>6QE/3-$)V1I2X@07,@;V8@2G5N92`S,"P@,C`Q,2P@=&AE('1O=&%L('5N MF5D(&]V M97(@82!W96EG:'1E9"!A=F5R86=E('!E6QE/3-$9&ES M<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="US='EL M93II=&%L:6,[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/DES65E6QE/3-$9&ES<&QA>3IB M;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/D]N($9E8G)U87)Y(#$L(#(P,3`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`P)3MT M97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.CAP=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF M;VYT('-T>6QE/3-$)V1I65A6QE/3-$=&5X="UA;&EG;CIL969T.R`^ M/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@] M,T0Y,R4@6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN M9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O M;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O M;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI M9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N M="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M:6YD96YT.C!P=#MM87)G:6XM'0M M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE#MT97AT+6%L:6=N.FQE M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E:6=H M=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^ M/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L M9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE#MT97AT+6%L:6=N M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E M:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X M.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z M8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM M'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$ M)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$=&5X="UA;&EG M;CIL969T.R`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`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M86QI9VXZF4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X- M"CPO='(^/'1R('-T>6QE/3-$8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.R`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`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/C`N,C`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)V)O M'0M86QI9VXZ3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE M/3-$9&ES<&QA>3II;FQI;F4[(#XQ+#`U,"PP,#`-"CPO9F]N=#X-"CPO9F]N M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@ M=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L:6=N.G)I M9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT* M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)V1I6QE/3-$)V)O'0M86QI9VXZ3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II;FQI;F4[(#XH,2PP-3`L M,#`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`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C`N-C(-"CPO9F]N M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@ M=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS M1&1I'0M:6YD96YT.C!P M=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T M>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C(L,30P M+#`P,`T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/C`N,S(-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$=&5X="UA;&EG;CIL M969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0- M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$ M)V1I6QE/3-$)V)O'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@ M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE"!S;VQI9#MT97AT+6%L:6=N M.FQE9G0[)R`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/BD-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/C`N,C`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS M1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE#MT97AT+6%L:6=N.G)I9VAT.R`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`S,"P@,C`Q,0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I M;F#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ;&5F=#LG(#X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE"!D;W5B;&4[=&5X="UA;&EG;CIR:6=H M=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#MT97AT+6%L:6=N M.G)I9VAT.R`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`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/C`N,S(-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M#MT97AT+6%L:6=N.G)I9VAT.R`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`L(#(P,3$@86YD(%-E<'1E;6)E M&5R8VES92!P2!E>&5R8VES86)L92!W97)E("9N8G-P.R0P+C8P(&%N9"`V M+C,X('EE87)S+"!R97-P96-T:79E;'DN#0H\+V9O;G0^#0H\+V1I=CX\9&EV M('-T>6QE/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@ M+SX-"CPO9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#L@/CQB'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I2!H87,@'!E;G-E(&ES(&)A7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`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`-"CPO9F]N M=#X-"CPO9&EV/@T*/"]T9#X\=&0@6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E%U;W1E9"!P'0M:6YD M96YT.C!P=#L@/CQB6QE/3-$=VED=&@Z-#5P=#L@/CQD:78^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO9&EV M/@T*/"]T9#X\=&0@6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/D]B6QE/3-$)V9O;G0M6QE M/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT.C!P=#MM87)G:6XM3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/DQE=F5L M)B,Q-C`[,R8C,38P.RT@#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D/CQD M:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$;6%R9VEN+6QE9G0Z,'!T.W1E>'0M:6YD96YT M.C!P=#MM87)G:6XM6QE/3-$=VED M=&@Z,3`P)3MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.CAP=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I M28C.#(Q-SMS(&UA2!F M86QL(&EN=&\@9&EF9F5R96YT(&QE=F5L'0M:6YD96YT.C!P=#L@/CQB6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E M;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E1H92!#;VUP86YY)B,X M,C$W.W,@;&EA8FEL:71I97,@;65A7!E'0M M:6YD96YT.C!P=#L@/CQB6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`@=VED=&@],T0Y-24@('-T>6QE/3-$)V9O;G0M6QE/3-$)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ M8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW M96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N M=&5R.R`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`^/&9O M;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$ M)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II;FQI M;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL M93TS1'!A9&1I;F#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O M6QE/3-$)V1I3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E("!S='EL93TS1'!A9&1I;F#L@/CQF;VYT('-T M>6QE/3-$)V1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`^/&9O;G0@3II M;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$)V)O M6QE/3-$)V1I3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE M/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[ M=&5X="UI;F1E;G0Z,'!T.VUA6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V1I6QE/3-$)V1I M6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN M93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$S)2!C;VQS<&%N/3-$,B`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2`@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/CQT6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S M='EL93TS1&1I'0M:6YD M96YT.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF M;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B9N8G-P.R0@#0H\+V9O;G0^#0H\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$=&5X="UA;&EG M;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQF M;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF M86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E M>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT M('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE M/3-$8F%C:V=R;W5N9"UC;VQO6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X M="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/E=AF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X- M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2`@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/C0Y+#`P,"`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2`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`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2`@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$)V)O3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B9N8G-P.R0@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@('-T>6QE/3-$)V)O6QE/3-$)V1I M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`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`-"CPO9F]N=#X-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2`@'0M86QI9VXZ3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/CQF;VYT('-T>6QE/3-$9&ES M<&QA>3II;FQI;F4[(#XM(`T*/"]F;VYT/@T*/"]F;VYT/@T*/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E("!S M='EL93TS1'!A9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE M/3-$<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`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`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`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F M=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE2`-"CPO9F]N=#X-"CPO9&EV M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@/CQF;VYT M('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZF4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/B4@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL M93TS1&1I'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ;&5F=#L@/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M86QI9VXZ MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$=&5X="UA M;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$U)2`@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI M;'DZ=&EM97,@;F5W(')O;6%N.R<@/C`N,#`@#0H\+V9O;G0^#0H\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/B4@#0H\+V9O;G0^#0H\+W1D/@T*/"]T'0M86QI9VXZ;&5F=#L@ M/CQD:78@F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UEF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2`@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/C`N,30@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$ M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B4@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$=&5X="UA;&EG M;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM M;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA#MT97AT+6%L M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[ M=&5X="UI;F1E;G0Z,'!T.VUA6QE/3-$<&%D9&EN9RUB;W1T;VTZ,G!X.W1E>'0M86QI9VXZ M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T M.R`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`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(#X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B8C,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$U)2`@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/C(N-2`-"CPO9F]N=#X- M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED M=&@],T0Q)2`@F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$8F%C:V=R;W5N9"UC;VQO6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G M:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/E9O;&%T:6QI='D@#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`-"CPO M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2`@ M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/C8U(`T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E("!S='EL93TS1'1E M>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1IF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE M'0M86QI9VXZ MF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B4@#0H\+V9O;G0^#0H\+W1D M/@T*/"]T'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6EE;&0@#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE6QE/3-$=&5X="UA;&EG M;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P M.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$U)2`@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/C`@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/B4@#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.R`-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E("!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$=&5X="UA M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ;&5F=#L@ M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$8F%C:V=R;W5N9"UC;VQO6QE/3-$9&ES<&QA>3IB;&]C M:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W M(')O;6%N.R<@/E)I3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.R`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`L M(#(P,3$L('1H92!P6EN9R!V86QU92!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(%-E2X@5&AE(%-E3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F,SEE,C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!;06)S=')A8W1=/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQD:78@6QE/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP M<'0[(#X\8G(@+SX-"CPO9&EV/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIR M:6=H=#L@/CQT86)L92!C96QL6QE/3-$)V9O;G0M#L@/CQF M;VYT('-T>6QE/3-$)V1I#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G M:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.FEN;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$ M<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II M;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A M;6EL>3IT:6UE6QE/3-$)V)O6QE/3-$)V1I6QE/3-$9&ES<&QA>3II M;FQI;F4[(#Y.:6YE($UO;G1H3II;FQI;F4[9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+69A;6EL>3IT:6UE#L@/CQF;VYT('-T>6QE/3-$ M)V1I#L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O M6QE/3-$)V1I#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN M;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$<&%D9&EN M9RUB;W1T;VTZ,G!X.R`^/&9O;G0@3II;FQI;F4[ M9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT M:6UE'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ8V5N=&5R.R`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`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'!A M9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7=E:6=H=#IB;VQD.V9O;G0M6QE/3-$9&ES M<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E;G0Z,'!T.VUA M3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/DYE="!I;F-O;64@*&QOF4Z,3!P M=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZF4Z,3!P=#MF M;VYT+69A;6EL>3IT:6UE6QE/3-$=&5X="UA;&EG;CIL969T.R`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`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$=&5X M="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B9N8G-P.R0-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ M=&EM97,@;F5W(')O;6%N.R<@/BD-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/CQT M6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP M<'0[=&5X="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US M:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D]T:&5R M(&-O;7!R96AE;G-I=F4@:6YC;VUE.@T*/"]F;VYT/@T*/"]D:78^#0H\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2`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`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`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`-"CPO9F]N=#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`@=VED=&@],T0Q)2!S='EL93TS1'!A M9&1I;F#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$<&%D9&EN M9RUB;W1T;VTZ-'!X.W1E>'0M86QI9VXZ;&5F=#L@/CQD:78@F4Z,3!P=#MF;VYT+69A;6EL M>3IT:6UE6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O M;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT/@T* M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ;&5F M=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I>F4Z M,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M M86QI9VXZ3II;FQI;F4[ M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@ M/B@X-3DL,#`P#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M;F]W3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@ M;F5W(')O;6%N.R<@/BD-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X.R`^ M/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F;VYT M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ M;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+7-I M>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ3II;FQI M;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N M.R<@/B@U-S$L,#`P#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@;F]W3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/BD-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X M.R`^/&9O;G0@3II;FQI;F4[9F]N="US:7IE.C$P M<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C,38P.PT*/"]F M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI M9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ3II M;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O M;6%N.R<@/C$L,S,P+#`P,`T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!W:61T:#TS1#$E('-T>6QE/3-$<&%D M9&EN9RUB;W1T;VTZ-'!X.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$<&%D9&EN9RUB M;W1T;VTZ-'!X.R`^/&9O;G0@3II;FQI;F4[9F]N M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/B8C M,38P.PT*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN M;&EN93MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE'0M86QI9VXZ3II;FQI;F4[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ=&EM M97,@;F5W(')O;6%N.R<@/B@R,RPV-#(L,#`P#0H\+V9O;G0^#0H\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@;F]W3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/BD-"CPO9F]N=#X-"CPO M=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^#0H-"CQD:78@ M3H@8FQO8VL[(&UA'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT+7=E M:6=H=#H@8F]L9#L@9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N)SY.3U1%(#$V("8C.#(Q,CL@3D54($E.0T]-12`H3$]3 M4RD@4$52(%-(05)%/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$)V1I M3H@8FQO8VL[(&UA'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W!A9&1I;F6QE/3-$)V1I6QE/3-$ M)V)O"!S;VQI9"<^#0H\9&EV('-T>6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@ M8F]L9#L@9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N)SY4:')E92!-;VYT:',@16YD960@2G5N92`S,"P\+V9O;G0^/"]D M:78^#0H\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@#L@=&5X="UA;&EG;CH@ M;&5F="<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7=E M:6=H=#H@8F]L9#L@9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@"<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9#L@ M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!C;VQS<&%N/3-$-B!V86QI9VX] M,T1B;W1T;VT@3H@8FQO8VL[(&UA'0M:6YD96YT.B`P<'0[(&UAF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I"<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`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`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@ M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I3H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!C;VQS M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI M;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M8V]L6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF M86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@8V]L6QE/3-$ M)V1I6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@;F]W3H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z M(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT6QE M/3-$)V1I3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I3H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!C;VQS<&%N M/3-$,B!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L M6QE/3-$)V1I6QE/3-$<&%D9&EN9RUL969T.C-P=#X-"CQD:78@3H@8FQO8VL[(&UA'0M:6YD96YT.B`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`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXQ-C$L-30S+#0P M,SPO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R!T97AT+6%L:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXQ-38L-3`R+#4W,SPO9F]N=#X\ M+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!T97AT+6%L M:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V1I M3H@ M=&EM97,@;F5W(')O;6%N)SXQ-C`L.3DP+#`S,SPO9F]N=#X\+W1D/@T*/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!T97AT+6%L:6=N.B!L969T M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`[(#PO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@ M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`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`[/"]F M;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M3H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF M86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`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`[/"]F;VYT/CPO M=&0^#0H\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M3H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M3H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI M;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M3H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z M(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`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`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`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`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V)O3H@:6YL:6YE.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE#L@=&5X="UA;&EG;CH@;&5F="<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`[(#PO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`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`[/"]F;VYT M/CPO=&0^#0H\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M3H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`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`P<'0[(&UA3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF M86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`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`[/"]F;VYT/CPO M=&0^#0H\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M3H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI M;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@#L@=&5X="UA;&EG;CH@ M;&5F="<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$ M)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`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`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`[/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V1I3H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE M/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M3H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F="<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF M86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@#L@=&5X M="UA;&EG;CH@;&5F="<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@"<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#AP=#L@9F]N M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#AP=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M3H@8FQO8VL[(&UA'0M:6YD96YT.B`P<'0[ M(&UA3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B!T:6UE"<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B!T:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M#L@=&5X M="UA;&EG;CH@;&5F="<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`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`L(#(P,3$L(#$L,C6QE/3-$)V1I7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`R,#$T M+B!"87-E9"!O;B!T:&4@86UE;F1M96YT+"!T:&4@0V]M<&%N>2!H87,@8V]M M;6ET=&5D('1O(&9U;F0@;F\@;&5S65A2!T M:&4@0V]M<&%N>2!A;F0@4VAA;F=H86D@56YI=F5R2X@07,@;V8@2G5N M92`S,"P@,C`Q,2P@=&AE&EM871E;'D@)FYB2!$ M96-E;6)E6QE M/3-$9&ES<&QA>3IB;&]C:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"@T* M/"]D:78^/&1I=B!S='EL93TS1&1I'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI M9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I2!W:6QL(&-O;G1I;G5E('1O(&EN=F5S="!I;B!R97-E87)C M:"!A;F0@9&5V96QO<&UE;G0@87,@:70@9W)O=W,F(S$V,#MI=',@8G5S:6YE M2!W M:6QL(&)E('5S960@=&\@9G5N9"!P2!B969O M2!I M2!C M;W5L9"!S965K(&-O;7!E;G-A=&EO;B!U<"!T;R!A;B!A9&1I=&EO;F%L(#$U M)2!O9B!T:&4@=&]T86P@8V]M;6ET=&5D(&%M;W5N="!F;W(@87!P2`F;F)S<#LD,"XW(&UI;&QI;VXN($%S(&]F($IU;F4@,S`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`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`H=&AE("8C.#(R,#M3:&%N9VAA M:2!';W9E2!397!T96UB M97(@,C$L(#(P,3`N($EN($%U9W5S="`R,#$P+"!T:&4@0V]M<&%N>2!R96-E M:79E9"!T:&4@87!P2!H87,@;F]T(&9U;F1E9"!T:&4F(S$V,#MO=71S=&%N9&EN M9R!R96UA:6YI;F<@8F%L86YC92!O9B`F;F)S<#LD,34N-2!M:6QL:6]N+B!7 M:71H('1H92!D96-I2!I;B!397!T96UB97(@,C`Q M,2X@#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$9&ES<&QA>3IB;&]C M:SMT97AT+6EN9&5N=#HP<'0[(#X\8G(@+SX-"@T*/"]D:78^/&1I=B!S='EL M93TS1&1I'0M:6YD96YT M.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF>3L@/CQF M;VYT('-T>6QE/3-$)V1I2!I;F-O2!I;B!9:7IH96YG+"!*:6%N9W-U(%!R;W9I;F-E(&]F($-H M:6YA('1O('-U<'!L96UE;G0@:71S(&5X:7-T:6YG('!R;V1U8W1I;VX@9F%C M:6QI=&EE'1E;F0@=&AE('!A>6UE;G0@;V8@2X@5&AE(')E9VES=&5R960@8V%P:71A;"!R97%U M:7)E;65N="!O=71S=&%N9&EN9R!AF4Z,3!P=#MF;VYT+69A;6EL>3IT:6UE&EM871E;'D@)FYB2!B>2!&96)R=6%R>2`X+"`R,#$R+B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!4'0M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S M=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X="UI;F1E M;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE.C$P<'0[ M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D%T($IU;F4@,S`L(#(P M,3$@86YD(%-E<'1E;6)E6%B M;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,L(')E;&%T960@<&%R='D@8F%L M86YC92!W87,@)FYB"!U<&]N(&5X97)C:7-E M(&]F('-T;V-K(&]P=&EO;G,@8GD@37(N(%EO=6YG(&EN('1H92!F:7-C86P@ M>65A2!T:&4@0V]M<&%N>2!T;R!-2!I;F-U'0M:6YD96YT.C!P=#L@/CQB'0M M:6YD96YT.C!P=#MM87)G:6XM'0M86QI9VXZ:G5S=&EF M>3L@/CQF;VYT('-T>6QE/3-$)V1I2!-65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!$ M:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`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`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X-"CQD M:78^/&1I=CX\9&EV/CQD:78@'0M:6YD96YT.C!P=#L@/CQB6QE/3-$9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[=&5X M="UI;F1E;G0Z,'!T.VUA3II;FQI;F4[9F]N="US:7IE M.C$P<'0[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@/D]N($IU;'D@ M,BP@,C`Q,2P@=&AE($-O;7!A;GD@:7-S=65D(#@L-C`P+#`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`R+"`R,#$Q M+"!T:&4@0V]M<&%N>2!P86ED('1H92!S:&]R="!T97)M(&QO86YS(&]F(&%P M<')O>&EM871E;'D@)FYB2`F;F)S<#LD M-S`V+#`P,"!W:6QL(&)E(&1U92!T;R!"3T,@;VX@075G=7-T(#$U+"`R,#$Q M+@T*#0H\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^#0H\ M+V1I=CX-"CPO9&EV/@T*/"]D:78^#0H\'1087)T I7V8S.64R-S$Y7S-B.&1?-#@Q,U\Y8F4S7V)F,F0T,&$T83=A,"TM#0H` ` end